
<html lang="en"     class="pb-page"  data-request-id="e20f54d1-cf84-4693-929f-76e6a6110c0e"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;article:article:10.1021/jm900357y;issue:issue:10.1021/jmcmar.2009.52.issue-15;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Combining Hit Identification Strategies: Fragment-Based and in Silico Approaches to Orally Active 2-Aminothieno[2,3-d]pyrimidine Inhibitors of the Hsp90 Molecular Chaperone" /></meta><meta name="dc.Creator" content="Paul A.  Brough" /></meta><meta name="dc.Creator" content="Xavier  Barril" /></meta><meta name="dc.Creator" content="Jenifer  Borgognoni" /></meta><meta name="dc.Creator" content="Patrick  Chene" /></meta><meta name="dc.Creator" content="Nicholas G. M.  Davies" /></meta><meta name="dc.Creator" content="Ben  Davis" /></meta><meta name="dc.Creator" content="Martin J.  Drysdale" /></meta><meta name="dc.Creator" content="Brian  Dymock" /></meta><meta name="dc.Creator" content="Suzanne A.  Eccles" /></meta><meta name="dc.Creator" content="Carlos  Garcia-Echeverria" /></meta><meta name="dc.Creator" content="Christophe  Fromont" /></meta><meta name="dc.Creator" content="Angela  Hayes" /></meta><meta name="dc.Creator" content="Roderick E.  Hubbard" /></meta><meta name="dc.Creator" content="Allan M.  Jordan" /></meta><meta name="dc.Creator" content="Michael Rugaard  Jensen" /></meta><meta name="dc.Creator" content="Andrew  Massey" /></meta><meta name="dc.Creator" content="Angela  Merrett" /></meta><meta name="dc.Creator" content="Antony  Padfield" /></meta><meta name="dc.Creator" content="Rachel  Parsons" /></meta><meta name="dc.Creator" content="Thomas  Radimerski" /></meta><meta name="dc.Creator" content="Florence I.  Raynaud" /></meta><meta name="dc.Creator" content="Alan  Robertson" /></meta><meta name="dc.Creator" content="Stephen D.  Roughley" /></meta><meta name="dc.Creator" content="Joseph  Schoepfer" /></meta><meta name="dc.Creator" content="Heather  Simmonite" /></meta><meta name="dc.Creator" content="Swee Y.  Sharp" /></meta><meta name="dc.Creator" content="Allan  Surgenor" /></meta><meta name="dc.Creator" content="Melanie  Valenti" /></meta><meta name="dc.Creator" content="Steven  Walls" /></meta><meta name="dc.Creator" content="Paul  Webb" /></meta><meta name="dc.Creator" content="Mike  Wood" /></meta><meta name="dc.Creator" content="Paul  Workman" /></meta><meta name="dc.Creator" content="Lisa  Wright" /></meta><meta name="dc.Description" content="Inhibitors of the Hsp90 molecular chaperone are showing considerable promise as potential molecular therapeutic agents for the treatment of cancer. Here we describe novel 2-aminothieno[2,3-d]pyrimi..." /></meta><meta name="Description" content="Inhibitors of the Hsp90 molecular chaperone are showing considerable promise as potential molecular therapeutic agents for the treatment of cancer. Here we describe novel 2-aminothieno[2,3-d]pyrimi..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="July 17, 2009" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm900357y" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2009 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm900357y" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm900357y" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm900357y" /></link>
        
    
    

<title>Combining Hit Identification Strategies: Fragment-Based and in Silico Approaches to Orally Active 2-Aminothieno[2,3-d]pyrimidine Inhibitors of the Hsp90 Molecular Chaperone | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm900357y" /></meta><meta property="og:title" content="Combining Hit Identification Strategies: Fragment-Based and in Silico Approaches to Orally Active 2-Aminothieno[2,3-d]pyrimidine Inhibitors of the Hsp90 Molecular Chaperone" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900357y/production/images/large/jm-2009-00357y_0015.jpeg" /></meta><meta property="og:description" content="Inhibitors of the Hsp90 molecular chaperone are showing considerable promise as potential molecular therapeutic agents for the treatment of cancer. Here we describe novel 2-aminothieno[2,3-d]pyrimidine ATP competitive Hsp90 inhibitors, which were designed by combining structural elements of distinct low affinity hits generated from fragment-based and in silico screening exercises in concert with structural information from X-ray protein crystallography. Examples from this series have high affinity (IC50 = 50−100 nM) for Hsp90 as measured in a fluorescence polarization (FP) competitive binding assay and are active in human cancer cell lines where they inhibit cell proliferation and exhibit a characteristic profile of depletion of oncogenic proteins and concomitant elevation of Hsp72. Several examples (34a, 34d and 34i) caused tumor growth regression at well tolerated doses when administered orally in a human BT474 human breast cancer xenograft model." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm900357y"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm900357y">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm900357y&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm900357y&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm900357y&amp;href=/doi/10.1021/jm900357y" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2009</span><span class="cit-fg-volume">, 52</span><span class="cit-fg-issue">, 15</span><span class="cit-fg-pageRange">, 4794-4809</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/52/15" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm900400w" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm900314j" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Combining Hit Identification Strategies: Fragment-Based and in Silico Approaches to Orally Active 2-Aminothieno[2,3-<i>d</i>]pyrimidine Inhibitors of the Hsp90 Molecular Chaperone</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Paul+A.++Brough">Paul A. Brough</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Xavier++Barril">Xavier Barril</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jenifer++Borgognoni">Jenifer Borgognoni</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Patrick++Chene">Patrick Chene</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Nicholas+G.+M.++Davies">Nicholas G. M. Davies</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ben++Davis">Ben Davis</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Martin+J.++Drysdale">Martin J. Drysdale</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Brian++Dymock">Brian Dymock</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Suzanne+A.++Eccles">Suzanne A. Eccles</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Carlos++Garcia-Echeverria">Carlos Garcia-Echeverria</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Christophe++Fromont">Christophe Fromont</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Angela++Hayes">Angela Hayes</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Roderick+E.++Hubbard">Roderick E. Hubbard</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Allan+M.++Jordan">Allan M. Jordan</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Michael+Rugaard++Jensen">Michael Rugaard Jensen</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Andrew++Massey">Andrew Massey</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Angela++Merrett">Angela Merrett</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Antony++Padfield">Antony Padfield</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Rachel++Parsons">Rachel Parsons</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Thomas++Radimerski">Thomas Radimerski</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Florence+I.++Raynaud">Florence I. Raynaud</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Alan++Robertson">Alan Robertson</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Stephen+D.++Roughley">Stephen D. Roughley</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Joseph++Schoepfer">Joseph Schoepfer</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Heather++Simmonite">Heather Simmonite</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Swee+Y.++Sharp">Swee Y. Sharp</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Allan++Surgenor">Allan Surgenor</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Melanie++Valenti">Melanie Valenti</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Steven++Walls">Steven Walls</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Paul++Webb">Paul Webb</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mike++Wood">Mike Wood</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Paul++Workman">Paul Workman</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Lisa++Wright">Lisa Wright</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Vernalis Ltd., Granta Park, Great Abington, Cambridge CB21 6GB, U.K.</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Cancer Research UK Centre for Cancer Therapeutics, The Institute of Cancer Research, Haddow Laboratories, Sutton, Surrey SM2 5NG, U.K.</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">§</span> <span class="aff-text">Novartis Institutes for Biomedical Research, Novartis Pharma AG, CH-4002 Basel, Switzerland</span></div><div class="corresp-info"><strong>*</strong>To whom correspondence should be addressed. Phone 44 (0)1223 895372. Fax: 44 (0)1223 895556. E-mail: <a href="/cdn-cgi/l/email-protection#c7b7e9a5b5a8b2a0af87b1a2b5a9a6abaeb4e9a4a8aa"><span class="__cf_email__" data-cfemail="ef9fc18d9d809a8887af998a9d818e83869cc18c8082">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm900357y&amp;href=/doi/10.1021%2Fjm900357y" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2009</span></span><span class="cit-volume">, 52</span><span class="cit-issue">, 15</span><span class="cit-pageRange">, 4794–4809</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">July 17, 2009</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>21 March 2009</li><li><span class="item_label"><b>Published</b> online</span>17 July 2009</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 13 August 2009</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm900357y" title="DOI URL">https://doi.org/10.1021/jm900357y</a></div><div class="article_header-article-copyright"><strong>Copyright © 2009 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D4794%26pageCount%3D16%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DPaul%2BA.%2BBrough%252C%2BXavier%2BBarril%252C%2BJenifer%2BBorgognoni%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D52%26issueNum%3D15%26contentID%3Djm900357y%26title%3DCombining%2BHit%2BIdentification%2BStrategies%253A%2BFragment-Based%2Band%2Bin%2BSilico%2BApproaches%2Bto%2BOrally%2BActive%2B2-Aminothieno%255B2%252C3-d%255Dpyrimidine%2BInhibitors%2Bof%2Bthe%2BHsp90%2BMolecular%2BChaperone%26numPages%3D16%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D4809%26publicationDate%3DAugust%2B2009">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm900357y"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">5348</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">127</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm900357y" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Combining Hit Identification Strategies: Fragment-Based and in Silico Approaches to Orally Active 2-Aminothieno[2,3-d]pyrimidine Inhibitors of the Hsp90 Molecular Chaperone&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Paul&quot;,&quot;last_name&quot;:&quot;A. Brough&quot;},{&quot;first_name&quot;:&quot;Xavier&quot;,&quot;last_name&quot;:&quot;Barril&quot;},{&quot;first_name&quot;:&quot;Jenifer&quot;,&quot;last_name&quot;:&quot;Borgognoni&quot;},{&quot;first_name&quot;:&quot;Patrick&quot;,&quot;last_name&quot;:&quot;Chene&quot;},{&quot;first_name&quot;:&quot;Nicholas&quot;,&quot;last_name&quot;:&quot;G. M. Davies&quot;},{&quot;first_name&quot;:&quot;Ben&quot;,&quot;last_name&quot;:&quot;Davis&quot;},{&quot;first_name&quot;:&quot;Martin&quot;,&quot;last_name&quot;:&quot;J. Drysdale&quot;},{&quot;first_name&quot;:&quot;Brian&quot;,&quot;last_name&quot;:&quot;Dymock&quot;},{&quot;first_name&quot;:&quot;Suzanne&quot;,&quot;last_name&quot;:&quot;A. Eccles&quot;},{&quot;first_name&quot;:&quot;Carlos&quot;,&quot;last_name&quot;:&quot;Garcia-Echeverria&quot;},{&quot;first_name&quot;:&quot;Christophe&quot;,&quot;last_name&quot;:&quot;Fromont&quot;},{&quot;first_name&quot;:&quot;Angela&quot;,&quot;last_name&quot;:&quot;Hayes&quot;},{&quot;first_name&quot;:&quot;Roderick&quot;,&quot;last_name&quot;:&quot;E. Hubbard&quot;},{&quot;first_name&quot;:&quot;Allan&quot;,&quot;last_name&quot;:&quot;M. Jordan&quot;},{&quot;first_name&quot;:&quot;Michael&quot;,&quot;last_name&quot;:&quot;Rugaard Jensen&quot;},{&quot;first_name&quot;:&quot;Andrew&quot;,&quot;last_name&quot;:&quot;Massey&quot;},{&quot;first_name&quot;:&quot;Angela&quot;,&quot;last_name&quot;:&quot;Merrett&quot;},{&quot;first_name&quot;:&quot;Antony&quot;,&quot;last_name&quot;:&quot;Padfield&quot;},{&quot;first_name&quot;:&quot;Rachel&quot;,&quot;last_name&quot;:&quot;Parsons&quot;},{&quot;first_name&quot;:&quot;Thomas&quot;,&quot;last_name&quot;:&quot;Radimerski&quot;},{&quot;first_name&quot;:&quot;Florence&quot;,&quot;last_name&quot;:&quot;I. Raynaud&quot;},{&quot;first_name&quot;:&quot;Alan&quot;,&quot;last_name&quot;:&quot;Robertson&quot;},{&quot;first_name&quot;:&quot;Stephen&quot;,&quot;last_name&quot;:&quot;D. Roughley&quot;},{&quot;first_name&quot;:&quot;Joseph&quot;,&quot;last_name&quot;:&quot;Schoepfer&quot;},{&quot;first_name&quot;:&quot;Heather&quot;,&quot;last_name&quot;:&quot;Simmonite&quot;},{&quot;first_name&quot;:&quot;Swee&quot;,&quot;last_name&quot;:&quot;Y. Sharp&quot;},{&quot;first_name&quot;:&quot;Allan&quot;,&quot;last_name&quot;:&quot;Surgenor&quot;},{&quot;first_name&quot;:&quot;Melanie&quot;,&quot;last_name&quot;:&quot;Valenti&quot;},{&quot;first_name&quot;:&quot;Steven&quot;,&quot;last_name&quot;:&quot;Walls&quot;},{&quot;first_name&quot;:&quot;Paul&quot;,&quot;last_name&quot;:&quot;Webb&quot;},{&quot;first_name&quot;:&quot;Mike&quot;,&quot;last_name&quot;:&quot;Wood&quot;},{&quot;first_name&quot;:&quot;Paul&quot;,&quot;last_name&quot;:&quot;Workman&quot;},{&quot;first_name&quot;:&quot;Lisa&quot;,&quot;last_name&quot;:&quot;Wright&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2009&quot;,&quot;month&quot;:&quot;07&quot;,&quot;day&quot;:&quot;17&quot;,&quot;issue&quot;:&quot;15&quot;,&quot;volume&quot;:&quot;52&quot;,&quot;pages&quot;:&quot;4794-4809&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm900357y&quot;},&quot;abstract&quot;:&quot;Inhibitors of the Hsp90 molecular chaperone are showing considerable promise as potential molecular therapeutic agents for the treatment of cancer. Here we describe novel 2-aminothieno[2,3-d]pyrimidine ATP competitive Hsp90 inhibitors, which were designed by combining structural elements of distinct low affinity hits generated from fragment-based and in silico screening exercises in concert with structural information from X-ray protein crystallography. Examples from this series have high affinity (IC50 = 50−100 nM) for Hsp90 as measured in a fluorescence polarization (FP) competitive binding assay and are active in human cancer cell lines where they inhibit cell proliferation and exhibit a characteristic profile of depletion of oncogenic proteins and concomitant elevation of Hsp72. Several examples (34a, 34d and 34i) caused tumor growth regression at well tolerated doses when administered orally in a human BT474 human breast cancer xenograft model.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm900357y&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm900357y" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm900357y&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm900357y" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm900357y&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm900357y" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm900357y&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm900357y&amp;href=/doi/10.1021/jm900357y" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm900357y" /></input><a href="/doi/pdf/10.1021/jm900357y" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (4 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm900357y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm900357y%26sid%3Dliteratum%253Aachs%26pmid%3D19610616%26genre%3Darticle%26aulast%3DBrough%26date%3D2009%26atitle%3DCombining%2BHit%2BIdentification%2BStrategies%253A%2BFragment-Based%2Band%2Bin%2BSilico%2BApproaches%2Bto%2BOrally%2BActive%2B2-Aminothieno%255B2%252C3-d%255Dpyrimidine%2BInhibitors%2Bof%2Bthe%2BHsp90%2BMolecular%2BChaperone%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D52%26issue%3D15%26spage%3D4794%26epage%3D4809%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292258" title="Cancer">Cancer</a>,</li><li><a href="/action/doSearch?ConceptID=291917" title="Pyrimidine">Pyrimidine</a>,</li><li><a href="/action/doSearch?ConceptID=290896" title="Cells">Cells</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291352" title="Screening assays">Screening assays</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/52/15" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900357y/production/images/medium/jm-2009-00357y_0015.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900357y/production/images/large/jm-2009-00357y_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900357y&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Inhibitors of the Hsp90 molecular chaperone are showing considerable promise as potential molecular therapeutic agents for the treatment of cancer. Here we describe novel 2-aminothieno[2,3-<i>d</i>]pyrimidine ATP competitive Hsp90 inhibitors, which were designed by combining structural elements of distinct low affinity hits generated from fragment-based and in silico screening exercises in concert with structural information from X-ray protein crystallography. Examples from this series have high affinity (IC<sub>50</sub> = 50−100 nM) for Hsp90 as measured in a fluorescence polarization (FP) competitive binding assay and are active in human cancer cell lines where they inhibit cell proliferation and exhibit a characteristic profile of depletion of oncogenic proteins and concomitant elevation of Hsp72. Several examples (<b>34a</b>, <b>34d</b> and <b>34i</b>) caused tumor growth regression at well tolerated doses when administered orally in a human BT474 human breast cancer xenograft model.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_70204" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_70204" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Heat shock protein 90 (Hsp90) is an important member of a class of proteins known as molecular chaperones. These chaperone proteins play a critical role in the conformational maturation, stability, and function of other “client” protein substrates within the cell.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> The mechanism of action of Hsp90 is complex, involving homodimerization and binding to substrates, cochaperones, and other accessory proteins operating in a chaperone cycle.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> This cycle is driven by the binding of ATP to Hsp90, hydrolysis to ADP, and subsequent ATP/ADP exchange, which enables the multimeric complexes within the conformational cycle to facilitate protein loading, activation, and release.<a onclick="showRef(event, 'ref3 ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref3 ref4 ref5">(3-5)</a></div><div class="NLM_p">There are over 100 client proteins of Hsp90 identified to date,<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> many of which are involved in signal transduction, cell cycle regulation, and apoptosis, including kinases, transcription factors, and hormone receptors.<a onclick="showRef(event, 'ref7 ref8 ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref7 ref8 ref9 ref10">(7-10)</a> The dysregulation of pathways involving these proteins is commonly associated with cancer pathology and Hsp90 thus plays a key role in assisting survival, proliferation, invasion, metastasis, and angiogenesis. Inhibition of Hsp90 function is therefore considered as a major therapeutic target, as it constitutes a combinatorial attack on these hallmark traits of cancer,<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> with the potential for broad spectrum activity and reduced liability for acquired drug resistance as a consequence of the ability to interfere with multiple oncogenic pathways.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a></div><div class="NLM_p">Pioneering studies with natural product inhibitors of Hsp90 function such as geldanamycin<a onclick="showRef(event, 'ref13 ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref13 ref14 ref15">(13-15)</a> (GM) and radicicol<a onclick="showRef(event, 'ref16 ref17'); return false;" href="javascript:void(0);" class="ref ref16 ref17">(16, 17)</a> (RD; Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>, <b>1a</b> and <b>2</b>) provided valuable characterization and showed that both GM and RD are able to inhibit Hsp90 function by binding to the ATP binding pocket in the N-terminal domain of Hsp90.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> The subsequent arrest of the Hsp90 chaperone cycle causes client proteins to be degraded by the ubiquitin−proteasome pathway, leading to cell cycle arrest and apoptosis in cancer cells.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> Further validation and proof of principle that Hsp90 is a promising anticancer drug has come from animal models and clinical studies with the GM analogue 17-allylamino-17-demethoxygeldanamycin (17-AAG; Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>; <b>1b</b>).<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> This first-in-class Hsp90 inhibitor has demonstrated evidence of target modulation and indications of clinical activity in melanoma, prostate, renal, multiple myeloma, and trastuzumab-refractory breast cancer.<a onclick="showRef(event, 'ref21 ref22 ref23 ref24'); return false;" href="javascript:void(0);" class="ref ref21 ref22 ref23 ref24">(21-24)</a> Additional clinical trials have been initiated with 17-AAG used as a single agent and in drug combinations in various cancer types. The prevalence of a high affinity form of Hsp90 in tumor cells,<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> the “addiction” of cancer cells to oncogenic client proteins, and the greater dependency upon Hsp90 of these clients (especially their activated mutated forms)<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> have been proposed as rationales for the remarkable selectivity of Hsp90 inhibitors for cancer versus normal cells.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900357y/production/images/medium/jm-2009-00357y_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900357y/production/images/large/jm-2009-00357y_0004.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Natural product derived Hsp90 inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900357y/production/images/large/jm-2009-00357y_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900357y&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">However, despite the good activity in preclinical models and the clinical progression of 17-AAG, this compound has several potential limitations including poor solubility, necessitating complex formulations, limited bioavailability, hepatotoxicity, and extensive metabolism by polymorphic enzymes.<a onclick="showRef(event, 'ref28 ref29 ref30'); return false;" href="javascript:void(0);" class="ref ref28 ref29 ref30">(28-30)</a> In particular, low level expression or mutation of the oxidoreductase NQO1, which catalyzes reduction of the benzoquinone moiety, has been shown to give rise to intrinsic and acquired resistance to 17-AAG.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> Some of these issues have been addressed with the development of the water-soluble ansamycin 17-dimethylamino-ethylamino-17-demethoxygeldanamycin (17-DMAG; Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>; <b>1c</b>),<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> which was in phase I/Ib clinical trials, and the hydroquinone pro-drug of 17-AAG (IPI-504; Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>; <b>1d</b>),<a onclick="showRef(event, 'ref33 ref34'); return false;" href="javascript:void(0);" class="ref ref33 ref34">(33, 34)</a> which is reported to be in phase I/II. A proprietary formulation of 17-AAG (KOS-953)<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> has advanced to phase III in combination with bortezomib (<a href="http://www.clinicaltrials.gov" class="extLink">www.clinicaltrials.gov</a>). However, the above issues and the inherent chemical complexity of the ansamycin inhibitors have led to significant efforts to identify novel small-molecule inhibitors of Hsp90 and this arena of research has been extensively reviewed.<a onclick="showRef(event, 'ref29 ref36 ref37 ref38 ref39 ref40 ref41 ref42 ref43 ref44 ref45 ref46 ref47'); return false;" href="javascript:void(0);" class="ref ref29 ref36 ref37 ref38 ref39 ref40 ref41 ref42 ref43 ref44 ref45 ref46 ref47">(29, 36-47)</a> The most advanced small molecule inhibitors described to date include purine,<a onclick="showRef(event, 'ref48 ref49'); return false;" href="javascript:void(0);" class="ref ref48 ref49">(48, 49)</a> benzamide,<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> and resorcinol<a onclick="showRef(event, 'ref51 ref52'); return false;" href="javascript:void(0);" class="ref ref51 ref52">(51, 52)</a> scaffold inhibitors as exemplified by compounds <b>3</b>−<b>5</b>, respectively (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>). These compounds are reportedly in phase I clinical trials for cancer.<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> We recently reported on the structure-based drug design program that led to the identification of the highly potent resorcinol inhibitor <b>5</b> (NVP-AUY922/VER-52296; Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>).<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> To deliver an orally bioavailable inhibitor back up compound, we felt it appropriate to identify a novel ATP competitive small molecule inhibitor with a distinct chemotype. Herein we report on the combination of hit identification strategies and the structure-based medicinal chemistry program that led to the identification of a new class of 2-aminothieno[2,3-<i>d</i>]pyrimidine Hsp90 inhibitors with oral efficacy in animal models of cancer.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900357y/production/images/medium/jm-2009-00357y_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900357y/production/images/large/jm-2009-00357y_0005.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Purine, benzamide, and resorcinol scaffold Hsp90 inhibitors progressed to phase I trials.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900357y/production/images/large/jm-2009-00357y_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900357y&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Hit Identification</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_50451" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_50451" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Finding novel compounds as starting points for optimization is a major challenge in drug discovery research. Fragment-based methods<a onclick="showRef(event, 'ref54 ref55 ref56 ref57 ref58 ref59'); return false;" href="javascript:void(0);" class="ref ref54 ref55 ref56 ref57 ref58 ref59">(54-59)</a> have emerged in the past 10 years as an effective way to sample chemical diversity with a limited number of low molecular weight compounds. The structures of the fragment binding to the protein can then be used to design new compounds with increased affinity, specificity and novelty. The approach we applied has been previously described<a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a> and included (i) the design of a fragment library, (ii) identification of fragments that bound competitively to Hsp90 by ligand-based NMR techniques, and (iii) rationalization of the fragment binding mode in the ATP binding site of Hsp90 by protein X-ray crystallography. This structural information was then used to evolve the fragments to hits, either by growing the fragment or by combining structural features from a number of compounds. Fragments bind to protein targets with relatively weak affinity, and for this reason, screening had to be conducted with the potential ligands at high concentrations. It was therefore important to devise a strategy that identified specific binding of fragments to the targeted site of the protein and that could exclude nonspecific or distal binding.</div><div class="NLM_p">The strategy employed was to identify fragments that bound to the enzyme and that were then displaced by a competitor molecule, in this case the purine scaffold inhibitor PU3,<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a> in a manner analogous to a standard biochemical competition assay. A wide variety of NMR methods have been proposed to monitor ligand binding.<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a> We have found that a combination of three widely used approaches (saturation transfer difference (STD),<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a> water-LOGSY,<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a> and T2 relaxation filtered 1D<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a>) gave a substantially more reliable experimental output than the use of any single technique and added little to the duration of either the data acquisition or analysis stages of the study. The designed fragment library<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a> was screened against N-terminal domain human Hsp90α by combining 10−12 compounds per tube. This number of compounds was found to be optimal before resonance overlap became an experimental issue with respect to spectral analysis. Spectra were recorded in presence and absence of the ATP competitive ligand PU3,<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a> and compounds that bound to Hsp90 were categorized as “Class 1” hits<a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a> if the expected changes on addition of the competitor ligand were seen with all three NMR experiments. The overall hit rate from an NMR screen of 1351 fragments was 6.1% (82 compounds), of which 59 compounds bound in all three experiments; 21 compounds bound in two of the experiments, and 2 compounds bound in only one experiment. Selected class 1 hits are shown in Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a> (compounds <b>6</b>−<b>11</b>). A significant number of noncompetitive compounds were identified from the NMR screening (158 in total). These compounds bound to Hsp90 but were not displaced by PU3 in the competition step and were thus not classed as hits and not further characterized. X-ray crystallography using the N-terminal domain of human Hsp90α established the binding mode of compounds <b>6</b>−<b>11</b> and structurally related fragments. It was interesting to note that the purine (<b>6</b>), 2-amino benzamide (<b>7</b>), and resorcinol fragments (<b>8</b> and <b>9</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>) all contain structural motifs found in the inhibitors described in Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>. Another fragment-based approach to identifying Hsp90 ligands has been subsequently disclosed.<a onclick="showRef(event, 'ref67'); return false;" href="javascript:void(0);" class="ref ref67">(67)</a> Elaboration of the initial fragment hits (which included a fragment linking strategy) led to the identification of high affinity Hsp90 ligands, although further biological characterization was not discussed. Recently, another group has reported on a fragment-based approach, which led to the identification of tetrahydrobenzopyrimidine Hsp90 inhibitors.<a onclick="showRef(event, 'ref68'); return false;" href="javascript:void(0);" class="ref ref68">(68)</a></div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900357y/production/images/medium/jm-2009-00357y_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900357y/production/images/large/jm-2009-00357y_0006.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Structures of Hsp90α ATP site binding fragments identified by 1D NMR experiments.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900357y/production/images/large/jm-2009-00357y_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900357y&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">We applied a parallel approach to hit identification, namely in silico (or virtual) screening. There has recently been increasing success in using molecular docking methods in the discovery of new chemical entities that bind to therapeutic target proteins, including Hsp90.<a onclick="showRef(event, 'ref69 ref70'); return false;" href="javascript:void(0);" class="ref ref69 ref70">(69, 70)</a> We utilized the proprietary docking software rDock and a previously described docking protocol<a onclick="showRef(event, 'ref69 ref71'); return false;" href="javascript:void(0);" class="ref ref69 ref71">(69, 71)</a> in an effort to identify novel Hsp90 ligands. The shape and size of the ATP binding site is altered upon binding of PU3 as a consequence of a flexible loop between residues 104 to 111.<a onclick="showRef(event, 'ref72'); return false;" href="javascript:void(0);" class="ref ref72">(72)</a> Therefore the structure of both open and helical forms (PDB codes <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1YET">1YET</a> and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1UY6">1UY6</a>) were used in the docking, and in addition, three highly conserved water molecules in the region of the D93 residue were treated as part of the receptor. A virtual library of 700000 compounds was selected from the 3.5 million commercially available compounds in our proprietary catalogue rCat.<a onclick="showRef(event, 'ref73'); return false;" href="javascript:void(0);" class="ref ref73">(73)</a> The output from the screen was further filtered to identify 719 commercially available compounds, which were obtained and screened in a fluorescence polarization (FP) assay,<a onclick="showRef(event, 'ref74'); return false;" href="javascript:void(0);" class="ref ref74">(74)</a> which measured directly competitive binding to the N-terminal ATP binding site. This exercise identified a number of hits including <b>12</b> and <b>13</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>). The binding affinity of these hits and the fragment derived hits disclosed in Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a> are shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>. These data demonstrated a number of hits with weak to moderate affinity for the Hsp90 ATP site. In addition to these binding data, X-ray crystallography provided structural information (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>) to guide further optimization. The challenge was to combine the structure−activity relationships (SAR) and X-ray crystallographic data relating to these hits (and other Hsp90 inhibitors) to enable the rapid progression to tractable leads and subsequent lead optimization.</div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900357y/production/images/medium/jm-2009-00357y_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900357y/production/images/large/jm-2009-00357y_0007.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Structures of Hsp90 ligands identified by virtual screening.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900357y/production/images/large/jm-2009-00357y_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900357y&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900357y/production/images/medium/jm-2009-00357y_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900357y/production/images/large/jm-2009-00357y_0008.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Detail of the X-ray crystal structures of N-terminal-Hsp90α in complex with a series of fragments and ligands, highlighting key protein amino acids and water molecules (red spheres).<a onclick="showRef(event, 'ref80'); return false;" href="javascript:void(0);" class="ref ref80">(80)</a> The structures were overlapped on the main chains of residues T109-D102 and T115-G215, which omit the flexible helix and N and C termini. The rmsd was between 0.22 and 0.40 Å across the data set. Protein carbon atoms in gray (bond types not shown), oxygen in red, nitrogen in blue, chlorine in green, sulfur in yellow. Electron density for <b>10</b> is 2<i>F</i><sub>o</sub> − <i>F</i><sub>c</sub> map, contoured at 3σ. All structures are from ligand soaks except where stated.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900357y/production/images/large/jm-2009-00357y_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900357y&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Binding Affinities<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a> for Hsp90 ATP Binding Site Measured by Fluorescence Polarization Assay for Selected Fragment and Virtual Screening Hits</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="left" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="rowsep1"><th class="rowsep1" align="center">compd no.</th><th class="rowsep1" align="center" char=".">FP IC<sub>50</sub> (μM)</th><th class="rowsep1" align="center">compd no.</th><th class="rowsep1" align="center" char=".">FP IC<sub>50</sub> (μM)</th></tr></thead><tbody><tr valign="top"><td align="left"><b>6</b></td><td align="char" char=".">>4000</td><td align="left"><b>12</b></td><td align="char" char=".">1.56</td></tr><tr valign="top"><td align="left"><b>7</b></td><td align="char" char=".">>4000</td><td align="left"><b>13</b></td><td align="char" char=".">0.90</td></tr><tr valign="top"><td align="left"><b>8</b></td><td align="char" char=".">490</td><td align="left"><b>14</b></td><td align="char" char=".">20</td></tr><tr valign="top"><td align="left"><b>9</b></td><td align="char" char=".">570</td><td align="left"><b>15</b></td><td align="char" char=".">535</td></tr><tr valign="top"><td align="left"><b>10</b></td><td align="char" char=".">350</td><td align="left"><b>16</b></td><td align="char" char=".">1250</td></tr><tr valign="top"><td align="left"><b>11</b></td><td align="char" char=".">>4000</td><td align="left"> </td><td align="char" char="."> </td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>a</sup><p class="last">Values are reported as a mean of at least two independent determinations.</p></div></div></div></div><div id="sec2_1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i4">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_42614" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_42614" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The 1,3,5 triazine <b>14</b> was prepared as outlined in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a> by condensation of benzamidine hydrochloride with dimethyl cyanodithioiminocarbonate by a modification of a method previously described.<a onclick="showRef(event, 'ref75'); return false;" href="javascript:void(0);" class="ref ref75">(75)</a> Pyrimidine <b>15</b> was prepared by the microwave mediated reaction of the commercially available 2-amino-4-chloro-6-methylpyrimidine with 2-mercapto-<i>N</i>-methyl acetamide. The thienopyrimidine scaffold was constructed as shown in Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a> by reacting ethyl-2-mercaptoacetate with 4,6-dichloro-5-formyl pyrimidine (<b>17</b>) to give compound <b>18</b>, which was reacted with aqueous ammonia at high temperature to afford key 2,4-diamino thienopyrimidine <b>16</b>.<a onclick="showRef(event, 'ref76'); return false;" href="javascript:void(0);" class="ref ref76">(76)</a> Compound <b>18</b> underwent Suzuki cross coupling reactions<a onclick="showRef(event, 'ref77'); return false;" href="javascript:void(0);" class="ref ref77">(77)</a> with commercially available boronic acids to furnish 4-aryl-2-aminopyrimidines <b>19a</b>−<b>e</b> (Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>). Saponification of the ethyl esters <b>19a</b> and <b>19e</b> gave the corresponding acids <b>20a</b> and <b>20e</b>, which underwent a HATU mediated coupling with ethylamine hydrochloride to afford ethyl amides <b>21a</b> and <b>21e</b>. Alternatively, ethyl amides <b>21b</b>−<b>d</b> were made by direct conversion of the ethyl esters by heating with ethylamine in methanol solution. The 5′-aryloxy derivatives <b>34a</b>−<b>m</b> (Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a>) were made by a similar method, although the key intermediate <b>26</b> required the prior synthesis of an appropriate cross coupling partner. Thus, the commercially available nitro phenol <b>22</b> was protected with a benzyl group (<b>23</b>) and the nitro group then reduced to aniline <b>24</b>. Subsequent diazotization of the aniline followed by quenching the intermediate diazonium salt with iodine afforded iodophenol derivative <b>25</b>, which was then converted to an intermediate boronate ester via a palladium mediated process.<a onclick="showRef(event, 'ref78'); return false;" href="javascript:void(0);" class="ref ref78">(78)</a> The boronate ester derivative of <b>25</b> underwent cross coupling with compound <b>18</b> (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>) to give compound <b>26</b>. It was found that only the ethyl amide <b>28</b> could be made by direct conversion from the ethyl ester <b>26</b>; other amides (<b>29</b> and <b>30</b>) were made via the carboxylic acid <b>27</b>. Boron trichloride mediated deprotection of benzyloxy compounds <b>28</b>−<b>30</b> gave corresponding phenols <b>31</b>−<b>33</b>, which were then derivatized to give <b>34a</b>−<b>i</b> by either reaction with alkyl halides or by Mitsunobu reactions<a onclick="showRef(event, 'ref79'); return false;" href="javascript:void(0);" class="ref ref79">(79)</a> with the appropriate alcohols. An alternative approach to the construction of the thienopyrimidines <b>34</b> is shown in Scheme <a class="ref internalNav" href="#sch5" aria-label="5">5</a>. In this case, compound <b>31</b> was reacted with 2-bromoethylacetaladehyde diethyl acetal to generate the acetal derivative <b>35</b>. In situ generation of the corresponding aldehyde and subsequent reductive amination reaction with appropriate amine and sodium triacetoxy borohydride afforded compounds <b>34j</b>−<b>m</b> (Scheme <a class="ref internalNav" href="#sch5" aria-label="5">5</a>).</div><figure id="sch1" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900357y/production/images/medium/jm-2009-00357y_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900357y/production/images/large/jm-2009-00357y_0017.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Close Analogues of the Fragment Hits <b>10</b> and <b>11</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900357y/production/images/large/jm-2009-00357y_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900357y&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) diisopropylamine, EtOH, 65 °C, 3.5 h, 30%. (b) MeOH, Et<sub>3</sub>N, microwave, 120 °C, 10 min, 14%.</p></p></figure><figure id="sch2" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900357y/production/images/medium/jm-2009-00357y_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900357y/production/images/large/jm-2009-00357y_0018.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of the 2,4-Diaminothieno[2,3-<i>d</i>]pyrimidine Scaffold<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900357y/production/images/large/jm-2009-00357y_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900357y&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) ethyl-2-mercaptoacetate, K<sub>2</sub>CO<sub>3</sub>, MeCN, 85 °C, 5 h, 82%. (b) aq NH<sub>3</sub>, microwave 130 °C, 15 min, 22%.</p></p></figure><figure id="sch3" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900357y/production/images/medium/jm-2009-00357y_0019.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900357y/production/images/large/jm-2009-00357y_0019.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of 4-Aryl 2-Aminothieno[2,3-<i>d</i>]pyrimidines <b>21a</b>−<b>21e</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900357y/production/images/large/jm-2009-00357y_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900357y&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 2X,4Y-phenylboronic acid, DMF, H<sub>2</sub>O, Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub>, NaHCO<sub>3</sub>, Δ. (b) EtNH<sub>2</sub>, MeOH, 85 °C (sealed tube), 18 h. (c) NaOH, H<sub>2</sub>O, EtOH, Δ. (d) HATU, diisopropylamine, EtNH<sub>2</sub>·HCl, DMF, 100 °C.</p></p></figure><figure id="sch4" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900357y/production/images/medium/jm-2009-00357y_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900357y/production/images/large/jm-2009-00357y_0001.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of 5′-Alkyloxy-2-aminothieno[2,3-<i>d</i>]pyrimidine Hsp90 Inhibitors <b>34a</b>−<b>i</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900357y/production/images/large/jm-2009-00357y_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900357y&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) BnBr, K<sub>2</sub>CO<sub>3</sub>, MeCN, Δ, 18 h, 96%. (b) Iron powder, AcOH, H<sub>2</sub>O, 85 °C, 1.5 h, 96%. (c) (i) NaNO<sub>2</sub>, HCl, H<sub>2</sub>O, AcOH, 0 to 5 °C, 30 min; (ii) I<sub>2</sub>, KI, H<sub>2</sub>O, rt,1.5 h, 90%. (d) (i) KOAc, bis(pinacolato)diboron, Pd(OAc)<sub>2</sub>, DMF, 90 °C, 18 h; (ii) <b>18</b>, K<sub>3</sub>PO<sub>4</sub>, 1,4-dioxane, Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub>, 100 °C, 3 h, 45%. (e) EtNH<sub>2</sub>, MeOH, Δ, 18 h, 84%. (f) NaOH, H<sub>2</sub>O, EtOH, D, 50 min, quant. (g) HATU, RNH<sub>2</sub>, DMF, diisopropylamine; 50 °C, 1 h. (h) BCl<sub>3</sub>, CH<sub>2</sub>Cl<sub>2</sub>, −78 °C to rt, 3 h, 87%. (i) R<sub>1</sub>Br/Cl, Cs<sub>2</sub>CO<sub>3</sub>, DMF, 100−140 °C, 1−2 h. (j) R<sub>1</sub>OH, DIAD, PPh<sub>3</sub>, THF, rt, 4 h.</p></p></figure><figure id="sch5" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900357y/production/images/medium/jm-2009-00357y_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900357y/production/images/large/jm-2009-00357y_0002.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthesis of Aminothieno[2,3-<i>d</i>]pyrimidine Hsp90 inhibitors <b>34j</b>−<b>m</b> via Reductive Amination<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900357y/production/images/large/jm-2009-00357y_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900357y&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 2-Bromoethylacetaldehyde diethyl acetal, Cs<sub>2</sub>CO<sub>3</sub>, DMF, 125 °C, 4 h, 71%. (b) (i) HCl (aq), THF, 48 h; (ii) amine, DCM, NaB(OAc)<sub>3</sub>H, 1.5 h.</p></p></figure></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i10">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_71365" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_71365" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Compound <b>13</b> was considered a suitable start point for further medicinal chemistry optimization, and a series of close analogues was synthesized and evaluated as Hsp90 inhibitors (unpublished results). In addition, however, the structural information provided by <b>13</b> and that from <b>12</b> and the fragment screening hits (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>) suggested the design of a novel chemotype. Overlays of the X-ray structures of fragment hits <b>10</b> and <b>11</b> with the in silico screening hits <b>12</b> and <b>13</b> led to the synthesis of compounds <b>14</b> and <b>15</b>. Compound <b>14</b> incorporated a phenyl substituent, similar to <b>12</b> and <b>13</b>, and compound <b>15</b> comprised an amide akin to <b>13</b>. From the X-ray structures of <b>12</b> and <b>13</b>, these groups were observed to make important contacts with the Hsp90 binding site (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>). Thus, replacement of the methyl group in triazine <b>10</b> to a phenyl group in triazine <b>14</b> improved affinity in the FP assay from 350 to 20 μM. Similarly, modification of amino-pyrimidine hit <b>11</b> afforded <b>15</b> with a significant improvement in binding affinity from >4000 to 535 μM (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). Further examination of the X-ray structural information of fragment hits, close analogues, and the hits from the virtual screening campaign and associated structural information afforded by X-ray crystallography (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>) led to the design of the 2-amino-thienopyrimidine scaffold exemplified initially by the 2,4-diaminothienopyrimidine <b>16</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>). Several salient features were apparent from the structural information.<a onclick="showRef(event, 'ref80'); return false;" href="javascript:void(0);" class="ref ref80">(80)</a> In particular, the binding pose adopted by the fragment <b>10</b> was dependent on the experimental technique (soak versus cocrystallization) utilized for ligand−protein complex preparation (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>). This highlights the subtleties of fragment−protein interactions and the value of obtaining multiple structures from diverse chemotypes. The binding mode of the aminothienopyrimidine core of compound <b>16</b> was consistent with that observed in crystals obtained via cocrystallization and was maintained in all subsequent analogues synthesized during the optimization phase. Interestingly, the binding mode for <b>10</b> obtained via ligand soak was reminiscent of that observed with the resorcinol inhibitor <b>5</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>), with the 2-amino moiety of the triazole mimicking the key interactions made by the 2-hydroxyl group in <b>5</b>. A further feature taken into account was the flexibility of the L107 residue, which adopts several ligand dependent orientations in the displayed data.</div><figure id="fig6" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900357y/production/images/medium/jm-2009-00357y_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900357y/production/images/large/jm-2009-00357y_0009.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Combining fragment and virtual screening hits; evolution to the 2-aminothieno[2,3-<i>d</i>]pyrimidine scaffold.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900357y/production/images/large/jm-2009-00357y_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900357y&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Although the affinity of compound <b>16</b> measured by FP assay was low (FP IC<sub>50</sub> = 1250 μM; Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>), we were confident from both structural information and the SAR available that incorporation of an aryl group at the 4-position of the 2-aminothieno[2,3-<i>d</i>]pyrimidine scaffold would lead to enhanced potency. A number of 4-aryl-2-aminothienopyrimidines were synthesized (Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>) and indeed displayed greatly enhanced affinity for the protein target (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). In addition, these compounds also inhibited the proliferation of cancer cell lines in vitro, as demonstrated by their GI<sub>50</sub> values against a human colon carcinoma (HCT116) cell line (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). The SAR (though limited) suggested that small lipophilic groups at the aryl 2′- and 4′-positions were advantageous in terms of affinity and antiproliferative effects. It seemed probable that further improvements in cell potency could be effected by incorporation of a solubilizing group into the amino thieno[2,3-<i>d</i>]pyrimidine scaffold. The structural information gained from the X-ray crystal structure of compound <b>21e</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>; PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2WI6">2WI6</a>) suggested that the 5′-position of the thienopyrimidine 4-aryl substituent was a suitable position for such a solubilizing moiety. A powerful tenet of structure-based design is that it allows structural information from one chemotype to be applied to other distinct chemical series. Comparing the X-ray crystal structures of <b>21e</b> and the resorcinol inhibitor <b>5</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>; PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2VCI">2VCI</a>) provided support for the planned solubilizing group position, as the vector from the 5′-position would orient solubilizing groups to a similar spatial region (toward solvent) as that occupied by the morpholine solubilizing moiety in <b>5</b>. By using the 5′-phenolic hydroxyl group as a handle for chemical derivatization, the diethylaminoethyl compound <b>34a</b> was prepared (Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a>). Compound <b>34a</b> demonstrated enhanced affinity (FP IC<sub>50</sub> = 0.056 μM) for the protein target (that could be rationalized by structural data, vide infra) and, in addition, displayed greatly enhanced antiproliferative activity (as compared to <b>21e</b>), with a GI<sub>50</sub> (HCT116) of 0.187 μM. Furthermore, <b>34a</b> demonstrated potency against a wider range of cell lines as shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>. Evaluation of in vitro drug metabolism and pharmacokinetic (DMPK) parameters, including plasma protein binding (PPB), microsomal turnover (TO), and cytochrome P450 inhibition established an acceptable druglike profile for <b>34a</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>). It was important to establish that the new compounds still retained the well-established molecular signature of known Hsp90 inhibitors on cellular biomarkers that would be indicative of target modulation (i.e., degradation of Hsp90 client proteins and up-regulation of the cochaperone Hsp72).<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a> shows that the compound <b>34a</b> gave the expected depletion of the client proteins CRAF and CDK4 and induction of Hsp72 in BT474 and HCT116 cells in vitro in a concentration-dependent manner, as determined by Western immunoblotting. Depletion of the client protein HER2 (ErbB2) was observed for BT474 cells treated with <b>34a</b> though the expression levels of HER2 in HCT116 cells are too low to be predictive in this cell line, and thus no expression was seen even with control. These biomarker study results supported the premise that the effects on cell growth were a consequence of chaperone inhibition.</div><figure id="fig7" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900357y/production/images/medium/jm-2009-00357y_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900357y/production/images/large/jm-2009-00357y_0010.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Effects of <b>34a</b> on expression of HER2, Hsp72, CRAF, and CDK4 in BT474 and HCT116 cells as determined by Western blot after 24 h. Compounds concentrations were 25, 50, 100, 200, and 400 nM concentrations. GAPDH was used as a loading control. Expression levels of HER2 in HCT116 cells are too low to be detected (consistent with etiology of this cell line).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900357y/production/images/large/jm-2009-00357y_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900357y&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Binding Affinities<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a> for Hsp90 ATP Binding Site Measured by Fluorescence Polarization Assay and Antiproliferation Potency (GI<sub>50</sub>)<a class="ref internalNav" href="#tbl2-fn1" aria-label="b">b</a> in a Human HCT116 Colon Carcinoma Cell Line for Selected 2-Amino-4-aryl-thieno[2,3-<i>d</i>]pyrimidine Hsp90 Inhibitors</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900357y/production/images/medium/jm-2009-00357y_0003.gif" alt="" id="fx1" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="center" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="rowsep1"><th class="rowsep1" align="center">compd no.</th><th class="rowsep1" align="center">X</th><th class="rowsep1" align="center">Y</th><th class="rowsep1" align="center" char=".">FP IC<sub>50</sub> (μM)</th><th class="rowsep1" align="center" char=".">GI<sub>50</sub> (HCT116) (μM)</th></tr></thead><tbody><tr valign="top"><td align="center"><b>21a</b></td><td align="left">H</td><td align="left">H</td><td align="char" char=".">5.7</td><td align="char" char=".">14.3</td></tr><tr valign="top"><td align="center"><b>21b</b></td><td align="left">H</td><td align="left">Cl</td><td align="char" char=".">0.72</td><td align="char" char=".">8.47</td></tr><tr valign="top"><td align="center"><b>21c</b></td><td align="left">Me</td><td align="left">Me</td><td align="char" char=".">0.34</td><td align="char" char=".">4.24</td></tr><tr valign="top"><td align="center"><b>21d</b></td><td align="left">Me</td><td align="left">CN</td><td align="char" char=".">0.30</td><td align="char" char=".">1.34</td></tr><tr valign="top"><td align="center"><b>21e</b></td><td align="left">Cl</td><td align="left">Cl</td><td align="char" char=".">0.23</td><td align="char" char=".">0.82</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>a</sup><p class="last">Values are reported as a mean of at least two independent determinations.</p></div><div class="footnote" id="tbl2-fn1"><sup>b</sup><p class="last">Antiproliferative potency as indicated by concentrations which lead to 50% growth inhibition (GI<sub>50</sub>) in a SRB assay.</p></div></div></div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Binding Affinity (FP Assay) and Antiproliferative Potency,<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a><sup>,</sup><a class="ref internalNav" href="#t3fn2" aria-label="b">b</a> (GI<sub>50</sub>) in Various Human Cancer Cell Lines for Compound <b>34a</b></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="rowsep1"><th class="rowsep1" align="center">compd no.</th><th class="rowsep1" align="center">human Hsp90β FP IC<sub>50</sub> (μM)</th><th class="rowsep1" align="center">HCT116 (colon) GI<sub>50</sub> (μM)</th><th class="rowsep1" align="center">BT474 (breast) GI<sub>50</sub> (μM)</th><th class="rowsep1" align="center">PC3 M (prostate) GI<sub>50</sub> (μM)</th><th class="rowsep1" align="center">A2058 (melanoma) GI<sub>50</sub> (μM)</th><th class="rowsep1" align="center">WM226.4 (melanoma) GI<sub>50</sub> (μM)</th><th class="rowsep1" align="center">A549 (lung) GI<sub>50</sub> (μM)</th></tr></thead><tbody><tr valign="top"><td align="center"><b>34a</b></td><td align="center">0.056</td><td align="center">0.187</td><td align="center">0.073</td><td align="center">0.498</td><td align="center">0.108</td><td align="center">0.145</td><td align="center">0.167</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>a</sup><p class="last">Values are reported as the mean of at least two independent determinations.</p></div><div class="footnote" id="t3fn2"><sup>b</sup><p class="last">Antiproliferative potency as indicated by concentrations which lead to 50% growth inhibition (GI<sub>50</sub>) in a SRB assay.</p></div></div></div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Measurement of Microsomal Turnover,<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a> Plasma Protein Binding (PPB),<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a> and Cytochrome P450 Inhibition<a class="ref internalNav" href="#t4fn3" aria-label="c">c</a> for Compound <b>34a</b></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="rowsep1"><th class="rowsep1" align="center"> </th><th class="rowsep1" colspan="3" align="center">microsomal turnover (%)</th><th class="rowsep1" colspan="3" align="center">PPB (% bound)</th><th class="rowsep1" colspan="5" align="center">CYP450 IC<sub>50</sub> (μM)</th></tr><tr valign="top"><th align="center" valign="top">compd no.</th><th align="center" valign="top">mouse</th><th align="center" valign="top">rat</th><th align="center" valign="top">human</th><th align="center" valign="top">mouse</th><th align="center" valign="top">rat</th><th align="center" valign="top">human</th><th align="center" valign="top">CYP 1A2</th><th align="center" valign="top">CYP 2C9</th><th align="center" valign="top">CYP 3A4</th><th align="center" valign="top">CYP 2D6</th><th align="center" valign="top">CYP 2C19</th></tr></thead><tbody><tr valign="top"><td align="center"><b>34a</b></td><td align="center">19.3</td><td align="center">16.9</td><td align="center">17.3</td><td align="center">90.7</td><td align="center">90.1</td><td align="center">96.2</td><td align="center">>10</td><td align="center">>10</td><td align="center">>10</td><td align="center">>10</td><td align="center">0.34</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>a</sup><p class="last">Data shown is the percent turnover of compound (<i>n</i> = 3) after a 10 min incubation of compound and NADPH. The results are expressed as percentage of controls without NADPH.</p></div><div class="footnote" id="t4fn2"><sup>b</sup><p class="last">Measured by equilibrium dialysis after a 6 h incubation.</p></div><div class="footnote" id="t4fn3"><sup>c</sup><p class="last">Values are reported as the mean of at least two independent determinations.</p></div></div></div><div class="NLM_p">These data and the subsequent evaluation of compound plasma concentrations (Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>) and compound tolerability following oral administration led to the selection of <b>34a</b> for a study of in vivo efficacy in a human cancer xenograft model. Thus <b>34a</b> was dosed at 50 and 100 mg/kg po daily to female Ncr athymic mice bearing established bilateral subcutaneous WM266.4 human melanoma tumors, a model we had previously shown to be responsive to NVP-AUY922.<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> Both dosing regimes demonstrated significant efficacy after 21 days of dosing. The values for percent treated/control ratio (<i>T</i>/<i>C</i>) were 24.6 and 15.9%, at doses of 50 and 100 mg/kg, respectively (Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a>), indicating 75.4 and 84.1% inhibition of tumor growth. Evidence of tumor biomarker modulation was also observed in this study (Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a>). The 50 mg/kg dose was well tolerated, with no significant body weight loss over the treatment period; the 100 mg/kg dose was less well tolerated, however, resulting in body weight loss and several dosing interruptions. Compound <b>34a</b> also showed good activity in the PC3 human prostate cancer xenograft model in which the tumors were grown orthotopically in the mouse prostate gland. Daily (po) doses of 50 and 100 mg/kg of <b>34a</b> gave <i>T</i>/<i>C</i> values of 23.0 and 19.9%, respectively (77.0 and 80.1% inhibition), with similar inhibition of local and distal lymph node metastases and evidence of biomarker modulation (data in <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>).</div><figure id="fig8" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900357y/production/images/medium/jm-2009-00357y_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900357y/production/images/large/jm-2009-00357y_0011.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Response of established WM266.4 human melanoma xenografts to <b>34a</b> therapy (50 and 100 mg/kg, qd, po). (A) Relative tumor volumes (compared with volumes at start of therapy). Key: black squares, vehicle controls; red triangles, <b>34a</b> at 50 mg/kg po; green inverted triangles, <b>34a</b> at 100 mg/kg po. (B) Mean weights of excised tumors after 21 days therapy. (C) Mean mouse body weights during therapy. (D) Pharmacodynamic biomarker changes assessed by Western blotting (24 h after final dose).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900357y/production/images/large/jm-2009-00357y_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900357y&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Binding Affinities<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a> for Hsp90, Antiproliferation Potency<a class="ref internalNav" href="#t5fn2" aria-label="b">b</a>, and Pharmacokinetic Parameters<a class="ref internalNav" href="#t5fn3" aria-label="c">c</a> for Selected 2-Aminothieno[2,3-<i>d</i>]pyrimidines</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="rowsep1"><th class="rowsep1" align="center">compd no.</th><th class="rowsep1" align="center" char=".">FP IC<sub>50</sub> (μM)</th><th class="rowsep1" align="center" char=".">GI<sub>50</sub> (BT474) (μM)</th><th class="rowsep1" align="center" char=".">AUC<sub>last</sub> (ng·h/mL)</th><th class="rowsep1" align="center" char="."><i>C</i><sub>max</sub> (ng/mL)</th><th class="rowsep1" align="center" char="."><i>T</i><sub>max</sub> (h)</th><th class="rowsep1" align="center" char=".">half life (h)</th></tr></thead><tbody><tr valign="top"><td align="left"><b>34a</b></td><td align="char" char=".">0.056</td><td align="char" char=".">0.073</td><td align="char" char=".">858</td><td align="char" char=".">238</td><td align="char" char=".">0.5</td><td align="char" char=".">2.2</td></tr><tr valign="top"><td align="left"><b>34b</b></td><td align="char" char=".">0.064</td><td align="char" char=".">0.075</td><td align="char" char=".">622</td><td align="char" char=".">160</td><td align="char" char=".">2.0</td><td align="char" char=".">2.6</td></tr><tr valign="top"><td align="left"><b>34c</b></td><td align="char" char=".">0.047</td><td align="char" char=".">0.095</td><td align="char" char=".">4831</td><td align="char" char=".">702</td><td align="char" char=".">1.0</td><td align="char" char=".">5.3</td></tr><tr valign="top"><td align="left"><b>34d</b></td><td align="char" char=".">0.058</td><td align="char" char=".">0.053</td><td align="char" char=".">1155</td><td align="char" char=".">380</td><td align="char" char=".">2.0</td><td align="char" char=".">2.5</td></tr><tr valign="top"><td align="left"><b>34e</b></td><td align="char" char=".">0.127</td><td align="char" char=".">0.072</td><td align="char" char=".">125</td><td align="char" char=".">437</td><td align="char" char=".">0.25</td><td align="char" char=".">0.1</td></tr><tr valign="top"><td align="left"><b>34f</b></td><td align="char" char=".">0.08</td><td align="char" char=".">0.072</td><td align="char" char=".">1354</td><td align="char" char=".">396</td><td align="char" char=".">2</td><td align="char" char=".">1.6</td></tr><tr valign="top"><td align="left"><b>34g</b></td><td align="char" char=".">0.029</td><td align="char" char=".">0.135</td><td align="char" char="."><a class="ref internalNav" href="#t5fn4" aria-label="d">d</a></td><td align="char" char="."><a class="ref internalNav" href="#t5fn4" aria-label="d">d</a></td><td align="char" char="."><a class="ref internalNav" href="#t5fn4" aria-label="d">d</a></td><td align="char" char="."><a class="ref internalNav" href="#t5fn4" aria-label="d">d</a></td></tr><tr valign="top"><td align="left"><b>34h</b></td><td align="char" char=".">0.080</td><td align="char" char=".">0.047</td><td align="char" char="."><a class="ref internalNav" href="#t5fn5" aria-label="e">e</a></td><td align="char" char="."><a class="ref internalNav" href="#t5fn5" aria-label="e">e</a></td><td align="char" char="."><a class="ref internalNav" href="#t5fn5" aria-label="e">e</a></td><td align="char" char="."><a class="ref internalNav" href="#t5fn5" aria-label="e">e</a></td></tr><tr valign="top"><td align="left"><b>34i</b></td><td align="char" char=".">0.176</td><td align="char" char=".">0.089</td><td align="char" char=".">1222</td><td align="char" char=".">370</td><td align="char" char=".">1</td><td align="char" char=".">2.5</td></tr><tr valign="top"><td align="left"><b>34j</b></td><td align="char" char=".">0.087</td><td align="char" char=".">0.097</td><td align="char" char=".">1698</td><td align="char" char=".">153</td><td align="char" char=".">4.0</td><td align="char" char=".">3.1</td></tr><tr valign="top"><td align="left"><b>34k</b></td><td align="char" char=".">0.102</td><td align="char" char=".">0.088</td><td align="char" char=".">854</td><td align="char" char=".">304</td><td align="char" char=".">2.0</td><td align="char" char=".">1.7</td></tr><tr valign="top"><td align="left"><b>34l</b></td><td align="char" char=".">0.084</td><td align="char" char=".">0.103</td><td align="char" char=".">956</td><td align="char" char=".">328</td><td align="char" char=".">2.0</td><td align="char" char=".">1.4</td></tr><tr valign="top"><td align="left"><b>34m</b></td><td align="char" char=".">0.058</td><td align="char" char=".">0.134</td><td align="char" char=".">208</td><td align="char" char=".">170</td><td align="char" char=".">0.25</td><td align="char" char=".">0.8</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup>a</sup><p class="last">Measured by FP assay, mean of at least two determinations.</p></div><div class="footnote" id="t5fn2"><sup>b</sup><p class="last">GI<sub>50</sub> values in a human breast cancer cell line (BT474), mean of at least two determinations.</p></div><div class="footnote" id="t5fn3"><sup>c</sup><p class="last">Plasma pharmacokinetics generated following a 10 mg/kg oral dose to male Balb-c mice.</p></div><div class="footnote" id="t5fn4"><sup>d</sup><p class="last">Not reported. Compound was only detected in a few samples (0.5 to 2 h) all below the limit of quantification (LLoQ 50 ng/mL).</p></div><div class="footnote" id="t5fn5"><sup>e</sup><p class="last">Not reported; compound only detected above the LLoQ, (50 ng/mL) at 15 min with a concentration of 296 ng/mL.</p></div></div></div><div class="NLM_p">These promising early findings led to synthesis and evaluation of analogues of <b>34a</b>. On the basis of binding affinity, antiproliferative potency, and in vitro DMPK properties, a further 12 compounds (Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a> and Scheme <a class="ref internalNav" href="#sch5" aria-label="5">5</a>, <b>34b</b>−<b>m</b>) were selected for oral pharmacokinetic (PK) studies in mice with a view to selecting compounds with an appropriate profile for additional pharmacodynamic biomarker studies and tumor xenograft efficacy experiments. Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a> shows binding affinity, antiproliferative data in a BT474 human breast cancer cell line (previously shown to be responsive to NVP-AUY922),<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> and pharmacokinetic data following oral dosing at 10 mg/kg for compounds <b>34a</b>−<b>m</b>. The ability of this set of analogues to modulate pharmacodynamic biomarkers in BT474 breast cancer cells was also determined. All 13 compounds listed in Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a> induced Hsp72 and significantly reduced HER2 expression as well as decreasing the levels of the Hsp90 client protein pAKT (Ser473 phosphorylated AKT) at concentrations of between 2 and 8 times their GI<sub>50</sub>. A subset of these results (for <b>34a</b>−<b>d</b> and <b>34i</b>−<b>j</b>) is shown in Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a>. In these examples, pharmacodynamic biomarkers are affected at compound concentrations of 2 and/or 4 times GI<sub>50</sub> for compounds <b>34a</b>−<b>d</b> and <b>34j</b> and at 4 and 8 times GI<sub>50</sub> for compound <b>34i</b>. Analysis of these and other profiling data such as microsomal stability (human, rat and mouse), hepatic clearance, and potency against cytochrome P450 isoforms led to the selection of compounds <b>34a</b>−<b>d</b> and <b>34i</b>−<b>j</b> for evaluation in a human BT474 breast cancer xenograft model in vivo. The effects of these compounds on the growth of established BT474 human breast cancer xenografts are shown in Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a> and Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>. Four of the compounds were efficacious in this model following once daily oral dosing at 30 mg/kg, and indeed, <b>34a</b>, <b>34b</b>, <b>34d</b> and <b>34i</b> caused tumor regressions of up to 28% (Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>). Two compounds (<b>34c</b> and <b>34j</b>) were not efficacious in this model, and two compounds (<b>34c</b> and <b>34b)</b> were not well tolerated using the selected dosing regime (Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>). For all four of the compounds that caused tumor regression, the expected mechanism-based pharmacodynamic biomarker responses were seen in the tumor tissues, indicative of Hsp90 inhibition (Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a>). These included the abrogation of the interaction between Hsp90 and p23, the degradation of HER2, and a decrease in levels of pAKT. In contrast, <b>34j</b>, which did not inhibit tumor cell growth in BT474 xenograft model, appeared to effect less robust pharmacodynamic biomarker changes (Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a>) despite high plasma exposure (Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>). As <b>34j</b> affected pharmacodynamic markers in vitro and displayed equivalent in vitro potency, it could be surmised that the compound did not attain appropriate tumor exposure, although in the absence of measured tumor concentrations for this particular study, this hypothesis was not confirmed. Overall, the tumor pharmacodynamic data shown in Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a> (and that from corresponding in vitro studies) support the notion that the tumor regression observed with four thienopyrimidines, <b>34a</b>, <b>34b</b>, <b>34d</b> and <b>34i</b> is due to inhibition of Hsp90 ATPase enzymatic activity.</div><figure id="fig9" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900357y/production/images/medium/jm-2009-00357y_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900357y/production/images/large/jm-2009-00357y_0013.jpeg" id="gr14" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Effects of thienopyrimidines <b>34a</b>−<b>d</b> and <b>34i</b>−<b>j</b> on expression of HER2, pAKT, and Hsp72 in BT474 cells as determined by Western blot at 24 h. Cells were exposed to compounds <b>34a</b>−<b>d</b> and <b>34j</b> at 4 and 2 times GI<sub>50</sub>, and compound <b>34i</b> was used at 8 and 4 times GI<sub>50</sub>. GAPDH was used as a loading control.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900357y/production/images/large/jm-2009-00357y_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900357y&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig10" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900357y/production/images/medium/jm-2009-00357y_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900357y/production/images/large/jm-2009-00357y_0012.jpeg" id="gr15" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Response of established BT474 human breast cancer xenografts to therapy with thienopyrimidines <b>34a</b>−<b>d</b> and <b>34i</b>−<b>j</b> (30 mg/kg, qd, po). (A) Mean relative tumor volumes. (B) Mean body weight changes in % during therapy. Bars represent SEM * <i>p</i> < 0.05, one-way ANOVA post hoc Dunnet’s.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900357y/production/images/large/jm-2009-00357y_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900357y&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig11" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900357y/production/images/medium/jm-2009-00357y_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900357y/production/images/large/jm-2009-00357y_0014.jpeg" id="gr16" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Tumor pharmacodynamic biomarker changes in nude mice bearing established BT474 human breast cancer xenografts following daily dosing of at 30 mg/kg of <b>34a</b>, <b>34b</b>, <b>34d</b>, <b>34j</b> or <b>34i</b>. BT474 tumors were collected from treated nude mice at the end of the efficacy experiment and assayed for either dissociation of p23 from Hsp90α or for client protein degradation (6 h after final dose).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900357y/production/images/large/jm-2009-00357y_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900357y&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig12" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900357y/production/images/medium/jm-2009-00357y_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900357y/production/images/large/jm-2009-00357y_0016.jpeg" id="gr17" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. Detail of the X-ray structure of compound <b>34d</b> bound to the ATP binding site of the N-terminal domain of human Hsp90α (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2WI7">2WI7</a>), showing selected amino acids and listing key ligand−protein interactions (note main chain atoms of N51 removed for clarity). Red spheres represent structurally conserved water molecules with key hydrogen bonding network shown as dotted lines. (A) Key H-bonds (to water and D93); (B) thieno-ring stacking with M98; (C) chlorine filling small amphiphilic pocket; (D) H-bond interaction with G97; (E) lipophilic interaction with L107/F138 and stacking with N51; (F) solvent exposed; (G) water-mediated H-bond to F138.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900357y/production/images/large/jm-2009-00357y_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900357y&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Tumor and Host Responses of BT474 Human Breast Cancer Xenograft Bearing Nude Mice to <b>34a</b>−<b>d</b> and <b>34i</b>−<b>j</b> Therapy<a class="ref internalNav" href="#tbl6-fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="center" /></col><col align="center" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="/" /></col></colgroup><thead><tr valign="top"><th align="center"> </th><th class="rowsep1" colspan="3" align="center">tumor response</th><th class="rowsep1" colspan="3" align="center" char="±">host response</th></tr><tr valign="top" class="rowsep1"><th class="rowsep1" align="center">compd no.</th><th class="rowsep1" align="center">T/C (%)</th><th class="rowsep1" align="center">regression (%)</th><th class="rowsep1" align="center" char="±">Δ tumor vol<a class="ref internalNav" href="#t6fn1" aria-label="b">b</a> (mm<sup>3</sup>)</th><th class="rowsep1" align="center" char="±">Δ body wt (g)</th><th class="rowsep1" align="center" char="±">Δ body wt (%)</th><th class="rowsep1" align="center" char="/">survival (alive/total)</th></tr></thead><tbody><tr valign="top"><td align="left">vehicle</td><td align="center">100</td><td align="center"> </td><td align="char" char="±">372 ± 52</td><td align="char" char="±">−3.0 ± 1.0</td><td align="char" char="±">−11 ± 3.6</td><td align="char" char="/">8/8</td></tr><tr valign="top"><td align="left"><b>34a</b></td><td align="center"> </td><td align="center">28.4</td><td align="char" char="±">−29 ± 12</td><td align="char" char="±">−3.1 ± 1.5</td><td align="char" char="±">−11 ± 5.2</td><td align="char" char="/">7/8</td></tr><tr valign="top"><td align="left"><b>34b</b></td><td align="center"> </td><td align="center">15.6</td><td align="char" char="±">−15 ± 47</td><td align="char" char="±">−2.3 ± 1.1</td><td align="char" char="±">−7.8 ± 3.6</td><td align="char" char="/">4/8</td></tr><tr valign="top"><td align="left"><b>34c</b></td><td align="center">85</td><td align="center"> </td><td align="char" char="±">316 ± 121</td><td align="char" char="±">−4.1 ± 1.3</td><td align="char" char="±">−14 ± 4.7</td><td align="char" char="/">6/8</td></tr><tr valign="top"><td align="left"><b>34d</b></td><td align="center"> </td><td align="center">3.0</td><td align="char" char="±">−3 ± 15</td><td align="char" char="±">−0.7 ± 1.3</td><td align="char" char="±">−2.3 ± 4.2</td><td align="char" char="/">8/8</td></tr><tr valign="top"><td align="left"><b>34i</b></td><td align="center"> </td><td align="center">27.4</td><td align="char" char="±">−28 ± 13</td><td align="char" char="±">−3.2 ± 1.3</td><td align="char" char="±">−11 ± 4.4</td><td align="char" char="/">8/8</td></tr><tr valign="top"><td align="left"><b>34j</b></td><td align="center">90</td><td align="center"> </td><td align="char" char="±">336 ± 66</td><td align="char" char="±">−1.1 ± 1.1</td><td align="char" char="±">−3.8 ± 4.1</td><td align="char" char="/">8/8</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl6-fn1"><div class="footnote" id="tbl6-fn1"><sup>a</sup><p class="last">The animals were dosed orally once per day at 30 mg/kg in a dose volume of 10 mL/kg. Vehicle was 0.5% sodium carboxymethyl-cellulose.</p></div><div class="footnote" id="t6fn1"><sup>b</sup><p class="last">Treatment was initiated when the average tumor volume reached approximately 100 mm<sup>3</sup>.</p></div></div></div><div class="NLM_p">Compound <b>34d</b> displayed potent antiproliferative effects in a wide range of cell lines covering different human cancer subtypes and genetic abnormalities; the GI<sub>50</sub> values for a representative selection are shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a>. The binding mode of compound <b>34d</b> was established by X-ray crystallography and, as expected, this was consistent with that seen previously for the 2-amino thieno[2,3-<i>d</i>] pyrimidine compound <b>21c</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>). The potency of <b>34d</b> and related analogues can be rationalized by the key interactions the compounds make with the protein within the N-terminal ATP binding site (Figure <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">12</a>). Compound <b>34d</b> makes several water-mediated hydrogen bonding interactions with D93. This critical interaction is seen in the structure of Hsp90 complexed with ADP<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> and indeed all reported Hsp90 inhibitors where structural information is available.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> The amide functionality also makes a direct hydrogen bond interaction with G97, mirroring that seen with the amide moiety of compound <b>5</b> and Hsp90. Key hydrophobic interactions include those with L107, F138 and stacking with N51. The 2′-chloro substituent on the aryl ring induces the two rings to adopt an appropriate angular relationship, which allowed the 2′-chloro to bind in a small lipophilic pocket, displacing a water molecule normally resident. This feature may provide a rationale for the increased binding affinity seen for <b>21c</b>, <b>21d</b>, and <b>21e</b> over <b>21a</b>. Another important water-mediated-interaction is that between the 5′ phenolic oxygen and carbonyl of F138 (interaction G in Figure <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">12</a>). This interaction can be inferred to explain the improved potency of 5′-aryl-alkoxy compounds such <b>34a</b> (FP IC<sub>50</sub> = 0.056 μM) over compounds such as <b>21e</b> (FP IC<sub>50</sub> = 0.230 μM), which cannot make this interaction. These affinity data and the structural information pertaining to <b>21c</b>, <b>34d</b> and related compounds clearly demonstrate the importance of conserved structural water molecules to ligand-protein interaction for Hsp90 inhibitors.</div><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. Binding Affinity (FP Assay) and Antiproliferative Potency (GI<sub>50</sub>) in Various Human Cancer Cell Lines for Compound <b>34d</b><a class="ref internalNav" href="#t7fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="rowsep1"><th class="rowsep1" align="center">compd no.</th><th class="rowsep1" align="center">human Hsp90β FP IC<sub>50</sub> (μM)</th><th class="rowsep1" align="center">HCT116 (colon) GI<sub>50</sub> (μM)</th><th class="rowsep1" align="center">MCF7 (breast) GI<sub>50</sub> (μM)</th><th class="rowsep1" align="center">PC3 M (prostate) GI<sub>50</sub> (μM)</th><th class="rowsep1" align="center">A375 (melanoma) GI<sub>50</sub> (μM)</th><th class="rowsep1" align="center">T24 (bladder) GI<sub>50</sub> (μM)</th><th class="rowsep1" align="center">U87MG (glioma)GI<sub>50</sub> (μM)</th></tr></thead><tbody><tr valign="top"><td align="left"><b>34d</b></td><td align="center">0.058</td><td align="center">0.120</td><td align="center">0.118</td><td align="center">1.05</td><td align="center">0.038</td><td align="center">0.145</td><td align="center">0.857</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t7fn1"><div class="footnote" id="t7fn1"><sup>a</sup><p class="last">Values are reported as the mean of at least two independent determinations.</p></div></div></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i17">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_76771" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_76771" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Several weakly binding Hsp90 inhibitors from distinct chemical classes were identified by a combination of fragment and in silico screening technologies. Analysis of the X-ray structures of these compounds and other inhibitors bound to Hsp90 allowed the design of a novel and orally active 2-aminothieno[2,3-<i>d</i>]pyrimidine class of Hsp90 inhibitor. Compounds from this series displayed binding affinity in the 50−100 nM range, as measured by a FP binding assay and significantly inhibited cell proliferation in a wide range of human cancer cell lines. The characteristic molecular biomarker signature of Hsp90 inhibition was seen in vitro and in vivo for active members of this series, and good exposure levels were obtained following oral administration. Statistically significant efficacy was observed in a subcutaneous BT474 human breast tumor xenograft model for compounds <b>34a</b>, <b>34b</b>, <b>34d</b> and <b>34i</b> when dosed orally qd at 30 mg/kg. This work demonstrates the rapid identification of novel orally active Hsp90 inhibitors from a structure-based research program, which combined elements from various hit identification approaches. Compound <b>34d</b> (NVP-BEP800/VER-82576<a onclick="showRef(event, 'ref81'); return false;" href="javascript:void(0);" class="ref ref81">(81)</a>) has been selected for further development and additional characterization of <b>34d</b>, and compounds from this series will be reported elsewhere.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i18">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_77344" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_77344" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Fluorescence Polarization Assay</h3><div class="NLM_p last">The ability of compounds to compete with a fluorescently labeled probe for binding to full length human Hsp90β was determined as described previously<a onclick="showRef(event, 'ref74'); return false;" href="javascript:void(0);" class="ref ref74">(74)</a> with a modified probe (VER-00051001). This probe binds with greater affinity to Hsp90 than that described previously, allowing the accurate determination of IC<sub>50</sub> for higher affinity compounds. Synthetic procedures for VER-00051001 and details relating to the FP assay can be found in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>.</div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> Cell Growth and Client Protein Degradation</h3><div class="NLM_p last">Growth inhibition assays using the SRB method were undertaken as previously described.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> Client protein degradation was determined by Western blotting. In brief, HCT116 cells were exposed to compounds <b>34a</b>−<b>d</b> and <b>34i</b>−<b>j</b> at 2, 4, or 8 times their cellular GI<sub>50</sub> for 24 h. Cell lysates were prepared in 50 mM Tris-HCl, 2% SDS pH6.8, and protein levels determined by the BCA method (Pierce, Rockford, IL). Equal amounts of lysate were separated by SDS-PAGE and proteins transferred to PVDF membrane. Her2 (ab8054, Abcam), Raf-1 (sc-133, Santa Cruz Biotechnology), and Hsp72 (SPA-810, StressGen) were determined using ECL (GE Bioscience). GAPDH (MAB374, Chemicon International) levels were determined to show equal protein loading.</div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> Pharmacokinetics</h3><div class="NLM_p last">Male Balb-c mice received a single 10 mg/kg dose of compound via oral gavage in 1% methyl cellulose (w/v). Plasma was prepared from terminal blood samples for analysis. LC-MS/MS was used for quantitative bioanalysis, and pharmacokinetic analysis was performed using WinNonLin (Pharsight).</div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> Plasma Protein Binding Measurements</h3><div class="NLM_p last">Plasma protein binding was determined by equilibrium dialysis using a HTDialysis 96-well Teflon block. Compounds were incubated in plasma at 5 μM for 6 h. Plasma and buffer samples were protein precipitated with acetonitrile and the supernatants analyzed by LC/MSMS. Percent bound was calculated as (1 − (buffer/plasma)) × 100.</div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> Microsomal Stability Studies</h3><div class="NLM_p last">Compounds were incubated in liver microsomes (0.5 mg/mL) at 1 μM for 10 min ± 2 mM NADPH. Samples were protein precipitated with acetonitrile and centrifuged, and supernatants were analyzed by LC/MSMS. Turnover was calculated as percent of control samples without NADPH. The experiment was carried out with liver microsomes from three different species (a human mixed pool, C57 mouse and SD rat).</div></div><div id="sec5_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> Efficacy Study in WM266.4 Melanoma Xenografts</h3><div class="NLM_p last">All work was performed in accordance with the Home Office regulations under the Animals (Scientific Procedures) Act 1986 and UKCCCR guidelines.<a onclick="showRef(event, 'ref82'); return false;" href="javascript:void(0);" class="ref ref82">(82)</a> Female Ncr athymic mice 6−8 weeks of age bred in-house were inoculated bilaterally sc with 2 million BRAF mutant human WM266.4 melanoma cells. Therapy with <b>34a</b> commenced on day 6 following tumor cell implantation when tumors were approximately 5 mm mean diameter. Mice were randomized into three groups of 9−10 animals. The compound was dissolved in DMSO and diluted in sterile saline/Tween 20 such that animals received the dose required in 0.1 mL of final solution per 10 g body weight. Final concentrations were DMSO, 10%; Tween 20, 5%; saline: 85%. Controls received an equal volume of vehicle. Animals were dosed daily at 50 or 100 mg/kg compound by oral gavage. Dosing continued until day 21 except for some variations in schedule to allow for body weight loss recovery. Mice receiving 100 mg/kg group were not dosed on days 6, 8, 11, and 16−19. Two mice were culled from the latter group on day 8 and 16 due to loss of condition. Tumor measurements and body weights were recorded three times weekly. The study was terminated on day 21. Cohorts of animals were culled 6, 16, and 24 h after the final dose of compound. Tumors were excised and weighed, and plasma and tumor samples frozen for pharmacokinetic and pharmacodynamic analyses (by Western blotting) as previously described.<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a></div></div><div id="sec5_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> Efficacy Study in BT474 Human Breast Cancer Xenografts</h3><div class="NLM_p last">The ER positive, HER2 overexpressing human breast ductal carcinoma cell line BT-474 was purchased from American Type Culture Collection (HTB-20, Manassas, VA). The cells were grown in DMEM high glucose (4.5 g/L) supplemented with 10% FCS, 200 mM <span class="smallcaps smallerCapital">l</span>-glutamine, and 1% sodium pyruvate (BioConcept, Allschwil, Switzerland). Two or three days prior to cell inoculation, each mouse was subcutaneously implanted on the upper dorsal side with a 17β-estradiol pellet (25 μg/day, 90 day release, Innovative Research of America, FL) using a trocar needle. BT-474 cells (5 × 10<sup>6</sup>) were injected in 200 μL Matrigel:HBSS (1:1 vol) (BD Matrigel Basement Membrane Matrix, BD Biosciences, CA) subcutaneously in the right flank. Treatment was initiated when the average tumor volume reached approximately 100 mm<sup>3</sup>. Tumor growth and body weights were monitored at regular intervals. The xenograft tumor sizes were measured manually with calipers, and the tumor volume was estimated using the formula: (<i>W</i> × <i>L</i> × <i>H</i> × π/6), where width (<i>W</i>), height (<i>H</i>), and length (<i>L</i>) are the three largest diameters. Invasive procedures were performed under Forene anesthesia. All experiments were performed using female Harlan HsdNpa: athymic Nude-nu mice which were obtained from Novartis internal breeding stocks (Laboratory Animal Services, Novartis Pharma AG, Basel, Switzerland). The animals were kept under optimized hygienic conditions (OHC) with a 12 h dark, 12 h light conditions. The animals were fed food and water ad libitum. All animal experiments were performed in strict adherence to the Swiss law for animal protection. The experimental protocols were approved by the Swiss Kantonal Veterinary Office of Basel Stadt.</div></div><div id="sec5_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> Chemistry</h3><div class="NLM_p last">Tested compounds are >95% chemical purity as measured by HPLC (except where stated in the experimental characterization for a particular compound). All compounds tested in vivo are >95% purity. The methods for HPLC analysis and a table of data for all tested compounds is provided in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>.</div></div><div id="sec5_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> 4-Methylsulfanyl-6-phenyl-[1,3,5]-triazin-2-ylamine (<b>14</b>)</h3><div class="NLM_p last">Dimethyl cyanodithioiminocarbonate (Acros, 100 mg, 0.68 mmol) and benzamidine hydrochloride (107 mg, 0.68 mmol) were suspended in EtOH (3 mL), and diisopropylethylamine (0.24 mL, 1.38 mmol) was added. The reaction mixture was heated to 65 °C for 3.5 h. The mixture was allowed to cool to ambient temperature, and the solvents were then removed in vacuo. The residual product was purified by flash chromatography on silica gel, eluting with DCM to afford the title compound <b>14</b> (45 mg, 30%) as a colorless solid: TLC <i>R</i><sub>f</sub> = 0.59 (MeOH/DCM 1:19); LCMS <i>t</i><sub>R</sub> = 2.10 min; <i>m</i>/<i>z</i> = 219 [M + H]<sup>+</sup>. <sup>1</sup>Η ΝΜR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 2.52 (s, 3H), 7.48−7.54 (m, 2H), 7.55−7.63 (m, 3H), 8.29−8.32 (m, 2H). <sup>13</sup>C ΝΜR (100.6 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.6 (CH<sub>3</sub>), 128.0 (CH), 128.5 (CH), 132.1 (CH), 135.6 (C), 165.6 (C), 168.7 (C), 180.7 (C). HRMS, calcd for C<sub>10</sub>H<sub>10</sub>N<sub>4</sub>S [M + H]<sup>+</sup> 219.0704, found 219.0707. HPLC (method C) 99.4% (<i>t</i><sub>R</sub> = 1.18 min).</div></div><div id="sec5_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> 2-(2-Amino-6-methyl-pyrimidin-4-ylsulfanyl)-<i>N</i>-methylacetamide (<b>15</b>)</h3><div class="NLM_p last">A mixture of 2-amino-4-chloro-6-methylpyrimidine (144 mg, 1.0 mmol), 2-mercapto-<i>N</i>-methyl acetamide (105 μL, 1.2 mmol), and triethylamine (167 μL, 1.2 mmol) in MeOH (3 mL) was heated in a microwave synthesizer at 120 °C for 10 min. The reaction mixture was cooled to ambient temperature, and the solvents were then removed in vacuo. The solid residue was purified by preparative HPLC (at pH 4) to afford the title compound <b>15</b> (20 mg, 9%) as a colorless solid: LCMS <i>t</i><sub>R</sub> = 0.45 min; <i>m</i>/<i>z</i> = 213, [M + H]<sup>+</sup>. <sup>1</sup>Η ΝΜR (400 MHz; DMSO-<i>d</i><sub>6</sub>) δ 2.13 (s, 3H), 2.59 (d, 3H, <i>J</i> = 4.5 Hz), 3.73 (s, 2H), 6.40 (s, 1H), 6.60 (brs, 2H), 7.96 (brq, 1H). <sup>13</sup>C ΝΜR (100.6 MHz, DMSO-<i>d</i><sub>6</sub>) δ 23.3 (CH<sub>3</sub>), 26.0 (CH<sub>3</sub>), 31.9 (CH<sub>2</sub>), 105.6 (CH), 162.4 (C), 166.0 (C), 167.9 (C), 168.0 (C). HRMS, calcd for C<sub>8</sub>H<sub>12</sub>N<sub>4O</sub>S [M + H]<sup>+</sup> 213.0810, found 213.0804. HPLC (method C) 99.3% (<i>t</i><sub>R</sub> = 0.55 min).</div></div><div id="sec5_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> 2-Amino-4-chloro-thieno[2,3-<i>d</i>]pyrimidine-6-carboxylic Acid Ethyl Ester (<b>18</b>)</h3><div class="NLM_p last">Ethyl-2-mercaptoacetate (2.86 mL, 26 mmol) was added dropwise to a suspension of 2-amino-4,6-dichloro-5-pyrimidine carbaldehyde (<b>17</b>) (Bionet Research Intermediates, UK; 5.0 g, 26 mmol) and K<sub>2</sub>CO<sub>3</sub> (9.0 g, 65.2 mmol) in MeCN (160 mL). The mixture was heated to 85 °C for 5 h and then allowed to cool to ambient temperature. The mixture was filtered, and the filtered solids were washed with MeCN (2 × 50 mL) and then water (2 × 50 mL) and dried in vacuo at 60 °C to afford the title compound <b>18</b> (5.52 g, 82%) as a yellow solid: LCMS <i>t</i><sub>R</sub> = 2.37 min; <i>m</i>/<i>z</i> = 260, 258 [M + H]<sup>+</sup>. <sup>1</sup>H ΝΜR (400 MHz; DMSO-<i>d</i><sub>6</sub>) δ 2.09 (t, 3H, <i>J</i> = 7.0 Hz), 4.31 (q, 2H, <i>J</i> = 7.0 Hz), 7.70 (brs, 2H), 7.78 (s, 1H).</div></div><div id="sec5_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> 2,4-Diaminothieno[2,3-<i>d</i>]pyrimidine-6-carboxylic Acid Amide (<b>16</b>)</h3><div class="NLM_p last">2-Amino-4-chloro-thieno[2,3-<i>d</i>]pyrimidine-6-carboxylic acid ethyl ester (<b>18</b>) (257 mg, 1.0 mmol) was suspended in aq ammonia solution (5 mL) then heated at 130 °C in a microwave synthesizer for 15 min. The reaction mixture was allowed to cool and concentrated in vacuo. The residue was purified by preparative HPLC (at pH 4) to afford the title compound <b>16</b> (45 mg, 22%) as a colorless solid: LCMS <i>t</i><sub>R</sub> = 0.74 min; <i>m</i>/<i>z</i> = 210, [M + H]<sup>+</sup>. <sup>1</sup>Η ΝΜR (400 MHz; DMSO-<i>d</i><sub>6</sub>) δ 6.29 (brs, 2H), 7.08 (brs, 2H), 7.2−7.4 (brs, 1H), 7.5−7.8 (brs, 1H), 7.82 (s, 1H). HRMS, calcd for C<sub>7</sub>H<sub>7</sub>N<sub>5</sub>O<sub>5</sub> [M + H]<sup>+</sup> 210.0450, found 210.0457. <sup>13</sup>C ΝΜR (100.6 MHz; DMSO-<i>d</i><sub>6</sub>) δ 109.0 (C), 123.0 (CH), 125.9 (C), 159.8 (C), 161.8 (C), 163.7 (C), 170.6 (C). HPLC (method C) 100% (<i>t</i><sub>R</sub> = 0.29 min).</div></div><div id="sec5_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> 2-Amino-4-phenylthieno[2,3-<i>d</i>]pyrimidine-6-carboxylic Acid Ethyl Ester (<b>19a</b>)</h3><div class="NLM_p last">Phenylboronic acid (2.25 g, 18.5 mmol) was added to a mixture of 2-amino-4-chloro-thieno[2,3-<i>d</i>]pyrimidine-6-carboxylic acid ethyl ester <b>18</b> (3.65 g, 14.2 mmol) and NaHCO<sub>3</sub> (3.56 g, 42.6 mmol) in DMF (66 mL) and water (11 mL). The mixture was degassed by evacuation−nitrogen purge (three cycles), followed by bubbling nitrogen gas through the reaction mixture for 10 min. Dichlorobis(triphenylphosphine)palladium(II) catalyst (650 mg, 5 mol %) was added, and the reaction mixture was heated under a nitrogen atmosphere at 80 °C for 5.5 h. The mixture was cooled, solvents were removed in vacuo, and the residue partitioned between water (100 mL) and EtOAc (100 mL). This mixture was filtered through a pad of celite 521, and the filtrate phases were separated. The organic phase was washed with water (100 mL) and then sat. aq NaCl solution (100 mL) and dried over anhydrous Na<sub>2</sub>SO<sub>4</sub> and filtered. The filtrate solvents were removed in vacuo, and the crude product was purified by flash chromatography on silica gel (50 g) eluting with a gradient of 10−50% EtOAc/hexane to afford the title compound <b>19a</b> (2.67 g, 63%) as a yellow solid: LCMS <i>t</i><sub>R</sub> = 2.57 min; <i>m</i>/<i>z</i> = 300 [M + H]<sup>+</sup>. <sup>1</sup>H ΝΜR (400 MHz; DMSO-<i>d</i><sub>6</sub>) δ 1.29 (t, 3H, <i>J</i> = 7.1 Hz), 4.30 (q, 2H, <i>J</i> = 7.1 Hz), 7.39 (brs, 2H), 7.58−7.62 (m, 3H), 7.83−7.89 (m, 2H) 7.87 (s, 1H).</div></div><div id="sec5_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> 2-Amino-4-phenylthieno[2,3-<i>d</i>]pyrimidine-6-carboxylic Acid (<b>20a</b>)</h3><div class="NLM_p last">Sodium hydroxide (134 mg, 3.35 mmol) was added to a suspension of 2-amino-4-phenyl-thieno[2,3-<i>d</i>]pyrimidine-6-carboxylic acid ethyl ester (<b>19a</b>; 200 mg, 0.67 mmol) in EtOH (10 mL) and water (2 mL). The mixture was heated to reflux for 45 min (affording a homogeneous solution) and then allowed to cool. EtOH was removed in vacuo and further water (20 mL) added. The residue pH was adjusted to 1 by dropwise addition of conc HCl. The resulting precipitate was filtered and then washed sequentially with water, EtOH, and diethyl ether and dried in vacuo to afford the title compound <b>20a</b> (130 mg, 72%) as a gray solid: LCMS <i>t</i><sub>R</sub> = 1.79 min; <i>m</i>/<i>z</i> = 272 [M + H]<sup>+</sup>. <sup>1</sup>Η ΝΜR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.32 (brs, 2H), 7.56−7.62 (m, 3H), 7.83 (s, 1H), 7.84−7.88 (m, 2H), 13.41 (brs, 1H).</div></div><div id="sec5_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> 2-Amino-4-phenylthieno[2,3-<i>d</i>]pyrimidine-6-carboxylic Acid Ethylamide (<b>21a</b>)</h3><div class="NLM_p last">2-Amino-4-phenyl-thieno[2,3-d]pyrimidine-6-carboxylic acid (50 mg, 0.18 mmol) was dissolved in DMF (3 mL) and <i>O</i>-(7-azabenzotriazolo-1-yl)-<i>N</i>,<i>N</i>,<i>N</i>′,<i>N</i>′-tetramethyluroniumhexafluorophosphate (HATU; 77 mg, 0.2 mmol) was added followed by ethylamine hydrochloride (23 mg, 0.27 mmol) and diisopropylethylamine (96 μL, 0.54 mmol). The reaction mixture was heated to 100 °C for 10 min in a microwave synthesizer. The mixture was cooled, poured into water, and extracted with EtOAc (25 mL). The phases were separated, and the organic phase was washed with water (2 × 20 mL) then sat. aq NaCl (2 × 20 mL) and dried over Na<sub>2</sub>SO<sub>4</sub>. The mix was filtered, the filtrate solvent removed in vacuo, and the resulting residue purified by flash chromatography on silica gel (5 g) eluting with a gradient of 20−100% EtOAc/hexane to afford the title compound <b>21a</b> (31 mg, 59%) as a yellow solid: LCMS <i>t</i><sub>R</sub> = 2.07 min; <i>m</i>/<i>z</i> = 299 [M + H]<sup>+</sup>. <sup>1</sup>Η ΝΜR (400 MHz; DMSO-<i>d</i><sub>6</sub>) δ 1.11 (t, 3H, <i>J</i> = 7.2 Hz), 3.26 (m, 2H), 7.14 (brs, 2H), 7.57−7.63 (m, 3H), 7.84−7.89 (m, 2H), 8.03 (s, 1H), 8.71 (t, 1H, <i>J</i> = 5.5 Hz). <sup>13</sup>C ΝΜR (100.6 MHz, DMSO-<i>d</i><sub>6</sub>) δ 14.8 (CH<sub>3</sub>), 34.0 (CH<sub>2</sub>), 119.8 (C), 121.8 (CH), 128.7 (CH), 128.8 (CH), 130.3 (CH), 132.1 (C), 137.2 (C), 161.1 (C), 161.2 (C), 163.2 (C), 172.0 (C). HRMS calcd for C<sub>15</sub>H<sub>14</sub>N<sub>4</sub>OS [M + H]<sup>+</sup> 299.0967, found 299.0969. HPLC (method C) 100% (<i>t</i><sub>R</sub> = 1.05 min).</div></div><div id="sec5_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> 2-Amino-4-(2,4-dimethylphenyl)thieno[2,3-<i>d</i>]pyrimidine-6-carboxylic Acid Ethyl Ester (<b>19c</b>)</h3><div class="NLM_p last">This compound was made using the synthetic procedure described for compound <b>19a</b>. Thus 2,4-dimethylphenylboronic acid (1.06 g, 7.06 mmol) was reacted with 2-amino-4-chloro-thieno[2,3-<i>d</i>]pyrimidine-6-carboxylic acid ethyl ester <b>18</b> (1.401 g, 5.43 mmol). The crude product was purified by flash chromatography on silica gel (50 g) eluting with a gradient of 10−50% EtOAc/hexane to afford the title compound <b>19c</b> (1.11 g, 63%) as an off-white solid: TLC <i>R</i><sub>f</sub> = 0.48 (1:1 EtOAc/hexane). LCMS <i>t</i><sub>R</sub> = 2.73 min; <i>m</i>/<i>z</i> = 328 [M + H]<sup>+</sup>. <sup>1</sup>Η ΝΜR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.26 (t, 3H, <i>J</i> = 7.1 Hz), 2.21 (s, 3H), 2.36 (s, 3H), 4.15 (q, 2H, <i>J</i> = 7.1 Hz), 7.16 (d, 1H, <i>J</i> = 7.8 Hz), 7.20 (s, 1H), 7.27 (d, 1H, <i>J</i> = 7.8 Hz), 7.36 (brs, 2H), 7.37 (s, 1H).</div></div><div id="sec5_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> 2-Amino-4-(2,4-dimethylphenyl)thieno[2,3-<i>d</i>]pyrimidine-6-carboxylic Acid Ethylamide (<b>21c</b>)</h3><div class="NLM_p last">2-Amino-4-(2,4-dimethyl-phenyl)-thieno[2,3-<i>d</i>]pyrimidine-6-carboxylic acid ethyl ester <b>19c</b> (353 mg, 1.07 mmol) was suspended in ethylamine in methanol solution (2.0 M, 4 mL, 8.0 mmol) and the mixture was heated in a sealed vial (Caution) at 85 °C for 18 h. The reaction mixture was cooled to 0 °C, the vial was opened, and the solvents were removed in vacuo. The solid residue was purified by flash chromatography on silica gel (10 g) eluting with a gradient of 25−70% EtOAc/hexane to afford the title compound <b>21c</b> (252 mg, 72%) as a colorless solid: TLC <i>R</i><sub>f</sub> = 0.19 (1:1 EtOAc/hexane); LCMS <i>t</i><sub>R</sub> = 2.28 min; <i>m</i>/<i>z</i> = 327 [M + H]<sup>+</sup>. <sup>1</sup>Η ΝΜR (400 MHz; DMSO-<i>d</i><sub>6</sub>) δ 1.06 (t, 3H, <i>J</i> = 7.1 Hz), 2.20 (s, 3H), 2.36 (s, 3H), 3.21 (m, 2H), 7.10 (brs, 2H), 7.16 (d, 1H, <i>J</i> = 7.9 Hz), 7.20 (s, 1H), 7.26 (d, 1H, <i>J</i> = 7.9 Hz), 7.56 (s, 1H)7.36 (brs, 2H), 7.37 (s, 1H), 8.60 (brt, 1H, <i>J</i> = 5.6 Hz). <sup>13</sup>C ΝΜR (100.6 MHz; DMSO-<i>d</i><sub>6</sub>) δ 14.7 (CH<sub>3</sub>), 19.5 (CH<sub>3</sub>), 20.8 (CH<sub>3</sub>), 34.0 (CH<sub>2</sub>), 121.4 (C), 121.7 (CH), 126.4 (CH), 129.0 (CH), 131.2 (CH), 132.0 (C), 134.0 (C), 135.2 (C), 138.5 (C), 161.0 (C), 161.1 (C), 165.1 (C), 171.2 (C). HRMS calcd for C<sub>17</sub>H<sub>18</sub>N<sub>4</sub>OS [M + H]<sup>+</sup> 327.1280, found 327.1284. HPLC (method A) 98.6% (<i>t</i><sub>R</sub> = 4.10 min).</div></div><div id="sec5_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> 1-Benzyloxy-2,4-dichloro-5-nitrobenzene (<b>23</b>)</h3><div class="NLM_p last">Potassium carbonate (12 g, 87 mmol) was added to a solution of 2,4-dichloro-5-nitrophenol (<b>22</b>, Lancaster Synthesis, Morecambe, Lancashire, UK; 15.6 g, 75 mmol) in acetone (200 mL). Benzyl bromide (9.0 mL, 76 mmol) was added and the suspension heated at reflux for 18 h. The resulting suspension was allowed to cool, water (500 mL) was added, and the mixture was extracted with DCM (2 × 200 mL). The combined extracts were washed sequentially with aq sodium hydroxide (2.0 M; 150 mL), water (2 × 200 mL) and sat. aq NaCl solution (150 mL). The solution was dried over anhydrous Na<sub>2</sub>SO<sub>4</sub> and concentrated in vacuo to afford the title compound <b>23</b> (21.5 g, 96%) as a pale-yellow solid: TLC <i>R</i><sub>f</sub> = 0.73 (DCM); LCMS <i>t</i><sub>R</sub> = 2.92 min; <i>m</i>/<i>z</i> = no ionization. <sup>1</sup>Η ΝΜR (400 MHz; CDCl<sub>3</sub>) δ 5.20 (s, 2H), 7.34−7.51 (m, 5H), 7.56 (s, 1H), 7.58 (s, 1H).</div></div><div id="sec5_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> 5-Benzyloxy-2,4-dichlorophenylamine (<b>24</b>)</h3><div class="NLM_p last">Iron powder (21 g, 376 mmol) was added to a suspension of 1-benzyloxy-2,4-dichloro-5-nitrobenzene (<b>23</b>; 21.5 g, 72 mmol) in acetic acid (300 mL) and water (150 mL) and the mixture was heated at 85 °C (oil bath temperature) for 90 min. The resulting suspension was filtered while still hot and then allowed to cool. Water (750 mL) was added and the mixture extracted with DCM (3 × 150 mL). The combined extracts were washed with aq sodium hydroxide (2.0 M, 300 mL), water (2 × 500 mL), and sat. aq NaCl solution (200 mL). The solution was dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered, and the filtrate solvents removed in vacuo to afford the title compound <b>24</b> (18.6 g, 96%) as a pale-brown solid: TLC <i>R</i><sub>f</sub> = 0.57 (DCM); LCMS <i>t</i><sub>R</sub> = 2.79 min; <i>m</i>/<i>z</i> = 270, 268 [M + H]<sup>+</sup>. <sup>1</sup>Η ΝΜR (400 MHz, CDCl<sub>3</sub>) δ 5.20 (s, 2H), 7.34−7.48 (m, 5H), 7.56 (s, 1H), 7.58 (s, 1H).</div></div><div id="sec5_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> 1-Benzyloxy-2,4-dichloro-5-iodobenzene (<b>25</b>)</h3><div class="NLM_p last">Hydrochloric acid (6.0 M, 60 mL) was added to a solution of 5-benzyloxy-2,4-dichlorophenylamine (<b>24</b>; 16.2 g, 60 mmol) in acetic acid (240 mL) and the resulting suspension cooled (ice/water/salt bath). A solution of sodium nitrite (4.8 g, 69.5 mmol) in water (40 mL) was added slowly (keeping the internal temperature <5 °C). On complete addition, the resulting solution was stirred for 30 min and then the resulting solution was poured into a solution of potassium iodide (20 g, 120 mmol) and iodine (4 g, 16 mmol) in water (200 mL), and the mixture was stirred for 90 min. Water (800 mL) was added and the mixture extracted with dichloromethane (3 × 250 mL). The combined extracts were washed with 10% (w/v) aq sodium thiosulfate solution (2 × 150 mL), aq sodium hydroxide (2.0 M; 250 mL), water (2 × 250 mL), and sat. aq sodium chloride solution (200 mL). The solution was dried over anhydrous Na<sub>2</sub>SO<sub>4</sub> and concentrated in vacuo to afford the title compound <b>25</b> (20.6 g, 90%) as a pale-brown solid: TLC: <i>R</i><sub>f</sub> = 0.82 (DCM); LCMS <i>t</i><sub>R</sub> = 3.08 min; <i>m</i>/<i>z</i> = no ionization. <sup>1</sup>Η ΝΜR (400 MHz; CDCl<sub>3</sub>) δ 5.10 (s, 2H), 7.33−7.48 (m, 7H).</div></div><div id="sec5_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> 2-Amino-4-(5-benzyloxy-2,4-dichlorophenyl)thieno[2,3-<i>d</i>]pyrimidine-6-carboxylic Acid Ethyl Ester (<b>26</b>)</h3><div class="NLM_p last">Potassium acetate (16 g, 163 mmol) was added to a solution of 1-benzyloxy-2,4-dichloro-5-iodo-benzene (<b>25</b>, 20.6 g, 54 mmol) and bis(pinacolato)diboron (Boron Molecular; 14.5 g, 57 mmol) in DMF (50 mL) under a nitrogen atmosphere. Palladium acetate (450 mg, cat.) was added and the mixture heated at 90 °C (oil bath temperature) for 18 h. The resulting solution was concentrated in vacuo, and the residue taken up in ethyl acetate (200 mL) and washed with water (3 × 200 mL) and then sat. aq sodium chloride solution (150 mL) and dried over anhydrous Na<sub>2</sub>SO<sub>4</sub> and concentrated to a pale-brown gum in vacuo. The residue was taken up in 1,4-dioxan (160 mL) and 2-amino-4-chlorothieno[2,3-<i>d</i>]pyrimidine-6-carboxylic acid ethyl ester (12.85 g, 50 mmol) and aq potassium phosphate (tribasic; 2.0 M; 40 mL) were added under a nitrogen atmosphere. Dichlorobis(triphenylphosphine)palladium(II) (cat.) was then added and the mixture heated at 100 °C (oil bath temperature) for 3 h. The mixture was allowed to cool and ethyl acetate (400 mL) added. This mixture was washed with sat. aq sodium chloride solution (100 mL), dried over anhydrous sodium sulfate, and concentrated to a pale-yellow solid, which was washed with diethyl ether/hexane (1:1) and then dried in vacuo at 40 °C to afford the title compound <b>26</b> (10.7 g, 45%) as an off-white solid: TLC <i>R</i><sub>f</sub> = 0.13 (EtOAc/hexane 1:3); LCMS <i>t</i><sub>R</sub> = 2.79 min; <i>m</i>/<i>z</i> = 476, 474 [M + H]<sup>+</sup>. <sup>1</sup>Η ΝΜR (400 MHz; DMSO-<i>d</i><sub>6</sub>) δ 1.28 (t, 3H, <i>J</i> = 7.1 Hz), 4.29 (q, 2H, <i>J</i> = 7.1 Hz), 5.22 (s, 2H), 7.32−7.37 (m, 1H), 7.38−7.43 (m, 3H), 7.44−7.47 (m, 2H), 7.48 (s, 1H), 7.52 (brs, 2H), 7.84 (s, 1H).</div></div><div id="sec5_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> 2-Amino-4-(5-benzyloxy-2,4-dichlorophenyl)thieno[2,3-<i>d</i>]pyrimidine-6-carboxylic Acid Ethylamide (<b>28</b>)</h3><div class="NLM_p last">A suspension of 2-amino-4-(5-benzyloxy-2,4-dichlorophenyl)thieno[2,3-<i>d</i>]pyrimidine-6-carboxylic acid ethyl ester (<b>26</b>; 14.0 g, 29.5 mmol) in methanolic ethylamine (2.0 M; 400 mL) was heated at reflux for 18 h. The resulting solution was concentrated and the residue triturated with diethyl ether/hexane and then filtered and dried in vacuo at 60 °C to furnish the title compound <b>28</b> (11.8 g. 84%) as a pale-brown powder: LCMS <i>t</i><sub>R</sub> = 2.65 min; <i>m</i>/<i>z</i> = 475.1, 473. [M + H]<sup>+</sup>. <sup>1</sup>Η ΝΜR (400 MHz; DMSO-<i>d</i><sub>6</sub>) δ 1.08 (t, 3H, <i>J</i> = 7.1 Hz), 3.23 (m, 2H), 5.23 (s, 2H), 7.24 (brs, 2H), 7.32−7.38 (m, 1H), 7.38−7.44 (m, 2H), 7.44−7.48 (m, 2H), 7.49 (s, 1H), 7.54 (s, 1H), 7.86 (s, 1H), 8.53 (brt, 1H, <i>J</i> = 5.5 Hz).</div></div><div id="sec5_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> 2-Amino-4-(2,4-dichloro-5-hydroxyphenyl)thieno[2,3-<i>d</i>]pyrimidine-6-carboxylic Acid Ethylamide (<b>31</b>)</h3><div class="NLM_p last">Boron trichloride solution (1.0 M in DCM, 100 mL, 0.10 mol) was added to a suspension of 2-amino-4-(5-benzyloxy-2,4-dichlorophenyl)thieno[2,3-<i>d</i>]pyrimidine-6-carboxylic acid ethylamide (<b>28</b>; 11.8 g, 24.9 mmol) in DCM at −78 °C under a nitrogen atmosphere. The suspension was stirred for 3 h at room temperature and then cooled in an ice/water bath. Methanol (20 mL) was added cautiously, and the resulting mixture was stirred for 1 h and then concentrated to a yellow/green solid. The solids were suspended in aq sodium acetate (10% w/v; 500 mL) and extracted with ethyl acetate (1000 mL). The extracts were washed with water (2 × 400 mL) and then sat. aq sodium chloride solution (200 mL). The organic solution was dried over anhydrous Na<sub>2</sub>SO<sub>4</sub> and concentrated to a pale-brown solid in vacuo, which was washed with hexane, filtered, and dried in vacuo to afford the title compound <b>31</b> (8.3 g, 87%) as a pale-brown solid: LCMS <i>t</i><sub>R</sub> = 2.18 min; <i>m</i>/<i>z</i> = 386, 384 [M + H]<sup>+</sup>. <sup>1</sup>Η ΝΜR (400 MHz; DMSO-<i>d</i><sub>6</sub>) δ 1.07 (t, 3H, <i>J</i> = 7.4 Hz), 3.21 (m, 2H), 7.05 (s, 1H), 7.26 (brs, 2H), 7.59 (s, 1H), 7.70 (s, 1H), 8.58 (brt, 1H, <i>J</i> = 5.3 Hz), 10.89 (s, 1H).</div></div><div id="sec5_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> 2-Amino-4-[2,4-dichloro-5-(2-diethylaminoethoxy)phenyl]thieno[2,3-<i>d</i>]pyrimidine-6-carboxylic Acid Ethylamide (<b>34a</b>)</h3><div class="NLM_p last">Cesium carbonate (3.2 g, 10 mmol) was added to a stirred solution of 2-amino-4-(2,4-dichloro-5-hydroxyphenyl)thieno[2,3-<i>d</i>]pyrimidine-6-carboxylic acid ethylamide (2.25 g, 5.9 mmol) in DMF (20 mL). 2-Bromo-<i>N</i>,<i>N</i>-diethylethylamine hydrobromide (Aldrich; 2.0 g, 7.7 mmol) was added and the mixture heated at 100 °C for 1 h. The resulting suspension was allowed to cool and concentrated to a brown solid. Dichloromethane (200 mL) was added to dissolve the crude solids and the organic solution then washed with water (4 × 200 mL), followed by sat. aq sodium chloride solution (1 × 200 mL). The phases were separated, and the organic phase was dried over anhydrous Na<sub>2</sub>SO<sub>4</sub> and concentrated to a dark-brown gum, which solidified on standing. The crude product was purified by column chromatography on silica gel, eluting with dichloromethane/methanol (9:1) to give the product as a pale-brown gum. Trituration with diethyl ether/hexane (1:1), filtration, and drying in vacuo gave the title compound <b>34a</b> (1.7 g, 60%) as an off-white powder: TLC <i>R</i><sub>f</sub> = 0.10 (DCM/MeOH 9:1); LCMS <i>t</i><sub>R</sub> = 1.86 min; <i>m</i>/<i>z</i> = 484, 482 [M + H]<sup>+</sup>. <sup>1</sup>Η ΝΜR (400 MHz; DMSO-<i>d</i><sub>6</sub>) δ 0.95 (t, 6H, <i>J</i> = 7.1 Hz), 1.07 (t, 3H, <i>J</i> = 7.2 Hz), 2.54 (q, 4H, <i>J</i> = 7.1 Hz), 2.80 (brt, 2H, <i>J</i> = 5.5 Hz), 3.21 (m, 2H), 4.12 (brt, 2H, <i>J</i> = 5.5 Hz), 7.27 (brs, 2H), 7.38 (s, 1H), 7.58 (s, 1H), 7.82 (s, 1H), 8.56 (brt, 1H, <i>J</i> = 5.5 Hz). <sup>13</sup>C ΝΜR (100.6 MHz; DMSO-<i>d</i><sub>6</sub>) δ 12.0 (CH<sub>3</sub>), 14.7 (CH<sub>3</sub>), 34.0 (CH<sub>2</sub>), 47.1 (CH<sub>2</sub>), 50.9 (CH<sub>2</sub>), 68.4 (CH<sub>2</sub>), 115.3 (CH), 121.3 (C), 121.3 (CH), 122.3 (C), 123.0 (C), 130.3 (CH), 132.6 (C), 135.6 (C), 153.0 (C), 160.8 (C), 161.1 (C), 161.5 (C), 171.1 (C). HRMS calcd for C<sub>21</sub>H<sub>25</sub>Cl<sub>2</sub>N<sub>5</sub>O<sub>2</sub>S [M + H]<sup>+</sup> 482.1184, found 482.1196. HPLC (method A) 99.3% (<i>t</i><sub>R</sub> = 4.68 min).</div></div><div id="sec5_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> 2-Amino-4-[2,4-dichloro-5-(2,2-diethoxy−ethoxy)phenyl]thieno[2,3-<i>d</i>]pyrimidine-6-carboxylic Acid Ethylamide (<b>35</b>)</h3><div class="NLM_p last">Cesium carbonate (5.0 g, 15.3 mmol) was added to a solution of 2-amino-4-(2,4-dichloro-5-hydroxyphenyl)thieno[2,3-<i>d</i>]pyrimidine-6-carboxylic acid ethylamide (<b>31</b>, 3.85 g, 10.0 mmol) in DMF (20 mL). Bromoacetaldehyde diethyl acetal (1.8 mL, 12 mmol) was added, and the reaction mixture was heated to 125 °C for 4 h. The resulting suspension was allowed to cool to ambient temperature and water (300 mL) was added and the mixture extracted with DCM (2 × 100 mL). The combined organic extracts were washed with water (4 × 200 mL) and then sat. aq sodium chloride solution (200 mL), dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, and filtered. The filtrate solvents were removed in vacuo to afford a pale-brown solid. The crude product was purified by column chromatography on silica gel, eluting with EtOAc/hexane (2:3) to give the title compound <b>35</b> (3.58 g, 71%) as a pale-yellow solid: TLC <i>R</i><sub>f</sub> = 0.20 (EtOAc/hexane 1:1); LCMS <i>t</i><sub>R</sub> = 2.61 min; <i>m</i>/<i>z</i> = 501, 499 [M + H]<sup>+</sup>. <sup>1</sup>Η ΝΜR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.07 (t, 3H, <i>J</i> = 7.1 Hz), 1.13 (t, 6H, <i>J</i> = 7.1 Hz), 3.22 (m, 2H), 3.54−3.62 (m, 2H), 3.65−3.73 (m, 2H), 4.08 (d, 2H, <i>J</i> = 5.3 Hz), 4.84 (t, 1H, <i>J</i> = 5.3 Hz), 7.22 (brs, 2H), 7.43 (s, 1H), 7.57 (s, 1H), 7.81 (s, 1H), 8.53 (brt, 1H, <i>J</i> = 5.6 Hz).</div></div><div id="sec5_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> General Procedure A: Preparation of <b>34j</b> to <b>34m</b> by Reductive Amination</h3><div class="NLM_p last">Aqueous HCl (6 N, 0.5 mL) was added to a solution of <b>35</b> (200 mg, 0.40 mmol) in THF (2.5 mL), and the mixture was stirred at ambient temperature for ca. 48 h. DCM (10 mL) was added, followed by the appropriate amine (5 equiv), and the mixture was stirred for 15 min. Sodium triacetoxyborohydride (750 mg, 3.54 mmol) was added and the resulting suspension stirred for 1.5 h. Further DCM (10 mL) was added, followed by aq sodium hydroxide solution (2.0 M, 5 mL) and the mixture was stirred for 5 min. The phases were separated, and the organic phase solvents were removed in vacuo. The crude product was purified by preparative HPLC at pH 4.</div></div><div id="sec5_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> 2-Amino-4-[2,4-dichloro-5-(2-cyclohexyaminoethoxy)phenyl]thieno[2,3-<i>d</i>]pyrimidine-6-carboxylic Acid Ethylamide (<b>34j</b>)</h3><div class="NLM_p last">This compound was prepared using general procedure A from <b>35</b> (200 mg, 0.40 mmol) and cyclohexylamine to afford the title compound <b>34j</b> (formate salt) (28 mg, 12%) as an off-white solid: LCMS <i>t</i><sub>R</sub> = 1.98 min; <i>m</i>/<i>z</i> = 510, 508 [M + H]<sup>+</sup>. <sup>1</sup>Η ΝΜR (400 MHz; DMSO-<i>d</i><sub>6</sub>) δ 1.00−1.10 (m, 3H), 1.08 (t, 3H, <i>J</i> = 7.0 Hz), 1.13−1.25 (m, 2H), 1.50−1.58 (m, 1H), 1.62−1.71 (m, 2H), 1.82−1.90 (m, 2H), 2.59 (m, 1H), 3.03 (brt, 2H, <i>J</i> = 5.6 Hz), 3.22 (m, 2H), 4.19 (brt, 2H, <i>J</i> = 5.6 Hz), 7.27 (brs, 2H), 7.38 (s, 1H), 7.57 (s, 1H), 7.84 (s, 1H), 8.23 (s, 1H), 8.60 (brt, 1H, <i>J</i> = 5.6 Hz). <sup>13</sup>C ΝΜR (100.6 MHz; DMSO-<i>d</i><sub>6</sub>) δ 14.7 (CH<sub>3</sub>), 24.3 (CH<sub>2</sub>), 25.6 (CH<sub>2</sub>), 32.0 (CH<sub>2</sub>), 34.0 (CH<sub>2</sub>), 44.1 (CH<sub>2</sub>), 55.7 (CH), 68.9 (CH<sub>2</sub>), 115.5 (CH), 121.2 (CH), 121.3 (C), 122.6 (C), 123.2 (C), 130.4 (CH), 132.6 (C), 135.6 (C), 152.8 (C), 160.8 (C), 161.1 (C), 161.5 (C), 164.1 (CH), 171.2 (C). HRMS calcd for C<sub>23</sub>H<sub>27</sub>Cl<sub>2</sub>N<sub>5</sub>O<sub>2</sub>S [M + H]<sup>+</sup> 508.1341, found 508.1355. HPLC (method A) 98.3% (<i>t</i><sub>R</sub> = 4.98 min).</div></div><div id="sec5_28" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> 2-Amino-4-{2,4-dichloro-5-[2-(4,4-difluoropiperidin-1-yl)ethoxy]phenyl}thieno[2,3-<i>d</i>]pyrimidine-6-carboxylic Acid Ethylamide (<b>34m</b>)</h3><div class="NLM_p last">This compound was prepared using general procedure A from <b>35</b> (200 mg, 0.40 mmol) and 4,4-difluoropiperidine hydrochloride (300 mg, 1.9 mmol) to afford the title compound <b>34m</b> (30 mg, 14%) as an off-white solid: LCMS <i>t</i><sub>R</sub> = 2.01 min; <i>m</i>/<i>z</i> = 532, 530 [M + H]<sup>+</sup>. <sup>1</sup>Η ΝΜR (400 MHz; DMSO-<i>d</i><sub>6</sub>) δ 1.07 (t, 3H, <i>J</i> = 7.2 Hz), 1.86−1.97 (m, 4H), 2.64 (m, 4H), 2.82 (t, 2H, <i>J</i> = 5.6 Hz), 3.22 (m, 2H), 4.21 (t, 2H, <i>J</i> = 5.6 Hz), 7.22 (brs, 2H), 7.40 (s, 1H), 7.53 (s, 1H), 7.81 (s, 1H), 8.53 (brt, 1H, <i>J</i> = 5.6 Hz). <sup>13</sup>C ΝΜR (100.6 MHz; DMSO-<i>d</i><sub>6</sub>) δ 14.7 (CH<sub>3</sub>), 33.4 (CH<sub>2</sub>, t, <i>J</i><sub>C−F</sub> = 22 Hz), 34.0 (CH<sub>2</sub>), 49.7 (CH<sub>2</sub>, t, <i>J</i><sub>C−F</sub> = 5 Hz), 55.1 (CH<sub>2</sub>), 67.8 (CH<sub>2</sub>), 115.4 (CH), 121.2 (CH), 121.3 (C), 122.5 (C), 122.6 (C, t, <i>J</i><sub>C−F</sub> = 241 Hz), 123.1 (C), 130.4 (CH), 132.6 (C), 135.6 (C), 152.9 (C), 160.8 (C), 161.1 (C), 161.5 (C), 171.1 (C). HRMS calcd for C<sub>22</sub>H<sub>23</sub>Cl<sub>2</sub>F<sub>2</sub>N<sub>5</sub>O<sub>2</sub>S [M + H]<sup>+</sup> 530.0996, found 530.1003. HPLC (method A) 90.2% (<i>t</i><sub>R</sub> = 5.09 min).</div></div><div id="sec5_29" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> 2-Amino-4-[2,4-dichloro-5-(2-pyrrolidin-1-yl-ethoxy)phenyl]thieno[2,3-<i>d</i>]pyrimidine-6-carboxylic Acid Ethylamide (<b>34d</b>)</h3><div class="NLM_p last">This compound was made using the synthetic procedure described for <b>34a</b>. Thus 2-amino-4-(2,4-dichloro-5-hydroxy-phenyl)thieno[2,3-<i>d</i>]pyrimidine-6-carboxylic acid ethylamide (<b>31</b>, 150 mg, 0.39 mmol) was reacted with 1-(2-chloroethyl)-pyrrolidine hydrochloride (Aldrich; 79 mg, 0.47 mmol). The crude product was purified by column chromatography on silica gel, eluting with dichloromethane/methanol (9:1) to give the product as a yellow glass. Trituration with EtOAc/hexane (1:1), filtration, and drying in vacuo gave the title compound <b>34d</b> (89 mg, 48%) as a cream-colored solid: TLC <i>R</i><sub>f</sub> = 0.14 (DCM/MeOH 9:1); LCMS <i>t</i><sub>R</sub> = 1.83 min; <i>m</i>/<i>z</i> = 482, 480 [M + H]<sup>+</sup>. <sup>1</sup>Η ΝΜR (400 MHz; DMSO-<i>d</i><sub>6</sub>) δ 1.07 (t, 3H, <i>J</i> = 7.3 Hz), 1.64−1.69 (m, 4H), 2.51−2.57 (m, 4H,), 2.82 (brt, 2H, <i>J</i> = 5.5 Hz) 3.22 (m, 2H), 4.19 (brt, 2H, <i>J</i> = 5.5 Hz), 7.24 (brs, 2H), 7.38 (s, 1H), 7.57 (s, 1H), 7.81 (s, 1H), 8.54 (brt, 1H, <i>J</i> = 5.6 Hz). <sup>13</sup>C ΝΜR (100.6 MHz; DMSO-<i>d</i><sub>6</sub>) δ 14.7 (CH<sub>3</sub>), 23.2 (CH<sub>2</sub>), 34.0 (CH<sub>2</sub>), 53.9 (CH<sub>2</sub>), 54.1 (CH<sub>2</sub>), 68.9 (CH<sub>2</sub>), 115.3 (CH), 121.2 (CH), 121.3 (C), 122.3 (C), 123.0 (C), 130.4 (CH), 132.6 (C), 135.6 (C), 152.9 (C), 160.8 (C), 161.1 (C), 161.5 (C), 171.1 (C). HRMS, calcd for C<sub>21</sub>H<sub>23</sub>Cl<sub>2</sub>N<sub>5</sub>O<sub>2</sub>S [M + H]<sup>+</sup> 480.1028, found 480.1004. HPLC (method B) 99.9% (<i>t</i><sub>R</sub> = 2.10 min).</div></div><div id="sec5_30" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> 2-Amino-4-(5-benzyloxy-2,4-dichlorophenyl)thieno[2,3-<i>d</i>]pyrimidine-6-carboxylic Acid (<b>27</b>)</h3><div class="NLM_p last">Sodium hydroxide (pearlescent; 190 mg, 4.76 mmol) was added to 2-amino-4-(5-benzyloxy-2,4-dichlorophenyl)thieno[2,3-<i>d</i>]pyrimidine-6-carboxylic acid ethyl ester (<b>26</b>; 1.13 g, 2.38 mmol). Ethanol (25 mL) was added, followed by water (2.5 mL), and the resulting suspension was heated to reflux for 50 min, causing a brown solution to form after 10 min. The reaction mixture was allowed to cool and ethanol was removed in vacuo. Water (25 mL) was added to the residue, and the mixture was cooled with an ice water bath and neutralized by careful addition of conc HCl. The water was removed by freeze-drying to afford the title compound <b>27</b> (1.34 g, quant) as a finely divided yellow powder (including 2.0 equiv of NaCl): LCMS <i>t</i><sub>R</sub> = 2.60 min; <i>m</i>/<i>z</i> = 448, 446 [M + H]<sup>+</sup>. <sup>1</sup>Η ΝΜR (400 MHz; DMSO-<i>d</i><sub>6</sub>) δ 5.21 (s, 2H), 7.13 (s, 1H), 7.22 (brs, 2H), 7.32−7.37 (m, 1H), 7.38−7.43 (m, 2H), 7.43−7.48 (m, 3H), 7.80 (s, 1H), CO<sub>2</sub><i>H</i> not observed.</div></div><div id="sec5_31" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> 2-Amino-4-(5-benzyloxy-2,4-dichlorophenyl)thieno[2,3-<i>d</i>]pyrimidine-6-carboxylic Acid Cyclopropylamide (<b>29</b>)</h3><div class="NLM_p last">2-Amino-4-(5-benzyloxy-2,4-dichlorophenyl)thieno[2,3-<i>d</i>]pyrimidine-6-carboxylic acid·2NaCl (<b>27</b>) (1.34 g, 2.38 mmol) was dissolved in DMF (25 mL) and <i>O</i>-(7-azabenzotriazolo-1-yl)-<i>N</i>,<i>N</i>,<i>N</i>′,<i>N</i>′-tetramethyluroniumhexafluorophosphate (HATU; 1.176 g, 3.1 mmol) was added, followed by diisopropylethylamine (1.2 mL, 6.9 mmol) and then cyclopropylamine (0.24 mL, 3.46 mmol). The reaction mixture was heated to 50 °C (oil bath temperature) for 1 h. The mixture was cooled and DMF removed in vacuo. The residue was partitioned between water (250 mL) and EtOAc (250 mL), the phases were separated, and the organic phase was washed with water (200 mL) and then sat. aq NaCl (250 mL) and dried over Na<sub>2</sub>SO<sub>4</sub>. The mix was filtered and filtrate solvents removed in vacuo, and the resulting residue purified by flash chromatography on silica gel (50 g) eluting with a gradient of 25−75% EtOAc in hexane to afford the title compound <b>29</b> (1.14 g, 98%) as a light-brown solid: LCMS <i>t</i><sub>R</sub> = 2.69 min; <i>m</i>/<i>z</i> = 487, 485 [M + H]<sup>+</sup>. <sup>1</sup>Η ΝΜR (400 MHz; DMSO-<i>d</i><sub>6</sub>) δ 0.49−0.54 (m, 2H), 0.65−0.70 (m, 2H), 2.76 (m, 1H), 5.22 (s, 2H), 7.29 (brs, 2H), 7.32−7.50 (m, 6H), 7.52 (s, 1H), 7.86 (s, 1H), 8.54 (d, 1H, <i>J</i> = 3.8 Hz).</div></div><div id="sec5_32" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> 2-Amino-4-(2,4-dichloro-5-hydroxyphenyl)thieno[2,3-<i>d</i>]pyrimidine-6-carboxylic Acid Cyclopropylamide (<b>32</b>)</h3><div class="NLM_p last">2-Amino-4-(5-benzyloxy-2,4-dichlorophenyl)thieno[2,3-<i>d</i>]pyrimidine-6-carboxylic acid cyclopropylamide (<b>27</b>; 2.33 g, 4.80 mmol) was suspended in anhydrous DCM (50 mL) under a nitrogen atmosphere and cooled with dry ice/acetone bath (ca. −78 °C). Boron trichloride (1.0 M in dichloromethane, 26.3 mL, 26.3 mmol) was added and the reaction mixture stirred for 15 min. The cooling bath was removed and mixture was stirred for 18 h at ambient temperature. The reaction mixture was cooled with ice−water bath, and methanol (10 mL) was added dropwise. The mixture was stirred for 1 h, the solvents removed in vacuo, and the residual solid partitioned between EtOAc (100 mL) and sat. NaHCO<sub>3</sub> (aq) solution (100 mL). The phases were separated and the organic phase was washed with sat. NaCl solution (100 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and the filtrate removed in vacuo to afford the title compound <b>32</b> (1.37 g, 72%) as a pale-brown powder: LCMS <i>t</i><sub>R</sub> = 2.21 min; <i>m</i>/<i>z</i> = 397, 395 [M + H]<sup>+</sup>. <sup>1</sup>Η ΝΜR (400 MHz; DMSO-<i>d</i><sub>6</sub>) δ 0.48−0.53 (m, 2H), 0.64−0.69 (m, 2H), 2.76 (m, 1H), 7.07 (s, 1H), 7.27 (brs, 2H), 7.57 (s, 1H), 7.71 (s, 1H), 8.57 (d, 1H, <i>J</i> = 4.1 Hz), 10.94 (brs, 1H).</div></div><div id="sec5_33" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> 2-Amino-4-[2,4-dichloro-5-(2-diethylaminoethoxy)phenyl]thieno[2,3-<i>d</i>]pyrimidine-6-carboxylic Acid Cyclopropylamide (<b>34b</b>)</h3><div class="NLM_p last">2-Amino-4-(2,4-dichloro-5-hydroxyphenyl)thieno[2,3-<i>d</i>]pyrimidine-6-carboxylic acid cyclopropylamide (<b>32</b>; 0.854 g, 2.16 mmol) was dissolved in anhydrous THF (50 mL). <i>N</i>,<i>N</i>-diethylethanolamine (0.34 mL, 2.59 mmol) was added, followed by triphenylphosphine (0.850 g, 3.24 mmol) and diisopropylazodicarboxylate (0.64 mL, 3.24 mmol). The reaction mixture was stirred at rt for 3 h and then EtOAc (200 mL) was added and the mixture washed sequentially with water (200 mL), sat. NaHCO<sub>3</sub> solution, and sat. NaCl solution. The organic phase was dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and the filtrate solvents removed in vacuo to afford a brown oil, which was purified by flash chromatography on silica gel (50 g) eluting with a gradient of 2−5% MeOH in DCM to afford the title compound <b>34b</b> (0.434 g, 41%) as a cream-colored solid: LCMS <i>t</i><sub>R</sub> = 1.86 min; <i>m</i>/<i>z</i> = 496, 494 [M + H]<sup>+</sup>. <sup>1</sup>Η ΝΜR (400 MHz; DMSO-<i>d</i><sub>6</sub>) δ 0.48−0.52 (m, 2H), 0.64−0.69 (m, 2H), 0.96 (t, 6H, <i>J</i> = 7.1 Hz), 2.49−2.57 (brm, 4H), 2.75 (m, 1H), 2.80 (brm, 2H), 4.11 (brt, 2H, <i>J</i> = 5.5 Hz), 7.26 (brs, 2H), 7.37 (s, 1H), 7.56 (s, 1H), 7.81 (s, 1H), 8.54 (d, 1H, <i>J</i> = 3.9 Hz). <sup>13</sup>C ΝΜR (100.6 MHz; DMSO-<i>d</i><sub>6</sub>) δ 5.7 (CH<sub>2</sub>), 12.0 (CH<sub>3</sub>), 22.9 (CH), 47.1 (CH<sub>2</sub>), 50.9 (CH<sub>2</sub>), 68.4 (CH<sub>2</sub>), 115.3 (CH), 121.3 (C), 121.5 (CH), 122.3 (C), 123.0 (C), 130.3 (CH), 132.3 (C), 135.6 (C), 153.0 (C), 161.1 (C), 161.6 (C), 162.3 (C), 171.2 (C). HRMS calcd for C<sub>22</sub>H<sub>25</sub>Cl<sub>2</sub>N<sub>5</sub>O<sub>2</sub>S [M + H]<sup>+</sup> 494.1184, found 494.1169. HPLC (method B) 98.8% (<i>t</i><sub>R</sub> = 2.47 min).</div></div><div id="sec5_34" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> 2-Amino-4-[2,4-dichloro-5-(1-ethyl-pyrrolidin-3-yloxy)phenyl]thieno[2,3-<i>d</i>]pyrimidine-6-carboxylic Acid Ethylamide (<b>34i</b>)</h3><div class="NLM_p last">2-Amino-4-(2,4-dichloro-5-hydroxyphenyl)thieno[2,3-<i>d</i>]pyrimidine-6-carboxylic acid ethylamide (<b>31</b>; 0.700 g, 1.83 mmol) was dissolved in anhydrous THF (50 mL). 1-Ethyl-3-pyrrolidinol (0.26 mL, 2.18 mmol) was added, followed by triphenylphosphine (0.863 g, 3.29 mmol) and diisopropylazodicarboxylate (0.65 mL, 3.29 mmol). The reaction mixture was stirred at rt for 16 h and then EtOAc (200 mL) was added and the mixture washed sequentially with water (200 mL), sat. NaHCO<sub>3</sub> solution (100 mL), and sat. NaCl solution (100 mL). The organic phase was dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and the filtrate solvents removed in vacuo to afford a brown oil, which was purified by flash chromatography on silica gel (50 g) eluting with 10% MeOH in DCM to afford the title compound <b>34i</b> (0.359 g, 41%) as a cream-colored powder: LCMS <i>t</i><sub>R</sub> = 1.83 min; <i>m</i>/<i>z</i> = 482, 480 [M + H]<sup>+</sup>. <sup>1</sup>Η ΝΜR (400 MHz; DMSO-<i>d</i><sub>6</sub>) δ 1.01 (t, 3H, <i>J</i> = 7.4 Hz), 1.07 (t, 3H, <i>J</i> = 7.4 Hz), 1.81 (m, 1H), 2.20−2.47 (m, 4H), 2.65−2.80 (m, 3H), 3.20 (m, 2H), 4.96 (m, 1H), 7.27 (s, 1H), 7.27 (brs, 2H), 7.56 (s, 1H), 7.82 (s, 1H), 8.55 (brt, 1H, <i>J</i> = 5.6 Hz). <sup>13</sup>C ΝΜR (100.6 MHz; DMSO-<i>d</i><sub>6</sub>) δ 13.6 (CH<sub>3</sub>), 14.7 (CH<sub>3</sub>), 31.6 (CH<sub>2</sub>), 34.0 (CH<sub>2</sub>), 49.2 (CH<sub>2</sub>), 52.0 (CH<sub>2</sub>), 59.3 (CH<sub>2</sub>), 78.2 (CH), 115.9 (CH), 121.2 (CH), 121.3 (C), 122.3 (C), 123.5 (C), 130.6 (CH), 132.6 (C), 135.5 (C), 152.0 (C), 160.8 (C), 161.1 (C), 161.5 (C), 171.1 (C). HRMS calcd for C<sub>21</sub>H<sub>23</sub>Cl<sub>2</sub>N<sub>5</sub>O<sub>2</sub>S [M + H]<sup>+</sup> 480.1028, found 480.1017. HPLC (method B) 99.1% (<i>t</i><sub>R</sub> = 2.43 min).</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i54"><a href="/doi/suppl/10.1021/jm900357y">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_57247" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_57247" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Data relating to the PC3 human prostate cancer xenograft model for compound <b>34a</b>; experimental procedures for the FP assay and synthesis of the FP assay probe and methods and parameters relating to X-ray crystallography and protein production; full chemistry experimental procedures and characterization data; methods for analytical and preparative HPLC; commercial sources for fragment and in silico screening hits; protocols relating to the 1D NMR screening of fragments; description of the process applied for the in silico screening campaign. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm900357y/suppl_file/jm900357y_si_001.pdf">jm900357y_si_001.pdf (374.63 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm900357y" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_61234" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_61234" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Paul A. Brough</span> - <span class="hlFld-Affiliation affiliation">Vernalis Ltd., Granta Park, Great Abington, Cambridge CB21 6GB, U.K.</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#6d1d430f1f02180a052d1b081f030c01041e430e0200"><span class="__cf_email__" data-cfemail="02722c60706d77656a427467706c636e6b712c616d6f">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xavier Barril</span> - <span class="hlFld-Affiliation affiliation">Vernalis Ltd., Granta Park, Great Abington, Cambridge CB21 6GB, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jenifer Borgognoni</span> - <span class="hlFld-Affiliation affiliation">Vernalis Ltd., Granta Park, Great Abington, Cambridge CB21 6GB, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Patrick Chene</span> - <span class="hlFld-Affiliation affiliation">Novartis Institutes for Biomedical Research, Novartis Pharma AG, CH-4002 Basel, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nicholas G. M. Davies</span> - <span class="hlFld-Affiliation affiliation">Vernalis Ltd., Granta Park, Great Abington, Cambridge CB21 6GB, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ben Davis</span> - <span class="hlFld-Affiliation affiliation">Vernalis Ltd., Granta Park, Great Abington, Cambridge CB21 6GB, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Martin J. Drysdale</span> - <span class="hlFld-Affiliation affiliation">Vernalis Ltd., Granta Park, Great Abington, Cambridge CB21 6GB, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Brian Dymock</span> - <span class="hlFld-Affiliation affiliation">Vernalis Ltd., Granta Park, Great Abington, Cambridge CB21 6GB, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Suzanne A. Eccles</span> - <span class="hlFld-Affiliation affiliation">Cancer Research UK Centre for Cancer Therapeutics, The Institute of Cancer Research, Haddow Laboratories, Sutton, Surrey SM2 5NG, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Carlos Garcia-Echeverria</span> - <span class="hlFld-Affiliation affiliation">Novartis Institutes for Biomedical Research, Novartis Pharma AG, CH-4002 Basel, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christophe Fromont</span> - <span class="hlFld-Affiliation affiliation">Vernalis Ltd., Granta Park, Great Abington, Cambridge CB21 6GB, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Angela Hayes</span> - <span class="hlFld-Affiliation affiliation">Cancer Research UK Centre for Cancer Therapeutics, The Institute of Cancer Research, Haddow Laboratories, Sutton, Surrey SM2 5NG, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Roderick E. Hubbard</span> - <span class="hlFld-Affiliation affiliation">Vernalis Ltd., Granta Park, Great Abington, Cambridge CB21 6GB, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Allan M. Jordan</span> - <span class="hlFld-Affiliation affiliation">Vernalis Ltd., Granta Park, Great Abington, Cambridge CB21 6GB, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael Rugaard Jensen</span> - <span class="hlFld-Affiliation affiliation">Novartis Institutes for Biomedical Research, Novartis Pharma AG, CH-4002 Basel, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Andrew Massey</span> - <span class="hlFld-Affiliation affiliation">Vernalis Ltd., Granta Park, Great Abington, Cambridge CB21 6GB, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Angela Merrett</span> - <span class="hlFld-Affiliation affiliation">Vernalis Ltd., Granta Park, Great Abington, Cambridge CB21 6GB, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Antony Padfield</span> - <span class="hlFld-Affiliation affiliation">Vernalis Ltd., Granta Park, Great Abington, Cambridge CB21 6GB, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Rachel Parsons</span> - <span class="hlFld-Affiliation affiliation">Vernalis Ltd., Granta Park, Great Abington, Cambridge CB21 6GB, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Thomas Radimerski</span> - <span class="hlFld-Affiliation affiliation">Novartis Institutes for Biomedical Research, Novartis Pharma AG, CH-4002 Basel, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Florence I. Raynaud</span> - <span class="hlFld-Affiliation affiliation">Cancer Research UK Centre for Cancer Therapeutics, The Institute of Cancer Research, Haddow Laboratories, Sutton, Surrey SM2 5NG, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Alan Robertson</span> - <span class="hlFld-Affiliation affiliation">Vernalis Ltd., Granta Park, Great Abington, Cambridge CB21 6GB, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stephen D. Roughley</span> - <span class="hlFld-Affiliation affiliation">Vernalis Ltd., Granta Park, Great Abington, Cambridge CB21 6GB, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Joseph Schoepfer</span> - <span class="hlFld-Affiliation affiliation">Novartis Institutes for Biomedical Research, Novartis Pharma AG, CH-4002 Basel, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Heather Simmonite</span> - <span class="hlFld-Affiliation affiliation">Vernalis Ltd., Granta Park, Great Abington, Cambridge CB21 6GB, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Swee Y. Sharp</span> - <span class="hlFld-Affiliation affiliation">Cancer Research UK Centre for Cancer Therapeutics, The Institute of Cancer Research, Haddow Laboratories, Sutton, Surrey SM2 5NG, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Allan Surgenor</span> - <span class="hlFld-Affiliation affiliation">Vernalis Ltd., Granta Park, Great Abington, Cambridge CB21 6GB, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Melanie Valenti</span> - <span class="hlFld-Affiliation affiliation">Cancer Research UK Centre for Cancer Therapeutics, The Institute of Cancer Research, Haddow Laboratories, Sutton, Surrey SM2 5NG, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Steven Walls</span> - <span class="hlFld-Affiliation affiliation">Vernalis Ltd., Granta Park, Great Abington, Cambridge CB21 6GB, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Paul Webb</span> - <span class="hlFld-Affiliation affiliation">Vernalis Ltd., Granta Park, Great Abington, Cambridge CB21 6GB, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mike Wood</span> - <span class="hlFld-Affiliation affiliation">Vernalis Ltd., Granta Park, Great Abington, Cambridge CB21 6GB, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Paul Workman</span> - <span class="hlFld-Affiliation affiliation">Cancer Research UK Centre for Cancer Therapeutics, The Institute of Cancer Research, Haddow Laboratories, Sutton, Surrey SM2 5NG, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lisa Wright</span> - <span class="hlFld-Affiliation affiliation">Vernalis Ltd., Granta Park, Great Abington, Cambridge CB21 6GB, U.K.</span></div></li></ul></li><li></li><li></li><li></li></ul></div><div class="ack"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i53">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_84647" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_84647" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We are grateful to Tim Haymes for analytical support, to Adam Hold and Loic Le Strat for compound purification, to Ruth Botting, Sarah Denny, Kiri Tan, Lynne Barratt, Eamon McCay, Jason Busby, Vanessa Martins, and Alan Henley for DMPK and bioanalysis studies, and to Sharon Gowan and Alexis de Haven Brandon for tumour xenograft and biomarker studies. We are also grateful to Helen Browne for assistance with manuscript preparation. This work was supported by Cancer Research UK [CRUK] programme grant numbers CA309/A2187 and C309/A8274. The ICR acknowledges NHS funding to the NIHR Biomedical Research Centre and from Vernalis. Paul Workman is a Cancer Research UK Life Fellow. The authors from The Institute of Cancer Research (ICR) declare a conflict of interest. The ICR has a commercial interest in Hsp90 inhibitors and operates a rewards to inventors scheme.</p></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i55">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_28027" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_28027" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 82 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Mosser, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morimoto, R. I.</span><span> </span><span class="NLM_article-title">Molecular chaperones and the stress of oncogenesis</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">2907</span><span class="NLM_x">–</span> <span class="NLM_lpage">2918</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm900357y&amp;key=10.1038%2Fsj.onc.1207529" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm900357y&amp;key=15077153" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm900357y&amp;key=1%3ACAS%3A528%3ADC%252BD2cXivFKmsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2004&pages=2907-2918&author=D.+D.+Mosserauthor=R.+I.+Morimoto&title=Molecular+chaperones+and+the+stress+of+oncogenesis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular chaperones and the stress of oncogenesis</span></div><div class="casAuthors">Mosser, Dick D.; Morimoto, Richard I.</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">2907-2918</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Protein-damaging stresses induce the expression of heat-shock proteins', which have essential roles in protecting cells from the potentially lethal effects of stress and proteotoxicity.  These stress-protective heat-shock proteins are often overexpressed in cells of various cancers and have been suggested to be contributing factors in tumorigenesis.  An underlying basis of oncogenesis is the acquisition and accumulation of mutations that provide the transformed cell with the combined characteristics of deregulated cell proliferation and suppressed cell death.  Heat-shock proteins with dual roles as regulators of protein conformation and stress sensors may therefore have intriguing and central roles in both cell proliferation and apoptosis.  It has been established that heat-shock proteins exhibit specificity to particular classes of polypeptide substrates and client proteins in vivo, and that chaperones can stabilize mutations that affect the folded conformation.  Likewise, overexpression of chaperones has also been shown to protect cells against apoptotic cell death.  The involvement of chaperones, therefore, in such diverse roles might suggest novel anticancer therapeutic approaches targeting heat-shock protein function for a broad spectrum of tumor types.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXglApcXUKQrVg90H21EOLACvtfcHk0li4ZDh5kmzlEQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXivFKmsLs%253D&md5=535effb8bca3679c2e29bffcb0077cc3</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fsj.onc.1207529&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.onc.1207529%26sid%3Dliteratum%253Aachs%26aulast%3DMosser%26aufirst%3DD.%2BD.%26aulast%3DMorimoto%26aufirst%3DR.%2BI.%26atitle%3DMolecular%2520chaperones%2520and%2520the%2520stress%2520of%2520oncogenesis%26jtitle%3DOncogene%26date%3D2004%26volume%3D23%26spage%3D2907%26epage%3D2918" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Pearl, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prodromou, C.</span><span> </span><span class="NLM_article-title">Structure and mechanism of the hsp90 molecular chaperone machinery</span> <span class="citation_source-journal">Annu. Rev. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">75</span><span class="NLM_x">, </span> <span class="NLM_fpage">271</span><span class="NLM_x">–</span> <span class="NLM_lpage">294</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm900357y&amp;key=10.1146%2Fannurev.biochem.75.103004.142738" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm900357y&amp;key=16756493" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm900357y&amp;key=1%3ACAS%3A528%3ADC%252BD28XosVKhs78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2006&pages=271-294&author=L.+H.+Pearlauthor=C.+Prodromou&title=Structure+and+mechanism+of+the+hsp90+molecular+chaperone+machinery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Structure and mechanism of the Hsp90 molecular chaperone machinery</span></div><div class="casAuthors">Pearl, Laurence H.; Prodromou, Chrisostomos</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Biochemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">75</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">271-294</span>CODEN:
                <span class="NLM_cas:coden">ARBOAW</span>;
        ISSN:<span class="NLM_cas:issn">0066-4154</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  Heat-shock protein 90 (Hsp90) is a mol. chaperone essential for activating many signaling proteins in the eukaryotic cell.  Biochem. and structural anal. of Hsp90 has revealed a complex mechanism of ATPase-coupled conformational changes and interactions with cochaperone proteins, which facilitate activation of Hsp90's diverse "clientele.".  Despite recent progress, key aspects of the ATPase-coupled mechanism of Hsp90 remain controversial, and the nature of the changes, engendered by Hsp90 in client proteins, is largely unknown.  Here, the authors discuss present knowledge of Hsp90 structure and function gleaned from crystallog. studies of individual domains and recent progress in obtaining a structure for the ATP-bound conformation of the intact dimeric chaperone.  Addnl., the authors describe the roles of the plethora of cochaperones with which Hsp90 cooperates and growing insights into their biochem. mechanisms, which come from crystal structures of Hsp90-cochaperone complexes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1Aa7D8Mk_qbVg90H21EOLACvtfcHk0li4ZDh5kmzlEQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XosVKhs78%253D&md5=a954553202a2a81fce297ac6a8378c67</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1146%2Fannurev.biochem.75.103004.142738&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.biochem.75.103004.142738%26sid%3Dliteratum%253Aachs%26aulast%3DPearl%26aufirst%3DL.%2BH.%26aulast%3DProdromou%26aufirst%3DC.%26atitle%3DStructure%2520and%2520mechanism%2520of%2520the%2520hsp90%2520molecular%2520chaperone%2520machinery%26jtitle%3DAnnu.%2520Rev.%2520Biochem.%26date%3D2006%26volume%3D75%26spage%3D271%26epage%3D294" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Obermann, W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sondermann, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Russo, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pavletich, N. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartl, F. U.</span><span> </span><span class="NLM_article-title">In vivo function of Hsp90 is dependent on ATP binding and ATP hydrolysis</span> <span class="citation_source-journal">J. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">143</span><span class="NLM_x">, </span> <span class="NLM_fpage">901</span><span class="NLM_x">–</span> <span class="NLM_lpage">910</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=143&publication_year=1998&pages=901-910&author=W.+M.+Obermannauthor=H.+Sondermannauthor=A.+A.+Russoauthor=N.+P.+Pavletichauthor=F.+U.+Hartl&title=In+vivo+function+of+Hsp90+is+dependent+on+ATP+binding+and+ATP+hydrolysis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DObermann%26aufirst%3DW.%2BM.%26aulast%3DSondermann%26aufirst%3DH.%26aulast%3DRusso%26aufirst%3DA.%2BA.%26aulast%3DPavletich%26aufirst%3DN.%2BP.%26aulast%3DHartl%26aufirst%3DF.%2BU.%26atitle%3DIn%2520vivo%2520function%2520of%2520Hsp90%2520is%2520dependent%2520on%2520ATP%2520binding%2520and%2520ATP%2520hydrolysis%26jtitle%3DJ.%2520Cell%2520Biol.%26date%3D1998%26volume%3D143%26spage%3D901%26epage%3D910" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Panaretou, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prodromou, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roe, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O'Brien, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ladbury, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piper, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pearl, L. H.</span><span> </span><span class="NLM_article-title">ATP binding and hydrolysis are essential to the function of the Hsp90 molecular chaperone in vivo</span> <span class="citation_source-journal">EMBO J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">4829</span><span class="NLM_x">–</span> <span class="NLM_lpage">4836</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1998&pages=4829-4836&author=B.+Panaretouauthor=C.+Prodromouauthor=S.+M.+Roeauthor=R.+O%27Brienauthor=J.+E.+Ladburyauthor=P.+W.+Piperauthor=L.+H.+Pearl&title=ATP+binding+and+hydrolysis+are+essential+to+the+function+of+the+Hsp90+molecular+chaperone+in+vivo"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPanaretou%26aufirst%3DB.%26aulast%3DProdromou%26aufirst%3DC.%26aulast%3DRoe%26aufirst%3DS.%2BM.%26aulast%3DO%2527Brien%26aufirst%3DR.%26aulast%3DLadbury%26aufirst%3DJ.%2BE.%26aulast%3DPiper%26aufirst%3DP.%2BW.%26aulast%3DPearl%26aufirst%3DL.%2BH.%26atitle%3DATP%2520binding%2520and%2520hydrolysis%2520are%2520essential%2520to%2520the%2520function%2520of%2520the%2520Hsp90%2520molecular%2520chaperone%2520in%2520vivo%26jtitle%3DEMBO%2520J.%26date%3D1998%26volume%3D17%26spage%3D4829%26epage%3D4836" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Pearl, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prodromou, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Workman, P.</span><span> </span><span class="NLM_article-title">The Hsp90 molecular chaperone: an open and shut case for treatment</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">410</span><span class="NLM_x">, </span> <span class="NLM_fpage">439</span><span class="NLM_x">–</span> <span class="NLM_lpage">453</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm900357y&amp;key=10.1042%2FBJ20071640" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm900357y&amp;key=18290764" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm900357y&amp;key=1%3ACAS%3A528%3ADC%252BD1cXisVWgtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=410&publication_year=2008&pages=439-453&author=L.+H.+Pearlauthor=C.+Prodromouauthor=P.+Workman&title=The+Hsp90+molecular+chaperone%3A+an+open+and+shut+case+for+treatment"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">The Hsp90 molecular chaperone: an open and shut case for treatment</span></div><div class="casAuthors">Pearl, Laurence H.; Prodromou, Chrisostomos; Workman, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">410</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">439-453</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">A review.  The mol. chaperone Hsp90 (90 kDa heat-shock protein) is a remarkably versatile protein involved in the stress response and in normal homeostatic control mechanisms.  It interacts with 'client proteins', including protein kinases, transcription factors and others, and either facilitates their stabilization and activation or directs them for proteasomal degrdn.  By this means, Hsp90 displays a multifaceted ability to influence signal transduction, chromatin remodelling and epigenetic regulation, development and morphol. evolution.  Hsp90 operates as a dimer in a conformational cycle driven by ATP binding and hydrolysis at the N-terminus.  The cycle is also regulated by a group of co-chaperones and accessory proteins.  Here the authors review the biol. of the Hsp90 mol. chaperone, emphasizing recent progress in the understanding of structure-function relationships and the identification of new client proteins.  In addn. we describe the exciting progress that has been made in the development of Hsp90 inhibitors, which are now showing promise in the clinic for cancer treatment.  The authors also identify the gaps in the current understanding and highlight important topics for future research.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6x-AH695RgrVg90H21EOLACvtfcHk0lgtSPRmGP3OYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXisVWgtrs%253D&md5=2623a81947643815e7b314e4859ef057</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1042%2FBJ20071640&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBJ20071640%26sid%3Dliteratum%253Aachs%26aulast%3DPearl%26aufirst%3DL.%2BH.%26aulast%3DProdromou%26aufirst%3DC.%26aulast%3DWorkman%26aufirst%3DP.%26atitle%3DThe%2520Hsp90%2520molecular%2520chaperone%253A%2520an%2520open%2520and%2520shut%2520case%2520for%2520treatment%26jtitle%3DBiochem.%2520J.%26date%3D2008%26volume%3D410%26spage%3D439%26epage%3D453" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span>For a list, see the web page maintained by D. Picard: <a href="http://www.picard.ch/downloads/Hsp90interactors.pdf" class="extLink">http://www.picard.ch/downloads/Hsp90interactors.pdf</a>. Accessed on July 13, 2009</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=For+a+list%2C+see+the+web+page+maintained+by+D.+Picard%3A+http%3A%2F%2Fwww.picard.ch%2Fdownloads%2FHsp90interactors.pdf.+Accessed+on+July+13%2C+2009"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Whitesell, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindquist, S. L.</span><span> </span><span class="NLM_article-title">HSP90 and the chaperoning of cancer</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">761</span><span class="NLM_x">–</span> <span class="NLM_lpage">772</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm900357y&amp;key=10.1038%2Fnrc1716" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm900357y&amp;key=16175177" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm900357y&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVGjs7bF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=761-772&author=L.+Whitesellauthor=S.+L.+Lindquist&title=HSP90+and+the+chaperoning+of+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">HSP90 and the chaperoning of cancer</span></div><div class="casAuthors">Whitesell, Luke; Lindquist, Susan L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">761-772</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Standing watch over the proteome, mol. chaperones are an ancient and evolutionarily conserved class of proteins that guide the normal folding, intracellular disposition and proteolytic turnover of many of the key regulators of cell growth, differentiation and survival.  This essential guardian function is subverted during oncogenesis to allow malignant transformation and to facilitate rapid somatic evolution.  Pharmacol. 'bribing' the essential guard duty of the chaperone HSP90 (heat-shock protein of 90 kDa) seems to offer a unique anticancer strategy of considerable promise.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp4Vmb5bGXgDLVg90H21EOLACvtfcHk0lgtSPRmGP3OYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVGjs7bF&md5=c418ec249a29c70047081cd241938931</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fnrc1716&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc1716%26sid%3Dliteratum%253Aachs%26aulast%3DWhitesell%26aufirst%3DL.%26aulast%3DLindquist%26aufirst%3DS.%2BL.%26atitle%3DHSP90%2520and%2520the%2520chaperoning%2520of%2520cancer%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2005%26volume%3D5%26spage%3D761%26epage%3D772" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Maloney, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Workman, P.</span><span> </span><span class="NLM_article-title">HSP90 as a new therapeutic target for cancer therapy: the story unfolds</span> <span class="citation_source-journal">Expert Opin. Biol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">3</span><span class="NLM_x">–</span> <span class="NLM_lpage">24</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm900357y&amp;key=10.1517%2F14712598.2.1.3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm900357y&amp;key=11772336" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm900357y&amp;key=1%3ACAS%3A528%3ADC%252BD38XnsVaksw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2002&pages=3-24&author=A.+Maloneyauthor=P.+Workman&title=HSP90+as+a+new+therapeutic+target+for+cancer+therapy%3A+the+story+unfolds"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">HSP90 as a new therapeutic target for cancer therapy: the story unfolds</span></div><div class="casAuthors">Maloney, Alison; Workman, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Biological Therapy</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">3-24</span>CODEN:
                <span class="NLM_cas:coden">EOBTA2</span>;
        ISSN:<span class="NLM_cas:issn">1471-2598</span>.
    
            (<span class="NLM_cas:orgname">Ashley Publications Ltd.</span>)
        </div><div class="casAbstract">A review. Current anticancer drug-development strategies involve identifying novel mol. targets which are crucial for tumorigenesis.  The mol. chaperone heat-shock protein (HSP) 90 is of interest as an anticancer drug target because of its importance in maintaining the conformation, stability and function of key oncogenic client proteins involved in signal transduction pathways leading to proliferation, cell cycle progression, and apoptosis, as well as other features of the malignant phenotype such as invasion, angiogenesis and metastasis.  The natural-product HSP90 inhibitors geldanamycin and radicicol exert their antitumor effect by inhibiting the intrinsic ATPase activity of HSP90, resulting in degrdn. of HSP90 client proteins via the ubiquitin proteosome pathway.  Anticancer selectivity may derive from the simultaneous combinatorial effects of HSP90 inhibitors on multiple cancer targets and pathways. 17-Allylamino-17-demethoxygeldanamycin (17AAG) showed good activity and cancer selectivity in preclin. models and has now progressed to Phase I clin. trials in cancer patients with encouraging initial results.  Phase II trials including combination studies with cytotoxic agents are now being planned and these should allow the therapeutic activity of 17AAG to be detd.  Second-generation HSP90 inhibitors may be designed to overcome some of the drawbacks of 17AAG, including limited oral bioavailability and soly.  They could also be engineered to target specific functions of HSP90, which may not only provide greater mol. selectivity and clin. benefit but may also increase understanding of the complex functions of this mol. chaperone.  HSP90 inhibitors provide proof of concept for drugs directed at HSP90 and protein folding and this principle may be applicable to other medical conditions involving protein aggregation and stability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxpya4HhGPu7Vg90H21EOLACvtfcHk0lgfrqS0WvaWlQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XnsVaksw%253D%253D&md5=b0542acde22286a95578e3ef4dac0d8e</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1517%2F14712598.2.1.3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14712598.2.1.3%26sid%3Dliteratum%253Aachs%26aulast%3DMaloney%26aufirst%3DA.%26aulast%3DWorkman%26aufirst%3DP.%26atitle%3DHSP90%2520as%2520a%2520new%2520therapeutic%2520target%2520for%2520cancer%2520therapy%253A%2520the%2520story%2520unfolds%26jtitle%3DExpert%2520Opin.%2520Biol.%2520Ther.%26date%3D2002%26volume%3D2%26spage%3D3%26epage%3D24" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Kamal, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boehm, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burrows, F. J.</span><span> </span><span class="NLM_article-title">Therapeutic and diagnostic implications of Hsp90 activation</span> <span class="citation_source-journal">Trends Mol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">283</span><span class="NLM_x">–</span> <span class="NLM_lpage">290</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2004&pages=283-290&author=A.+Kamalauthor=M.+F.+Boehmauthor=F.+J.+Burrows&title=Therapeutic+and+diagnostic+implications+of+Hsp90+activation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKamal%26aufirst%3DA.%26aulast%3DBoehm%26aufirst%3DM.%2BF.%26aulast%3DBurrows%26aufirst%3DF.%2BJ.%26atitle%3DTherapeutic%2520and%2520diagnostic%2520implications%2520of%2520Hsp90%2520activation%26jtitle%3DTrends%2520Mol.%2520Med.%26date%3D2004%26volume%3D10%26spage%3D283%26epage%3D290" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Chiosis, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vilenchik, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Solit, D.</span><span> </span><span class="NLM_article-title">Hsp90: the vulnerable chaperone</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">881</span><span class="NLM_x">–</span> <span class="NLM_lpage">888</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2004&pages=881-888&author=G.+Chiosisauthor=M.+Vilenchikauthor=J.+Kimauthor=D.+Solit&title=Hsp90%3A+the+vulnerable+chaperone"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChiosis%26aufirst%3DG.%26aulast%3DVilenchik%26aufirst%3DM.%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DSolit%26aufirst%3DD.%26atitle%3DHsp90%253A%2520the%2520vulnerable%2520chaperone%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2004%26volume%3D9%26spage%3D881%26epage%3D888" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Hanahan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinberg, R. A.</span><span> </span><span class="NLM_article-title">The hallmarks of cancer</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">100</span><span class="NLM_x">, </span> <span class="NLM_fpage">57</span><span class="NLM_x">–</span> <span class="NLM_lpage">70</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm900357y&amp;key=10.1016%2FS0092-8674%2800%2981683-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm900357y&amp;key=10647931" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm900357y&amp;key=1%3ACAS%3A528%3ADC%252BD3cXks1CktA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2000&pages=57-70&author=D.+Hanahanauthor=R.+A.+Weinberg&title=The+hallmarks+of+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">The hallmarks of cancer</span></div><div class="casAuthors">Hanahan, Douglas; Weinberg, Robert A.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, Massachusetts)</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">100</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">57-70</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review is given with many refs. on principles governing the transformation of normal human cells into malignant cancers.  The authors suggest that research over the past decades has revealed a small no. of mol., biochem., and cellular traits (acquired capabilities) shared by most and perhaps all types of cancer.  Topics included are the acquired capabilities self-sufficiency in growth signals, insensitivity to antigrowth signals, evading apoptosis, limitless replicative potential, sustained angiogenesis, and tissue invasion and metastasis followed by genome instability as an enabling characteristic and alternative pathways to cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGooXmGqKjM1C7Vg90H21EOLACvtfcHk0lgfrqS0WvaWlQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXks1CktA%253D%253D&md5=1d23c4400dad34c7f32d4a0c41890349</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2FS0092-8674%2800%2981683-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0092-8674%252800%252981683-9%26sid%3Dliteratum%253Aachs%26aulast%3DHanahan%26aufirst%3DD.%26aulast%3DWeinberg%26aufirst%3DR.%2BA.%26atitle%3DThe%2520hallmarks%2520of%2520cancer%26jtitle%3DCell%26date%3D2000%26volume%3D100%26spage%3D57%26epage%3D70" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Workman, P.</span><span> </span><span class="NLM_article-title">Combinatorial attack on multistep oncogenesis by inhibiting the Hsp90 molecular chaperone</span> <span class="citation_source-journal">Cancer Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">206</span><span class="NLM_x">, </span> <span class="NLM_fpage">149</span><span class="NLM_x">–</span> <span class="NLM_lpage">157</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm900357y&amp;key=10.1016%2Fj.canlet.2003.08.032" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm900357y&amp;key=15013520" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm900357y&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhvFaiu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=206&publication_year=2004&pages=149-157&author=P.+Workman&title=Combinatorial+attack+on+multistep+oncogenesis+by+inhibiting+the+Hsp90+molecular+chaperone"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Combinatorial attack on multistep oncogenesis by inhibiting the Hsp90 molecular chaperone</span></div><div class="casAuthors">Workman, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">206</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">149-157</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  The mol. chaperone Hsp90 is not only of major current interest in fundamental biol. research but also recognized as an exciting new target for the treatment of cancer and other diseases.  In addn. to playing an important role in response to proteotoxic heat shock and others stresses, Hsp90 is also crit. for maintaining normal cellular homeostasis.  Hsp90 is responsible for ensuring the conformational stability, shape and function of a selected range of key proteins, including many kinases and transcription factors.  Furthermore, recent studies show that Hsp90 plays a key role in development and evolution.  Hsp90 is overexpressed in cancer cells and is thought to be involved in dealing with the cellular stress assocd. with malignancy, as well as being essential for a range of key oncogenic proteins, including ErbB2, Raf-1, Akt/PKB, mutant p53 and many others.  A major attraction of Hsp90 inhibitors is their potential to inhibit a range of 'mission crit.' cancer pathways, thereby blocking all of the hallmark traits' of malignancy and exhibiting broad-spectrum antitumor activity.  The first-in-class Hsp90 inhibitor 17AAG has entered clin. trials with promising early results and a range of other agents is under investigation and preclin. development.  This article reviews the current status and future prospects for the exploitation of Hsp90 as a new mol. target for cancer treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVh9SsuC7uE7Vg90H21EOLACvtfcHk0lh1x__ituQycg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhvFaiu7s%253D&md5=082cb68ad7ccf630d7f1ccedde160744</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2003.08.032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2003.08.032%26sid%3Dliteratum%253Aachs%26aulast%3DWorkman%26aufirst%3DP.%26atitle%3DCombinatorial%2520attack%2520on%2520multistep%2520oncogenesis%2520by%2520inhibiting%2520the%2520Hsp90%2520molecular%2520chaperone%26jtitle%3DCancer%2520Lett.%26date%3D2004%26volume%3D206%26spage%3D149%26epage%3D157" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">DeBoer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meulman, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wnuk, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peterson, D. H.</span><span> </span><span class="NLM_article-title">Geldanamycin, a new antibiotic</span> <span class="citation_source-journal">J. Antibiot. (Tokyo)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1970</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">442</span><span class="NLM_x">–</span> <span class="NLM_lpage">447</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm900357y&amp;key=10.7164%2Fantibiotics.23.442" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm900357y&amp;key=5459626" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm900357y&amp;key=1%3ACAS%3A528%3ADyaE3MXhtFyltQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=1970&pages=442-447&author=C.+DeBoerauthor=P.+A.+Meulmanauthor=R.+J.+Wnukauthor=D.+H.+Peterson&title=Geldanamycin%2C+a+new+antibiotic"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Geldanamycin, a new antibiotic</span></div><div class="casAuthors">De Boer, Clarence; Meulman, P. A.; Wnuk, R. J.; Peterson, Durey Harold</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Antibiotics</span>
        (<span class="NLM_cas:date">1970</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">442-7</span>CODEN:
                <span class="NLM_cas:coden">JANTAJ</span>;
        ISSN:<span class="NLM_cas:issn">0021-8820</span>.
    </div><div class="casAbstract">Geldanamycin, an antibiotic isolated in cryst. form from culture filtrates of Streptomyces hygroscopicus, was moderately active in vitro against protozoa, bacteria, and fungi.  Geldanamycin was also active against L-1210 and KB tumor cells growing in culture and against the parasite Syphacia obvelata in vivo.  Phys. and chem. properties indicated that geldanamycin is a complex mol. consisting of an unsatd. moiety attached to a quinone.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpu-1yq8CsQ5bVg90H21EOLACvtfcHk0lh1x__ituQycg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE3MXhtFyltQ%253D%253D&md5=c3b43c17ee1cdafdf44ffbe0ae1348f7</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.7164%2Fantibiotics.23.442&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7164%252Fantibiotics.23.442%26sid%3Dliteratum%253Aachs%26aulast%3DDeBoer%26aufirst%3DC.%26aulast%3DMeulman%26aufirst%3DP.%2BA.%26aulast%3DWnuk%26aufirst%3DR.%2BJ.%26aulast%3DPeterson%26aufirst%3DD.%2BH.%26atitle%3DGeldanamycin%252C%2520a%2520new%2520antibiotic%26jtitle%3DJ.%2520Antibiot.%2520%2528Tokyo%2529%26date%3D1970%26volume%3D23%26spage%3D442%26epage%3D447" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Supko, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickman, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grever, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malspeis, L.</span><span> </span><span class="NLM_article-title">Preclinical pharmacologic evaluation of geldanamycin as an antitumor agent</span> <span class="citation_source-journal">Cancer Chemother. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">305</span><span class="NLM_x">–</span> <span class="NLM_lpage">315</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm900357y&amp;key=10.1007%2FBF00689048" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm900357y&amp;key=7628050" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm900357y&amp;key=1%3ACAS%3A528%3ADyaK2MXnsFShtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=1995&pages=305-315&author=J.+G.+Supkoauthor=R.+L.+Hickmanauthor=M.+R.+Greverauthor=L.+Malspeis&title=Preclinical+pharmacologic+evaluation+of+geldanamycin+as+an+antitumor+agent"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Preclinical pharmacologic evaluation of geldanamycin as an antitumor agent</span></div><div class="casAuthors">Supko, Jeffrey G.; Hickman, Robert L.; Grever, Michael R.; Malspeis, Louis</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Chemotherapy and Pharmacology</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">305-15</span>CODEN:
                <span class="NLM_cas:coden">CCPHDZ</span>;
        ISSN:<span class="NLM_cas:issn">0344-5704</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">The plasma pharmacokinetics of the antitumor antibiotic geldanamycin (GM; NSC 122750), a naturally occurring benzoquinoid ansamycin, were characterized in mice and a beagle dog.  Concns. of GM well above 0.1 μg/mL, which were typically effective against neoplastic cell lines responsive to the drug in vitro, were achieved in the plasma of the mice and the dog treated by i.v. injection.  However, the systemic duration of the drug was relatively short.  Plasma levels decayed to <0.1 μg/mL within 3-4 h after administration of the apparent max. tolerated doses, which were approx. 20 mg/kg for the mice and 4 mg/kg for the dog.  The drug exhibited linear pharmacokinetic behavior within the dose ranges studied.  However, there were significant interspecies differences in its disposition.  Whereas the mean biol. half-life of GM was slightly longer in the mice (77.7 min) than in the dog (57.9 min), its mean residence time in the dog (46.6 min) was >2-fold greater than that in the mice (20.7 min).  Nevertheless, the drug was cleared from plasma much faster by the dog (49.4 mL/min/kg) than by the mice (30.5 mL/min/kg).  These apparent anomalies were principally assocd. with differences in the relative significance of the terminal phase upon overall drug disposition.  The liver appeared to be the principal target organ of acute drug toxicity in the dog.  Doses of 2.0 and 4.2 mg/kg both produced elevations in serum levels of the transaminases and other indicators of liver function characteristic of acute hepatic necrosis.  Addnl. effects included symptoms of minor gastrointestinal toxicity and alterations in serum chem. parameters consistent with less severe nephrotoxicity.  The drug-related toxicity appeared to be reversible.  In consideration of the potential for acute hepatotoxic reactions to GM, as well as to the other benzoquinoid ansamycins based upon structural analogy, addnl. pharmacol. and therapeutic information is required to ascertain whether these compds. are viable candidates for clin. development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9-P4wBmA1f7Vg90H21EOLACvtfcHk0lgsYqj9U_mQWg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXnsFShtLs%253D&md5=cde4aa9e616ff38b67dafed67b05d174</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1007%2FBF00689048&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF00689048%26sid%3Dliteratum%253Aachs%26aulast%3DSupko%26aufirst%3DJ.%2BG.%26aulast%3DHickman%26aufirst%3DR.%2BL.%26aulast%3DGrever%26aufirst%3DM.%2BR.%26aulast%3DMalspeis%26aufirst%3DL.%26atitle%3DPreclinical%2520pharmacologic%2520evaluation%2520of%2520geldanamycin%2520as%2520an%2520antitumor%2520agent%26jtitle%3DCancer%2520Chemother.%2520Pharmacol.%26date%3D1995%26volume%3D36%26spage%3D305%26epage%3D315" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Neckers, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schulte, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mimnaugh, E.</span><span> </span><span class="NLM_article-title">Geldanamycin as a potential anticancer agent: its molecular target and biochemical activity</span> <span class="citation_source-journal">Invest. New Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">361</span><span class="NLM_x">–</span> <span class="NLM_lpage">373</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1999&pages=361-373&author=L.+Neckersauthor=T.+W.+Schulteauthor=E.+Mimnaugh&title=Geldanamycin+as+a+potential+anticancer+agent%3A+its+molecular+target+and+biochemical+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNeckers%26aufirst%3DL.%26aulast%3DSchulte%26aufirst%3DT.%2BW.%26aulast%3DMimnaugh%26aufirst%3DE.%26atitle%3DGeldanamycin%2520as%2520a%2520potential%2520anticancer%2520agent%253A%2520its%2520molecular%2520target%2520and%2520biochemical%2520activity%26jtitle%3DInvest.%2520New%2520Drugs%26date%3D1999%26volume%3D17%26spage%3D361%26epage%3D373" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Delmotte, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delmotte-Plaque, J.</span><span> </span><span class="NLM_article-title">A new antifungal substance of fungal origin</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1953</span><span class="NLM_x">, </span> <span class="NLM_volume">171</span><span class="NLM_x">, </span> <span class="NLM_fpage">344</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=171&publication_year=1953&pages=344&author=P.+Delmotteauthor=J.+Delmotte-Plaque&title=A+new+antifungal+substance+of+fungal+origin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDelmotte%26aufirst%3DP.%26aulast%3DDelmotte-Plaque%26aufirst%3DJ.%26atitle%3DA%2520new%2520antifungal%2520substance%2520of%2520fungal%2520origin%26jtitle%3DNature%26date%3D1953%26volume%3D171%26spage%3D344" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Soga, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiotsu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akinaga, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharma, S. V.</span><span> </span><span class="NLM_article-title">Development of radicicol analogues</span> <span class="citation_source-journal">Curr. Cancer Drug Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">359</span><span class="NLM_x">–</span> <span class="NLM_lpage">369</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm900357y&amp;key=10.2174%2F1568009033481859" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm900357y&amp;key=14529387" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm900357y&amp;key=1%3ACAS%3A528%3ADC%252BD3sXnsV2is74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2003&pages=359-369&author=S.+Sogaauthor=Y.+Shiotsuauthor=S.+Akinagaauthor=S.+V.+Sharma&title=Development+of+radicicol+analogues"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Development of radicicol analogues</span></div><div class="casAuthors">Soga, Shiro; Shiotsu, Yukimasa; Akinaga, Shiro; Sharma, Sreenath V.</div><div class="citationInfo"><span class="NLM_cas:title">Current Cancer Drug Targets</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">359-369</span>CODEN:
                <span class="NLM_cas:coden">CCDTB9</span>;
        ISSN:<span class="NLM_cas:issn">1568-0096</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Radicicol, a macrocyclic antibiotic produced by fungi, was originally isolated many years ago, and was described as tyrosine kinase inhibitor.  We also rediscovered radicicol as an inhibitor of signal transduction of oncogene products, such as K-ras and v-Src, using yeast and mammalian cell-based assays.  In a study of mechanisms of action, it was revealed that radicicol depletes the Hsp90 client signaling mols. in cells, and thus inhibit the signal transduction pathway.  In addn., direct binding of radicicol to the N-terminal ATP/ADP binding site of Hsp90 was shown, and thus radicicol has been recognized as a structurally unique antibiotic that binds and inhibits the mol. chaperone Hsp90.  Although radicicol itself has little or no activity in animals because of instability in animals, its oxime derivs. showed potent antitumor activities against human tumor xenograft models.  Hsp90 client proteins were depleted and apoptosis was induced in the tumor specimen treated with radicicol oxime derivs.  Taken together, these results suggest that the antitumor activity of radicicol oxime derivs. is mediated by binding to Hsp90 and destabilization of Hsp90 client proteins in the tumor.  Among Hsp90 clients, we focused on ErbB2 and Bcr-Abl as examples of important targets of Hsp90 inhibitors.  Radicicol oxime showed potent antitumor activity against ER neg./ErbB2 overexpressing breast cancer and Bcr-Abl expressing CML.  Putative mechanisms of action and future directions of radicicol oxime against these kinds of tumor are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-uapkd0TYQrVg90H21EOLACvtfcHk0lgsYqj9U_mQWg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXnsV2is74%253D&md5=59ef4ec5535cec06665a164be0b12305</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.2174%2F1568009033481859&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568009033481859%26sid%3Dliteratum%253Aachs%26aulast%3DSoga%26aufirst%3DS.%26aulast%3DShiotsu%26aufirst%3DY.%26aulast%3DAkinaga%26aufirst%3DS.%26aulast%3DSharma%26aufirst%3DS.%2BV.%26atitle%3DDevelopment%2520of%2520radicicol%2520analogues%26jtitle%3DCurr.%2520Cancer%2520Drug%2520Targets%26date%3D2003%26volume%3D3%26spage%3D359%26epage%3D369" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Roe, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prodromou, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O'Brien, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ladbury, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piper, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pearl, L. H.</span><span> </span><span class="NLM_article-title">Structural basis for inhibition of the Hsp90 molecular chaperone by the antitumor antibiotics radicicol and geldanamycin</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">260</span><span class="NLM_x">–</span> <span class="NLM_lpage">266</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm980403y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1999&pages=260-266&author=S.+M.+Roeauthor=C.+Prodromouauthor=R.+O%27Brienauthor=J.+E.+Ladburyauthor=P.+W.+Piperauthor=L.+H.+Pearl&title=Structural+basis+for+inhibition+of+the+Hsp90+molecular+chaperone+by+the+antitumor+antibiotics+radicicol+and+geldanamycin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fjm980403y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm980403y%26sid%3Dliteratum%253Aachs%26aulast%3DRoe%26aufirst%3DS.%2BM.%26aulast%3DProdromou%26aufirst%3DC.%26aulast%3DO%2527Brien%26aufirst%3DR.%26aulast%3DLadbury%26aufirst%3DJ.%2BE.%26aulast%3DPiper%26aufirst%3DP.%2BW.%26aulast%3DPearl%26aufirst%3DL.%2BH.%26atitle%3DStructural%2520basis%2520for%2520inhibition%2520of%2520the%2520Hsp90%2520molecular%2520chaperone%2520by%2520the%2520antitumor%2520antibiotics%2520radicicol%2520and%2520geldanamycin%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1999%26volume%3D42%26spage%3D260%26epage%3D266" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Hostein, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robertson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DiStefano, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Workman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clarke, P. A.</span><span> </span><span class="NLM_article-title">Inhibition of signal transduction by the Hsp90 inhibitor 17-allylamino-17-demethoxygeldanamycin results in cytostasis and apoptosis</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">4003</span><span class="NLM_x">–</span> <span class="NLM_lpage">4009</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2001&pages=4003-4009&author=I.+Hosteinauthor=D.+Robertsonauthor=F.+DiStefanoauthor=P.+Workmanauthor=P.+A.+Clarke&title=Inhibition+of+signal+transduction+by+the+Hsp90+inhibitor+17-allylamino-17-demethoxygeldanamycin+results+in+cytostasis+and+apoptosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHostein%26aufirst%3DI.%26aulast%3DRobertson%26aufirst%3DD.%26aulast%3DDiStefano%26aufirst%3DF.%26aulast%3DWorkman%26aufirst%3DP.%26aulast%3DClarke%26aufirst%3DP.%2BA.%26atitle%3DInhibition%2520of%2520signal%2520transduction%2520by%2520the%2520Hsp90%2520inhibitor%252017-allylamino-17-demethoxygeldanamycin%2520results%2520in%2520cytostasis%2520and%2520apoptosis%26jtitle%3DCancer%2520Res.%26date%3D2001%26volume%3D61%26spage%3D4003%26epage%3D4009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Schulte, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neckers, L. M.</span><span> </span><span class="NLM_article-title">The benzoquinone ansamycin 17-allylamino-17-demethoxygeldanamycin binds to HSP90 and shares important biologic activities with geldanamycin</span> <span class="citation_source-journal">Cancer Chemother. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">273</span><span class="NLM_x">–</span> <span class="NLM_lpage">279</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm900357y&amp;key=10.1007%2Fs002800050817" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm900357y&amp;key=9744771" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm900357y&amp;key=1%3ACAS%3A528%3ADyaK1cXls1Wlt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1998&pages=273-279&author=T.+W.+Schulteauthor=L.+M.+Neckers&title=The+benzoquinone+ansamycin+17-allylamino-17-demethoxygeldanamycin+binds+to+HSP90+and+shares+important+biologic+activities+with+geldanamycin"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">The benzoquinone ansamycin 17-allylamino-17-demethoxygeldanamycin binds to HSP90 and shares important biologic activities with geldanamycin</span></div><div class="casAuthors">Schulte, Theodor W.; Neckers, Leonard M.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Chemotherapy and Pharmacology</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">273-279</span>CODEN:
                <span class="NLM_cas:coden">CCPHDZ</span>;
        ISSN:<span class="NLM_cas:issn">0344-5704</span>.
    
            (<span class="NLM_cas:orgname">Springer-Verlag</span>)
        </div><div class="casAbstract">Binding of 17-allylamino-17-demethoxygeldanamycin (17-AG) to the heat-shock protein HSP90 was studied in vitro using a geldanamycin (GA)-affinity beads competition assay.  The drug-induced destabilization was studied of p185erbB2, Raf-1, and mutant p53 in SKBR3 breast cancer cells by Western blotting.  The antiproliferative activities of 17-AG and GA were compared using the MTT assay.  The 17-AG bound specifically to HSP90 in a similar manner as GA itself.  It also led to degrdn. of the receptor Tyr kinase p185erbB2, the Ser/Thr kinase Raf-1, and mutant p53.  GA and 17-AG displayed comparable antiproliferative effects in SKBR3 and MCF7 cells.  Even though HSP90 binding with 17-AG was weaker than by GA, 17-AG and GA caused biol. effects in tumor cells at similar doses.  Since 17-AG had a better toxicity profile than GA, it was suggested as benzoquinone ansamycin candidate for clin. development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGouj3pMDUB7kLVg90H21EOLACvtfcHk0lhxK4lD6iFYiQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXls1Wlt7Y%253D&md5=3d6ac0592b10d66b391f824272523de2</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1007%2Fs002800050817&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs002800050817%26sid%3Dliteratum%253Aachs%26aulast%3DSchulte%26aufirst%3DT.%2BW.%26aulast%3DNeckers%26aufirst%3DL.%2BM.%26atitle%3DThe%2520benzoquinone%2520ansamycin%252017-allylamino-17-demethoxygeldanamycin%2520binds%2520to%2520HSP90%2520and%2520shares%2520important%2520biologic%2520activities%2520with%2520geldanamycin%26jtitle%3DCancer%2520Chemother.%2520Pharmacol.%26date%3D1998%26volume%3D42%26spage%3D273%26epage%3D279" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Banerji, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O'Donnell, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scurr, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pacey, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stapleton, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asad, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simmons, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maloney, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raynaud, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walton, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lakhani, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaye, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Workman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Judson, I.</span><span> </span><span class="NLM_article-title">Phase I pharmacokinetic and pharmacodynamic study of 17-allylamino, 17-demethoxygeldanamycin in patients with advanced malignancies</span> <span class="citation_source-journal">J. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">4152</span><span class="NLM_x">–</span> <span class="NLM_lpage">4161</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm900357y&amp;key=10.1200%2FJCO.2005.00.612" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm900357y&amp;key=15961763" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm900357y&amp;key=1%3ACAS%3A528%3ADC%252BD2MXmt1elsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2005&pages=4152-4161&author=U.+Banerjiauthor=A.+O%27Donnellauthor=M.+Scurrauthor=S.+Paceyauthor=S.+Stapletonauthor=Y.+Asadauthor=L.+Simmonsauthor=A.+Maloneyauthor=F.+Raynaudauthor=M.+Campbellauthor=M.+Waltonauthor=S.+Lakhaniauthor=S.+Kayeauthor=P.+Workmanauthor=I.+Judson&title=Phase+I+pharmacokinetic+and+pharmacodynamic+study+of+17-allylamino%2C+17-demethoxygeldanamycin+in+patients+with+advanced+malignancies"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Phase I pharmacokinetic and pharmacodynamic study of 17-allylamino, 17-demethoxygeldanamycin in patients with advanced malignancies</span></div><div class="casAuthors">Banerji, Udai; O'Donnell, Anne; Scurr, Michelle; Pacey, Simon; Stapleton, Sarah; Asad, Yasmin; Simmons, Laura; Maloney, Alison; Raynaud, Florence; Campbell, Maeli; Walton, Michael; Lakhani, Sunil; Kaye, Stanley; Workman, Paul; Judson, Ian</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Oncology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">4152-4161</span>CODEN:
                <span class="NLM_cas:coden">JCONDN</span>;
        ISSN:<span class="NLM_cas:issn">0732-183X</span>.
    
            (<span class="NLM_cas:orgname">American Society of Clinical Oncology</span>)
        </div><div class="casAbstract">Purpose: To study the toxicity and pharmacokinetic-pharmacodynamic profile of 17-allylamino, 17-demethoxygeldanamycin (17-AAG) and to recommend a dose for phase II trials.  Patients and Methods: This was a phase I study examg. a once-weekly dosing schedule of 17-AAG.  Thirty patients with advanced malignancies were treated.  Results: The highest dose level reached was 450 mg/m2/wk.  The dose-limiting toxicities (DLTs) encountered were grade 3 diarrhea in three patients (one at 320 mg/m2/wk and two at 450 mg/m2/wk) and grade 3 to 4 hepatotoxicity (AST/ALT) in one patient at 450 mg/m2/wk.  Two of nine DLTs were at the highest dose level.  Two patients with metastatic melanoma had stable disease and were treated for 15 and 41 mo, resp.  The dose vs. area under the curve-relationship for 17-AAG was linear (r2 = .71) over the dose range 10 to 450 mg/m2/wk, with peak plasma concns. of 8,998 μg/L (std. deviation, 2,881) at the highest dose level.  After the demonstration of pharmacodynamic changes in peripheral blood leukocytes, pre- and 24 h post-treatment, tumor biopsies were performed and demonstrated target inhibition (c-RAF-1 inhibition in four of six patients, CDK4 depletion in eight of nine patients and HSP70 induction in eight of nine patients) at the dose levels 320 and 450 mg/m2/wk.  It was not possible to reproducibly demonstrate these changes in biopsies taken 5 days after treatment.  Conclusion: It has been possible to demonstrate that 17-AAG exhibits a tolerable toxicity profile with therapeutic plasma concns. and target inhibition for 24 h after treatment and some indications of clin. activity at the dose level 450 mg/m2/wk.  We recommend this dose for phase II clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoaKgFbodgT_bVg90H21EOLACvtfcHk0lhaPbcbngcABQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXmt1elsrY%253D&md5=6ba10e24a68a1d9bd09d87239eea1ca6</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1200%2FJCO.2005.00.612&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2005.00.612%26sid%3Dliteratum%253Aachs%26aulast%3DBanerji%26aufirst%3DU.%26aulast%3DO%2527Donnell%26aufirst%3DA.%26aulast%3DScurr%26aufirst%3DM.%26aulast%3DPacey%26aufirst%3DS.%26aulast%3DStapleton%26aufirst%3DS.%26aulast%3DAsad%26aufirst%3DY.%26aulast%3DSimmons%26aufirst%3DL.%26aulast%3DMaloney%26aufirst%3DA.%26aulast%3DRaynaud%26aufirst%3DF.%26aulast%3DCampbell%26aufirst%3DM.%26aulast%3DWalton%26aufirst%3DM.%26aulast%3DLakhani%26aufirst%3DS.%26aulast%3DKaye%26aufirst%3DS.%26aulast%3DWorkman%26aufirst%3DP.%26aulast%3DJudson%26aufirst%3DI.%26atitle%3DPhase%2520I%2520pharmacokinetic%2520and%2520pharmacodynamic%2520study%2520of%252017-allylamino%252C%252017-demethoxygeldanamycin%2520in%2520patients%2520with%2520advanced%2520malignancies%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2005%26volume%3D23%26spage%3D4152%26epage%3D4161" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Goetz, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toft, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reid, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ames, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stensgard, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Safgren, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adjei, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sloan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atherton, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vasile, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salazaar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adjei, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Croghan, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erlichman, C.</span><span> </span><span class="NLM_article-title">Phase I trial of 17-allylamino-17-demethoxygeldanamycin in patients with advanced cancer</span> <span class="citation_source-journal">J. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">1078</span><span class="NLM_x">–</span> <span class="NLM_lpage">1087</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm900357y&amp;key=10.1200%2FJCO.2005.09.119" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm900357y&amp;key=15718306" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm900357y&amp;key=1%3ACAS%3A528%3ADC%252BD2MXitl2gtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2005&pages=1078-1087&author=M.+P.+Goetzauthor=D.+Toftauthor=J.+Reidauthor=M.+Amesauthor=B.+Stensgardauthor=S.+Safgrenauthor=A.+A.+Adjeiauthor=J.+Sloanauthor=P.+Athertonauthor=V.+Vasileauthor=S.+Salazaarauthor=A.+Adjeiauthor=G.+Croghanauthor=C.+Erlichman&title=Phase+I+trial+of+17-allylamino-17-demethoxygeldanamycin+in+patients+with+advanced+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Phase I trial of 17-allylamino-17-demethoxygeldanamycin in patients with advanced cancer</span></div><div class="casAuthors">Goetz, Matthew P.; Toft, David; Reid, Joel; Ames, Matthew; Stensgard, Bridget; Safgren, Stephanie; Adjei, Araba A.; Sloan, Jeff; Atherton, Pamela; Vasile, Vlad; Salazaar, Sandra; Adjei, Alex; Croghan, Gary; Erlichman, Charles</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Oncology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1078-1087</span>CODEN:
                <span class="NLM_cas:coden">JCONDN</span>;
        ISSN:<span class="NLM_cas:issn">0732-183X</span>.
    
            (<span class="NLM_cas:orgname">American Society of Clinical Oncology</span>)
        </div><div class="casAbstract">Purpose We detd. the max.-tolerated dose (MTD) and the dose-limiting toxicities (DLT) of 17-allylamino-17-demethoxygeldanamycin (17-AAG) when infused on days 1, 8, and 15 of a 28-day cycle in advanced solid tumor patients.  We also characterized the pharmacokinetics of 17-AAG, its effect on chaperone and client proteins, and whether cytochrome P 450 (CYP) 3A5 and NAD(P)H:quinone oxidoreductase 1 (NQO1) polymorphisms affected 17-AAG disposition or toxicity.  Patients and Methods An accelerated titrn. design was used.  Biomarkers were measured in peripheral-blood mononuclear cells (PBMCs) at baseline and on days 1 and 15, and pharmacokinetic anal. was performed on day 1 of cycle 1.  CYP3A5*3 and NQO1*2 genotypes were detd. and correlated with pharmacokinetics and toxicity.  Results Twenty-one patients received 52 courses at 11 dose levels.  DLTs at 431 mg/m2 were grade 3 bilirubin (n = 1), AST (n = 1), anemia (n = 1), nausea (n = 1), vomiting (n = 1), and myalgias (n = 1).  No tumor responses were seen.  17-AAG consistently increased heat shock protein (Hsp) 70 levels in PBMCs.  At the MTD, the clearance and half-life (t1/2) of 17-AAG were 11.6 L/h/m2 and 4.15 h, resp.; whereas the active metabolite 17-aminogeldanamycin had a t1/2 of 7.63 h.  The CYP3A5*3 and NQO1*2 polymorphisms were not assocd. with 17-AAG toxicity.  The CYP3A5*3 polymorphism was assocd. with higher 17-AAG clearance.  Conclusion The MTD of weekly 17-AAG is 308 mg/m2.  17-AAG induced Hsp70 in PBMCs, indicating that Hsp90 has been affected.  Further evaluation of 17-AAG is ongoing using a twice-weekly regimen, and this schedule of 17-AAG is being tested in combination with chemotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFPRrruDVbcLVg90H21EOLACvtfcHk0lhaPbcbngcABQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXitl2gtbw%253D&md5=b4ea280cb99c9977e6fa4bdb5f6efc06</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1200%2FJCO.2005.09.119&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2005.09.119%26sid%3Dliteratum%253Aachs%26aulast%3DGoetz%26aufirst%3DM.%2BP.%26aulast%3DToft%26aufirst%3DD.%26aulast%3DReid%26aufirst%3DJ.%26aulast%3DAmes%26aufirst%3DM.%26aulast%3DStensgard%26aufirst%3DB.%26aulast%3DSafgren%26aufirst%3DS.%26aulast%3DAdjei%26aufirst%3DA.%2BA.%26aulast%3DSloan%26aufirst%3DJ.%26aulast%3DAtherton%26aufirst%3DP.%26aulast%3DVasile%26aufirst%3DV.%26aulast%3DSalazaar%26aufirst%3DS.%26aulast%3DAdjei%26aufirst%3DA.%26aulast%3DCroghan%26aufirst%3DG.%26aulast%3DErlichman%26aufirst%3DC.%26atitle%3DPhase%2520I%2520trial%2520of%252017-allylamino-17-demethoxygeldanamycin%2520in%2520patients%2520with%2520advanced%2520cancer%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2005%26volume%3D23%26spage%3D1078%26epage%3D1087" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Weigel, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blaney, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reid, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Safgren, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bagatell, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kersey, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neglia, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ivy, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ingle, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whitesell, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilbertson, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krailo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ames, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adamson, P. C.</span><span> </span><span class="NLM_article-title">A Phase I Study of 17-Allylaminogeldanamycin in Relapsed/Refractory Pediatric Patients with Solid Tumors: A Children's Oncology Group Study</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">1789</span><span class="NLM_x">–</span> <span class="NLM_lpage">1793</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Fjm900357y&amp;key=10.1158%2F1078-0432.CCR-06-2270" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Fjm900357y&amp;key=17363534" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm900357y&amp;key=1%3ACAS%3A528%3ADC%252BD2sXivV2gtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2007&pages=1789-1793&author=B.+J.+Weigelauthor=S.+M.+Blaneyauthor=J.+M.+Reidauthor=S.+L.+Safgrenauthor=R.+Bagatellauthor=J.+Kerseyauthor=J.+P.+Negliaauthor=S.+P.+Ivyauthor=A.+M.+Ingleauthor=L.+Whitesellauthor=R.+J.+Gilbertsonauthor=M.+Krailoauthor=M.+Amesauthor=P.+C.+Adamson&title=A+Phase+I+Study+of+17-Allylaminogeldanamycin+in+Relapsed%2FRefractory+Pediatric+Patients+with+Solid+Tumors%3A+A+Children%27s+Oncology+Group+Study"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">A phase I study of 17-allylaminogeldanamycin in relapsed/refractory pediatric patients with solid tumors: a children's oncology group Study</span></div><div class="casAuthors">Weigel, Brenda J.; Blaney, Susan M.; Reid, Joel M.; Safgren, Stephanie L.; Bagatell, Rochelle; Kersey, John; Neglia, Joseph P.; Ivy, S. Percy; Ingle, Ashish M.; Whitesell, Luke; Gilbertson, Richard J.; Krailo, Mark; Ames, Matthew; Adamson, Peter C.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1789-1793</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">To det. the recommended phase 2 dose, dose-limiting toxicities (DLT), pharmacokinetic profile, and pharmacodynamics of the heat shock protein (Hsp) 90 inhibitor, 17-allylaminogeldanamycin (17-AAG).  17-AAG was administered as a 60-min infusion, on days 1, 4, 8, and 11 of a 21-day cycle at dose levels of 150, 200, 270, and 360 mg/m2/dose.  Pharmacokinetic studies and evaluations for Hsp72 and Akt levels in peripheral blood mononuclear cells were done during the first course of therapy.  Seventeen patients (7 males), median 7 years of age (range, 1-19 years), were enrolled using a std. dose escalation scheme.  No DLTs were obsd.  Although there were no objective responses, three patients remain on therapy at 6+, 7+, and 9+ months with stable disease.  One patient with hepatoblastoma had a redn. in α-fetoprotein and stable disease over three cycles.  At 270 mg/m2/dose, the Cmax and areas under the plasma concn.-time curves of 17-AAG were 5,303 ± 1,591 ng/mL and 13,656 ± 4,757 ng/mL h, resp., similar to the exposure in adults.  The mean terminal half-life for 17-AAG was 3.24 ± 0.80 h.  Induction of Hsp72, a surrogate marker for inhibition of Hsp90, was detected at the 270 mg/m2 dose level.  Drug exposures consistent with those required for anticancer activity in preclin. models were achieved without DLT.  Evidence for drug-induced modulation of Hsp90 systemically was also detected.  The recommended phase II dose of 17-AAG is 360 mg/m2/d.  Non-DMSO-contg. formulations may improve acceptance of this drug by children and their families.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5bX_5e9xYaLVg90H21EOLACvtfcHk0liS6YW109o5pg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXivV2gtLw%253D&md5=993461ceb86c7e6fa3c759a482eea16e</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-06-2270&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-06-2270%26sid%3Dliteratum%253Aachs%26aulast%3DWeigel%26aufirst%3DB.%2BJ.%26aulast%3DBlaney%26aufirst%3DS.%2BM.%26aulast%3DReid%26aufirst%3DJ.%2BM.%26aulast%3DSafgren%26aufirst%3DS.%2BL.%26aulast%3DBagatell%26aufirst%3DR.%26aulast%3DKersey%26aufirst%3DJ.%26aulast%3DNeglia%26aufirst%3DJ.%2BP.%26aulast%3DIvy%26aufirst%3DS.%2BP.%26aulast%3DIngle%26aufirst%3DA.%2BM.%26aulast%3DWhitesell%26aufirst%3DL.%26aulast%3DGilbertson%26aufirst%3DR.%2BJ.%26aulast%3DKrailo%26aufirst%3DM.%26aulast%3DAmes%26aufirst%3DM.%26aulast%3DAdamson%26aufirst%3DP.%2BC.%26atitle%3DA%2520Phase%2520I%2520Study%2520of%252017-Allylaminogeldanamycin%2520in%2520Relapsed%252FRefractory%2520Pediatric%2520Patients%2520with%2520Solid%2520Tumors%253A%2520A%2520Children%2527s%2520Oncology%2520Group%2520Study%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2007%26volume%3D13%26spage%3D1789%26epage%3D1793" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Solit, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Osman, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polsky, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panageas, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daud, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goydos, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teitcher, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolchok, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Germino, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krown, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coit, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chapman, P. B.</span><span> </span><span class="NLM_article-title">Phase II Trial of 17-Allylamino-17-Demethoxygeldanamycin in Patients with Metastatic Melanoma</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">8302</span><span class="NLM_x">–</span> <span class="NLM_lpage">8307</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Fjm900357y&amp;key=10.1158%2F1078-0432.CCR-08-1002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Fjm900357y&amp;key=19088048" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Fjm900357y&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsV2it7nP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2008&pages=8302-8307&author=D.+B.+Solitauthor=I.+Osmanauthor=D.+Polskyauthor=K.+S.+Panageasauthor=A.+Daudauthor=J.+S.+Goydosauthor=J.+Teitcherauthor=J.+D.+Wolchokauthor=F.+J.+Germinoauthor=S.+E.+Krownauthor=D.+Coitauthor=N.+Rosenauthor=P.+B.+Chapman&title=Phase+II+Trial+of+17-Allylamino-17-Demethoxygeldanamycin+in+Patients+with+Metastatic+Melanoma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Phase II Trial of 17-Allylamino-17-Demethoxygeldanamycin in Patients with Metastatic Melanoma</span></div><div class="casAuthors">Solit, David B.; Osman, Iman; Polsky, David; Panageas, Katherine S.; Daud, Adil; Goydos, James S.; Teitcher, Jerrold; Wolchok, Jedd D.; Germino, F. Joseph; Krown, Susan E.; Coit, Daniel; Rosen, Neal; Chapman, Paul B.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">8302-8307</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">PURPOSE: Activation of the mitogen-activated protein kinase (MAPK) pathway and the phosphatidylinositol 3-kinase/AKT pathway seems to be crit. for melanoma proliferation.  Components of these pathways are client proteins of heat-shock protein 90 (hsp90), suggesting that inhibition of hsp90 could have significant antimelanoma effects.  We conducted a phase II trial using the hsp90 inhibitor 17-allylamino-17-demethoxygeldanamycin (17-AAG) in melanoma patients.  The primary end points were clin. responses and whether treatment inhibited MAPK pathway activity.  Exptl. Design: Melanoma patients with measurable disease were stratified on the basis of whether or not their tumor harbored a V600E BRAF mutation.  The hsp90 inhibitor 17-AAG was administered i.v. once weekly x6 wk at 450 mg/m2.  Tumor biopsies were obtained pretreatment and 18 to 50 h after the first dose of 17-AAG, and were snap-frozen.  RESULTS: Fifteen evaluable patients were treated; nine had BRAF mutations and six were wild-type.  No objective responses were obsd.  Western blot anal. of tumor biopsies showed an increase in hsp70 and a decrease in cyclin D1 expression in the posttreatment biopsies but no significant effect on RAF kinases or phospho-extracellular signal-regulated kinase expression.  Plasma analyzed by mutant-specific PCR for V600E BRAF showed 86% sensitivity and 67% specificity in predicting tumor DNA sequencing results.  CONCLUSIONS: At this dose and schedule of 17-AAG, the effects of 17-AAG on RAF kinase expression were short-lived, and no objective antimelanoma responses were seen.  Future trials in melanoma should focus on a more potent hsp90 inhibitor or a formulation that can be administered chronically for a more prolonged suppression of the MAPK pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8xsVn1x3UJrVg90H21EOLACvtfcHk0liS6YW109o5pg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsV2it7nP&md5=aa8e989cf8bd0f198920bd08808e2627</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-08-1002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-08-1002%26sid%3Dliteratum%253Aachs%26aulast%3DSolit%26aufirst%3DD.%2BB.%26aulast%3DOsman%26aufirst%3DI.%26aulast%3DPolsky%26aufirst%3DD.%26aulast%3DPanageas%26aufirst%3DK.%2BS.%26aulast%3DDaud%26aufirst%3DA.%26aulast%3DGoydos%26aufirst%3DJ.%2BS.%26aulast%3DTeitcher%26aufirst%3DJ.%26aulast%3DWolchok%26aufirst%3DJ.%2BD.%26aulast%3DGermino%26aufirst%3DF.%2BJ.%26aulast%3DKrown%26aufirst%3DS.%2BE.%26aulast%3DCoit%26aufirst%3DD.%26aulast%3DRosen%26aufirst%3DN.%26aulast%3DChapman%26aufirst%3DP.%2BB.%26atitle%3DPhase%2520II%2520Trial%2520of%252017-Allylamino-17-Demethoxygeldanamycin%2520in%2520Patients%2520with%2520Metastatic%2520Melanoma%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2008%26volume%3D14%26spage%3D8302%26epage%3D8307" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Kamal, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thao, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sensintaffar, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boehm, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fritz, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burrows, F. J.</span><span> </span><span class="NLM_article-title">A high-affinity conformation of Hsp90 confers tumour selectivity on Hsp90 inhibitors</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">425</span><span class="NLM_x">, </span> <span class="NLM_fpage">407</span><span class="NLM_x">–</span> <span class="NLM_lpage">410</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Fjm900357y&amp;key=10.1038%2Fnature01913" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Fjm900357y&amp;key=14508491" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm900357y&amp;key=1%3ACAS%3A528%3ADC%252BD3sXnsV2kt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=425&publication_year=2003&pages=407-410&author=A.+Kamalauthor=L.+Thaoauthor=J.+Sensintaffarauthor=L.+Zhangauthor=M.+F.+Boehmauthor=L.+C.+Fritzauthor=F.+J.+Burrows&title=A+high-affinity+conformation+of+Hsp90+confers+tumour+selectivity+on+Hsp90+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">A high-affinity conformation of Hsp90 confers tumor selectivity on Hsp90 inhibitors</span></div><div class="casAuthors">Kamal, Adeela; Thao, Lia; Sensintaffar, John; Zhang, Lin; Boehm, Marcus F.; Fritz, Lawrence C.; Burrows, Francis J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">425</span>
        (<span class="NLM_cas:issue">6956</span>),
    <span class="NLM_cas:pages">407-410</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Heat shock protein 90 (Hsp90) is a mol. chaperone that plays a key role in the conformational maturation of oncogenic signaling proteins, including HER-2/ErbB2, Akt, Raf-1, Bcr-Abl and mutated p53.  Hsp90 inhibitors bind to Hsp90, and induce the proteasomal degrdn. of Hsp90 client proteins.  Although Hsp90 is highly expressed in most cells, Hsp90 inhibitors selectively kill cancer cells compared to normal cells, and the Hsp90 inhibitor 17-allylaminogeldanamycin (17-AAG) is currently in phase I clin. trials.  However, the mol. basis of the tumor selectivity of Hsp90 inhibitors is unknown.  Here we report that Hsp90 derived from tumor cells has a 100-fold higher binding affinity for 17-AAG than does Hsp90 from normal cells.  Tumor Hsp90 is present entirely in multi-chaperone complexes with high ATPase activity, whereas Hsp90 from normal tissues is in a latent, uncomplexed state.  In vitro reconstitution of chaperone complexes with Hsp90 resulted in increased binding affinity to 17-AAG, and increased ATPase activity.  These results suggest that tumor cells contain Hsp90 complexes in an activated, high-affinity conformation that facilitates malignant progression, and that may represent a unique target for cancer therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp0ozo1K3wfA7Vg90H21EOLACvtfcHk0lgurkpXs28WPw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXnsV2kt7w%253D&md5=7c83fca7aaf685b589c4aef6e5f39b02</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1038%2Fnature01913&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature01913%26sid%3Dliteratum%253Aachs%26aulast%3DKamal%26aufirst%3DA.%26aulast%3DThao%26aufirst%3DL.%26aulast%3DSensintaffar%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DBoehm%26aufirst%3DM.%2BF.%26aulast%3DFritz%26aufirst%3DL.%2BC.%26aulast%3DBurrows%26aufirst%3DF.%2BJ.%26atitle%3DA%2520high-affinity%2520conformation%2520of%2520Hsp90%2520confers%2520tumour%2520selectivity%2520on%2520Hsp90%2520inhibitors%26jtitle%3DNature%26date%3D2003%26volume%3D425%26spage%3D407%26epage%3D410" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">da Rocha, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedlos, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Light, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Springer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Workman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marais, R.</span><span> </span><span class="NLM_article-title">Activated B-RAF is an Hsp90 client protein that is targeted by the anticancer drug 17-allylamino-17-demethoxygeldanamycin</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">10686</span><span class="NLM_x">–</span> <span class="NLM_lpage">10691</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2005&pages=10686-10691&author=D.+S.+da+Rochaauthor=F.+Friedlosauthor=Y.+Lightauthor=C.+Springerauthor=P.+Workmanauthor=R.+Marais&title=Activated+B-RAF+is+an+Hsp90+client+protein+that+is+targeted+by+the+anticancer+drug+17-allylamino-17-demethoxygeldanamycin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3Dda%2BRocha%26aufirst%3DD.%2BS.%26aulast%3DFriedlos%26aufirst%3DF.%26aulast%3DLight%26aufirst%3DY.%26aulast%3DSpringer%26aufirst%3DC.%26aulast%3DWorkman%26aufirst%3DP.%26aulast%3DMarais%26aufirst%3DR.%26atitle%3DActivated%2520B-RAF%2520is%2520an%2520Hsp90%2520client%2520protein%2520that%2520is%2520targeted%2520by%2520the%2520anticancer%2520drug%252017-allylamino-17-demethoxygeldanamycin%26jtitle%3DCancer%2520Res.%26date%3D2005%26volume%3D65%26spage%3D10686%26epage%3D10691" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Workman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burrows, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neckers, L.</span><span> </span><span class="NLM_article-title">Drugging the cancer chaperone HSP90: combinatorial therapeutic exploitation of oncogene addiction and tumor stress</span> <span class="citation_source-journal">Ann. N.Y. Acad. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">1113</span><span class="NLM_x">, </span> <span class="NLM_fpage">202</span><span class="NLM_x">–</span> <span class="NLM_lpage">216</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Fjm900357y&amp;key=10.1196%2Fannals.1391.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Fjm900357y&amp;key=17513464" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm900357y&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVanurfF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1113&publication_year=2007&pages=202-216&author=P.+Workmanauthor=F.+Burrowsauthor=L.+Neckers&title=Drugging+the+cancer+chaperone+HSP90%3A+combinatorial+therapeutic+exploitation+of+oncogene+addiction+and+tumor+stress"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Drugging the cancer chaperone HSP90: combinatorial therapeutic expolitation on oncogene addiction and tumor stress</span></div><div class="casAuthors">Workman, Paul; Burrows, Francis; Neckers, Len; Rosen, Neal</div><div class="citationInfo"><span class="NLM_cas:title">Annals of the New York Academy of Sciences</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">1113</span>
        (<span class="NLM_cas:issue">Stress Responses in Biology and Medicine</span>),
    <span class="NLM_cas:pages">202-216</span>CODEN:
                <span class="NLM_cas:coden">ANYAA9</span>;
        ISSN:<span class="NLM_cas:issn">0077-8923</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing, Inc.</span>)
        </div><div class="casAbstract">A review.  The mol. chaperone HSP90 has emerged as an exciting target for cancer treatment.  We review the potential advantages of HSP90 inhibitors, particularly the simultaneous combinatorial depletion of multiple oncogenic "client" proteins, leading to blockade of many cancer-causing pathways and the antagonism of all of the hallmark pathol. traits of malignancy.  Cancer selectivity is achieved by exploiting cancer "dependencies," including oncogene addiction and the stressed state of malignant cells.  The multiple downstream effects of HSP90 inhibitors should make the development of resistance more difficult than with agents having more restricted effects.  We review the various classes of HSP90 inhibitor that have been developed, including the natural products geldanamycin and radicicol and also the purine scaffold and pyrazole/isoxazole class of synthetic small mol. inhibitors.  A first-in-class HSP90 drug, the geldanamycin analog 17-AAG, has provided proof of concept for HSP90 inhibition in patients at well tolerated doses and therapeutic activity has been seen.  Other inhibitors show promise in preclin. and clin. development.  Opportunities and challenges for HSP90 inhibitors are discussed, including use in combination with other agents.  Most of the current HSP90 inhibitors act by blocking the essential nucleotide binding and ATPase activity required for chaperone function.  Potential new approaches are discussed, for example, interference with cochaperone binding and function in the superchaperone complex.  Biomarkers for use with HSP90 inhibitors are described.  We stress how basic and translational research has been mutually beneficial and indicate future directions to enhance our understanding of mol. chaperones and their exploitation in cancer and other diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoi_I-DGevqj7Vg90H21EOLACvtfcHk0lgcHzVV-EHe0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVanurfF&md5=a537c5d947847c6b3cdf613968214623</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1196%2Fannals.1391.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1196%252Fannals.1391.012%26sid%3Dliteratum%253Aachs%26aulast%3DWorkman%26aufirst%3DP.%26aulast%3DBurrows%26aufirst%3DF.%26aulast%3DNeckers%26aufirst%3DL.%26atitle%3DDrugging%2520the%2520cancer%2520chaperone%2520HSP90%253A%2520combinatorial%2520therapeutic%2520exploitation%2520of%2520oncogene%2520addiction%2520and%2520tumor%2520stress%26jtitle%3DAnn.%2520N.Y.%2520Acad.%2520Sci.%26date%3D2007%26volume%3D1113%26spage%3D202%26epage%3D216" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Egorin, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolff, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Callery, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Musser, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eiseman, J. L.</span><span> </span><span class="NLM_article-title">Metabolism of 17-(allylamino)-17-demethoxygeldanamycin (NSC 330507) by murine and human hepatic preparations</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">2385</span><span class="NLM_x">–</span> <span class="NLM_lpage">2396</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=1998&pages=2385-2396&author=M.+J.+Egorinauthor=D.+M.+Rosenauthor=J.+H.+Wolffauthor=P.+S.+Calleryauthor=S.+M.+Musserauthor=J.+L.+Eiseman&title=Metabolism+of+17-%28allylamino%29-17-demethoxygeldanamycin+%28NSC+330507%29+by+murine+and+human+hepatic+preparations"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEgorin%26aufirst%3DM.%2BJ.%26aulast%3DRosen%26aufirst%3DD.%2BM.%26aulast%3DWolff%26aufirst%3DJ.%2BH.%26aulast%3DCallery%26aufirst%3DP.%2BS.%26aulast%3DMusser%26aufirst%3DS.%2BM.%26aulast%3DEiseman%26aufirst%3DJ.%2BL.%26atitle%3DMetabolism%2520of%252017-%2528allylamino%2529-17-demethoxygeldanamycin%2520%2528NSC%2520330507%2529%2520by%2520murine%2520and%2520human%2520hepatic%2520preparations%26jtitle%3DCancer%2520Res.%26date%3D1998%26volume%3D58%26spage%3D2385%26epage%3D2396" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Kelland, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharp, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Myers, T. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Workman, P.</span><span> </span><span class="NLM_article-title">DT-Diaphorase expression and tumor cell sensitivity to 17-allylamino, 17-demethoxygeldanamycin, an inhibitor of heat shock protein 90</span> <span class="citation_source-journal">J. Natl. Cancer Inst.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">91</span><span class="NLM_x">, </span> <span class="NLM_fpage">1940</span><span class="NLM_x">–</span> <span class="NLM_lpage">1949</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Fjm900357y&amp;key=10.1093%2Fjnci%2F91.22.1940" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Fjm900357y&amp;key=10564678" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Fjm900357y&amp;key=1%3ACAS%3A528%3ADyaK1MXotVaitr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=1999&pages=1940-1949&author=L.+R.+Kellandauthor=S.+Y.+Sharpauthor=P.+M.+Rogersauthor=T.+G.+Myersauthor=P.+Workman&title=DT-Diaphorase+expression+and+tumor+cell+sensitivity+to+17-allylamino%2C+17-demethoxygeldanamycin%2C+an+inhibitor+of+heat+shock+protein+90"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">DT-diaphorase expression and tumor cell sensitivity to 17-allylamino-17-demethoxygeldanamycin, an inhibitor of heat shock protein 90</span></div><div class="casAuthors">Kelland, Lloyd R.; Sharp, Swee Y.; Rogers, Paul M.; Myers, Timothy G.; Workman, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the National Cancer Institute</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">91</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">1940-1949</span>CODEN:
                <span class="NLM_cas:coden">JNCIEQ</span>;
        ISSN:<span class="NLM_cas:issn">0027-8874</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Background: To our knowledge, 17-allylamino-17-demethoxygeldanamycin (17AAG) is the first inhibitor of heat shock protein 90 (Hsp90) to enter a phase I clin. trial in cancer.  Inhibition of Hsp90, a chaperone protein (a protein that helps other proteins avoid misfolding pathways that produce inactive or aggregated states), leads to depletion of important oncogenic proteins, including Raf-1 and mutant p53 (also known as TP53).  Given its ansamycin benzoquinone structure, we questioned whether the antitumor activity of 17AAG was affected by expression of the NQO1 gene, which encodes the quinone-metabolizing enzyme DT-diaphorase.  Methods: The antitumor activity of 17AAG and other Hsp90 inhibitors was detd. by use of a sulforhodamine B-based cell growth inhibition assay in culture and by the arrest of xenograft tumor growth in nude mice.  DT-diaphorase activity was detd. by use of a spectrophotometric assay, and protein expression was detd. by western immunoblotting.  Results: In two independent in vitro human tumor cell panels, we obsd. a pos. relation between DT-diaphorase expression level and growth inhibition by 17AAG.  Stable, high-level expression of the active NQO1 gene transfected into the DT-diaphorase-deficient (by NQO1 mutation) BE human colon carcinoma cell line resulted in a 32-fold increase in 17AAG growth-inhibition activity.  Increased sensitivity to 17AAG in the transfected cell line was also confirmed in xenografts.  The extent of depletion of Raf-1 and mutant p53 protein confirmed that the Hsp90 inhibition mechanism was maintained in cells with high and low levels of DT-diaphorase.  17AAG was shown to be a substrate for purified human DT-diaphorase.  Conclusion: These results suggest that the antitumor activity and possibly the toxicol. properties of 17AAG in humans may be influenced by the expression of DT-diaphorase.  Careful monitoring for NQO1 polymorphism and the level of tumor DT-diaphorase activity is therefore recommended in clin. trials with 17AAG.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5zBsj7Xagm7Vg90H21EOLACvtfcHk0lgcHzVV-EHe0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXotVaitr8%253D&md5=508d5f614ce715ae495263171b286bff</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1093%2Fjnci%2F91.22.1940&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjnci%252F91.22.1940%26sid%3Dliteratum%253Aachs%26aulast%3DKelland%26aufirst%3DL.%2BR.%26aulast%3DSharp%26aufirst%3DS.%2BY.%26aulast%3DRogers%26aufirst%3DP.%2BM.%26aulast%3DMyers%26aufirst%3DT.%2BG.%26aulast%3DWorkman%26aufirst%3DP.%26atitle%3DDT-Diaphorase%2520expression%2520and%2520tumor%2520cell%2520sensitivity%2520to%252017-allylamino%252C%252017-demethoxygeldanamycin%252C%2520an%2520inhibitor%2520of%2520heat%2520shock%2520protein%252090%26jtitle%3DJ.%2520Natl.%2520Cancer%2520Inst.%26date%3D1999%26volume%3D91%26spage%3D1940%26epage%3D1949" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Meli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pennati, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daidone, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plescia, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toba, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Altieri, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zaffaroni, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colombo, G.</span><span> </span><span class="NLM_article-title">Small-Molecule Targeting of Heat Shock Protein 90 Chaperone Function: Rational Identification of a New Anticancer Lead</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">7721</span><span class="NLM_x">–</span> <span class="NLM_lpage">7730</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm060836y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=7721-7730&author=M.+Meliauthor=M.+Pennatiauthor=M.+Curtoauthor=M.+G.+Daidoneauthor=J.+Plesciaauthor=S.+Tobaauthor=D.+C.+Altieriauthor=N.+Zaffaroniauthor=G.+Colombo&title=Small-Molecule+Targeting+of+Heat+Shock+Protein+90+Chaperone+Function%3A+Rational+Identification+of+a+New+Anticancer+Lead"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fjm060836y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060836y%26sid%3Dliteratum%253Aachs%26aulast%3DMeli%26aufirst%3DM.%26aulast%3DPennati%26aufirst%3DM.%26aulast%3DCurto%26aufirst%3DM.%26aulast%3DDaidone%26aufirst%3DM.%2BG.%26aulast%3DPlescia%26aufirst%3DJ.%26aulast%3DToba%26aufirst%3DS.%26aulast%3DAltieri%26aufirst%3DD.%2BC.%26aulast%3DZaffaroni%26aufirst%3DN.%26aulast%3DColombo%26aufirst%3DG.%26atitle%3DSmall-Molecule%2520Targeting%2520of%2520Heat%2520Shock%2520Protein%252090%2520Chaperone%2520Function%253A%2520Rational%2520Identification%2520of%2520a%2520New%2520Anticancer%2520Lead%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D7721%26epage%3D7730" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Gaspar, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharp, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pacey, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walton, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vassal, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eccles, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pearson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Workman, P.</span><span> </span><span class="NLM_article-title">Acquired Resistance to 17-Allylamino-17-Demethoxygeldanamycin (Tanespimycin) in Glioblastoma Cells</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x">, </span> <span class="NLM_fpage">1966</span><span class="NLM_x">–</span> <span class="NLM_lpage">1975</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2009&pages=1966-1975&author=N.+Gasparauthor=S.+Y.+Sharpauthor=S.+Paceyauthor=D.+Jonesauthor=M.+Waltonauthor=G.+Vassalauthor=S.+Ecclesauthor=A.+Pearsonauthor=P.+Workman&title=Acquired+Resistance+to+17-Allylamino-17-Demethoxygeldanamycin+%28Tanespimycin%29+in+Glioblastoma+Cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGaspar%26aufirst%3DN.%26aulast%3DSharp%26aufirst%3DS.%2BY.%26aulast%3DPacey%26aufirst%3DS.%26aulast%3DJones%26aufirst%3DD.%26aulast%3DWalton%26aufirst%3DM.%26aulast%3DVassal%26aufirst%3DG.%26aulast%3DEccles%26aufirst%3DS.%26aulast%3DPearson%26aufirst%3DA.%26aulast%3DWorkman%26aufirst%3DP.%26atitle%3DAcquired%2520Resistance%2520to%252017-Allylamino-17-Demethoxygeldanamycin%2520%2528Tanespimycin%2529%2520in%2520Glioblastoma%2520Cells%26jtitle%3DCancer%2520Res.%26date%3D2009%26volume%3D69%26spage%3D1966%26epage%3D1975" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Kaur, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belotti, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burger, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher-Nielson, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borsotti, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riccardi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thillainathan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollingshead, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sausville, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giavazzi, R.</span><span> </span><span class="NLM_article-title">Antiangiogenic properties of 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin: an orally bioavailable heat shock protein 90 modulator</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">4813</span><span class="NLM_x">–</span> <span class="NLM_lpage">4821</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Fjm900357y&amp;key=10.1158%2F1078-0432.CCR-03-0795" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Fjm900357y&amp;key=15269157" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm900357y&amp;key=1%3ACAS%3A528%3ADC%252BD2cXlvVegs7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2004&pages=4813-4821&author=G.+Kaurauthor=D.+Belottiauthor=A.+M.+Burgerauthor=K.+Fisher-Nielsonauthor=P.+Borsottiauthor=E.+Riccardiauthor=J.+Thillainathanauthor=M.+Hollingsheadauthor=E.+A.+Sausvilleauthor=R.+Giavazzi&title=Antiangiogenic+properties+of+17-%28dimethylaminoethylamino%29-17-demethoxygeldanamycin%3A+an+orally+bioavailable+heat+shock+protein+90+modulator"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Antiangiogenic properties of 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin: an orally bioavailable heat shock protein 90 modulator</span></div><div class="casAuthors">Kaur, Gurmeet; Belotti, Dorina; Burger, Angelika M.; Fisher-Nielson, Kirsten; Borsotti, Patrizia; Riccardi, Elena; Thillainathan, Jagada; Hollingshead, Melinda; Sausville, Edward A.; Giavazzi, Raffaella</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">4813-4821</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The purpose of this study was to investigate the antiangiogenic properties of 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin (17-DMAG; NSC707545), a water-sol. benzoquinone ansamycin.  The activity of 17-DMAG, in vivo, was evaluated for inhibition of fibroblast growth factor (FGF)-2-induced angiogenesis in s.c. implanted Matrigel in mice.  In vitro, the activity of 17-DMAG on endothelial cells (human umbilical vein endothelial cells; HUVEC) was tested in FGF-2; and vascular endothelial growth factor (VEGF)-induced proliferation and apoptosis, motility, and extracellular matrix invasion; and on the alignment of capillary like structures in Matrigel.  The protein level of heat shock protein (Hsp)90 and client proteins was examd. by Western blot in FGF-2 and VEGF-stimulated HUVEC.  Daily oral administration of 17-DMAG affected the angiogenic response in Matrigel in a dose-dependent manner.  The Hb content in the Matrigel implants was significantly inhibited, and the histol. anal. confirmed a decrease of CD31+ endothelial cells and of structures organized in cord and erythrocyte-contg. vessels.  In vitro, the compd. inhibited dose-dependently the migration and the extracellular matrix-invasiveness of HUVEC and their capacity to form capillary like structures in Matrigel. 17-DMAG treatment also inhibited FGF-2 and VEGF-induced HUVEC proliferation and resulted in apoptosis.  Accordingly, the expression of Hsp90 direct client proteins (pAkt and c-Raf-1) or their downstream substrates including pERK was also affected. 17-DMAG consistently increased the expression of Hsp70.  Throughout the study similar results were obtained with 17-allylamino-17-demethoxygeldanamycin (17-AAG; NSC330507), the analog compd. currently undergoing clin. trials.  We show that the Hsp90 targeting agents 17-DMAG and 17-AAG inhibit angiogenesis.  The strong effects on endothelial cell functions, in vitro, indicate that the antiangiogenic activity of 17-DMAG/17-AAG could also be due to a direct effect on endothelial cells.  The oral bioavailability of 17-DMAG might be of advantage in investigating the potential of this compd. in clin. trials with antiangiogenic as well as antiproliferative endpoints.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrbGsLTxbCrQ7Vg90H21EOLACvtfcHk0ljYSsY66fpZMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXlvVegs7s%253D&md5=e78331697485d2c1948adec2d4f124e6</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-03-0795&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-03-0795%26sid%3Dliteratum%253Aachs%26aulast%3DKaur%26aufirst%3DG.%26aulast%3DBelotti%26aufirst%3DD.%26aulast%3DBurger%26aufirst%3DA.%2BM.%26aulast%3DFisher-Nielson%26aufirst%3DK.%26aulast%3DBorsotti%26aufirst%3DP.%26aulast%3DRiccardi%26aufirst%3DE.%26aulast%3DThillainathan%26aufirst%3DJ.%26aulast%3DHollingshead%26aufirst%3DM.%26aulast%3DSausville%26aufirst%3DE.%2BA.%26aulast%3DGiavazzi%26aufirst%3DR.%26atitle%3DAntiangiogenic%2520properties%2520of%252017-%2528dimethylaminoethylamino%2529-17-demethoxygeldanamycin%253A%2520an%2520orally%2520bioavailable%2520heat%2520shock%2520protein%252090%2520modulator%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2004%26volume%3D10%26spage%3D4813%26epage%3D4821" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Ge, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Normant, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porter, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ali, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dembski, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Georges, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grenier, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pak, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patterson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sydor, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tibbitts, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tong, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palombella, V. J.</span><span> </span><span class="NLM_article-title">Design, synthesis, and biological evaluation of hydroquinone derivatives of 17-amino-17-demethoxygeldanamycin as potent, water-soluble inhibitors of Hsp90</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">4606</span><span class="NLM_x">–</span> <span class="NLM_lpage">4615</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0603116" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=4606-4615&author=J.+Geauthor=E.+Normantauthor=J.+R.+Porterauthor=J.+A.+Aliauthor=M.+S.+Dembskiauthor=Y.+Gaoauthor=A.+T.+Georgesauthor=L.+Grenierauthor=R.+H.+Pakauthor=J.+Pattersonauthor=J.+R.+Sydorauthor=T.+T.+Tibbittsauthor=J.+K.+Tongauthor=J.+Adamsauthor=V.+J.+Palombella&title=Design%2C+synthesis%2C+and+biological+evaluation+of+hydroquinone+derivatives+of+17-amino-17-demethoxygeldanamycin+as+potent%2C+water-soluble+inhibitors+of+Hsp90"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fjm0603116&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0603116%26sid%3Dliteratum%253Aachs%26aulast%3DGe%26aufirst%3DJ.%26aulast%3DNormant%26aufirst%3DE.%26aulast%3DPorter%26aufirst%3DJ.%2BR.%26aulast%3DAli%26aufirst%3DJ.%2BA.%26aulast%3DDembski%26aufirst%3DM.%2BS.%26aulast%3DGao%26aufirst%3DY.%26aulast%3DGeorges%26aufirst%3DA.%2BT.%26aulast%3DGrenier%26aufirst%3DL.%26aulast%3DPak%26aufirst%3DR.%2BH.%26aulast%3DPatterson%26aufirst%3DJ.%26aulast%3DSydor%26aufirst%3DJ.%2BR.%26aulast%3DTibbitts%26aufirst%3DT.%2BT.%26aulast%3DTong%26aufirst%3DJ.%2BK.%26aulast%3DAdams%26aufirst%3DJ.%26aulast%3DPalombella%26aufirst%3DV.%2BJ.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520biological%2520evaluation%2520of%2520hydroquinone%2520derivatives%2520of%252017-amino-17-demethoxygeldanamycin%2520as%2520potent%252C%2520water-soluble%2520inhibitors%2520of%2520Hsp90%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D4606%26epage%3D4615" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Sydor, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Normant, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pien, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porter, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ge, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grenier, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pak, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ali, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dembski, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hudak, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patterson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Penders, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pink, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Read, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woodward, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grayzel, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrett, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palombella, V. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tong, J. K.</span><span> </span><span class="NLM_article-title">Development of 17-allylamino-17-demethoxygeldanamycin hydroquinone hydrochloride (IPI-504), an anticancer agent directed against Hsp90</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">103</span><span class="NLM_x">, </span> <span class="NLM_fpage">17408</span><span class="NLM_x">–</span> <span class="NLM_lpage">17413</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2006&pages=17408-17413&author=J.+R.+Sydorauthor=E.+Normantauthor=C.+S.+Pienauthor=J.+R.+Porterauthor=J.+Geauthor=L.+Grenierauthor=R.+H.+Pakauthor=J.+A.+Aliauthor=M.+S.+Dembskiauthor=J.+Hudakauthor=J.+Pattersonauthor=C.+Pendersauthor=M.+Pinkauthor=M.+A.+Readauthor=J.+Sangauthor=C.+Woodwardauthor=Y.+Zhangauthor=D.+S.+Grayzelauthor=J.+Wrightauthor=J.+A.+Barrettauthor=V.+J.+Palombellaauthor=J.+Adamsauthor=J.+K.+Tong&title=Development+of+17-allylamino-17-demethoxygeldanamycin+hydroquinone+hydrochloride+%28IPI-504%29%2C+an+anticancer+agent+directed+against+Hsp90"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSydor%26aufirst%3DJ.%2BR.%26aulast%3DNormant%26aufirst%3DE.%26aulast%3DPien%26aufirst%3DC.%2BS.%26aulast%3DPorter%26aufirst%3DJ.%2BR.%26aulast%3DGe%26aufirst%3DJ.%26aulast%3DGrenier%26aufirst%3DL.%26aulast%3DPak%26aufirst%3DR.%2BH.%26aulast%3DAli%26aufirst%3DJ.%2BA.%26aulast%3DDembski%26aufirst%3DM.%2BS.%26aulast%3DHudak%26aufirst%3DJ.%26aulast%3DPatterson%26aufirst%3DJ.%26aulast%3DPenders%26aufirst%3DC.%26aulast%3DPink%26aufirst%3DM.%26aulast%3DRead%26aufirst%3DM.%2BA.%26aulast%3DSang%26aufirst%3DJ.%26aulast%3DWoodward%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DGrayzel%26aufirst%3DD.%2BS.%26aulast%3DWright%26aufirst%3DJ.%26aulast%3DBarrett%26aufirst%3DJ.%2BA.%26aulast%3DPalombella%26aufirst%3DV.%2BJ.%26aulast%3DAdams%26aufirst%3DJ.%26aulast%3DTong%26aufirst%3DJ.%2BK.%26atitle%3DDevelopment%2520of%252017-allylamino-17-demethoxygeldanamycin%2520hydroquinone%2520hydrochloride%2520%2528IPI-504%2529%252C%2520an%2520anticancer%2520agent%2520directed%2520against%2520Hsp90%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2006%26volume%3D103%26spage%3D17408%26epage%3D17413" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Modi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stopeck, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gordon, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendelson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Solit, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bagatell, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wheler, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Norton, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cropp, G. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hannah, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hudis, C. A.</span><span> </span><span class="NLM_article-title">Combination of trastuzumab and tanespimycin (17-AAG, KOS-953) is safe and active in trastuzumab-refractory HER-2-overexpressing breast cancer: a phase I dose-escalation study</span> <span class="citation_source-journal">J. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">5410</span><span class="NLM_x">–</span> <span class="NLM_lpage">5417</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Fjm900357y&amp;key=10.1200%2FJCO.2007.11.7960" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Fjm900357y&amp;key=18048823" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Fjm900357y&amp;key=1%3ACAS%3A528%3ADC%252BD1cXnvVCisQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2007&pages=5410-5417&author=S.+Modiauthor=A.+T.+Stopeckauthor=M.+S.+Gordonauthor=D.+Mendelsonauthor=D.+B.+Solitauthor=R.+Bagatellauthor=W.+Maauthor=J.+Whelerauthor=N.+Rosenauthor=L.+Nortonauthor=G.+F.+Croppauthor=R.+G.+Johnsonauthor=A.+L.+Hannahauthor=C.+A.+Hudis&title=Combination+of+trastuzumab+and+tanespimycin+%2817-AAG%2C+KOS-953%29+is+safe+and+active+in+trastuzumab-refractory+HER-2-overexpressing+breast+cancer%3A+a+phase+I+dose-escalation+study"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Combination of trastuzumab and tanespimycin (17-AAG, KOS-953) is safe and active in trastuzumab-refractory HER-2-overexpressing breast cancer: a phase I dose-escalation study</span></div><div class="casAuthors">Modi, Shanu; Stopeck, Alison T.; Gordon, Michael S.; Mendelson, David; Solit, David B.; Bagatell, Rochelle; Ma, Weining; Wheler, Jennifer; Rosen, Neal; Norton, Larry; Cropp, Gillian F.; Johnson, Robert G.; Hannah, Alison L.; Hudis, Clifford A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Oncology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">34</span>),
    <span class="NLM_cas:pages">5410-5417</span>CODEN:
                <span class="NLM_cas:coden">JCONDN</span>;
        ISSN:<span class="NLM_cas:issn">0732-183X</span>.
    
            (<span class="NLM_cas:orgname">American Society of Clinical Oncology</span>)
        </div><div class="casAbstract">Purpose: This phase I study examd. whether a heat shock protein (Hsp) 90 inhibitor tanespimycin (17-AAG; KOS-953) could be administered safely in combination with trastuzumab at a dose that inhibits Hsp90 function in vivo in lymphocytes.  Patients and Methods: Patients with an advanced solid tumor progressing during std. therapy were eligible.  Patients were treated with weekly trastuzumab followed by i.v. tanespimycin, assessed in escalating dose levels.  Results: Twenty-five patients were enrolled onto four tanespimycin dose levels: 225 (n = 4), 300 (n = 3), 375 (n = 8), and 450 mg/m2 (n = 10).  Dose-limiting toxicity (DLT) was obsd. at the third and fourth cohort (1 patient each): more than 2-wk delay for grade 4 fatigue/grade 2 nausea and anorexia (375 mg/m2); more than 2-wk delay for thrombocytopenia (450 mg/m2).  Drug-related grade 3 toxicity included emesis, increased ALT, hypersensitivity reactions (two patients each), and drug-induced thrombocytopenia (n = 1).  Common mild to moderate toxicities included fatigue, nausea, diarrhea, emesis, headache, rash/pruritus, increased AST/ALT, and anorexia.  Pharmacokinetic anal. demonstrated no difference in tanespimycin kinetics with or without trastuzumab.  Pharmacodynamic testing showed reactive induction of Hsp70 (a marker of Hsp90 inhibition) in lymphocytes at all dose levels.  Antitumor activity was noted (partial response, n = 1; minor response, n = 4; stable disease ≥ 4 mo, n = 4).  Tumor regressions were seen only in patients with human epidermal growth factor receptor 2 (HER-2)-pos. metastatic breast cancer.  Conclusion: Tanespimycin plus trastuzumab is well tolerated and has antitumor activity in patients with HER-2+ breast cancer whose tumors have progressed during treatment with trastuzumab.  These data suggest that Hsp90 function can be inhibited in vivo to a degree sufficient to cause inhibition of tumor growth.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMOMgqgGMiFbVg90H21EOLACvtfcHk0liz0WKDsH0r0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXnvVCisQ%253D%253D&md5=a99de102e2458d4428b39a239a06ada4</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1200%2FJCO.2007.11.7960&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2007.11.7960%26sid%3Dliteratum%253Aachs%26aulast%3DModi%26aufirst%3DS.%26aulast%3DStopeck%26aufirst%3DA.%2BT.%26aulast%3DGordon%26aufirst%3DM.%2BS.%26aulast%3DMendelson%26aufirst%3DD.%26aulast%3DSolit%26aufirst%3DD.%2BB.%26aulast%3DBagatell%26aufirst%3DR.%26aulast%3DMa%26aufirst%3DW.%26aulast%3DWheler%26aufirst%3DJ.%26aulast%3DRosen%26aufirst%3DN.%26aulast%3DNorton%26aufirst%3DL.%26aulast%3DCropp%26aufirst%3DG.%2BF.%26aulast%3DJohnson%26aufirst%3DR.%2BG.%26aulast%3DHannah%26aufirst%3DA.%2BL.%26aulast%3DHudis%26aufirst%3DC.%2BA.%26atitle%3DCombination%2520of%2520trastuzumab%2520and%2520tanespimycin%2520%252817-AAG%252C%2520KOS-953%2529%2520is%2520safe%2520and%2520active%2520in%2520trastuzumab-refractory%2520HER-2-overexpressing%2520breast%2520cancer%253A%2520a%2520phase%2520I%2520dose-escalation%2520study%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2007%26volume%3D25%26spage%3D5410%26epage%3D5417" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Drysdale, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brough, P. A.</span><span> </span><span class="NLM_article-title">Medicinal chemistry of Hsp90 inhibitors</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">859</span><span class="NLM_x">–</span> <span class="NLM_lpage">868</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Fjm900357y&amp;key=10.2174%2F156802608784911644" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Fjm900357y&amp;key=18673171" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Fjm900357y&amp;key=1%3ACAS%3A528%3ADC%252BD1cXnsVant7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2008&pages=859-868&author=M.+J.+Drysdaleauthor=P.+A.+Brough&title=Medicinal+chemistry+of+Hsp90+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Medicinal chemistry of Hsp90 inhibitors</span></div><div class="casAuthors">Drysdale, Martin J.; Brough, Paul A.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">859-868</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Heat shock protein (Hsp90) inhibitors are an increasingly interesting and important class of compds. where the first in class, natural product derived inhibitors such as 17-allylaminogeldanamycin (17-AAG), are entering late stage clin. development.  Recently the emergence of synthetic, small mol. inhibitors has been described and both NVP-AUY922 and BIIB021 have entered clin. development.  The medicinal chem. of these and other published small mol. Hsp90 inhibitors is described in this review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_sn_Ez1pvv7Vg90H21EOLACvtfcHk0ljx7RTw0YDNew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXnsVant7Y%253D&md5=3e85f368ba92e36692b957c6e73d44a8</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.2174%2F156802608784911644&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802608784911644%26sid%3Dliteratum%253Aachs%26aulast%3DDrysdale%26aufirst%3DM.%2BJ.%26aulast%3DBrough%26aufirst%3DP.%2BA.%26atitle%3DMedicinal%2520chemistry%2520of%2520Hsp90%2520inhibitors%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2008%26volume%3D8%26spage%3D859%26epage%3D868" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Chiosis, G.</span><span> </span><span class="NLM_article-title">Discovery and development of purine-scaffold Hsp90 inhibitors</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">1183</span><span class="NLM_x">–</span> <span class="NLM_lpage">1191</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Fjm900357y&amp;key=10.2174%2F156802606777812013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Fjm900357y&amp;key=16842155" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Fjm900357y&amp;key=1%3ACAS%3A528%3ADC%252BD28Xpt1ejtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2006&pages=1183-1191&author=G.+Chiosis&title=Discovery+and+development+of+purine-scaffold+Hsp90+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and development of purine-scaffold Hsp90 inhibitors</span></div><div class="casAuthors">Chiosis, Gabriela</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1183-1191</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Hsp90 allows cancer cells to tolerate the many components of dysregulated pathways in a transformation-specific manner by interacting with several client substrates, such as kinases, hormone receptors and transcription factors that are directly involved in driving multistep malignancy, and also with mutated oncogenic proteins required for the transformed phenotype.  This distinctive broad involvement in maintaining the transformed phenotype has suggested Hsp90 as an important target in cancer therapy.  Discovery of pharmacol. agents that selectively inhibit its function have aided in probing the biol. functions of Hsp90 at the mol. level and in validating it as a novel target for anticancer drug action.  Two natural product derivs., 17-allylamino-17-desmethoxy-geldanamycin (17AAG) and 17-dimethylaminoethylamino-17-desmethoxy-geldanamycin (17DMAG) have further entered clin. trials, proving that Hsp90 may be modulated pharmacol. without causing target related toxicities in humans.  In spite of their usefulness as proof-of-principle compds., the clin. use of these two agents has been encumbered with some limitations due to their structural characteristics and also to less than optimal pharmacol. profiles.  Thus, the identification of Hsp90 inhibitors with improved structural characteristics and better pharmacol. profiles is a major focus of interest in the field.  One such emerging class is the purine-scaffold series.  This review intends to inform the reader on efforts ranging from the discovery to their clin. translation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqtpMNMTF3zyLVg90H21EOLACvtfcHk0ljx7RTw0YDNew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xpt1ejtLw%253D&md5=f619bbb69cd7ac43a2112d56e5a904f2</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.2174%2F156802606777812013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802606777812013%26sid%3Dliteratum%253Aachs%26aulast%3DChiosis%26aufirst%3DG.%26atitle%3DDiscovery%2520and%2520development%2520of%2520purine-scaffold%2520Hsp90%2520inhibitors%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2006%26volume%3D6%26spage%3D1183%26epage%3D1191" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Chiosis, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodina, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moulick, K.</span><span> </span><span class="NLM_article-title">Emerging Hsp90 inhibitors: from discovery to clinic</span> <span class="citation_source-journal">Anticancer Agents Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">8</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Fjm900357y&amp;key=10.2174%2F187152006774755483" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Fjm900357y&amp;key=16475922" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Fjm900357y&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVChsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2006&pages=1-8&author=G.+Chiosisauthor=A.+Rodinaauthor=K.+Moulick&title=Emerging+Hsp90+inhibitors%3A+from+discovery+to+clinic"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Emerging Hsp90 inhibitors: from discovery to clinic</span></div><div class="casAuthors">Chiosis, G.; Rodina, A.; Moulick, K.</div><div class="citationInfo"><span class="NLM_cas:title">Anti-Cancer Agents in Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-8</span>CODEN:
                <span class="NLM_cas:coden">AAMCE4</span>;
        ISSN:<span class="NLM_cas:issn">1871-5206</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Hsp90 is a chaperone with important roles in maintaining transformation and in elevating the survival and growth potential of cancer cells.  Activation of signaling pathways mediated by Hsp90 protein clients is necessary for cell proliferation, regulation of cell cycle progression and apoptosis.  Addnl., gain-of-function mutations responsible for transformation often require Hsp90 for the maintenance of their folded, functionally active conformations.  These characteristics promise Hsp90 as an important target in cancer therapy and prompt for the identification, development and clin. translation of small mol. inhibitors of the chaperone.  This review intends to update the reader on the status of several existing and emerging classes of direct inhibitors of Hsp90 ATPase activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9M20C3VvXMLVg90H21EOLACvtfcHk0ljBmNxA_ClTgQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVChsbw%253D&md5=647687cf4918d8b1f7c35e9197e41163</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.2174%2F187152006774755483&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F187152006774755483%26sid%3Dliteratum%253Aachs%26aulast%3DChiosis%26aufirst%3DG.%26aulast%3DRodina%26aufirst%3DA.%26aulast%3DMoulick%26aufirst%3DK.%26atitle%3DEmerging%2520Hsp90%2520inhibitors%253A%2520from%2520discovery%2520to%2520clinic%26jtitle%3DAnticancer%2520Agents%2520Med.%2520Chem.%26date%3D2006%26volume%3D6%26spage%3D1%26epage%3D8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Chiosis, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopes, E. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Solit, D.</span><span> </span><span class="NLM_article-title">Heat shock protein-90 inhibitors: a chronicle from geldanamycin to today's agents</span> <span class="citation_source-journal">Curr. Opin. Invest. Drugs (Thomson Scientific)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">534</span><span class="NLM_x">–</span> <span class="NLM_lpage">541</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Fjm900357y&amp;key=16784024" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Fjm900357y&amp;key=1%3ACAS%3A528%3ADC%252BD28XmsFyqtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2006&pages=534-541&author=G.+Chiosisauthor=E.+C.+Lopesauthor=D.+Solit&title=Heat+shock+protein-90+inhibitors%3A+a+chronicle+from+geldanamycin+to+today%27s+agents"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Heat shock protein-90 inhibitors: a chronicle from geldanamycin to today's agents</span></div><div class="casAuthors">Chiosis, Gabriela; Lopes, Eloisi Caldas; Solit, David</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Investigational Drugs (Thomson Scientific)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">534-541</span>CODEN:
                <span class="NLM_cas:coden">COIDAZ</span>;
        ISSN:<span class="NLM_cas:issn">1472-4472</span>.
    
            (<span class="NLM_cas:orgname">Thomson Scientific</span>)
        </div><div class="casAbstract">A review.  Heat shock protein (Hsp)90 is a chaperone with essential roles in maintaining transformation and in elevating the survival and growth potential of cancer cells.  The recognition of Hsp90 as an important target in cancer therapy has prompted the identification, development and clin. translation of a large array of Hsp90 inhibitors.  This review discusses the modalities that may interfere with this chaperone's function and describes the status of existing and emerging Hsp90 inhibitor classes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGraZ8Rv0_20LrVg90H21EOLACvtfcHk0ljBmNxA_ClTgQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XmsFyqtbk%253D&md5=a863ba2ec3251f5a732b418c2d478918</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChiosis%26aufirst%3DG.%26aulast%3DLopes%26aufirst%3DE.%2BC.%26aulast%3DSolit%26aufirst%3DD.%26atitle%3DHeat%2520shock%2520protein-90%2520inhibitors%253A%2520a%2520chronicle%2520from%2520geldanamycin%2520to%2520today%2527s%2520agents%26jtitle%3DCurr.%2520Opin.%2520Invest.%2520Drugs%2520%2528Thomson%2520Scientific%2529%26date%3D2006%26volume%3D7%26spage%3D534%26epage%3D541" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Dymock, B. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drysdale, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonald, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Workman, P.</span><span> </span><span class="NLM_article-title">Inhibitors of HSP90 and other chaperones for the treatment of cancer</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">837</span><span class="NLM_x">–</span> <span class="NLM_lpage">847</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Fjm900357y&amp;key=10.1517%2F13543776.14.6.837" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Fjm900357y&amp;key=1%3ACAS%3A528%3ADC%252BD2cXktlyqsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=837-847&author=B.+W.+Dymockauthor=M.+J.+Drysdaleauthor=E.+McDonaldauthor=P.+Workman&title=Inhibitors+of+HSP90+and+other+chaperones+for+the+treatment+of+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitors of HSP90 and other chaperones for the treatment of cancer</span></div><div class="casAuthors">Dymock, Brian W.; Drysdale, Martin J.; McDonald, Edward; Workman, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">837-847</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Ashley Publications Ltd.</span>)
        </div><div class="casAbstract">A review with refs.  Mol. chaperones are proteins that ensure the appropriate folding, stability and function of other proteins in the cell.  There is increasing evidence that mol. chaperones are not only important in normal cell homeostasis and response to stresses, such as heat shock, but can also be involved in disease pathol.  In particular, HSP90 has emerged as an important potential drug target in oncol.  This is because it is essential for the stability of a long list of client proteins', including ErbB2/human epithelial growth factor receptor (HER)2, Raf-1, Akt/protein kinase B (PKB), Polo-1, Met, mutant p53 and human telomerase reverse transcriptase (hTERT), as well as the estrogen and androgen receptor.  Inhibition of HSP90 leads to depletion of these oncogenic clients by the ubiquitin proteasome pathway, thereby providing a simultaneous combinatorial attack on all of the hallmark phenotypic traits of cancer cells.  Because of the rapid progress made, this review focuses on the patents dealing with the discovery and application of small mol. inhibitors of HSP90, although limited coverage of other applications in the area of HSP90 and addnl. chaperones is also included.  Pioneering work with natural products, namely geldanamycin and related ansamycin antibiotics together with radicicol macrocycle derivs., established the therapeutic potential of inhibiting the essential N-terminal ATPase of HSP90 by competing at the nucleotide binding site.  A geldanamycin analog, 17-(desmethoxy), 17-allylamino geldanamycin (17AAG), is completing Phase I clin. trials with promising initial results.  The use of high-throughput screening and rational design based on X-ray crystal structures of HSP90 has led to the discovery of small mol. HSP90 inhibitors based on purine and pyrazole scaffolds.  The continued progression of these various compd. classes into clin. trials should help to establish proof of concept for inhibition of HSP90 as a viable therapeutic approach for the treatment of cancer and potentially other diseases.  This would in turn validate protein folding as a strategy for drug development and encourage addnl. chaperones to be explored as mol. targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZ19fmQE-bzbVg90H21EOLACvtfcHk0ljBmNxA_ClTgQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXktlyqsL8%253D&md5=68f468698084591e41c9c0a337542ca1</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1517%2F13543776.14.6.837&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.14.6.837%26sid%3Dliteratum%253Aachs%26aulast%3DDymock%26aufirst%3DB.%2BW.%26aulast%3DDrysdale%26aufirst%3DM.%2BJ.%26aulast%3DMcDonald%26aufirst%3DE.%26aulast%3DWorkman%26aufirst%3DP.%26atitle%3DInhibitors%2520of%2520HSP90%2520and%2520other%2520chaperones%2520for%2520the%2520treatment%2520of%2520cancer%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2004%26volume%3D14%26spage%3D837%26epage%3D847" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Neckers, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neckers, K.</span><span> </span><span class="NLM_article-title">Heat-shock protein 90 inhibitors as novel cancer chemotherapeutics—an update</span> <span class="citation_source-journal">Expert Opin. Emerging Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">137</span><span class="NLM_x">–</span> <span class="NLM_lpage">149</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Fjm900357y&amp;key=10.1517%2F14728214.10.1.137" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Fjm900357y&amp;key=15757409" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Fjm900357y&amp;key=1%3ACAS%3A528%3ADC%252BD2MXislCrt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2005&pages=137-149&author=L.+Neckersauthor=K.+Neckers&title=Heat-shock+protein+90+inhibitors+as+novel+cancer+chemotherapeutics%E2%80%94an+update"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Heat-shock protein 90 inhibitors as novel cancer chemotherapeutics - an update</span></div><div class="casAuthors">Neckers, Len; Neckers, Katharine</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Emerging Drugs</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">137-149</span>CODEN:
                <span class="NLM_cas:coden">EOEDA3</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    
            (<span class="NLM_cas:orgname">Ashley Publications Ltd.</span>)
        </div><div class="casAbstract">A review.  Heat-shock protein 90 (Hsp90) is a mol. chaperone whose assocn. is required for stability and function of a growing no. of signalling proteins that have been implicated in cancer cell survival, including several mutated proteins that are only found in specific cancers.  Furthermore, a growing body of evidence suggests that cancer cells are particularly dependent on Hsp90 for their growth and survival, and, therefore, are more sensitive to the effects of its inhibition than are non-transformed cells and tissues.  Several chem. distinct Hsp90 inhibitors have shown encouraging antitumor activity in multiple preclin. model systems, and one Hsp90 inhibitor, the benzoquinone ansamycin 17-allylamino, 17-demethoxygeldanamycin, has completed five Phase I clin. trials, with a no. of Phase II trials soon to be underway or in progress.  Other Hsp90 inhibitors are either in Phase I clin. trial or under development.  This update will focus on how the latest developments in Hsp90 biol. may better inform the clin. development of Hsp90 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozi0ii7Nj7IbVg90H21EOLACvtfcHk0lhDlsVX657VYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXislCrt7o%253D&md5=91e907d6208cb717cbc3648f3d025dd3</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1517%2F14728214.10.1.137&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14728214.10.1.137%26sid%3Dliteratum%253Aachs%26aulast%3DNeckers%26aufirst%3DL.%26aulast%3DNeckers%26aufirst%3DK.%26atitle%3DHeat-shock%2520protein%252090%2520inhibitors%2520as%2520novel%2520cancer%2520chemotherapeutics%25E2%2580%2594an%2520update%26jtitle%3DExpert%2520Opin.%2520Emerging%2520Drugs%26date%3D2005%26volume%3D10%26spage%3D137%26epage%3D149" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Janin, Y. L.</span><span> </span><span class="NLM_article-title">Heat shock protein 90 inhibitors. A text book example of medicinal chemistry?</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">7503</span><span class="NLM_x">–</span> <span class="NLM_lpage">7512</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm050759r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=7503-7512&author=Y.+L.+Janin&title=Heat+shock+protein+90+inhibitors.+A+text+book+example+of+medicinal+chemistry%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1021%2Fjm050759r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050759r%26sid%3Dliteratum%253Aachs%26aulast%3DJanin%26aufirst%3DY.%2BL.%26atitle%3DHeat%2520shock%2520protein%252090%2520inhibitors.%2520A%2520text%2520book%2520example%2520of%2520medicinal%2520chemistry%253F%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D7503%26epage%3D7512" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Drysdale, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brough, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Massey, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jensen, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoepfer, J.</span><span> </span><span class="NLM_article-title">Targeting Hsp90 for the treatment of cancer</span> <span class="citation_source-journal">Curr. Opin. Drug Discovery Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">483</span><span class="NLM_x">–</span> <span class="NLM_lpage">495</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Fjm900357y&amp;key=16889231" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Fjm900357y&amp;key=1%3ACAS%3A528%3ADC%252BD28XntVChs7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2006&pages=483-495&author=M.+J.+Drysdaleauthor=P.+A.+Broughauthor=A.+Masseyauthor=M.+R.+Jensenauthor=J.+Schoepfer&title=Targeting+Hsp90+for+the+treatment+of+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting Hsp90 for the treatment of cancer</span></div><div class="casAuthors">Drysdale, Martin J.; Brough, Paul A.; Massey, Andrew; Jensen, Michael Rugaard; Schoepfer, Joseph</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Drug Discovery & Development</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">483-495</span>CODEN:
                <span class="NLM_cas:coden">CODDFF</span>;
        ISSN:<span class="NLM_cas:issn">1367-6733</span>.
    
            (<span class="NLM_cas:orgname">Thomson Scientific</span>)
        </div><div class="casAbstract">A review.  Heat shock protein (Hsp)90 is a mol. chaperone that is responsible for the correct folding of a large no. of proteins, which allows these proteins to achieve their functional conformation.  Client proteins of Hsp90 include many overexpressed or mutated oncogenes that are known to be crit. for the transformed phenotype obsd. in tumors.  The compds. 17-AAG (Kosan Biosciences Inc/National Cancer Institute) and 17-DMAG (Kosan Biosciences Inc/National Cancer Institute) are Hsp90 inhibitors that are derived from the prototypical ansamycin natural product Hsp90 inhibitor geldanamycin.  These compds. have demonstrated preclin. efficacy in mouse xenograft models, and are now undergoing phase II and I clin. trials, resp.  Preclin. efficacy studies of these compds. are collated and discussed in this review.  More recent disclosures of small-mol. Hsp90 inhibitors include purine and resorcinol analogs, and the first small-mol. Hsp90 compds. showing oral efficacy have been described.  Inhibition of Hsp90 not only results in the degrdn. of client proteins, but also results in the induction of another chaperone, Hsp70.  Hsp70 is known to be anti-apoptotic, and therefore the induction of Hsp70 may ultimately limit the efficacy of Hsp90 inhibitors under certain circumstances.  Histone deacetylase inhibitors have recently been demonstrated to exert some of their effect through modulation of Hsp90 chaperoning activity, and some mechanistic aspects of this control are also discussed herein.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-VkK7aR3PuLVg90H21EOLACvtfcHk0lhDlsVX657VYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XntVChs7k%253D&md5=117860d15c90611ea5da8fc356fe814f</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDrysdale%26aufirst%3DM.%2BJ.%26aulast%3DBrough%26aufirst%3DP.%2BA.%26aulast%3DMassey%26aufirst%3DA.%26aulast%3DJensen%26aufirst%3DM.%2BR.%26aulast%3DSchoepfer%26aufirst%3DJ.%26atitle%3DTargeting%2520Hsp90%2520for%2520the%2520treatment%2520of%2520cancer%26jtitle%3DCurr.%2520Opin.%2520Drug%2520Discovery%2520Dev.%26date%3D2006%26volume%3D9%26spage%3D483%26epage%3D495" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">McDonald, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Workman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, K.</span><span> </span><span class="NLM_article-title">Inhibitors of the HSP90 molecular chaperone: attacking the master regulator in cancer</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">1091</span><span class="NLM_x">–</span> <span class="NLM_lpage">1107</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Fjm900357y&amp;key=10.2174%2F156802606777812004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Fjm900357y&amp;key=16842148" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Fjm900357y&amp;key=1%3ACAS%3A528%3ADC%252BD28Xpt1ejt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2006&pages=1091-1107&author=E.+McDonaldauthor=P.+Workmanauthor=K.+Jones&title=Inhibitors+of+the+HSP90+molecular+chaperone%3A+attacking+the+master+regulator+in+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitors of the HSP90 molecular chaperone: attacking the master regulator in cancer</span></div><div class="casAuthors">McDonald, Edward; Workman, Paul; Jones, Keith</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1091-1107</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The heat shock protein 90 (HSP90) chaperones represent some 1-2% of all cellular protein and are key players in protein quality control in cells.  They are over expressed in many human cancers and the fact that many oncogenic proteins are clients has prompted much recent research on HSP90 inhibitors as new cancer therapeutics.  A brief introduction is followed by a detailed review of the various classes of inhibitors, both natural product-based and synthetic, that have emerged over the last decade.  The natural products geldanamycin, radicicol and novobiocin have provided the start points for new drugs in this area and their medicinal chem. is reviewed, including the exciting recent results emerging from clin. trials using geldanamycin analogs.  The detailed understanding of the binding mode of these compds. to HSP90 has been significantly enhanced by x-ray crystallog. of HSP90 constructs co-crystd. with various ligands.  Efforts to replace the natural product inhibitors with more drug-like synthetic compds. have mushroomed over the last 4 years.  The purines and the 3,4-diarylpyrazoles have proven to be the most successful and their medicinal chem. is reviewed with particular emphasis on structure-based design.  Protein/ligand co-crystal structures have shown that conserved water mols. in the active site are a vital part of the hydrogen-bonding network established on binding both natural product and synthetic inhibitors.  Medicinal chemists have used this information to develop high affinity lead compds.  Recent research provides the platform for exciting developments in the area of HSP90 inhibition over the next few years.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZvK2PleGilLVg90H21EOLACvtfcHk0lijFASjnRarXg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xpt1ejt7s%253D&md5=76ebc6e48e0b91a5a9dceba18f7c38f4</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.2174%2F156802606777812004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802606777812004%26sid%3Dliteratum%253Aachs%26aulast%3DMcDonald%26aufirst%3DE.%26aulast%3DWorkman%26aufirst%3DP.%26aulast%3DJones%26aufirst%3DK.%26atitle%3DInhibitors%2520of%2520the%2520HSP90%2520molecular%2520chaperone%253A%2520attacking%2520the%2520master%2520regulator%2520in%2520cancer%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2006%26volume%3D6%26spage%3D1091%26epage%3D1107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Messaoudi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peyrat, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brion, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alami, M.</span><span> </span><span class="NLM_article-title">Recent advances in Hsp90 inhibitors as antitumor agents</span> <span class="citation_source-journal">Anti-Cancer Agents Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">761</span><span class="NLM_x">–</span> <span class="NLM_lpage">782</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2008&pages=761-782&author=S.+Messaoudiauthor=J.+F.+Peyratauthor=J.+D.+Brionauthor=M.+Alami&title=Recent+advances+in+Hsp90+inhibitors+as+antitumor+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMessaoudi%26aufirst%3DS.%26aulast%3DPeyrat%26aufirst%3DJ.%2BF.%26aulast%3DBrion%26aufirst%3DJ.%2BD.%26aulast%3DAlami%26aufirst%3DM.%26atitle%3DRecent%2520advances%2520in%2520Hsp90%2520inhibitors%2520as%2520antitumor%2520agents%26jtitle%3DAnti-Cancer%2520Agents%2520Med.%2520Chem.%26date%3D2008%26volume%3D8%26spage%3D761%26epage%3D782" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Taldone, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gozman, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maharaj, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiosis, G.</span><span> </span><span class="NLM_article-title">Targeting Hsp90: small-molecule inhibitors and their clinical development</span> <span class="citation_source-journal">Curr. Opin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">370</span><span class="NLM_x">–</span> <span class="NLM_lpage">374</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Fjm900357y&amp;key=10.1016%2Fj.coph.2008.06.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Fjm900357y&amp;key=18644253" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Fjm900357y&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtFCktL7J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2008&pages=370-374&author=T.+Taldoneauthor=A.+Gozmanauthor=R.+Maharajauthor=G.+Chiosis&title=Targeting+Hsp90%3A+small-molecule+inhibitors+and+their+clinical+development"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting Hsp90: small-molecule inhibitors and their clinical development</span></div><div class="casAuthors">Taldone, Tony; Gozman, Alexander; Maharaj, Ronnie; Chiosis, Gabriela</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Pharmacology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">370-374</span>CODEN:
                <span class="NLM_cas:coden">COPUBK</span>;
        ISSN:<span class="NLM_cas:issn">1471-4892</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The Hsp90 multichaperone complex has important roles in the development and progression of malignant transformation.  Several small-mol. inhibitors of Hsp90 of diverse chemotypes have shown potent antitumor activity in a wide-range of malignancies, and are currently in clin. or late-stage preclin. investigation.  This review intends to update the reader on advances made over the past two years in the clin. development of Hsp90 inhibitors in advanced cancers.  It will refer to the two 17-AAG formulations, tanespimycin and IPI-504, and to synthetic small mols., among which are the purine-scaffold Hsp90 inhibitor CNF2024/BIIB021, the isoxazole deriv. VER-52296/NVP-AUY922, and the carbazol-4-one benzamide deriv. SNX-5422, and will present our current knowledge on their clin. performance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpaxbcGVj_eb7Vg90H21EOLACvtfcHk0lijFASjnRarXg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtFCktL7J&md5=2f471b76eec1e93de88ecaa46865db6d</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1016%2Fj.coph.2008.06.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.coph.2008.06.015%26sid%3Dliteratum%253Aachs%26aulast%3DTaldone%26aufirst%3DT.%26aulast%3DGozman%26aufirst%3DA.%26aulast%3DMaharaj%26aufirst%3DR.%26aulast%3DChiosis%26aufirst%3DG.%26atitle%3DTargeting%2520Hsp90%253A%2520small-molecule%2520inhibitors%2520and%2520their%2520clinical%2520development%26jtitle%3DCurr.%2520Opin.%2520Pharmacol.%26date%3D2008%26volume%3D8%26spage%3D370%26epage%3D374" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Taldone, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiosis, G.</span><span> </span><span class="NLM_article-title">Discovery and development of heat shock protein 90 inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">2225</span><span class="NLM_x">–</span> <span class="NLM_lpage">2235</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Fjm900357y&amp;key=10.1016%2Fj.bmc.2008.10.087" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Fjm900357y&amp;key=19017562" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Fjm900357y&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjsFWqtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2009&pages=2225-2235&author=T.+Taldoneauthor=W.+Sunauthor=G.+Chiosis&title=Discovery+and+development+of+heat+shock+protein+90+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and development of heat shock protein 90 inhibitors</span></div><div class="casAuthors">Taldone, Tony; Sun, Weilin; Chiosis, Gabriela</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2225-2235</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Heat shock protein 90 (Hsp90) is an important target in cancer because of its role in maintaining transformation and has recently become the focus of several drug discovery and development efforts.  While compds. with different modes of action are known, the focus of this review is on those classes of compds. which inhibit Hsp90 by binding to the N-terminal ATP pocket.  These include natural product inhibitors such as geldanamycin and radicicol and synthetic inhibitors comprised of purines, pyrazoles, isoxazoles and other scaffolds.  The synthetic inhibitors have been discovered either by structure-based design, high throughput screening and more recently using fragment-based design and virtual screening techniques.  This review will discuss the discovery of these different classes, as well as their development as potential clin. agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJ1tTxPzeWb7Vg90H21EOLACvtfcHk0lig3sM_0mgW8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjsFWqtLk%253D&md5=13800f6147289bd5c9260941b2a9dbdd</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2008.10.087&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2008.10.087%26sid%3Dliteratum%253Aachs%26aulast%3DTaldone%26aufirst%3DT.%26aulast%3DSun%26aufirst%3DW.%26aulast%3DChiosis%26aufirst%3DG.%26atitle%3DDiscovery%2520and%2520development%2520of%2520heat%2520shock%2520protein%252090%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2009%26volume%3D17%26spage%3D2225%26epage%3D2235" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Kasibhatla, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biamonte, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Busch, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karjian, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sensintaffar, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamal, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lough, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brekken, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lundgren, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grecko, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Timony, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ran, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mansfield, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fritz, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ulm, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burrows, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boehm, M. F.</span><span> </span><span class="NLM_article-title">Rationally designed high-affinity 2-amino-6-halopurine heat shock protein 90 inhibitors that exhibit potent antitumor activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">2767</span><span class="NLM_x">–</span> <span class="NLM_lpage">2778</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm050752%2B" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=2767-2778&author=S.+R.+Kasibhatlaauthor=K.+Hongauthor=M.+A.+Biamonteauthor=D.+J.+Buschauthor=P.+L.+Karjianauthor=J.+L.+Sensintaffarauthor=A.+Kamalauthor=R.+E.+Loughauthor=J.+Brekkenauthor=K.+Lundgrenauthor=R.+Greckoauthor=G.+A.+Timonyauthor=Y.+Ranauthor=R.+Mansfieldauthor=L.+C.+Fritzauthor=E.+Ulmauthor=F.+J.+Burrowsauthor=M.+F.+Boehm&title=Rationally+designed+high-affinity+2-amino-6-halopurine+heat+shock+protein+90+inhibitors+that+exhibit+potent+antitumor+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1021%2Fjm050752%2B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050752%252B%26sid%3Dliteratum%253Aachs%26aulast%3DKasibhatla%26aufirst%3DS.%2BR.%26aulast%3DHong%26aufirst%3DK.%26aulast%3DBiamonte%26aufirst%3DM.%2BA.%26aulast%3DBusch%26aufirst%3DD.%2BJ.%26aulast%3DKarjian%26aufirst%3DP.%2BL.%26aulast%3DSensintaffar%26aufirst%3DJ.%2BL.%26aulast%3DKamal%26aufirst%3DA.%26aulast%3DLough%26aufirst%3DR.%2BE.%26aulast%3DBrekken%26aufirst%3DJ.%26aulast%3DLundgren%26aufirst%3DK.%26aulast%3DGrecko%26aufirst%3DR.%26aulast%3DTimony%26aufirst%3DG.%2BA.%26aulast%3DRan%26aufirst%3DY.%26aulast%3DMansfield%26aufirst%3DR.%26aulast%3DFritz%26aufirst%3DL.%2BC.%26aulast%3DUlm%26aufirst%3DE.%26aulast%3DBurrows%26aufirst%3DF.%2BJ.%26aulast%3DBoehm%26aufirst%3DM.%2BF.%26atitle%3DRationally%2520designed%2520high-affinity%25202-amino-6-halopurine%2520heat%2520shock%2520protein%252090%2520inhibitors%2520that%2520exhibit%2520potent%2520antitumor%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D2767%26epage%3D2778" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group">Lundgren, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brekken, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huser, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powell, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Timple, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Busch, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neely, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sensintaffar, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Y. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKenzie, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scannevin, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamal, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kasibhatla, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boehm, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burrows, F. J.</span><span> </span><span class="NLM_article-title">BIIB021, an orally available, fully synthetic small-molecule inhibitor of the heat shock protein Hsp90</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">921</span><span class="NLM_x">–</span> <span class="NLM_lpage">929</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Fjm900357y&amp;key=10.1158%2F1535-7163.MCT-08-0758" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Fjm900357y&amp;key=19372565" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Fjm900357y&amp;key=1%3ACAS%3A528%3ADC%252BD1MXks1amt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=921-929&author=K.+Lundgrenauthor=H.+Zhangauthor=J.+Brekkenauthor=N.+Huserauthor=R.+E.+Powellauthor=N.+Timpleauthor=D.+J.+Buschauthor=L.+Neelyauthor=J.+L.+Sensintaffarauthor=Y.+C.+Yangauthor=A.+McKenzieauthor=J.+Friedmanauthor=R.+Scannevinauthor=A.+Kamalauthor=K.+Hongauthor=S.+R.+Kasibhatlaauthor=M.+F.+Boehmauthor=F.+J.+Burrows&title=BIIB021%2C+an+orally+available%2C+fully+synthetic+small-molecule+inhibitor+of+the+heat+shock+protein+Hsp90"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">BIIB021, an orally available, fully synthetic small-molecule inhibitor of the heat shock protein Hsp90</span></div><div class="casAuthors">Lundgren, Karen; Zhang, Hong; Brekken, John; Huser, Nanni; Powell, Rachel E.; Timple, Noel; Busch, David J.; Neely, Laura; Sensintaffar, John L.; Yang, Yong-ching; McKenzie, Andres; Friedman, Jessica; Scannevin, Robert; Kamal, Adeela; Hong, Kevin; Kasibhatla, Srinivas R.; Boehm, Marcus F.; Burrows, Francis J.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">921-929</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Inhibition of heat shock protein 90 (Hsp90) results in the degrdn. of oncoproteins that drive malignant progression, inducing cell death, making Hsp90 a target of substantial interest for cancer therapy.  BIIB021 is a novel, fully synthetic inhibitor of Hsp90 that binds competitively with geldanamycin in the ATP-binding pocket of Hsp90.  In tumor cells, BIIB021 induced the degrdn. of Hsp90 client proteins including HER-2, AKT, and Raf-1 and up-regulated expression of the heat shock proteins Hsp70 and Hsp27.  BIIB021 treatment resulted in growth inhibition and cell death in cell lines from a variety of tumor types at nanomolar concns.  Oral administration of BIIB021 led to the degrdn. of Hsp90 client proteins measured in tumor tissue and resulted in the inhibition of tumor growth in several human tumor xenograft models.  Studies to investigate the antitumor effects of BIIB021 showed activity on both daily and intermittent dosing schedules, providing dose schedule flexibility for clin. studies.  Assays measuring the HER-2 protein in tumor tissue and the HER-2 extracellular domain in plasma were used to show interdiction of the Hsp90 pathway and utility as potential biomarkers in clin. trials for BIIB021.  Together, these data show that BIIB021 is a promising new oral inhibitor of Hsp90 with antitumor activity in preclin. models.[Mol Cancer Ther 2009;8(4):921-9].</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSbI2RYG4aF7Vg90H21EOLACvtfcHk0lig3sM_0mgW8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXks1amt74%253D&md5=271e2311ab807bc74b2ac66b81e514e1</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-08-0758&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-08-0758%26sid%3Dliteratum%253Aachs%26aulast%3DLundgren%26aufirst%3DK.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DBrekken%26aufirst%3DJ.%26aulast%3DHuser%26aufirst%3DN.%26aulast%3DPowell%26aufirst%3DR.%2BE.%26aulast%3DTimple%26aufirst%3DN.%26aulast%3DBusch%26aufirst%3DD.%2BJ.%26aulast%3DNeely%26aufirst%3DL.%26aulast%3DSensintaffar%26aufirst%3DJ.%2BL.%26aulast%3DYang%26aufirst%3DY.%2BC.%26aulast%3DMcKenzie%26aufirst%3DA.%26aulast%3DFriedman%26aufirst%3DJ.%26aulast%3DScannevin%26aufirst%3DR.%26aulast%3DKamal%26aufirst%3DA.%26aulast%3DHong%26aufirst%3DK.%26aulast%3DKasibhatla%26aufirst%3DS.%2BR.%26aulast%3DBoehm%26aufirst%3DM.%2BF.%26aulast%3DBurrows%26aufirst%3DF.%2BJ.%26atitle%3DBIIB021%252C%2520an%2520orally%2520available%252C%2520fully%2520synthetic%2520small-molecule%2520inhibitor%2520of%2520the%2520heat%2520shock%2520protein%2520Hsp90%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2009%26volume%3D8%26spage%3D921%26epage%3D929" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Chandarlapaty, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawai, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silinski, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fadden, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Partdrige, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hall, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steed, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Norton, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Solit, D. B.</span><span> </span><span class="NLM_article-title">SNX2112, a Synthetic Heat Shock Protein 90 Inhibitor, Has Potent Antitumor Activity against HER Kinase-Dependent Cancers</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">240</span><span class="NLM_x">–</span> <span class="NLM_lpage">248</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50a&amp;dbid=16&amp;doi=10.1021%2Fjm900357y&amp;key=10.1158%2F1078-0432.CCR-07-1667" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50a&amp;dbid=8&amp;doi=10.1021%2Fjm900357y&amp;key=18172276" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50a&amp;dbid=32&amp;doi=10.1021%2Fjm900357y&amp;key=1%3ACAS%3A528%3ADC%252BD1cXoslGq" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2008&pages=240-248&author=S.+Chandarlapatyauthor=A.+Sawaiauthor=Q.+Yeauthor=A.+Scottauthor=M.+Silinskiauthor=K.+Huangauthor=P.+Faddenauthor=J.+Partdrigeauthor=S.+Hallauthor=P.+Steedauthor=L.+Nortonauthor=N.+Rosenauthor=D.+B.+Solit&title=SNX2112%2C+a+Synthetic+Heat+Shock+Protein+90+Inhibitor%2C+Has+Potent+Antitumor+Activity+against+HER+Kinase-Dependent+Cancers"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50aR"><div class="casContent"><span class="casTitleNuber">50a</span><div class="casTitle"><span class="NLM_cas:atitle">SNX2112, a Synthetic Heat Shock Protein 90 Inhibitor, Has Potent Antitumor Activity against HER Kinase-Dependent Cancers</span></div><div class="casAuthors">Chandarlapaty, Sarat; Sawai, Ayana; Ye, Qing; Scott, Anisa; Silinski, Melanie; Huang, Ken; Fadden, Pat; Partdrige, Jeff; Hall, Steven; Steed, Paul; Norton, Larry; Rosen, Neal; Solit, David B.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">240-248</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">PURPOSE: The heat shock protein 90 (Hsp90) chaperone plays an important role in transformation by regulating the conformational maturation and stability of oncogenic kinases and transcription factors.  Ansamycins, such as 17-(allylamino)-17-demethoxygeldanmycin (17-AAG), inhibit Hsp90 function; induce the degrdn. of Hsp90 client proteins such as HER2, and have shown activity in early clin. trials.  However, the utility of these drugs has been limited by their hepatotoxicity, poor soly., and poorly tolerated formulations.  Exptl. Design: We detd. the pharmacodynamic and antitumor properties of a novel, synthetic Hsp90 inhibitor, SNX-2112, in cell culture and xenograft models of HER kinase-dependent cancers.  RESULTS: We show in a panel of tumor cell lines that SNX-2112 and its prodrug SNX-5542 are Hsp90 inhibitors with properties and potency similar to that of 17-AAG, including: degrdn. of HER2, mutant epidermal growth factor receptor, and other client proteins, inhibition of extracellular signal-regulated kinase and Akt activation, and induction of a Rb-dependent G1 arrest with subsequent apoptosis.  SNX-5542 can be administered to mice orally on a daily schedule.  Following oral administration, SNX-5542 is rapidly converted to SNX-2112, which accumulates in tumors relative to normal tissues.  A single dose of SNX-5542 causes HER2 degrdn. and inhibits its downstream signaling for up to 24 h, and daily dosing results in regression of HER2-dependent xenografts.  SNX-5542 also shows greater activity than 17-AAG in a non-small cell lung cancer xenograft model expressing mutant EGFR.  CONCLUSIONS: These results suggest that Hsp90 inhibition with SNX-2112 (delivered as a prodrug) may represent a promising therapeutic strategy for tumors whose growth and survival is dependent on Hsp90 clients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqER6BYKwq_PLVg90H21EOLACvtfcHk0lhm1UYFI26nyg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXoslGq&md5=d0aff2ef77885c47803acd1d6cb446c5</span></div><a href="/servlet/linkout?suffix=cit50a&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-07-1667&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-07-1667%26sid%3Dliteratum%253Aachs%26aulast%3DChandarlapaty%26aufirst%3DS.%26aulast%3DSawai%26aufirst%3DA.%26aulast%3DYe%26aufirst%3DQ.%26aulast%3DScott%26aufirst%3DA.%26aulast%3DSilinski%26aufirst%3DM.%26aulast%3DHuang%26aufirst%3DK.%26aulast%3DFadden%26aufirst%3DP.%26aulast%3DPartdrige%26aufirst%3DJ.%26aulast%3DHall%26aufirst%3DS.%26aulast%3DSteed%26aufirst%3DP.%26aulast%3DNorton%26aufirst%3DL.%26aulast%3DRosen%26aufirst%3DN.%26aulast%3DSolit%26aufirst%3DD.%2BB.%26atitle%3DSNX2112%252C%2520a%2520Synthetic%2520Heat%2520Shock%2520Protein%252090%2520Inhibitor%252C%2520Has%2520Potent%2520Antitumor%2520Activity%2520against%2520HER%2520Kinase-Dependent%2520Cancers%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2008%26volume%3D14%26spage%3D240%26epage%3D248" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit50b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Huang, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Veal, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fadden, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rice, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eaves, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strachan, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barabasz, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group"> Foley, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barta, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group"> Ma, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silinski, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group"> Hu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Partridge, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dubois, L. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freed, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steed, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ommen,  A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, E. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hughes, P. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woodward, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanson, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCall, W. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Markworth, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hinkley, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jenks, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geng, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Otto, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pronk, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verleysen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hall, S. E.</span><span> </span><span class="NLM_article-title">Discovery of Novel 2-Aminobenzamide Inhibitors of Heat Shock Protein 90 as Potent, Selective and Orally Active Antitumor Agents</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">4288</span><span class="NLM_x">–</span> <span class="NLM_lpage">4305</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm900230j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref50/cit50b&amp;dbid=32&amp;doi=10.1021%2Fjm900357y&amp;key=1%3ACAS%3A528%3ADC%252BD1MXns1Onsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=4288-4305&author=K.+H.+Huangauthor=J.+M.+Vealauthor=R.+P.+Faddenauthor=J.+W.+Riceauthor=J.+Eavesauthor=J.+P.+Strachanauthor=A.+F.+Barabaszauthor=B.+E.++Foleyauthor=T.+E.+Bartaauthor=W.++Maauthor=M.+A.+Silinskiauthor=M.++Huauthor=J.+M.+Partridgeauthor=A.+Scottauthor=L.+G.+Duboisauthor=T.+Freedauthor=P.+M.+Steedauthor=+A.+J.+Ommenauthor=E.+D.+Smithauthor=P.+F.+Hughesauthor=A.+R.+Woodwardauthor=G.+J.+Hansonauthor=W.+S.+McCallauthor=C.+J.+Markworthauthor=L.+Hinkleyauthor=M.+Jenksauthor=L.+Gengauthor=M.+Lewisauthor=J.+Ottoauthor=B.+Pronkauthor=K.+Verleysenauthor=S.+E.+Hall&title=Discovery+of+Novel+2-Aminobenzamide+Inhibitors+of+Heat+Shock+Protein+90+as+Potent%2C+Selective+and+Orally+Active+Antitumor+Agents"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50bR"><div class="casContent"><span class="casTitleNuber">50b</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Novel 2-Aminobenzamide Inhibitors of Heat Shock Protein 90 as Potent, Selective and Orally Active Antitumor Agents</span></div><div class="casAuthors">Huang, Kenneth H.; Veal, James M.; Fadden, R. Patrick; Rice, John W.; Eaves, Jeron; Strachan, Jon-Paul; Barabasz, Amy F.; Foley, Briana E.; Barta, Thomas E.; Ma, Wei; Silinski, Melanie A.; Hu, Mei; Partridge, Jeffrey M.; Scott, Anisa; DuBois, Laura G.; Freed, Tiffany; Steed, Paul M.; Ommen, Andy J.; Smith, Emilie D.; Hughes, Philip F.; Woodward, Angela R.; Hanson, Gunnar J.; McCall, W. Stephen; Markworth, Christopher J.; Hinkley, Lindsay; Jenks, Matthew; Geng, Lifeng; Lewis, Meredith; Otto, James; Pronk, Bert; Verleysen, Katleen; Hall, Steven E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">4288-4305</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A novel class of heat shock protein 90 (Hsp90) inhibitors was developed from an unbiased screen to identify protein targets for a diverse compd. library.  These indol-4-one and indazol-4-one derived 2-aminobenzamides showed strong binding affinity to Hsp90, and optimized analogs exhibited nanomolar antiproliferative activity across multiple cancer cell lines.  Heat shock protein 70 (Hsp70) induction and specific client protein degrdn. in cells on treatment with the inhibitors supported Hsp90 inhibition as the mechanism of action.  Computational chem. and X-ray crystallog. anal. of selected member compds. clearly defined the protein-inhibitor interaction and assisted the design of analogs. 4-[6,6-Dimethyl-4-oxo-3-(trifluoromethyl)-4,5,6,7-tetrahydro-1H-indazol-1-yl]-2-[(trans-4-hydroxycyclohexyl)amino]benzamide (SNX-2112) (I) was identified as highly selective and potent (IC50 Her2 = 11 nM, HT-29 = 3 nM); its prodrug amino-acetic acid 4-[2-carbamoyl-5-(6,6-dimethyl-4-oxo-3-trifluoromethyl-4,5,6,7-tetrahydro-indazol-1-yl)-phenylamino]-cyclohexyl ester methanesulfonate (SNX-5422) (II)was orally bioavailable and efficacious in a broad range of xenograft tumor models (e.g. 67% growth delay in a HT-29 model) and is now in multiple phase I clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFjrhELWrFkbVg90H21EOLACvtfcHk0liGn4dekWGdNQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXns1Onsrk%253D&md5=99e5039e1761e9099d634acd79a15a6a</span></div><a href="/servlet/linkout?suffix=cit50b&amp;dbid=16384&amp;doi=10.1021%2Fjm900230j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900230j%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DK.%2BH.%26aulast%3DVeal%26aufirst%3DJ.%2BM.%26aulast%3DFadden%26aufirst%3DR.%2BP.%26aulast%3DRice%26aufirst%3DJ.%2BW.%26aulast%3DEaves%26aufirst%3DJ.%26aulast%3DStrachan%26aufirst%3DJ.%2BP.%26aulast%3DBarabasz%26aufirst%3DA.%2BF.%26aulast%3DFoley%26aufirst%3DB.%2BE.%26aulast%3DBarta%26aufirst%3DT.%2BE.%26aulast%3DMa%26aufirst%3DW.%26aulast%3DSilinski%26aufirst%3DM.%2BA.%26aulast%3DHu%26aufirst%3DM.%26aulast%3DPartridge%26aufirst%3DJ.%2BM.%26aulast%3DScott%26aufirst%3DA.%26aulast%3DDubois%26aufirst%3DL.%2BG.%26aulast%3DFreed%26aufirst%3DT.%26aulast%3DSteed%26aufirst%3DP.%2BM.%26aulast%3DOmmen%26aufirst%3DA.%2BJ.%26aulast%3DSmith%26aufirst%3DE.%2BD.%26aulast%3DHughes%26aufirst%3DP.%2BF.%26aulast%3DWoodward%26aufirst%3DA.%2BR.%26aulast%3DHanson%26aufirst%3DG.%2BJ.%26aulast%3DMcCall%26aufirst%3DW.%2BS.%26aulast%3DMarkworth%26aufirst%3DC.%2BJ.%26aulast%3DHinkley%26aufirst%3DL.%26aulast%3DJenks%26aufirst%3DM.%26aulast%3DGeng%26aufirst%3DL.%26aulast%3DLewis%26aufirst%3DM.%26aulast%3DOtto%26aufirst%3DJ.%26aulast%3DPronk%26aufirst%3DB.%26aulast%3DVerleysen%26aufirst%3DK.%26aulast%3DHall%26aufirst%3DS.%2BE.%26atitle%3DDiscovery%2520of%2520Novel%25202-Aminobenzamide%2520Inhibitors%2520of%2520Heat%2520Shock%2520Protein%252090%2520as%2520Potent%252C%2520Selective%2520and%2520Orally%2520Active%2520Antitumor%2520Agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D4288%26epage%3D4305" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group">Brough, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aherne, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barril, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borgognoni, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boxall, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cansfield, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheung, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, N. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drysdale, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dymock, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eccles, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finch, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fink, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayes, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howes, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hubbard, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">James, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jordan, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lockie, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martins, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Massey, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matthews, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonald, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Northfield, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pearl, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prodromou, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ray, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raynaud, F. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roughley, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharp, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Surgenor, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walmsley, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webb, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Workman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, L.</span><span> </span><span class="NLM_article-title">4,5-Diarylisoxazole Hsp90 chaperone inhibitors: potential therapeutic agents for the treatment of cancer</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">196</span><span class="NLM_x">–</span> <span class="NLM_lpage">218</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm701018h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=196-218&author=P.+A.+Broughauthor=W.+Aherneauthor=X.+Barrilauthor=J.+Borgognoniauthor=K.+Boxallauthor=J.+E.+Cansfieldauthor=K.+M.+Cheungauthor=I.+Collinsauthor=N.+G.+Daviesauthor=M.+J.+Drysdaleauthor=B.+Dymockauthor=S.+A.+Ecclesauthor=H.+Finchauthor=A.+Finkauthor=A.+Hayesauthor=R.+Howesauthor=R.+E.+Hubbardauthor=K.+Jamesauthor=A.+M.+Jordanauthor=A.+Lockieauthor=V.+Martinsauthor=A.+Masseyauthor=T.+P.+Matthewsauthor=E.+McDonaldauthor=C.+J.+Northfieldauthor=L.+H.+Pearlauthor=C.+Prodromouauthor=S.+Rayauthor=F.+I.+Raynaudauthor=S.+D.+Roughleyauthor=S.+Y.+Sharpauthor=A.+Surgenorauthor=D.+L.+Walmsleyauthor=P.+Webbauthor=M.+Woodauthor=P.+Workmanauthor=L.+Wright&title=4%2C5-Diarylisoxazole+Hsp90+chaperone+inhibitors%3A+potential+therapeutic+agents+for+the+treatment+of+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1021%2Fjm701018h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm701018h%26sid%3Dliteratum%253Aachs%26aulast%3DBrough%26aufirst%3DP.%2BA.%26aulast%3DAherne%26aufirst%3DW.%26aulast%3DBarril%26aufirst%3DX.%26aulast%3DBorgognoni%26aufirst%3DJ.%26aulast%3DBoxall%26aufirst%3DK.%26aulast%3DCansfield%26aufirst%3DJ.%2BE.%26aulast%3DCheung%26aufirst%3DK.%2BM.%26aulast%3DCollins%26aufirst%3DI.%26aulast%3DDavies%26aufirst%3DN.%2BG.%26aulast%3DDrysdale%26aufirst%3DM.%2BJ.%26aulast%3DDymock%26aufirst%3DB.%26aulast%3DEccles%26aufirst%3DS.%2BA.%26aulast%3DFinch%26aufirst%3DH.%26aulast%3DFink%26aufirst%3DA.%26aulast%3DHayes%26aufirst%3DA.%26aulast%3DHowes%26aufirst%3DR.%26aulast%3DHubbard%26aufirst%3DR.%2BE.%26aulast%3DJames%26aufirst%3DK.%26aulast%3DJordan%26aufirst%3DA.%2BM.%26aulast%3DLockie%26aufirst%3DA.%26aulast%3DMartins%26aufirst%3DV.%26aulast%3DMassey%26aufirst%3DA.%26aulast%3DMatthews%26aufirst%3DT.%2BP.%26aulast%3DMcDonald%26aufirst%3DE.%26aulast%3DNorthfield%26aufirst%3DC.%2BJ.%26aulast%3DPearl%26aufirst%3DL.%2BH.%26aulast%3DProdromou%26aufirst%3DC.%26aulast%3DRay%26aufirst%3DS.%26aulast%3DRaynaud%26aufirst%3DF.%2BI.%26aulast%3DRoughley%26aufirst%3DS.%2BD.%26aulast%3DSharp%26aufirst%3DS.%2BY.%26aulast%3DSurgenor%26aufirst%3DA.%26aulast%3DWalmsley%26aufirst%3DD.%2BL.%26aulast%3DWebb%26aufirst%3DP.%26aulast%3DWood%26aufirst%3DM.%26aulast%3DWorkman%26aufirst%3DP.%26aulast%3DWright%26aufirst%3DL.%26atitle%3D4%252C5-Diarylisoxazole%2520Hsp90%2520chaperone%2520inhibitors%253A%2520potential%2520therapeutic%2520agents%2520for%2520the%2520treatment%2520of%2520cancer%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D196%26epage%3D218" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group">Eccles, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Massey, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raynaud, F. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharp, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Box, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valenti, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patterson, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haven Brandon, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gowan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boxall, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aherne, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowlands, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayes, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martins, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Urban, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boxall, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prodromou, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pearl, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">James, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matthews, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheung, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalusa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonald, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barril, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brough, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cansfield, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dymock, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drysdale, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finch, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howes, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hubbard, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Surgenor, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webb, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Workman, P.</span><span> </span><span class="NLM_article-title">NVP-AUY922: A Novel Heat Shock Protein 90 Inhibitor Active against Xenograft Tumor Growth, Angiogenesis, and Metastasis</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">2850</span><span class="NLM_x">–</span> <span class="NLM_lpage">2860</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2008&pages=2850-2860&author=S.+A.+Ecclesauthor=A.+Masseyauthor=F.+I.+Raynaudauthor=S.+Y.+Sharpauthor=G.+Boxauthor=M.+Valentiauthor=L.+Pattersonauthor=A.+Haven+Brandonauthor=S.+Gowanauthor=F.+Boxallauthor=W.+Aherneauthor=M.+Rowlandsauthor=A.+Hayesauthor=V.+Martinsauthor=F.+Urbanauthor=K.+Boxallauthor=C.+Prodromouauthor=L.+Pearlauthor=K.+Jamesauthor=T.+P.+Matthewsauthor=K.+M.+Cheungauthor=A.+Kalusaauthor=K.+Jonesauthor=E.+McDonaldauthor=X.+Barrilauthor=P.+A.+Broughauthor=J.+E.+Cansfieldauthor=B.+Dymockauthor=M.+J.+Drysdaleauthor=H.+Finchauthor=R.+Howesauthor=R.+E.+Hubbardauthor=A.+Surgenorauthor=P.+Webbauthor=M.+Woodauthor=L.+Wrightauthor=P.+Workman&title=NVP-AUY922%3A+A+Novel+Heat+Shock+Protein+90+Inhibitor+Active+against+Xenograft+Tumor+Growth%2C+Angiogenesis%2C+and+Metastasis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEccles%26aufirst%3DS.%2BA.%26aulast%3DMassey%26aufirst%3DA.%26aulast%3DRaynaud%26aufirst%3DF.%2BI.%26aulast%3DSharp%26aufirst%3DS.%2BY.%26aulast%3DBox%26aufirst%3DG.%26aulast%3DValenti%26aufirst%3DM.%26aulast%3DPatterson%26aufirst%3DL.%26aulast%3DHaven%2BBrandon%26aufirst%3DA.%26aulast%3DGowan%26aufirst%3DS.%26aulast%3DBoxall%26aufirst%3DF.%26aulast%3DAherne%26aufirst%3DW.%26aulast%3DRowlands%26aufirst%3DM.%26aulast%3DHayes%26aufirst%3DA.%26aulast%3DMartins%26aufirst%3DV.%26aulast%3DUrban%26aufirst%3DF.%26aulast%3DBoxall%26aufirst%3DK.%26aulast%3DProdromou%26aufirst%3DC.%26aulast%3DPearl%26aufirst%3DL.%26aulast%3DJames%26aufirst%3DK.%26aulast%3DMatthews%26aufirst%3DT.%2BP.%26aulast%3DCheung%26aufirst%3DK.%2BM.%26aulast%3DKalusa%26aufirst%3DA.%26aulast%3DJones%26aufirst%3DK.%26aulast%3DMcDonald%26aufirst%3DE.%26aulast%3DBarril%26aufirst%3DX.%26aulast%3DBrough%26aufirst%3DP.%2BA.%26aulast%3DCansfield%26aufirst%3DJ.%2BE.%26aulast%3DDymock%26aufirst%3DB.%26aulast%3DDrysdale%26aufirst%3DM.%2BJ.%26aulast%3DFinch%26aufirst%3DH.%26aulast%3DHowes%26aufirst%3DR.%26aulast%3DHubbard%26aufirst%3DR.%2BE.%26aulast%3DSurgenor%26aufirst%3DA.%26aulast%3DWebb%26aufirst%3DP.%26aulast%3DWood%26aufirst%3DM.%26aulast%3DWright%26aufirst%3DL.%26aulast%3DWorkman%26aufirst%3DP.%26atitle%3DNVP-AUY922%253A%2520A%2520Novel%2520Heat%2520Shock%2520Protein%252090%2520Inhibitor%2520Active%2520against%2520Xenograft%2520Tumor%2520Growth%252C%2520Angiogenesis%252C%2520and%2520Metastasis%26jtitle%3DCancer%2520Res.%26date%3D2008%26volume%3D68%26spage%3D2850%26epage%3D2860" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span>See <a href="http://www.clinicaltrials.gov" class="extLink">www.clinicaltrials.gov</a> for details of clinical trials relating Hsp90 inhibitors. Accessed on July 13, 2009.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=See+www.clinicaltrials.gov+for+details+of+clinical+trials+relating+Hsp90+inhibitors.+Accessed+on+July+13%2C+2009."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group">Congreve, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chessari, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tisi, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woodhead, A. J.</span><span> </span><span class="NLM_article-title">Recent developments in fragment-based drug discovery</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">3661</span><span class="NLM_x">–</span> <span class="NLM_lpage">3680</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm8000373" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=3661-3680&author=M.+Congreveauthor=G.+Chessariauthor=D.+Tisiauthor=A.+J.+Woodhead&title=Recent+developments+in+fragment-based+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1021%2Fjm8000373&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm8000373%26sid%3Dliteratum%253Aachs%26aulast%3DCongreve%26aufirst%3DM.%26aulast%3DChessari%26aufirst%3DG.%26aulast%3DTisi%26aufirst%3DD.%26aulast%3DWoodhead%26aufirst%3DA.%2BJ.%26atitle%3DRecent%2520developments%2520in%2520fragment-based%2520drug%2520discovery%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D3661%26epage%3D3680" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group">Erlanson, D. A.</span><span> </span><span class="NLM_article-title">Fragment-based lead discovery: a chemical update</span> <span class="citation_source-journal">Curr. Opin. Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">643</span><span class="NLM_x">–</span> <span class="NLM_lpage">652</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Fjm900357y&amp;key=10.1016%2Fj.copbio.2006.10.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Fjm900357y&amp;key=17084612" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Fjm900357y&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1eqs7zF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2006&pages=643-652&author=D.+A.+Erlanson&title=Fragment-based+lead+discovery%3A+a+chemical+update"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Fragment-based lead discovery: A chemical update</span></div><div class="casAuthors">Erlanson, Daniel A.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Biotechnology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">643-652</span>CODEN:
                <span class="NLM_cas:coden">CUOBE3</span>;
        ISSN:<span class="NLM_cas:issn">0958-1669</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Fragment-based lead discovery constructs drug leads from small mol. fragments.  In theory, this is a highly efficient method for drug discovery, and the technique has become enormously popular in the past few years.  In this review, I describe how a variety of approaches in fragment-based lead discovery - including NMR, x-ray crystallog., mass spectrometry, functional screening, and in silico screening - have produced drug leads.  Although the examples show that the technique can reliably generate potent mols., there is still much work to be done to maintain the efficiency of mols.' binding affinities as fragments are linked, expanded, and otherwise improved.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoa2pK6tEB4ZrVg90H21EOLACvtfcHk0lirsNylss_KDQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1eqs7zF&md5=9b13f54a7fd849df9e74b9a5f58be93d</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1016%2Fj.copbio.2006.10.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.copbio.2006.10.007%26sid%3Dliteratum%253Aachs%26aulast%3DErlanson%26aufirst%3DD.%2BA.%26atitle%3DFragment-based%2520lead%2520discovery%253A%2520a%2520chemical%2520update%26jtitle%3DCurr.%2520Opin.%2520Biotechnol.%26date%3D2006%26volume%3D17%26spage%3D643%26epage%3D652" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group">Hajduk, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greer, J.</span><span> </span><span class="NLM_article-title">A decade of fragment-based drug design: strategic advances and lessons learned</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">211</span><span class="NLM_x">–</span> <span class="NLM_lpage">219</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Fjm900357y&amp;key=10.1038%2Fnrd2220" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Fjm900357y&amp;key=17290284" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Fjm900357y&amp;key=1%3ACAS%3A528%3ADC%252BD2sXit12rtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=211-219&author=P.+J.+Hajdukauthor=J.+Greer&title=A+decade+of+fragment-based+drug+design%3A+strategic+advances+and+lessons+learned"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">A decade of fragment-based drug design: strategic advances and lessons learned</span></div><div class="casAuthors">Hajduk, Philip J.; Greer, Jonathan</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">211-219</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Since the early 1990s, several technol. and scientific advances - such as combinatorial chem., high-throughput screening and the sequencing of the human genome - have been heralded as remedies to the problems facing the pharmaceutical industry.  The use of these technologies in some form is now well established at most pharmaceutical companies; however, the return on investment in terms of marketed products has not met expectations.  Fragment-based drug design is another tool for drug discovery that has emerged in the past decade.  Here, we describe the development and evolution of fragment-based drug design, analyze the role that this approach can have in combination with other discovery technologies and highlight the impact that fragment-based methods have made in progressing new medicines into the clinic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpOB8K3AESqTbVg90H21EOLACvtfcHk0lg6bAvmJ-fG5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXit12rtr4%253D&md5=bae574da3671475d8488615c3bfa9849</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1038%2Fnrd2220&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2220%26sid%3Dliteratum%253Aachs%26aulast%3DHajduk%26aufirst%3DP.%2BJ.%26aulast%3DGreer%26aufirst%3DJ.%26atitle%3DA%2520decade%2520of%2520fragment-based%2520drug%2520design%253A%2520strategic%2520advances%2520and%2520lessons%2520learned%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2007%26volume%3D6%26spage%3D211%26epage%3D219" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group">Hubbard, R. E.</span><span> </span><span class="NLM_article-title">Fragment approaches in structure-based drug discovery</span> <span class="citation_source-journal">J. Synchrotron Radiat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">227</span><span class="NLM_x">–</span> <span class="NLM_lpage">230</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Fjm900357y&amp;key=10.1107%2FS090904950705666X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Fjm900357y&amp;key=18421145" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Fjm900357y&amp;key=1%3ACAS%3A528%3ADC%252BD1cXksl2qtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2008&pages=227-230&author=R.+E.+Hubbard&title=Fragment+approaches+in+structure-based+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Fragment approaches in structure-based drug discovery</span></div><div class="casAuthors">Hubbard, Roderick E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Synchrotron Radiation</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">227-230</span>CODEN:
                <span class="NLM_cas:coden">JSYRES</span>;
        ISSN:<span class="NLM_cas:issn">0909-0495</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">A review.  There has been considerable interest recently in what is known as 'fragment-based lead discovery'.  The novel feature of the approach is to begin with small low-affinity compds.  The main advantage is that a larger potential chem. diversity can be sampled with fewer compds., which is particularly important for new target classes.  The approach relies on careful design of the fragment library, a method that can detect binding of the fragment to the protein target, detn. of the structure of the fragment bound to the target, and the conventional use of structural information to guide compd. optimization.  In this article the methods are reviewed, and experiences in fragment-based discovery of lead series of compds. against kinases such as PDK1 and ATPases such as Hsp90 are discussed.  The examples illustrate some of the key benefits and issues of the approach and also provide anecdotal examples of the patterns seen in selectivity and the binding mode of fragments across different protein targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMyf3C0s8UCLVg90H21EOLACvtfcHk0lg6bAvmJ-fG5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXksl2qtrs%253D&md5=44ec2d62df13dea4dca716f634d6cdd3</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1107%2FS090904950705666X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS090904950705666X%26sid%3Dliteratum%253Aachs%26aulast%3DHubbard%26aufirst%3DR.%2BE.%26atitle%3DFragment%2520approaches%2520in%2520structure-based%2520drug%2520discovery%26jtitle%3DJ.%2520Synchrotron%2520Radiat.%26date%3D2008%26volume%3D15%26spage%3D227%26epage%3D230" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group">Jahnke, W.; Erlanson, D. A.</span> <span class="citation_source-book">Fragment-Based Approaches in Drug Discovery</span>; <span class="NLM_publisher-name">Wiley</span>: <span class="NLM_publisher-loc">Weinheim, Germany</span>,<span class="NLM_x"> </span><span class="NLM_year">2007</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&author=W.+Jahnke&author=D.+A.+Erlanson&title=Fragment-Based+Approaches+in+Drug+Discovery"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DJahnke%26aufirst%3DW.%26btitle%3DFragment-Based%2520Approaches%2520in%2520Drug%2520Discovery%26pub%3DWiley%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group">Jhoti, H.; Leach, A. R.</span> <span class="citation_source-book">Structure-Based Drug Discovery</span>; <span class="NLM_publisher-name">Springer</span>: <span class="NLM_publisher-loc">Dordrecht, The Netherlands</span>,<span class="NLM_x"> </span><span class="NLM_year">2007</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&author=H.+Jhoti&author=A.+R.+Leach&title=Structure-Based+Drug+Discovery"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DJhoti%26aufirst%3DH.%26btitle%3DStructure-Based%2520Drug%2520Discovery%26pub%3DSpringer%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group">Hubbard, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drysdale, M. J.</span><span> </span><span class="NLM_article-title">The SeeDs approach: integrating fragments into drug discovery</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">1568</span><span class="NLM_x">–</span> <span class="NLM_lpage">1581</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Fjm900357y&amp;key=10.2174%2F156802607782341109" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Fjm900357y&amp;key=17979768" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Fjm900357y&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVOrur7J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2007&pages=1568-1581&author=R.+E.+Hubbardauthor=B.+Davisauthor=I.+Chenauthor=M.+J.+Drysdale&title=The+SeeDs+approach%3A+integrating+fragments+into+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">The SeeDs approach: integrating fragments into drug discovery</span></div><div class="casAuthors">Hubbard, Roderick E.; Davis, Ben; Chen, Ijen; Drysdale, Martin J.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">1568-1581</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Finding novel compds. as starting points for optimization is a major challenge in drug discovery research.  Fragment-based methods have emerged in the past ten years as an effective way to sample chem. diversity with a limited no. of low mol. wt. compds.  The structures of the fragments(s) binding to the protein can then be used to design new compds. with increased affinity, specificity and novelty.  This article describes the Vernalis approach to fragment based drug discovery, called SeeDs (Structural exploitation of exptl. Drug startpoints).  The approach includes the design of a fragment library, identification of fragments that bind competitively to a target by ligand-based NMR techniques and protein crystal structures to characterize binding.  Fragments that bind are then evolved to hits, either by growing the fragment or by combining structural features from a no. of compds.  The process is illustrated with examples from recent medicinal chem. programs to discover compds. against the oncol. targets Hsp90 and PDK1.  In addn., we summarize our experience with using mol. docking calcns. to predict fragment binding and anecdotes on the selectivity and binding modes for fragments seen against a range of targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGox6z6oFlEi67Vg90H21EOLACvtfcHk0lhIiPYGG2kf4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVOrur7J&md5=6bfa0109e33c2c23cc4c5a5bcd1ed12f</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.2174%2F156802607782341109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802607782341109%26sid%3Dliteratum%253Aachs%26aulast%3DHubbard%26aufirst%3DR.%2BE.%26aulast%3DDavis%26aufirst%3DB.%26aulast%3DChen%26aufirst%3DI.%26aulast%3DDrysdale%26aufirst%3DM.%2BJ.%26atitle%3DThe%2520SeeDs%2520approach%253A%2520integrating%2520fragments%2520into%2520drug%2520discovery%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2007%26volume%3D7%26spage%3D1568%26epage%3D1581" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group">Chiosis, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Timaul, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucas, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munster, P. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, F. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sepp-Lorenzino, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, N.</span><span> </span><span class="NLM_article-title">A small molecule designed to bind to the adenine nucleotide pocket of Hsp90 causes Her2 degradation and the growth arrest and differentiation of breast cancer cells</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">289</span><span class="NLM_x">–</span> <span class="NLM_lpage">299</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Fjm900357y&amp;key=10.1016%2FS1074-5521%2801%2900015-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Fjm900357y&amp;key=11306353" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Fjm900357y&amp;key=1%3ACAS%3A528%3ADC%252BD3MXjsVCitbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2001&pages=289-299&author=G.+Chiosisauthor=M.+N.+Timaulauthor=B.+Lucasauthor=P.+N.+Munsterauthor=F.+F.+Zhengauthor=L.+Sepp-Lorenzinoauthor=N.+Rosen&title=A+small+molecule+designed+to+bind+to+the+adenine+nucleotide+pocket+of+Hsp90+causes+Her2+degradation+and+the+growth+arrest+and+differentiation+of+breast+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">A small molecule designed to bind to the adenine nucleotide pocket of Hsp90 causes Her2 degradation and the growth arrest and differentiation of breast cancer cells</span></div><div class="casAuthors">Chiosis, Gabriela; Timaul, Merna N.; Lucas, Brian; Munster, Pamela N.; Zheng, Fuzhong F.; Sepp-Lorenzino, Laura; Rosen, Neal</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">289-299</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">Background: The Hsp90s contain a conserved pocket that binds ATP/ADP and plays an important role in the regulation of chaperone function.  Occupancy of this pocket by several natural products (geldanamycin (GM) and radicicol) alters Hsp90 function and results in the degrdn. of a subset of proteins (i.e. steroid receptors, Her2, Raf).  We have used the structural features of this pocket to design a small mol. inhibitor of Hsp90.  Results: The designed small mol. PU3 competes with GM for Hsp90 binding with a relative affinity of 15-20 μM.  PU3 induces degrdn. of proteins, including Her2, in a manner similar to GM.  Furthermore, PU3 inhibits the growth of breast cancer cells causing retinoblastoma protein hypophosphorylation, G1 arrest and differentiation.  Conclusions: PU3 is representative of a novel class of synthetic compds. that binds to Hsp90 and inhibits the proliferation of cancer cells.  These reagents could provide a new strategy for the treatment of cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqwVErTsVLPMrVg90H21EOLACvtfcHk0lhIiPYGG2kf4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXjsVCitbs%253D&md5=6a51b7e8c95c320fa27f62d9f9f645f5</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1016%2FS1074-5521%2801%2900015-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1074-5521%252801%252900015-1%26sid%3Dliteratum%253Aachs%26aulast%3DChiosis%26aufirst%3DG.%26aulast%3DTimaul%26aufirst%3DM.%2BN.%26aulast%3DLucas%26aufirst%3DB.%26aulast%3DMunster%26aufirst%3DP.%2BN.%26aulast%3DZheng%26aufirst%3DF.%2BF.%26aulast%3DSepp-Lorenzino%26aufirst%3DL.%26aulast%3DRosen%26aufirst%3DN.%26atitle%3DA%2520small%2520molecule%2520designed%2520to%2520bind%2520to%2520the%2520adenine%2520nucleotide%2520pocket%2520of%2520Hsp90%2520causes%2520Her2%2520degradation%2520and%2520the%2520growth%2520arrest%2520and%2520differentiation%2520of%2520breast%2520cancer%2520cells%26jtitle%3DChem.%2520Biol.%26date%3D2001%26volume%3D8%26spage%3D289%26epage%3D299" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group">Lepre, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, J. W.</span><span> </span><span class="NLM_article-title">Theory and applications of NMR-based screening in pharmaceutical research</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">104</span><span class="NLM_x">, </span> <span class="NLM_fpage">3641</span><span class="NLM_x">–</span> <span class="NLM_lpage">3676</span></span><div class="citationLinks">[<a href="/doi/10.1021/cr030409h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Fjm900357y&amp;key=1%3ACAS%3A528%3ADC%252BD2cXlvFGiurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2004&pages=3641-3676&author=C.+A.+Lepreauthor=J.+M.+Mooreauthor=J.+W.+Peng&title=Theory+and+applications+of+NMR-based+screening+in+pharmaceutical+research"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Theory and Applications of NMR-Based Screening in Pharmaceutical Research</span></div><div class="casAuthors">Lepre, Christopher A.; Moore, Jonathan M.; Peng, Jeffrey W.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">104</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3641-3675</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrrS0z7FwNhp7Vg90H21EOLACvtfcHk0lhIiPYGG2kf4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXlvFGiurY%253D&md5=2e43f7f4e6fc94e0022531c44804f0a3</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1021%2Fcr030409h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr030409h%26sid%3Dliteratum%253Aachs%26aulast%3DLepre%26aufirst%3DC.%2BA.%26aulast%3DMoore%26aufirst%3DJ.%2BM.%26aulast%3DPeng%26aufirst%3DJ.%2BW.%26atitle%3DTheory%2520and%2520applications%2520of%2520NMR-based%2520screening%2520in%2520pharmaceutical%2520research%26jtitle%3DChem.%2520Rev.%26date%3D2004%26volume%3D104%26spage%3D3641%26epage%3D3676" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group">Mayer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyer, B.</span><span> </span><span class="NLM_article-title">Characterisation of ligand binding by saturation transfer difference NMR spectroscopy</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">1784</span><span class="NLM_x">–</span> <span class="NLM_lpage">1788</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1999&pages=1784-1788&author=M.+Mayerauthor=B.+Meyer&title=Characterisation+of+ligand+binding+by+saturation+transfer+difference+NMR+spectroscopy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMayer%26aufirst%3DM.%26aulast%3DMeyer%26aufirst%3DB.%26atitle%3DCharacterisation%2520of%2520ligand%2520binding%2520by%2520saturation%2520transfer%2520difference%2520NMR%2520spectroscopy%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D1999%26volume%3D38%26spage%3D1784%26epage%3D1788" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group">Dalvit, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pevarello, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tato, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Veronesi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vulpetti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sundstrom, M.</span><span> </span><span class="NLM_article-title">Identification of compounds with binding affinity to proteins via magnetization transfer from bulk water</span> <span class="citation_source-journal">J. Biomol. NMR</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">65</span><span class="NLM_x">–</span> <span class="NLM_lpage">68</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Fjm900357y&amp;key=10.1023%2FA%3A1008354229396" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Fjm900357y&amp;key=11061229" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Fjm900357y&amp;key=1%3ACAS%3A528%3ADC%252BD3cXnvVGit7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2000&pages=65-68&author=C.+Dalvitauthor=P.+Pevarelloauthor=M.+Tatoauthor=M.+Veronesiauthor=A.+Vulpettiauthor=M.+Sundstrom&title=Identification+of+compounds+with+binding+affinity+to+proteins+via+magnetization+transfer+from+bulk+water"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of compounds with binding affinity to proteins via magnetization transfer from bulk water</span></div><div class="casAuthors">Dalvit, Claudio; Pevarello, Paolo; Tato, Marco; Veronesi, Marina; Vulpetti, Anna; Sundstrom, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biomolecular NMR</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">65-68</span>CODEN:
                <span class="NLM_cas:coden">JBNME9</span>;
        ISSN:<span class="NLM_cas:issn">0925-2738</span>.
    
            (<span class="NLM_cas:orgname">Kluwer Academic Publishers</span>)
        </div><div class="casAbstract">A powerful screening by NMR methodol. (WaterLOGSY), based on transfer of magnetization from bulk water, for the identification of compds. that interact with target biomols. (proteins, RNA and DNA fragments) is described.  The method exploits efficiently the large reservoir of H2O magnetization.  The high sensitivity of the technique reduces the amt. of biomol. and ligands needed for the screening, which constitutes an important requirement for high throughput screening by NMR of large libraries of compds.  Application of the method to a compd. mixt. against the cyclin-dependent kinase 2 (cdk2) protein is presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoR8Jo0PHYdALVg90H21EOLACvtfcHk0lh4H5OOo-6NlA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXnvVGit7o%253D&md5=e0fd0e5815f9bd20ed09d8033882feb6</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1023%2FA%3A1008354229396&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FA%253A1008354229396%26sid%3Dliteratum%253Aachs%26aulast%3DDalvit%26aufirst%3DC.%26aulast%3DPevarello%26aufirst%3DP.%26aulast%3DTato%26aufirst%3DM.%26aulast%3DVeronesi%26aufirst%3DM.%26aulast%3DVulpetti%26aufirst%3DA.%26aulast%3DSundstrom%26aufirst%3DM.%26atitle%3DIdentification%2520of%2520compounds%2520with%2520binding%2520affinity%2520to%2520proteins%2520via%2520magnetization%2520transfer%2520from%2520bulk%2520water%26jtitle%3DJ.%2520Biomol.%2520NMR%26date%3D2000%26volume%3D18%26spage%3D65%26epage%3D68" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group">Hajduk, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olejniczak, E. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fesik, S. W.</span><span> </span><span class="NLM_article-title">One-Dimensional Relaxation and Diffusion-Edited NMR Methods for Screening Compounds that Bind to Macromolecules</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">119</span><span class="NLM_x">, </span> <span class="NLM_fpage">12257</span><span class="NLM_x">–</span> <span class="NLM_lpage">12261</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja9715962" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=119&publication_year=1997&pages=12257-12261&author=P.+J.+Hajdukauthor=E.+T.+Olejniczakauthor=S.+W.+Fesik&title=One-Dimensional+Relaxation+and+Diffusion-Edited+NMR+Methods+for+Screening+Compounds+that+Bind+to+Macromolecules"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1021%2Fja9715962&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja9715962%26sid%3Dliteratum%253Aachs%26aulast%3DHajduk%26aufirst%3DP.%2BJ.%26aulast%3DOlejniczak%26aufirst%3DE.%2BT.%26aulast%3DFesik%26aufirst%3DS.%2BW.%26atitle%3DOne-Dimensional%2520Relaxation%2520and%2520Diffusion-Edited%2520NMR%2520Methods%2520for%2520Screening%2520Compounds%2520that%2520Bind%2520to%2520Macromolecules%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1997%26volume%3D119%26spage%3D12257%26epage%3D12261" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group">Baurin, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aboul-Ela, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barril, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drysdale, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dymock, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finch, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fromont, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richardson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simmonite, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hubbard, R. E.</span><span> </span><span class="NLM_article-title">Design and characterization of libraries of molecular fragments for use in NMR screening against protein targets</span> <span class="citation_source-journal">J. Chem. Inf. Comput. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">2157</span><span class="NLM_x">–</span> <span class="NLM_lpage">2166</span></span><div class="citationLinks">[<a href="/doi/10.1021/ci049806z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Fjm900357y&amp;key=1%3ACAS%3A528%3ADC%252BD2cXotlaru78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2004&pages=2157-2166&author=N.+Baurinauthor=F.+Aboul-Elaauthor=X.+Barrilauthor=B.+Davisauthor=M.+Drysdaleauthor=B.+Dymockauthor=H.+Finchauthor=C.+Fromontauthor=C.+Richardsonauthor=H.+Simmoniteauthor=R.+E.+Hubbard&title=Design+and+characterization+of+libraries+of+molecular+fragments+for+use+in+NMR+screening+against+protein+targets"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Characterization of Libraries of Molecular Fragments for Use in NMR Screening against Protein Targets</span></div><div class="casAuthors">Baurin, Nicolas; Aboul-Ela, Fareed; Barril, Xavier; Davis, Ben; Drysdale, Martin; Dymock, Brian; Finch, Harry; Fromont, Christophe; Richardson, Christine; Simmonite, Heather; Hubbard, Roderick E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Computer Sciences</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2157-2166</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">0095-2338</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We have designed four generations of a low mol. wt. fragment library for use in NMR-based screening against protein targets.  The library initially contained 723 fragments which were selected manually from the Available Chems. Directory.  A series of in silico filters and property calcns. were developed to automate the selection process, allowing a larger database of 1.79M available compds. to be searched for a further 357 compds. that were added to the library.  A kinase binding pharmacophore was then derived to select 174 kinase-focused fragments.  Finally, an addnl. 61 fragments were selected to increase the no. of different pharmacophores represented within the library.  All of the fragments added to the library passed quality checks to ensure they were suitable for the screening protocol, with appropriate soly., purity, chem. stability, and unambiguous NMR spectrum.  The successive generations of libraries have been characterized through anal. of structural properties (mol. wt., lipophilicity, polar surface area, no. of rotatable bonds, and hydrogen-bonding potential) and by analyzing their pharmacophoric complexity.  These calcns. have been used to compare the fragment libraries with a drug-like ref. set of compds. and a set of mols. that bind to protein active sites.  In addn., an anal. of the overall results of screening the library against the ATP binding site of two protein targets (HSP90 and CDK2) reveals different patterns of fragment binding, demonstrating that the approach can find selective compds. that discriminate between related binding sites.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo652Eyyn5Lc7Vg90H21EOLACvtfcHk0lgY8cfp_kBVLg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXotlaru78%253D&md5=7376be270294dae6997609448513c5d7</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1021%2Fci049806z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci049806z%26sid%3Dliteratum%253Aachs%26aulast%3DBaurin%26aufirst%3DN.%26aulast%3DAboul-Ela%26aufirst%3DF.%26aulast%3DBarril%26aufirst%3DX.%26aulast%3DDavis%26aufirst%3DB.%26aulast%3DDrysdale%26aufirst%3DM.%26aulast%3DDymock%26aufirst%3DB.%26aulast%3DFinch%26aufirst%3DH.%26aulast%3DFromont%26aufirst%3DC.%26aulast%3DRichardson%26aufirst%3DC.%26aulast%3DSimmonite%26aufirst%3DH.%26aulast%3DHubbard%26aufirst%3DR.%2BE.%26atitle%3DDesign%2520and%2520characterization%2520of%2520libraries%2520of%2520molecular%2520fragments%2520for%2520use%2520in%2520NMR%2520screening%2520against%2520protein%2520targets%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Comput.%2520Sci.%26date%3D2004%26volume%3D44%26spage%3D2157%26epage%3D2166" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group">Huth, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petros, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kunzer, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wendt, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mack, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swift, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Judge, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richardson, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tahir, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matayoshi, E. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dorwin, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ladror, U. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Severin, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walter, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartley, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fesik, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elmore, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hajduk, P. J.</span><span> </span><span class="NLM_article-title">Discovery and design of novel HSP90 inhibitors using multiple fragment-based design strategies</span> <span class="citation_source-journal">Chem. Biol. Drug Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">12</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Fjm900357y&amp;key=10.1111%2Fj.1747-0285.2007.00535.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Fjm900357y&amp;key=17630989" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Fjm900357y&amp;key=1%3ACAS%3A528%3ADC%252BD2sXovFCktrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2007&pages=1-12&author=J.+R.+Huthauthor=C.+Parkauthor=A.+M.+Petrosauthor=A.+R.+Kunzerauthor=M.+D.+Wendtauthor=X.+Wangauthor=C.+L.+Lynchauthor=J.+C.+Mackauthor=K.+M.+Swiftauthor=R.+A.+Judgeauthor=J.+Chenauthor=P.+L.+Richardsonauthor=S.+Jinauthor=S.+K.+Tahirauthor=E.+D.+Matayoshiauthor=S.+A.+Dorwinauthor=U.+S.+Ladrorauthor=J.+M.+Severinauthor=K.+A.+Walterauthor=D.+M.+Bartleyauthor=S.+W.+Fesikauthor=S.+W.+Elmoreauthor=P.+J.+Hajduk&title=Discovery+and+design+of+novel+HSP90+inhibitors+using+multiple+fragment-based+design+strategies"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and design of novel HSP90 inhibitors using multiple fragment-based design strategies</span></div><div class="casAuthors">Huth, Jeffrey R.; Park, Chang; Petros, Andrew M.; Kunzer, Aaron R.; Wendt, Michael D.; Wang, Xilu; Lynch, Christopher L.; Mack, Jamey C.; Swift, Kerry M.; Judge, Russell A.; Chen, Jun; Richardson, Paul L.; Jin, Sha; Tahir, Stephen K.; Matayoshi, Edward D.; Dorwin, Sarah A.; Ladror, Uri S.; Severin, Jean M.; Walter, Karl A.; Bartley, Diane M.; Fesik, Stephen W.; Elmore, Steven W.; Hajduk, Philip J.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Biology & Drug Design</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-12</span>CODEN:
                <span class="NLM_cas:coden">CBDDAL</span>;
        ISSN:<span class="NLM_cas:issn">1747-0277</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">The mol. chaperone HSP90 has been shown to facilitate cancer cell survival by stabilizing key proteins responsible for a malignant phenotype.  The authors report here the results of parallel fragment-based drug design approaches in the design of novel HSP9O inhibitors.  Initial aminopyrimidine leads were elaborated using high-throughput org. synthesis to yield nanomolar inhibitors of the enzyme.  Second site leads were also identified which bound to HSP90 in two distinct conformations, an 'open' and 'closed' form.  Intriguingly, linked fragment approaches targeting both of these conformations were successful in producing novel, micromolar inhibitors.  Overall, this study shows that, with only a few fragment hits, multiple lead series can be generated for HSP90 due to the inherent flexibility of the active site.  Thus, ample opportunities exist to use these lead series in the development of clin. useful HSP90 inhibitors for the treatment of cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXkkVC5aQLFbVg90H21EOLACvtfcHk0lgY8cfp_kBVLg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXovFCktrY%253D&md5=ae1aa497320e997ae5c0971f7c9ab341</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1111%2Fj.1747-0285.2007.00535.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1747-0285.2007.00535.x%26sid%3Dliteratum%253Aachs%26aulast%3DHuth%26aufirst%3DJ.%2BR.%26aulast%3DPark%26aufirst%3DC.%26aulast%3DPetros%26aufirst%3DA.%2BM.%26aulast%3DKunzer%26aufirst%3DA.%2BR.%26aulast%3DWendt%26aufirst%3DM.%2BD.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DLynch%26aufirst%3DC.%2BL.%26aulast%3DMack%26aufirst%3DJ.%2BC.%26aulast%3DSwift%26aufirst%3DK.%2BM.%26aulast%3DJudge%26aufirst%3DR.%2BA.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DRichardson%26aufirst%3DP.%2BL.%26aulast%3DJin%26aufirst%3DS.%26aulast%3DTahir%26aufirst%3DS.%2BK.%26aulast%3DMatayoshi%26aufirst%3DE.%2BD.%26aulast%3DDorwin%26aufirst%3DS.%2BA.%26aulast%3DLadror%26aufirst%3DU.%2BS.%26aulast%3DSeverin%26aufirst%3DJ.%2BM.%26aulast%3DWalter%26aufirst%3DK.%2BA.%26aulast%3DBartley%26aufirst%3DD.%2BM.%26aulast%3DFesik%26aufirst%3DS.%2BW.%26aulast%3DElmore%26aufirst%3DS.%2BW.%26aulast%3DHajduk%26aufirst%3DP.%2BJ.%26atitle%3DDiscovery%2520and%2520design%2520of%2520novel%2520HSP90%2520inhibitors%2520using%2520multiple%2520fragment-based%2520design%2520strategies%26jtitle%3DChem.%2520Biol.%2520Drug%2520Des.%26date%3D2007%26volume%3D70%26spage%3D1%26epage%3D12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group">Barker, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barker, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boggio, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chauhan, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corden, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Courtney, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Falke, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fusar, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardiner, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamelin, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hesterkamp, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ichihara, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mather, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mercurio, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minucci, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montalbetti, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muller, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phillips, B. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varessi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whittaker, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winkler, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yarnold, C. J.</span><span> </span><span class="NLM_article-title">Fragment-Based Identification of Hsp90 Inhibitors</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">963</span><span class="NLM_x">–</span> <span class="NLM_lpage">966</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Fjm900357y&amp;key=10.1002%2Fcmdc.200900011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Fjm900357y&amp;key=19301319" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Fjm900357y&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmslChtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2009&pages=963-966&author=J.+J.+Barkerauthor=O.+Barkerauthor=R.+Boggioauthor=V.+Chauhanauthor=R.+K.+Chengauthor=V.+Cordenauthor=S.+M.+Courtneyauthor=N.+Edwardsauthor=V.+M.+Falkeauthor=F.+Fusarauthor=M.+Gardinerauthor=E.+M.+Hamelinauthor=T.+Hesterkampauthor=O.+Ichiharaauthor=R.+S.+Jonesauthor=O.+Matherauthor=C.+Mercurioauthor=S.+Minucciauthor=C.+A.+Montalbettiauthor=A.+Mullerauthor=D.+Patelauthor=B.+G.+Phillipsauthor=M.+Varessiauthor=M.+Whittakerauthor=D.+Winklerauthor=C.+J.+Yarnold&title=Fragment-Based+Identification+of+Hsp90+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Fragment-based Identification of Hsp90 Inhibitors</span></div><div class="casAuthors">Barker, John J.; Barker, Oliver; Boggio, Roberto; Chauhan, Viddhata; Cheng, Robert K. Y.; Corden, Vincent; Courtney, Stephen M.; Edwards, Neil; Falque, Virginie M.; Fusar, Fulvia; Gardiner, Mihaly; Hamelin, Estelle M. N.; Hesterkamp, Thomas; Ichihara, Osamu; Jones, Richard S.; Mather, Owen; Mercurio, Ciro; Minucci, Saverio; Montalbetti, Christian A. G. N.; Muller, Annett; Patel, Deepti; Phillips, Banu G.; Varasi, Mario; Whittaker, Mark; Winkler, Dirk; Yarnold, Christopher J.</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">963-966</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Heat shock protein 90 (Hsp90) plays a key role in stress response and protection of the cell against the effects of mutation.  Herein we report the identification of an Hsp90 inhibitor identified by fragment screening using a high-concn. biochem. assay, as well as its optimization by in silico searching coupled with a structure-based drug design (SBDD) approach.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsaGeZbmBYH7Vg90H21EOLACvtfcHk0ljygWCsp-Lm9Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmslChtbk%253D&md5=c44357e5d1b341c6bc540798951a687f</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.200900011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.200900011%26sid%3Dliteratum%253Aachs%26aulast%3DBarker%26aufirst%3DJ.%2BJ.%26aulast%3DBarker%26aufirst%3DO.%26aulast%3DBoggio%26aufirst%3DR.%26aulast%3DChauhan%26aufirst%3DV.%26aulast%3DCheng%26aufirst%3DR.%2BK.%26aulast%3DCorden%26aufirst%3DV.%26aulast%3DCourtney%26aufirst%3DS.%2BM.%26aulast%3DEdwards%26aufirst%3DN.%26aulast%3DFalke%26aufirst%3DV.%2BM.%26aulast%3DFusar%26aufirst%3DF.%26aulast%3DGardiner%26aufirst%3DM.%26aulast%3DHamelin%26aufirst%3DE.%2BM.%26aulast%3DHesterkamp%26aufirst%3DT.%26aulast%3DIchihara%26aufirst%3DO.%26aulast%3DJones%26aufirst%3DR.%2BS.%26aulast%3DMather%26aufirst%3DO.%26aulast%3DMercurio%26aufirst%3DC.%26aulast%3DMinucci%26aufirst%3DS.%26aulast%3DMontalbetti%26aufirst%3DC.%2BA.%26aulast%3DMuller%26aufirst%3DA.%26aulast%3DPatel%26aufirst%3DD.%26aulast%3DPhillips%26aufirst%3DB.%2BG.%26aulast%3DVaressi%26aufirst%3DM.%26aulast%3DWhittaker%26aufirst%3DM.%26aulast%3DWinkler%26aufirst%3DD.%26aulast%3DYarnold%26aufirst%3DC.%2BJ.%26atitle%3DFragment-Based%2520Identification%2520of%2520Hsp90%2520Inhibitors%26jtitle%3DChemMedChem%26date%3D2009%26volume%3D4%26spage%3D963%26epage%3D966" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group">Barril, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brough, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drysdale, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hubbard, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Massey, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Surgenor, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, L.</span><span> </span><span class="NLM_article-title">Structure-based discovery of a new class of Hsp90 inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">5187</span><span class="NLM_x">–</span> <span class="NLM_lpage">5191</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=5187-5191&author=X.+Barrilauthor=P.+Broughauthor=M.+Drysdaleauthor=R.+E.+Hubbardauthor=A.+Masseyauthor=A.+Surgenorauthor=L.+Wright&title=Structure-based+discovery+of+a+new+class+of+Hsp90+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBarril%26aufirst%3DX.%26aulast%3DBrough%26aufirst%3DP.%26aulast%3DDrysdale%26aufirst%3DM.%26aulast%3DHubbard%26aufirst%3DR.%2BE.%26aulast%3DMassey%26aufirst%3DA.%26aulast%3DSurgenor%26aufirst%3DA.%26aulast%3DWright%26aufirst%3DL.%26atitle%3DStructure-based%2520discovery%2520of%2520a%2520new%2520class%2520of%2520Hsp90%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D5187%26epage%3D5191" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group">Knox, A. J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Price, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pawlak, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golfis, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flood, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fayne, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meegan, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lloyd, D. G.</span><span> </span><span class="NLM_article-title">Integration of Ligand and Structure-Based Virtual Screening for the Identification of the First Dual Targeting Agent for Heat Shock Protein 90 (Hsp90) and Tubulin</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">2177</span><span class="NLM_x">–</span> <span class="NLM_lpage">2180</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm801569z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Fjm900357y&amp;key=1%3ACAS%3A528%3ADC%252BD1MXktFGrt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=2177-2180&author=A.+J.+S.+Knoxauthor=T.+Priceauthor=M.+Pawlakauthor=G.+Golfisauthor=C.+T.+Floodauthor=D.+Fayneauthor=D.+C.+Williamsauthor=M.+J.+Meeganauthor=D.+G.+Lloyd&title=Integration+of+Ligand+and+Structure-Based+Virtual+Screening+for+the+Identification+of+the+First+Dual+Targeting+Agent+for+Heat+Shock+Protein+90+%28Hsp90%29+and+Tubulin"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Integration of Ligand and Structure-Based Virtual Screening for the Identification of the First Dual Targeting Agent for Heat Shock Protein 90 (Hsp90) and Tubulin</span></div><div class="casAuthors">Knox, Andrew J. S.; Price, Trevor; Pawlak, Michal; Golfis, Georgia; Flood, Christopher T.; Fayne, Darren; Williams, D. Clive; Meegan, Mary J.; Lloyd, David G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2177-2180</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We describe the discovery of a novel indazole-based scaffold that represents the "first-in-class" dual Hsp90/tubulin binding compd.  Individual known ligands for both targets shared similar 3',4',5'-trimethoxyphenyl cores, and from this it was hypothesized that application of an integrated ligand and structure-based virtual screening (VS) workflow could yield a single scaffold with dual binding affinity.  Following validation of the VS protocol, we successfully identified a novel dual inhibitor, sourced from a com. screening collection of 160 000 compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrRptEHjoTCsLVg90H21EOLACvtfcHk0ljygWCsp-Lm9Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXktFGrt70%253D&md5=c8268f36a0da627404be37696c5afe4b</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1021%2Fjm801569z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm801569z%26sid%3Dliteratum%253Aachs%26aulast%3DKnox%26aufirst%3DA.%2BJ.%2BS.%26aulast%3DPrice%26aufirst%3DT.%26aulast%3DPawlak%26aufirst%3DM.%26aulast%3DGolfis%26aufirst%3DG.%26aulast%3DFlood%26aufirst%3DC.%2BT.%26aulast%3DFayne%26aufirst%3DD.%26aulast%3DWilliams%26aufirst%3DD.%2BC.%26aulast%3DMeegan%26aufirst%3DM.%2BJ.%26aulast%3DLloyd%26aufirst%3DD.%2BG.%26atitle%3DIntegration%2520of%2520Ligand%2520and%2520Structure-Based%2520Virtual%2520Screening%2520for%2520the%2520Identification%2520of%2520the%2520First%2520Dual%2520Targeting%2520Agent%2520for%2520Heat%2520Shock%2520Protein%252090%2520%2528Hsp90%2529%2520and%2520Tubulin%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D2177%26epage%3D2180" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">71</a></strong><div class="NLM_citation" id="cit71"><span><span class="NLM_contrib-group">Barril, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hubbard, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morley, S. D.</span><span> </span><span class="NLM_article-title">Virtual screening in structure-based drug discovery</span> <span class="citation_source-journal">Mini. Rev. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">779</span><span class="NLM_x">–</span> <span class="NLM_lpage">791</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Fjm900357y&amp;key=15379645" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Fjm900357y&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmslajsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2004&pages=779-791&author=X.+Barrilauthor=R.+E.+Hubbardauthor=S.+D.+Morley&title=Virtual+screening+in+structure-based+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Virtual screening in structure-based drug discovery</span></div><div class="casAuthors">Barril, X.; Hubbard, R. E.; Morley, S. D.</div><div class="citationInfo"><span class="NLM_cas:title">Mini-Reviews in Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">779-791</span>CODEN:
                <span class="NLM_cas:coden">MMCIAE</span>;
        ISSN:<span class="NLM_cas:issn">1389-5575</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Recent advances in structure detn. and computational methods have encouraged the development of structure-based virtual screening.  Here we survey progress in the field and review the most recent methods, validation expts. and real applications, including an inhouse example of hit identification for the oncol. target Hsp90.  These results provide a basis for discussing the current state of structure-based virtual screening and to outline the developments that are expected to have a major impact in the near future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoy7o9-h9rF3bVg90H21EOLACvtfcHk0lgURHWhXM8lKA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmslajsbo%253D&md5=2625c1aec0337bcc67d6b62dd9b8a737</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBarril%26aufirst%3DX.%26aulast%3DHubbard%26aufirst%3DR.%2BE.%26aulast%3DMorley%26aufirst%3DS.%2BD.%26atitle%3DVirtual%2520screening%2520in%2520structure-based%2520drug%2520discovery%26jtitle%3DMini.%2520Rev.%2520Med.%2520Chem.%26date%3D2004%26volume%3D4%26spage%3D779%26epage%3D791" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref72"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref72'); return false;" data-citation="" class="refNumLink">72</a></strong><div class="NLM_citation" id="cit72"><span><span class="NLM_contrib-group">Wright, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barril, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dymock, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheridan, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Surgenor, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beswick, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drysdale, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collier, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Massey, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fink, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fromont, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aherne, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boxall, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharp, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Workman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hubbard, R. E.</span><span> </span><span class="NLM_article-title">Structure−activity relationships in purine-based inhibitor binding to HSP90 isoforms</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">775</span><span class="NLM_x">–</span> <span class="NLM_lpage">785</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Fjm900357y&amp;key=10.1016%2Fj.chembiol.2004.03.033" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Fjm900357y&amp;key=15217611" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Fjm900357y&amp;key=1%3ACAS%3A528%3ADC%252BD2cXlt1Sjsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2004&pages=775-785&author=L.+Wrightauthor=X.+Barrilauthor=B.+Dymockauthor=L.+Sheridanauthor=A.+Surgenorauthor=M.+Beswickauthor=M.+Drysdaleauthor=A.+Collierauthor=A.+Masseyauthor=N.+Daviesauthor=A.+Finkauthor=C.+Fromontauthor=W.+Aherneauthor=K.+Boxallauthor=S.+Sharpauthor=P.+Workmanauthor=R.+E.+Hubbard&title=Structure%E2%88%92activity+relationships+in+purine-based+inhibitor+binding+to+HSP90+isoforms"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Activity Relationships in Purine-Based Inhibitor Binding to HSP90 Isoforms</span></div><div class="casAuthors">Wright, Lisa; Barril, Xavier; Dymock, Brian; Sheridan, Louisa; Surgenor, Allan; Beswick, Mandy; Drysdale, Martin; Collier, Adam; Massey, Andy; Davies, Nick; Fink, Alex; Fromont, Christophe; Aherne, Wynne; Boxall, Kathy; Sharp, Swee; Workman, Paul; Hubbard, Roderick E.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">775-785</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Inhibition of the ATPase activity of the chaperone protein HSP90 is a potential strategy for treatment of cancers.  We have detd. structures of the HSP90α N-terminal domain complexed with the purine-based inhibitor, PU3, and analogs with enhanced potency both in enzyme and cell-based assays.  The compds. induce upregulation of HSP70 and downregulation of the known HSP90 client proteins Raf-1, CDK4, and ErbB2, confirming that the mols. inhibit cell growth by a mechanism dependent on HSP90 inhibition.  We have also detd. the first structure of the N-terminal domain of HSP90β, complexed with PU3.  The structures allow a detailed rationale to be developed for the obsd. affinity of the PU3 class of compds. for HSP90 and also provide a structural framework for design of compds. with improved binding affinity and drug-like properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2Z11Wd4hiXrVg90H21EOLACvtfcHk0lgURHWhXM8lKA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXlt1Sjsrs%253D&md5=dd2146dba0f4b3198d5bc7023e645812</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2004.03.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2004.03.033%26sid%3Dliteratum%253Aachs%26aulast%3DWright%26aufirst%3DL.%26aulast%3DBarril%26aufirst%3DX.%26aulast%3DDymock%26aufirst%3DB.%26aulast%3DSheridan%26aufirst%3DL.%26aulast%3DSurgenor%26aufirst%3DA.%26aulast%3DBeswick%26aufirst%3DM.%26aulast%3DDrysdale%26aufirst%3DM.%26aulast%3DCollier%26aufirst%3DA.%26aulast%3DMassey%26aufirst%3DA.%26aulast%3DDavies%26aufirst%3DN.%26aulast%3DFink%26aufirst%3DA.%26aulast%3DFromont%26aufirst%3DC.%26aulast%3DAherne%26aufirst%3DW.%26aulast%3DBoxall%26aufirst%3DK.%26aulast%3DSharp%26aufirst%3DS.%26aulast%3DWorkman%26aufirst%3DP.%26aulast%3DHubbard%26aufirst%3DR.%2BE.%26atitle%3DStructure%25E2%2588%2592activity%2520relationships%2520in%2520purine-based%2520inhibitor%2520binding%2520to%2520HSP90%2520isoforms%26jtitle%3DChem.%2520Biol.%26date%3D2004%26volume%3D11%26spage%3D775%26epage%3D785" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref73"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref73'); return false;" data-citation="" class="refNumLink">73</a></strong><div class="NLM_citation" id="cit73"><span><span class="NLM_contrib-group">Baurin, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richardson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foloppe, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jordan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roughley, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parratt, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greaney, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morley, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hubbard, R. E.</span><span> </span><span class="NLM_article-title">Drug-like annotation and duplicate analysis of a 23-supplier chemical database totalling 2.7 million compounds</span> <span class="citation_source-journal">J. Chem. Inf. Comput. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">643</span><span class="NLM_x">–</span> <span class="NLM_lpage">651</span></span><div class="citationLinks">[<a href="/doi/10.1021/ci034260m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Fjm900357y&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVGhs7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2004&pages=643-651&author=N.+Baurinauthor=R.+Bakerauthor=C.+Richardsonauthor=I.+Chenauthor=N.+Foloppeauthor=A.+Potterauthor=A.+Jordanauthor=S.+Roughleyauthor=M.+Parrattauthor=P.+Greaneyauthor=D.+Morleyauthor=R.+E.+Hubbard&title=Drug-like+annotation+and+duplicate+analysis+of+a+23-supplier+chemical+database+totalling+2.7+million+compounds"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">Drug-like Annotation and Duplicate Analysis of a 23-Supplier Chemical Database Totaling 2.7 Million Compounds</span></div><div class="casAuthors">Baurin, N.; Baker, R.; Richardson, C.; Chen, I.; Foloppe, N.; Potter, A.; Jordan, A.; Roughley, S.; Parratt, M.; Greaney, P.; Morley, D.; Hubbard, R. E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Computer Sciences</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">643-651</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">0095-2338</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We have implemented five drug-like filters, based on 1D and 2D mol. descriptors, and applied them to characterize the drug-like properties of com. available chem. compds.  In addn. to previously published filters (Lipinski and Veber), we implemented a filter for medicinal chem. tractability based on lists of chem. features drawn up by a panel of medicinal chemists.  A filter based on the modeling of aq. soly. (> 1 μM) was derived inhouse, as well as another based on the modeling of Caco-2 passive membrane permeability (> 10 nm/s).  A library of 2.7 million compds. was collated from the 23 compd. suppliers and analyzed with these filters, highlighting a tendency toward highly lipophilic compds.  The library contains 1.6M unique structures, of which 37% (607 223) passed all five drug-like filters.  None of the 23 suppliers provides all the members of the drug-like subset, emphasizing the benefit of considering compds. from various compd. suppliers as a source of diversity for drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVcetJEknX-bVg90H21EOLACvtfcHk0ljnZ-IBnakKuA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVGhs7w%253D&md5=b038e9e8d97a6d62da3b6fe426570646</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1021%2Fci034260m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci034260m%26sid%3Dliteratum%253Aachs%26aulast%3DBaurin%26aufirst%3DN.%26aulast%3DBaker%26aufirst%3DR.%26aulast%3DRichardson%26aufirst%3DC.%26aulast%3DChen%26aufirst%3DI.%26aulast%3DFoloppe%26aufirst%3DN.%26aulast%3DPotter%26aufirst%3DA.%26aulast%3DJordan%26aufirst%3DA.%26aulast%3DRoughley%26aufirst%3DS.%26aulast%3DParratt%26aufirst%3DM.%26aulast%3DGreaney%26aufirst%3DP.%26aulast%3DMorley%26aufirst%3DD.%26aulast%3DHubbard%26aufirst%3DR.%2BE.%26atitle%3DDrug-like%2520annotation%2520and%2520duplicate%2520analysis%2520of%2520a%252023-supplier%2520chemical%2520database%2520totalling%25202.7%2520million%2520compounds%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Comput.%2520Sci.%26date%3D2004%26volume%3D44%26spage%3D643%26epage%3D651" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref74"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref74'); return false;" data-citation="" class="refNumLink">74</a></strong><div class="NLM_citation" id="cit74"><span><span class="NLM_contrib-group">Howes, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barril, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dymock, B. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grant, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Northfield, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robertson, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Surgenor, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wayne, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">James, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matthews, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheung, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonald, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Workman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drysdale, M. J.</span><span> </span><span class="NLM_article-title">A fluorescence polarization assay for inhibitors of Hsp90</span> <span class="citation_source-journal">Anal. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">350</span><span class="NLM_x">, </span> <span class="NLM_fpage">202</span><span class="NLM_x">–</span> <span class="NLM_lpage">213</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=350&publication_year=2006&pages=202-213&author=R.+Howesauthor=X.+Barrilauthor=B.+W.+Dymockauthor=K.+Grantauthor=C.+J.+Northfieldauthor=A.+G.+Robertsonauthor=A.+Surgenorauthor=J.+Wayneauthor=L.+Wrightauthor=K.+Jamesauthor=T.+Matthewsauthor=K.+M.+Cheungauthor=E.+McDonaldauthor=P.+Workmanauthor=M.+J.+Drysdale&title=A+fluorescence+polarization+assay+for+inhibitors+of+Hsp90"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHowes%26aufirst%3DR.%26aulast%3DBarril%26aufirst%3DX.%26aulast%3DDymock%26aufirst%3DB.%2BW.%26aulast%3DGrant%26aufirst%3DK.%26aulast%3DNorthfield%26aufirst%3DC.%2BJ.%26aulast%3DRobertson%26aufirst%3DA.%2BG.%26aulast%3DSurgenor%26aufirst%3DA.%26aulast%3DWayne%26aufirst%3DJ.%26aulast%3DWright%26aufirst%3DL.%26aulast%3DJames%26aufirst%3DK.%26aulast%3DMatthews%26aufirst%3DT.%26aulast%3DCheung%26aufirst%3DK.%2BM.%26aulast%3DMcDonald%26aufirst%3DE.%26aulast%3DWorkman%26aufirst%3DP.%26aulast%3DDrysdale%26aufirst%3DM.%2BJ.%26atitle%3DA%2520fluorescence%2520polarization%2520assay%2520for%2520inhibitors%2520of%2520Hsp90%26jtitle%3DAnal.%2520Biochem.%26date%3D2006%26volume%3D350%26spage%3D202%26epage%3D213" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref75"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref75'); return false;" data-citation="" class="refNumLink">75</a></strong><div class="NLM_citation" id="cit75"><span><span class="NLM_contrib-group">Wittenbrook, L. S.</span><span> </span><span class="NLM_article-title">Chemistry of <i>N</i>-cyanodithioimidocarbonic acid. III. Intermediate in heterocyclic synthesis</span> <span class="citation_source-journal">J. Heterocycl. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1975</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">37</span><span class="NLM_x">–</span> <span class="NLM_lpage">42</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=1975&pages=37-42&author=L.+S.+Wittenbrook&title=Chemistry+of+N-cyanodithioimidocarbonic+acid.+III.+Intermediate+in+heterocyclic+synthesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWittenbrook%26aufirst%3DL.%2BS.%26atitle%3DChemistry%2520of%2520N-cyanodithioimidocarbonic%2520acid.%2520III.%2520Intermediate%2520in%2520heterocyclic%2520synthesis%26jtitle%3DJ.%2520Heterocycl.%2520Chem.%26date%3D1975%26volume%3D12%26spage%3D37%26epage%3D42" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref76"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref76'); return false;" data-citation="" class="refNumLink">76</a></strong><div class="NLM_citation" id="cit76"><span><span class="NLM_contrib-group">Clark, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shahhet, M. S.</span><span> </span><span class="NLM_article-title">Synthesis of thieno[2,3-<i>d</i>]pyrimidines from 4,6-dichloropyrimidine-5-carboxaldehydes</span> <span class="citation_source-journal">J. Heterocycl. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">1065</span><span class="NLM_x">–</span> <span class="NLM_lpage">1072</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=1993&pages=1065-1072&author=J.+Clarkauthor=M.+S.+Shahhet&title=Synthesis+of+thieno%5B2%2C3-d%5Dpyrimidines+from+4%2C6-dichloropyrimidine-5-carboxaldehydes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DClark%26aufirst%3DJ.%26aulast%3DShahhet%26aufirst%3DM.%2BS.%26atitle%3DSynthesis%2520of%2520thieno%255B2%252C3-d%255Dpyrimidines%2520from%25204%252C6-dichloropyrimidine-5-carboxaldehydes%26jtitle%3DJ.%2520Heterocycl.%2520Chem.%26date%3D1993%26volume%3D30%26spage%3D1065%26epage%3D1072" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref77"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref77'); return false;" data-citation="" class="refNumLink">77</a></strong><div class="NLM_citation" id="cit77"><span><span class="NLM_contrib-group">Miyaura, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, H.</span><span> </span><span class="NLM_article-title">Palladium-Catalyzed Cross-Coupling Reactions of Organoboron Compounds</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">95</span><span class="NLM_x">, </span> <span class="NLM_fpage">2457</span><span class="NLM_x">–</span> <span class="NLM_lpage">2483</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=2005&pages=2457-2483&author=N.+Miyauraauthor=H.+Suzuki&title=Palladium-Catalyzed+Cross-Coupling+Reactions+of+Organoboron+Compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMiyaura%26aufirst%3DN.%26aulast%3DSuzuki%26aufirst%3DH.%26atitle%3DPalladium-Catalyzed%2520Cross-Coupling%2520Reactions%2520of%2520Organoboron%2520Compounds%26jtitle%3DChem.%2520Rev.%26date%3D2005%26volume%3D95%26spage%3D2457%26epage%3D2483" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref78"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref78'); return false;" data-citation="" class="refNumLink">78</a></strong><div class="NLM_citation" id="cit78"><span><span class="NLM_contrib-group">Zhu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duquette, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, M.</span><span> </span><span class="NLM_article-title">An Improved Preparation of Arylboronates: Application in One-Pot Suzuki Biaryl Synthesis</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">3729</span><span class="NLM_x">–</span> <span class="NLM_lpage">3732</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo0269114" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2003&pages=3729-3732&author=L.+Zhuauthor=J.+Duquetteauthor=M.+Zhang&title=An+Improved+Preparation+of+Arylboronates%3A+Application+in+One-Pot+Suzuki+Biaryl+Synthesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1021%2Fjo0269114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo0269114%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DL.%26aulast%3DDuquette%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DM.%26atitle%3DAn%2520Improved%2520Preparation%2520of%2520Arylboronates%253A%2520Application%2520in%2520One-Pot%2520Suzuki%2520Biaryl%2520Synthesis%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2003%26volume%3D68%26spage%3D3729%26epage%3D3732" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref79"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref79'); return false;" data-citation="" class="refNumLink">79</a></strong><div class="NLM_citation" id="cit79"><span><span class="NLM_contrib-group">Hughes, D. L.</span><span> </span><span class="NLM_article-title">The Mitsunobu Reaction</span> <span class="citation_source-journal">Org. React.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">335</span><span class="NLM_x">–</span> <span class="NLM_lpage">656</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Fjm900357y&amp;key=10.1002%2F0471264180.or042.02" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Fjm900357y&amp;key=1%3ACAS%3A528%3ADyaK2cXkvVajtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1992&pages=335-656&author=D.+L.+Hughes&title=The+Mitsunobu+Reaction"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">The Mitsunobu reaction</span></div><div class="casAuthors">Hughes, David L.</div><div class="citationInfo"><span class="NLM_cas:title">Organic Reactions (New York)</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">335-656</span>CODEN:
                <span class="NLM_cas:coden">ORREAW</span>;
        ISSN:<span class="NLM_cas:issn">0078-6179</span>.
    </div><div class="casAbstract">A review with 887 refs., mainly covering the di-Et azodicarboxylate/triphenylphosphine redox system with emphasis on the literature between 1981 and 1988.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKenjnWCm_GLVg90H21EOLACvtfcHk0lg14JGstYVRfw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXkvVajtb4%253D&md5=b863281e19bd0a84a975ba0824dbf42a</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1002%2F0471264180.or042.02&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F0471264180.or042.02%26sid%3Dliteratum%253Aachs%26aulast%3DHughes%26aufirst%3DD.%2BL.%26atitle%3DThe%2520Mitsunobu%2520Reaction%26jtitle%3DOrg.%2520React.%26date%3D1992%26volume%3D42%26spage%3D335%26epage%3D656" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref80"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref80'); return false;" data-citation="" class="refNumLink">80</a></strong><div class="note"><p class="first last">PDB codes: compound <b>10</b> (cocrystal) = <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2WI2">2WI2</a>, <b>10</b> (soak) = <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2WI3">2WI3</a>, <b>11</b> = <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2WI1">2WI1</a>, <b>12</b> = <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2WI4">2WI4</a>, <b>13</b> = <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2WI5">2WI5</a>, <b>21e</b> = <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2WI6">2WI6</a>, and <b>34d</b> = <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2WI7">2WI7</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref81"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref81'); return false;" data-citation="" class="refNumLink">81</a></strong><div class="NLM_citation" id="cit81a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Dymock, B. W.; Drysdale, M. J.; Fromont, C.; Jordan, A.; Barril-Alonso, X.</span><span> </span><span class="NLM_article-title">Preparation of pyrimidothiophenes as HSP90 inhibitors</span>. PCT Int. Appl. WO200500521552,<span class="NLM_x"> </span><span class="NLM_year">2005</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&author=B.+W.+Dymock&author=M.+J.+Drysdale&author=C.+Fromont&author=A.+Jordan&author=X.+Barril-Alonso&title=Preparation+of+pyrimidothiophenes+as+HSP90+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit81a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DDymock%26aufirst%3DB.%2BW.%26atitle%3DPreparation%2520of%2520pyrimidothiophenes%2520as%2520HSP90%2520inhibitors%26date%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit81b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Brough, P. A.; Barril-Alonso, X.; Drysdale, M. J.</span><span> </span><span class="NLM_article-title">Preparation of pyrimidithiophene derivatives for use as HSP90 inhibitors</span>. PCT International Application WO2006090094,<span class="NLM_x"> </span><span class="NLM_year">2006</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&author=P.+A.+Brough&author=X.+Barril-Alonso&author=M.+J.+Drysdale&title=Preparation+of+pyrimidithiophene+derivatives+for+use+as+HSP90+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit81b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBrough%26aufirst%3DP.%2BA.%26atitle%3DPreparation%2520of%2520pyrimidithiophene%2520derivatives%2520for%2520use%2520as%2520HSP90%2520inhibitors%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref82"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref82'); return false;" data-citation="" class="refNumLink">82</a></strong><div class="NLM_citation" id="cit82"><span><span class="NLM_contrib-group">Workman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Twentyman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balkwill, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balmain, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaplin, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Double, J.</span><span> </span><span class="NLM_article-title">United Kingdom Coordinating Committee on Cancer Research guidelines for the welfare of animals in experimental neoplasia, 2nd Ed</span> <span class="citation_source-journal">Br. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">77</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">10</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Fjm900357y&amp;key=10.1038%2Fbjc.1998.1" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=1998&pages=1-10&author=P.+Workmanauthor=P.+Twentymanauthor=F.+Balkwillauthor=A.+Balmainauthor=C.+Chaplinauthor=J.+Double&title=United+Kingdom+Coordinating+Committee+on+Cancer+Research+guidelines+for+the+welfare+of+animals+in+experimental+neoplasia%2C+2nd+Ed"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1038%2Fbjc.1998.1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fbjc.1998.1%26sid%3Dliteratum%253Aachs%26aulast%3DWorkman%26aufirst%3DP.%26aulast%3DTwentyman%26aufirst%3DP.%26aulast%3DBalkwill%26aufirst%3DF.%26aulast%3DBalmain%26aufirst%3DA.%26aulast%3DChaplin%26aufirst%3DC.%26aulast%3DDouble%26aufirst%3DJ.%26atitle%3DUnited%2520Kingdom%2520Coordinating%2520Committee%2520on%2520Cancer%2520Research%2520guidelines%2520for%2520the%2520welfare%2520of%2520animals%2520in%2520experimental%2520neoplasia%252C%25202nd%2520Ed%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D1998%26volume%3D77%26spage%3D1%26epage%3D10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50a','cit50b'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70'],'ref71':['cit71'],'ref72':['cit72'],'ref73':['cit73'],'ref74':['cit74'],'ref75':['cit75'],'ref76':['cit76'],'ref77':['cit77'],'ref78':['cit78'],'ref79':['cit79'],'ref80':[],'ref81':['cit81a','cit81b'],'ref82':['cit82']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 127 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Richard D. Smith, <span class="NLM_string-name hlFld-ContribAuthor">Heather A. Carlson</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of Cryptic Binding Sites Using MixMD with Standard and Accelerated Molecular Dynamics. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2021,</strong> <em>61 </em>
                                    (3)
                                     , 1287-1299. <a href="https://doi.org/10.1021/acs.jcim.0c01002" title="DOI URL">https://doi.org/10.1021/acs.jcim.0c01002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jcim.0c01002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jcim.0c01002%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DIdentification%252Bof%252BCryptic%252BBinding%252BSites%252BUsing%252BMixMD%252Bwith%252BStandard%252Band%252BAccelerated%252BMolecular%252BDynamics%26aulast%3DSmith%26aufirst%3DRichard%2BD.%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D26082020%26date%3D18022021%26volume%3D61%26issue%3D3%26spage%3D1287%26epage%3D1299" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Li Li, Lei Wang, Qi-Dong You, <span class="NLM_string-name hlFld-ContribAuthor">Xiao-Li Xu</span>. </span><span class="cited-content_cbyCitation_article-title">Heat Shock Protein 90 Inhibitors: An Update on Achievements, Challenges, and Future Directions. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (5)
                                     , 1798-1822. <a href="https://doi.org/10.1021/acs.jmedchem.9b00940" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b00940</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b00940&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b00940%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DHeat%252BShock%252BProtein%252B90%252BInhibitors%25253A%252BAn%252BUpdate%252Bon%252BAchievements%25252C%252BChallenges%25252C%252Band%252BFuture%252BDirections%26aulast%3DLi%26aufirst%3DLi%26date%3D2020%26date%3D2019%26date%3D2019%26date%3D13062019%26date%3D12112019%26date%3D30102019%26volume%3D63%26issue%3D5%26spage%3D1798%26epage%3D1822" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">James
B. Murray, James Davidson, Ijen Chen, Ben Davis, Pawel Dokurno, Christopher J. Graham, Richard Harris, Allan Jordan, Natalia Matassova, Christopher Pedder, Stuart Ray, Stephen D. Roughley, Julia Smith, Claire Walmsley, Yikang Wang, Neil Whitehead, Douglas S. Williamson, Patrick Casara, Thierry Le Diguarher, John Hickman, Jerome Stark, András Kotschy, Olivier Geneste, <span class="NLM_string-name hlFld-ContribAuthor">Roderick E. Hubbard</span>. </span><span class="cited-content_cbyCitation_article-title">Establishing Drug Discovery and Identification of Hit Series for the Anti-apoptotic Proteins, Bcl-2 and Mcl-1. </span><span class="cited-content_cbyCitation_journal-name">ACS Omega</span><span> <strong>2019,</strong> <em>4 </em>
                                    (5)
                                     , 8892-8906. <a href="https://doi.org/10.1021/acsomega.9b00611" title="DOI URL">https://doi.org/10.1021/acsomega.9b00611</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsomega.9b00611&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsomega.9b00611%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Omega%26atitle%3DEstablishing%252BDrug%252BDiscovery%252Band%252BIdentification%252Bof%252BHit%252BSeries%252Bfor%252Bthe%252BAnti-apoptotic%252BProteins%25252C%252BBcl-2%252Band%252BMcl-1%26aulast%3DMurray%26aufirst%3DJames%2BB.%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D05032019%26date%3D08032019%26volume%3D4%26issue%3D5%26spage%3D8892%26epage%3D8906" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Doris
A. Schuetz, Thomas Seidel, Arthur Garon, Riccardo Martini, Markus Körbel, Gerhard F. Ecker, <span class="NLM_string-name hlFld-ContribAuthor">Thierry Langer</span>. </span><span class="cited-content_cbyCitation_article-title">GRAIL: GRids of phArmacophore Interaction fieLds. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Theory and Computation</span><span> <strong>2018,</strong> <em>14 </em>
                                    (9)
                                     , 4958-4970. <a href="https://doi.org/10.1021/acs.jctc.8b00495" title="DOI URL">https://doi.org/10.1021/acs.jctc.8b00495</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jctc.8b00495&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jctc.8b00495%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Theory%2520and%2520Computation%26atitle%3DGRAIL%25253A%252BGRids%252Bof%252BphArmacophore%252BInteraction%252BfieLds%26aulast%3DSchuetz%26aufirst%3DDoris%2BA.%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D22052018%26date%3D20082018%26date%3D03082018%26volume%3D14%26issue%3D9%26spage%3D4958%26epage%3D4970" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jeffrey R.  Wagner</span>, <span class="hlFld-ContribAuthor ">Jesper  Sørensen</span>, <span class="hlFld-ContribAuthor ">Nathan  Hensley</span>, <span class="hlFld-ContribAuthor ">Celia  Wong</span>, <span class="hlFld-ContribAuthor ">Clare  Zhu</span>, <span class="hlFld-ContribAuthor ">Taylor  Perison</span>, and <span class="hlFld-ContribAuthor ">Rommie E.  Amaro</span>  . </span><span class="cited-content_cbyCitation_article-title">POVME 3.0: Software for Mapping Binding Pocket Flexibility. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Theory and Computation</span><span> <strong>2017,</strong> <em>13 </em>
                                    (9)
                                     , 4584-4592. <a href="https://doi.org/10.1021/acs.jctc.7b00500" title="DOI URL">https://doi.org/10.1021/acs.jctc.7b00500</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jctc.7b00500&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jctc.7b00500%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Theory%2520and%2520Computation%26atitle%3DPOVME%252B3.0%25253A%252BSoftware%252Bfor%252BMapping%252BBinding%252BPocket%252BFlexibility%26aulast%3DWagner%26aufirst%3DJeffrey%2BR.%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D14052017%26date%3D30082017%26date%3D12092017%26date%3D11082017%26volume%3D13%26issue%3D9%26spage%3D4584%26epage%3D4592" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Paul A.  Brough</span>, <span class="hlFld-ContribAuthor ">Lisa  Baker</span>, <span class="hlFld-ContribAuthor ">Simon  Bedford</span>, <span class="hlFld-ContribAuthor ">Kirsten  Brown</span>, <span class="hlFld-ContribAuthor ">Seema  Chavda</span>, <span class="hlFld-ContribAuthor ">Victoria  Chell</span>, <span class="hlFld-ContribAuthor ">Jalanie  D’Alessandro</span>, <span class="hlFld-ContribAuthor ">Nicholas G. M.  Davies</span>, <span class="hlFld-ContribAuthor ">Ben  Davis</span>, <span class="hlFld-ContribAuthor ">Loic  Le Strat</span>, <span class="hlFld-ContribAuthor ">Alba T.  Macias</span>, <span class="hlFld-ContribAuthor ">Daniel  Maddox</span>, <span class="hlFld-ContribAuthor ">Patrick C.  Mahon</span>, <span class="hlFld-ContribAuthor ">Andrew J.  Massey</span>, <span class="hlFld-ContribAuthor ">Natalia  Matassova</span>, <span class="hlFld-ContribAuthor ">Sean  McKenna</span>, <span class="hlFld-ContribAuthor ">Johannes W. G.  Meissner</span>, <span class="hlFld-ContribAuthor ">Jonathan D.  Moore</span>, <span class="hlFld-ContribAuthor ">James B.  Murray</span>, <span class="hlFld-ContribAuthor ">Christopher J.  Northfield</span>, <span class="hlFld-ContribAuthor ">Charles  Parry</span>, <span class="hlFld-ContribAuthor ">Rachel  Parsons</span>, <span class="hlFld-ContribAuthor ">Stephen D.  Roughley</span>, <span class="hlFld-ContribAuthor ">Terry  Shaw</span>, <span class="hlFld-ContribAuthor ">Heather  Simmonite</span>, <span class="hlFld-ContribAuthor ">Stephen  Stokes</span>, <span class="hlFld-ContribAuthor ">Allan  Surgenor</span>, <span class="hlFld-ContribAuthor ">Emma  Stefaniak</span>, <span class="hlFld-ContribAuthor ">Alan  Robertson</span>, <span class="hlFld-ContribAuthor ">Yikang  Wang</span>, <span class="hlFld-ContribAuthor ">Paul  Webb</span>, <span class="hlFld-ContribAuthor ">Neil  Whitehead</span>, and <span class="hlFld-ContribAuthor ">Mike  Wood</span>  . </span><span class="cited-content_cbyCitation_article-title">Application of Off-Rate Screening in the Identification of Novel Pan-Isoform Inhibitors of Pyruvate Dehydrogenase Kinase. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (6)
                                     , 2271-2286. <a href="https://doi.org/10.1021/acs.jmedchem.6b01478" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b01478</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b01478&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b01478%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DApplication%252Bof%252BOff-Rate%252BScreening%252Bin%252Bthe%252BIdentification%252Bof%252BNovel%252BPan-Isoform%252BInhibitors%252Bof%252BPyruvate%252BDehydrogenase%252BKinase%26aulast%3DBrough%26aufirst%3DPaul%2BA.%26date%3D2017%26date%3D2017%26date%3D2016%26date%3D21102016%26date%3D15022017%26date%3D23032017%26volume%3D60%26issue%3D6%26spage%3D2271%26epage%3D2286" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ido Y.  Ben-Shalom</span>, <span class="hlFld-ContribAuthor ">Stefania  Pfeiffer-Marek</span>, <span class="hlFld-ContribAuthor ">Karl-Heinz  Baringhaus</span>, and <span class="hlFld-ContribAuthor ">Holger  Gohlke</span>  . </span><span class="cited-content_cbyCitation_article-title">Efficient Approximation of Ligand Rotational and Translational Entropy Changes upon Binding for Use in MM-PBSA Calculations. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2017,</strong> <em>57 </em>
                                    (2)
                                     , 170-189. <a href="https://doi.org/10.1021/acs.jcim.6b00373" title="DOI URL">https://doi.org/10.1021/acs.jcim.6b00373</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jcim.6b00373&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jcim.6b00373%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DEfficient%252BApproximation%252Bof%252BLigand%252BRotational%252Band%252BTranslational%252BEntropy%252BChanges%252Bupon%252BBinding%252Bfor%252BUse%252Bin%252BMM-PBSA%252BCalculations%26aulast%3DBen-Shalom%26aufirst%3DIdo%2BY.%26date%3D2017%26date%3D2017%26date%3D2016%26date%3D22062016%26date%3D20012017%26date%3D27022017%26date%3D20122016%26volume%3D57%26issue%3D2%26spage%3D170%26epage%3D189" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shipra  Malhotra</span> and <span class="hlFld-ContribAuthor ">John  Karanicolas</span>  . </span><span class="cited-content_cbyCitation_article-title">When Does Chemical Elaboration Induce a Ligand To Change Its Binding Mode?. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (1)
                                     , 128-145. <a href="https://doi.org/10.1021/acs.jmedchem.6b00725" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b00725</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b00725&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b00725%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DWhen%252BDoes%252BChemical%252BElaboration%252BInduce%252Ba%252BLigand%252BTo%252BChange%252BIts%252BBinding%252BMode%25253F%26aulast%3DMalhotra%26aufirst%3DShipra%26date%3D2017%26date%3D2016%26date%3D2016%26date%3D11052016%26date%3D16122016%26date%3D12012017%26date%3D30112016%26volume%3D60%26issue%3D1%26spage%3D128%26epage%3D145" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bernard  Pirard</span> and <span class="hlFld-ContribAuthor ">Peter  Ertl</span>  . </span><span class="cited-content_cbyCitation_article-title">Evaluation of a Semi-Automated Workflow for Fragment Growing. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2015,</strong> <em>55 </em>
                                    (1)
                                     , 180-193. <a href="https://doi.org/10.1021/ci5006355" title="DOI URL">https://doi.org/10.1021/ci5006355</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ci5006355&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fci5006355%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DEvaluation%252Bof%252Ba%252BSemi-Automated%252BWorkflow%252Bfor%252BFragment%252BGrowing%26aulast%3DPirard%26aufirst%3DBernard%26date%3D2015%26date%3D2015%26date%3D2014%26date%3D22102014%26date%3D06012015%26date%3D26012015%26date%3D16122014%26volume%3D55%26issue%3D1%26spage%3D180%26epage%3D193" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sarah  Barelier</span>, <span class="hlFld-ContribAuthor ">Jennifer A.  Cummings</span>, <span class="hlFld-ContribAuthor ">Alissa M.  Rauwerdink</span>, <span class="hlFld-ContribAuthor ">Daniel S.  Hitchcock</span>, <span class="hlFld-ContribAuthor ">Jeremiah D.  Farelli</span>, <span class="hlFld-ContribAuthor ">Steven C.  Almo</span>, <span class="hlFld-ContribAuthor ">Frank M.  Raushel</span>, <span class="hlFld-ContribAuthor ">Karen N.  Allen</span>, and <span class="hlFld-ContribAuthor ">Brian K.  Shoichet</span>  . </span><span class="cited-content_cbyCitation_article-title">Substrate Deconstruction and the Nonadditivity of Enzyme Recognition. </span><span class="cited-content_cbyCitation_journal-name">Journal of the American Chemical Society</span><span> <strong>2014,</strong> <em>136 </em>
                                    (20)
                                     , 7374-7382. <a href="https://doi.org/10.1021/ja501354q" title="DOI URL">https://doi.org/10.1021/ja501354q</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ja501354q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fja501354q%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520the%2520American%2520Chemical%2520Society%26atitle%3DSubstrate%252BDeconstruction%252Band%252Bthe%252BNonadditivity%252Bof%252BEnzyme%252BRecognition%26aulast%3DBarelier%26aufirst%3DSarah%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D08022014%26date%3D12052014%26date%3D21052014%26date%3D02052014%26volume%3D136%26issue%3D20%26spage%3D7374%26epage%3D7382" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">James B.  Murray</span>, <span class="hlFld-ContribAuthor ">Stephen D.  Roughley</span>, <span class="hlFld-ContribAuthor ">Natalia  Matassova</span>, and <span class="hlFld-ContribAuthor ">Paul A.  Brough</span>  . </span><span class="cited-content_cbyCitation_article-title">Off-Rate Screening (ORS) By Surface Plasmon Resonance. An Efficient Method to Kinetically Sample Hit to Lead Chemical Space from Unpurified Reaction Products. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (7)
                                     , 2845-2850. <a href="https://doi.org/10.1021/jm401848a" title="DOI URL">https://doi.org/10.1021/jm401848a</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm401848a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm401848a%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DOff-Rate%252BScreening%252B%252528ORS%252529%252BBy%252BSurface%252BPlasmon%252BResonance.%252BAn%252BEfficient%252BMethod%252Bto%252BKinetically%252BSample%252BHit%252Bto%252BLead%252BChemical%252BSpace%252Bfrom%252BUnpurified%252BReaction%252BProducts%26aulast%3DMurray%26aufirst%3DJames%2BB.%26date%3D2014%26date%3D2014%26date%3D2013%26date%3D29112013%26date%3D24022014%26date%3D10042014%26date%3D12022014%26volume%3D57%26issue%3D7%26spage%3D2845%26epage%3D2850" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Diane  Joseph-McCarthy</span>, <span class="hlFld-ContribAuthor ">Arthur J.  Campbell</span>, <span class="hlFld-ContribAuthor ">Gunther  Kern</span>, and <span class="hlFld-ContribAuthor ">Demetri  Moustakas</span>  . </span><span class="cited-content_cbyCitation_article-title">Fragment-Based Lead Discovery and Design. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2014,</strong> <em>54 </em>
                                    (3)
                                     , 693-704. <a href="https://doi.org/10.1021/ci400731w" title="DOI URL">https://doi.org/10.1021/ci400731w</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ci400731w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fci400731w%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DFragment-Based%252BLead%252BDiscovery%252Band%252BDesign%26aulast%3DJoseph-McCarthy%26aufirst%3DDiane%26date%3D2014%26date%3D2014%26date%3D2013%26date%3D09122013%26date%3D19022014%26date%3D24032014%26date%3D03022014%26volume%3D54%26issue%3D3%26spage%3D693%26epage%3D704" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jad  Rouhana</span>, <span class="hlFld-ContribAuthor ">Francois  Hoh</span>, <span class="hlFld-ContribAuthor ">Sébastien  Estaran</span>, <span class="hlFld-ContribAuthor ">Corinne  Henriquet</span>, <span class="hlFld-ContribAuthor ">Yvan  Boublik</span>, <span class="hlFld-ContribAuthor ">Aziz  Kerkour</span>, <span class="hlFld-ContribAuthor ">Romain  Trouillard</span>, <span class="hlFld-ContribAuthor ">Jean  Martinez</span>, <span class="hlFld-ContribAuthor ">Martine  Pugnière</span>, <span class="hlFld-ContribAuthor ">André  Padilla</span>, and <span class="hlFld-ContribAuthor ">Alain  Chavanieu</span>  . </span><span class="cited-content_cbyCitation_article-title">Fragment-Based Identification of a Locus in the Sec7 Domain of Arno for the Design of Protein–Protein Interaction Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2013,</strong> <em>56 </em>
                                    (21)
                                     , 8497-8511. <a href="https://doi.org/10.1021/jm4009357" title="DOI URL">https://doi.org/10.1021/jm4009357</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm4009357&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm4009357%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DFragment-Based%252BIdentification%252Bof%252Ba%252BLocus%252Bin%252Bthe%252BSec7%252BDomain%252Bof%252BArno%252Bfor%252Bthe%252BDesign%252Bof%252BProtein%2525E2%252580%252593Protein%252BInteraction%252BInhibitors%26aulast%3DRouhana%26aufirst%3DJad%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D24062013%26date%3D29102013%26date%3D14112013%26date%3D11102013%26volume%3D56%26issue%3D21%26spage%3D8497%26epage%3D8511" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tony  Taldone</span>, <span class="hlFld-ContribAuthor ">Pallav D.  Patel</span>, <span class="hlFld-ContribAuthor ">Maulik  Patel</span>, <span class="hlFld-ContribAuthor ">Hardik J.  Patel</span>, <span class="hlFld-ContribAuthor ">Christopher E.  Evans</span>, <span class="hlFld-ContribAuthor ">Anna  Rodina</span>, <span class="hlFld-ContribAuthor ">Stefan  Ochiana</span>, <span class="hlFld-ContribAuthor ">Smit K.  Shah</span>, <span class="hlFld-ContribAuthor ">Mohammad  Uddin</span>, <span class="hlFld-ContribAuthor ">Daniel  Gewirth</span>, and <span class="hlFld-ContribAuthor ">Gabriela  Chiosis</span>  . </span><span class="cited-content_cbyCitation_article-title">Experimental and Structural Testing Module to Analyze Paralogue-Specificity and Affinity in the Hsp90 Inhibitors Series. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2013,</strong> <em>56 </em>
                                    (17)
                                     , 6803-6818. <a href="https://doi.org/10.1021/jm400619b" title="DOI URL">https://doi.org/10.1021/jm400619b</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm400619b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm400619b%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DExperimental%252Band%252BStructural%252BTesting%252BModule%252Bto%252BAnalyze%252BParalogue-Specificity%252Band%252BAffinity%252Bin%252Bthe%252BHsp90%252BInhibitors%252BSeries%26aulast%3DTaldone%26aufirst%3DTony%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D26042013%26date%3D21082013%26date%3D12092013%26volume%3D56%26issue%3D17%26spage%3D6803%26epage%3D6818" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Elinor  Meiby</span>, <span class="hlFld-ContribAuthor ">Heather  Simmonite</span>, <span class="hlFld-ContribAuthor ">Loic  le Strat</span>, <span class="hlFld-ContribAuthor ">Ben  Davis</span>, <span class="hlFld-ContribAuthor ">Natalia  Matassova</span>, <span class="hlFld-ContribAuthor ">Jonathan D.  Moore</span>, <span class="hlFld-ContribAuthor ">Michael  Mrosek</span>, <span class="hlFld-ContribAuthor ">James  Murray</span>, <span class="hlFld-ContribAuthor ">Roderick E.  Hubbard</span>, and <span class="hlFld-ContribAuthor ">Sten  Ohlson</span>  . </span><span class="cited-content_cbyCitation_article-title">Fragment Screening by Weak Affinity Chromatography: Comparison with Established Techniques for Screening against HSP90. </span><span class="cited-content_cbyCitation_journal-name">Analytical Chemistry</span><span> <strong>2013,</strong> <em>85 </em>
                                    (14)
                                     , 6756-6766. <a href="https://doi.org/10.1021/ac400715t" title="DOI URL">https://doi.org/10.1021/ac400715t</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ac400715t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fac400715t%26sid%3Dliteratum%253Aachs%26jtitle%3DAnalytical%2520Chemistry%26atitle%3DFragment%252BScreening%252Bby%252BWeak%252BAffinity%252BChromatography%25253A%252BComparison%252Bwith%252BEstablished%252BTechniques%252Bfor%252BScreening%252Bagainst%252BHSP90%26aulast%3DMeiby%26aufirst%3DElinor%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D08032013%26date%3D10062013%26date%3D27062013%26date%3D16072013%26date%3D10062013%26volume%3D85%26issue%3D14%26spage%3D6756%26epage%3D6766" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Vladimir  Chupakhin</span>, <span class="hlFld-ContribAuthor ">Gilles  Marcou</span>, <span class="hlFld-ContribAuthor ">Igor  Baskin</span>, <span class="hlFld-ContribAuthor ">Alexandre  Varnek</span>, and <span class="hlFld-ContribAuthor ">Didier  Rognan</span>  . </span><span class="cited-content_cbyCitation_article-title">Predicting Ligand Binding Modes from Neural Networks Trained on Protein–Ligand Interaction Fingerprints. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2013,</strong> <em>53 </em>
                                    (4)
                                     , 763-772. <a href="https://doi.org/10.1021/ci300200r" title="DOI URL">https://doi.org/10.1021/ci300200r</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ci300200r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fci300200r%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DPredicting%252BLigand%252BBinding%252BModes%252Bfrom%252BNeural%252BNetworks%252BTrained%252Bon%252BProtein%2525E2%252580%252593Ligand%252BInteraction%252BFingerprints%26aulast%3DChupakhin%26aufirst%3DVladimir%26date%3D2013%26date%3D2013%26date%3D2012%26date%3D23042012%26date%3D29032013%26date%3D22042013%26date%3D12032013%26volume%3D53%26issue%3D4%26spage%3D763%26epage%3D772" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Paul J.  Barrett</span>, <span class="hlFld-ContribAuthor ">Jiang  Chen</span>, <span class="hlFld-ContribAuthor ">Min-Kyu  Cho</span>, <span class="hlFld-ContribAuthor ">Ji-Hun  Kim</span>, <span class="hlFld-ContribAuthor ">Zhenwei  Lu</span>, <span class="hlFld-ContribAuthor ">Sijo  Mathew</span>, <span class="hlFld-ContribAuthor ">Dungeng  Peng</span>, <span class="hlFld-ContribAuthor ">Yuanli  Song</span>, <span class="hlFld-ContribAuthor ">Wade D.  Van Horn</span>, <span class="hlFld-ContribAuthor ">Tiandi  Zhuang</span>, <span class="hlFld-ContribAuthor ">Frank D.  Sönnichsen</span>, and <span class="hlFld-ContribAuthor ">Charles R.  Sanders</span>  . </span><span class="cited-content_cbyCitation_article-title">The Quiet Renaissance of Protein Nuclear Magnetic Resonance. </span><span class="cited-content_cbyCitation_journal-name">Biochemistry</span><span> <strong>2013,</strong> <em>52 </em>
                                    (8)
                                     , 1303-1320. <a href="https://doi.org/10.1021/bi4000436" title="DOI URL">https://doi.org/10.1021/bi4000436</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/bi4000436&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fbi4000436%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemistry%26atitle%3DThe%252BQuiet%252BRenaissance%252Bof%252BProtein%252BNuclear%252BMagnetic%252BResonance%26aulast%3DBarrett%26aufirst%3DPaul%2BJ.%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D10012013%26date%3D30012013%26date%3D12022013%26date%3D26022013%26date%3D31012013%26volume%3D52%26issue%3D8%26spage%3D1303%26epage%3D1320" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dipen M.  Shah</span>, <span class="hlFld-ContribAuthor ">Eiso  AB</span>, <span class="hlFld-ContribAuthor ">Tammo  Diercks</span>, <span class="hlFld-ContribAuthor ">Mathias A. S.  Hass</span>, <span class="hlFld-ContribAuthor ">Nico A. J.   van Nuland</span>, and <span class="hlFld-ContribAuthor ">Gregg  Siegal</span>  . </span><span class="cited-content_cbyCitation_article-title">Rapid Protein–Ligand Costructures from Sparse NOE Data. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2012,</strong> <em>55 </em>
                                    (23)
                                     , 10786-10790. <a href="https://doi.org/10.1021/jm301396d" title="DOI URL">https://doi.org/10.1021/jm301396d</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm301396d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm301396d%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DRapid%252BProtein%2525E2%252580%252593Ligand%252BCostructures%252Bfrom%252BSparse%252BNOE%252BData%26aulast%3DShah%26aufirst%3DDipen%2BM.%26date%3D2012%26date%3D2012%26date%3D2012%26date%3D27092012%26date%3D19112012%26date%3D13122012%26date%3D12112012%26volume%3D55%26issue%3D23%26spage%3D10786%26epage%3D10790" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Duncan E.  Scott</span>, <span class="hlFld-ContribAuthor ">Anthony G.  Coyne</span>, <span class="hlFld-ContribAuthor ">Sean A.  Hudson</span>, and <span class="hlFld-ContribAuthor ">Chris  Abell</span>  . </span><span class="cited-content_cbyCitation_article-title">Fragment-Based Approaches in Drug Discovery and Chemical Biology. </span><span class="cited-content_cbyCitation_journal-name">Biochemistry</span><span> <strong>2012,</strong> <em>51 </em>
                                    (25)
                                     , 4990-5003. <a href="https://doi.org/10.1021/bi3005126" title="DOI URL">https://doi.org/10.1021/bi3005126</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/bi3005126&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fbi3005126%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemistry%26atitle%3DFragment-Based%252BApproaches%252Bin%252BDrug%252BDiscovery%252Band%252BChemical%252BBiology%26aulast%3DScott%26aufirst%3DDuncan%2BE.%26date%3D2012%26date%3D2012%26date%3D2012%26date%3D2012%26date%3D19042012%26date%3D01062012%26date%3D14062012%26date%3D26062012%26volume%3D51%26issue%3D25%26spage%3D4990%26epage%3D5003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Richard A.  Ward</span>, <span class="hlFld-ContribAuthor ">Claire  Brassington</span>, <span class="hlFld-ContribAuthor ">Alexander L.  Breeze</span>, <span class="hlFld-ContribAuthor ">Alessandro  Caputo</span>, <span class="hlFld-ContribAuthor ">Susan  Critchlow</span>, <span class="hlFld-ContribAuthor ">Gareth  Davies</span>, <span class="hlFld-ContribAuthor ">Louise  Goodwin</span>, <span class="hlFld-ContribAuthor ">Giles  Hassall</span>, <span class="hlFld-ContribAuthor ">Ryan  Greenwood</span>, <span class="hlFld-ContribAuthor ">Geoffrey A.  Holdgate</span>, <span class="hlFld-ContribAuthor ">Michael  Mrosek</span>, <span class="hlFld-ContribAuthor ">Richard A.  Norman</span>, <span class="hlFld-ContribAuthor ">Stuart  Pearson</span>, <span class="hlFld-ContribAuthor ">Jonathan  Tart</span>, <span class="hlFld-ContribAuthor ">Julie A.  Tucker</span>, <span class="hlFld-ContribAuthor ">Martin  Vogtherr</span>, <span class="hlFld-ContribAuthor ">David  Whittaker</span>, <span class="hlFld-ContribAuthor ">Jonathan  Wingfield</span>, <span class="hlFld-ContribAuthor ">Jon  Winter</span>, and <span class="hlFld-ContribAuthor ">Kevin  Hudson</span>  . </span><span class="cited-content_cbyCitation_article-title">Design and Synthesis of Novel Lactate Dehydrogenase A Inhibitors by Fragment-Based Lead Generation. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2012,</strong> <em>55 </em>
                                    (7)
                                     , 3285-3306. <a href="https://doi.org/10.1021/jm201734r" title="DOI URL">https://doi.org/10.1021/jm201734r</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm201734r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm201734r%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%252Band%252BSynthesis%252Bof%252BNovel%252BLactate%252BDehydrogenase%252BA%252BInhibitors%252Bby%252BFragment-Based%252BLead%252BGeneration%26aulast%3DWard%26aufirst%3DRichard%2BA.%26date%3D2012%26date%3D2012%26date%3D2011%26date%3D23122011%26date%3D26032012%26date%3D12042012%26date%3D14032012%26volume%3D55%26issue%3D7%26spage%3D3285%26epage%3D3306" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Riccardo  Baruchello</span>, <span class="hlFld-ContribAuthor ">Daniele  Simoni</span>, <span class="hlFld-ContribAuthor ">Giuseppina  Grisolia</span>, <span class="hlFld-ContribAuthor ">Giuseppina  Barbato</span>, <span class="hlFld-ContribAuthor ">Paolo  Marchetti</span>, <span class="hlFld-ContribAuthor ">Riccardo  Rondanin</span>, <span class="hlFld-ContribAuthor ">Stefania  Mangiola</span>, <span class="hlFld-ContribAuthor ">Giuseppe  Giannini</span>, <span class="hlFld-ContribAuthor ">Tiziana  Brunetti</span>, <span class="hlFld-ContribAuthor ">Domenico  Alloatti</span>, <span class="hlFld-ContribAuthor ">Grazia  Gallo</span>, <span class="hlFld-ContribAuthor ">Andrea  Ciacci</span>, <span class="hlFld-ContribAuthor ">Loredana  Vesci</span>, <span class="hlFld-ContribAuthor ">Massimo  Castorina</span>, <span class="hlFld-ContribAuthor ">Ferdinando M.  Milazzo</span>, <span class="hlFld-ContribAuthor ">Maria L.  Cervoni</span>, <span class="hlFld-ContribAuthor ">Mario B.  Guglielmi</span>, <span class="hlFld-ContribAuthor ">Marcella  Barbarino</span>, <span class="hlFld-ContribAuthor ">Rosanna  Foderà</span>, <span class="hlFld-ContribAuthor ">Claudio  Pisano</span>, and <span class="hlFld-ContribAuthor ">Walter  Cabri</span>  . </span><span class="cited-content_cbyCitation_article-title">Novel 3,4-Isoxazolediamides as Potent Inhibitors of Chaperone Heat Shock Protein 90. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2011,</strong> <em>54 </em>
                                    (24)
                                     , 8592-8604. <a href="https://doi.org/10.1021/jm201155e" title="DOI URL">https://doi.org/10.1021/jm201155e</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm201155e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm201155e%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNovel%252B3%25252C4-Isoxazolediamides%252Bas%252BPotent%252BInhibitors%252Bof%252BChaperone%252BHeat%252BShock%252BProtein%252B90%26aulast%3DBaruchello%26aufirst%3DRiccardo%26date%3D2011%26date%3D2011%26date%3D2011%26date%3D30082011%26date%3D23112011%26date%3D22122011%26date%3D09112011%26volume%3D54%26issue%3D24%26spage%3D8592%26epage%3D8604" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Roman A.  Laskowski</span> and <span class="hlFld-ContribAuthor ">Mark B.  Swindells</span>  . </span><span class="cited-content_cbyCitation_article-title">LigPlot+: Multiple Ligand–Protein Interaction Diagrams for Drug Discovery. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2011,</strong> <em>51 </em>
                                    (10)
                                     , 2778-2786. <a href="https://doi.org/10.1021/ci200227u" title="DOI URL">https://doi.org/10.1021/ci200227u</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ci200227u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fci200227u%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DLigPlot%25252B%25253A%252BMultiple%252BLigand%2525E2%252580%252593Protein%252BInteraction%252BDiagrams%252Bfor%252BDrug%252BDiscovery%26aulast%3DLaskowski%26aufirst%3DRoman%2BA.%26date%3D2011%26date%3D2011%26date%3D2011%26date%3D23052011%26date%3D05102011%26date%3D24102011%26date%3D15092011%26volume%3D51%26issue%3D10%26spage%3D2778%26epage%3D2786" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Stephen D.  Roughley</span> and <span class="hlFld-ContribAuthor ">Roderick E.  Hubbard</span>  . </span><span class="cited-content_cbyCitation_article-title">How Well Can Fragments Explore Accessed Chemical Space? A Case Study from Heat Shock Protein 90. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2011,</strong> <em>54 </em>
                                    (12)
                                     , 3989-4005. <a href="https://doi.org/10.1021/jm200350g" title="DOI URL">https://doi.org/10.1021/jm200350g</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm200350g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm200350g%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DHow%252BWell%252BCan%252BFragments%252BExplore%252BAccessed%252BChemical%252BSpace%25253F%252BA%252BCase%252BStudy%252Bfrom%252BHeat%252BShock%252BProtein%252B90%26aulast%3DRoughley%26aufirst%3DStephen%2BD.%26date%3D2011%26date%3D2011%26date%3D2011%26date%3D25032011%26date%3D24052011%26date%3D23062011%26date%3D11052011%26volume%3D54%26issue%3D12%26spage%3D3989%26epage%3D4005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Muhammad K.  Haider</span>, <span class="hlFld-ContribAuthor ">Hugues-Olivier  Bertrand</span>, and <span class="hlFld-ContribAuthor ">Roderick E.  Hubbard</span>  . </span><span class="cited-content_cbyCitation_article-title">Predicting Fragment Binding Poses Using a Combined MCSS MM-GBSA Approach. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2011,</strong> <em>51 </em>
                                    (5)
                                     , 1092-1105. <a href="https://doi.org/10.1021/ci100469n" title="DOI URL">https://doi.org/10.1021/ci100469n</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ci100469n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fci100469n%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DPredicting%252BFragment%252BBinding%252BPoses%252BUsing%252Ba%252BCombined%252BMCSS%252BMM-GBSA%252BApproach%26aulast%3DHaider%26aufirst%3DMuhammad%2BK.%26date%3D2011%26date%3D2011%26date%3D2010%26date%3D02122010%26date%3D29042011%26date%3D23052011%26volume%3D51%26issue%3D5%26spage%3D1092%26epage%3D1105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Luke  Zehnder</span>, <span class="hlFld-ContribAuthor ">Michael  Bennett</span>, <span class="hlFld-ContribAuthor ">Jerry  Meng</span>, <span class="hlFld-ContribAuthor ">Buwen  Huang</span>, <span class="hlFld-ContribAuthor ">Sacha  Ninkovic</span>, <span class="hlFld-ContribAuthor ">Fen  Wang</span>, <span class="hlFld-ContribAuthor ">John  Braganza</span>, <span class="hlFld-ContribAuthor ">John  Tatlock</span>, <span class="hlFld-ContribAuthor ">Tanya  Jewell</span>, <span class="hlFld-ContribAuthor ">Joe Zhongxiang  Zhou</span>, <span class="hlFld-ContribAuthor ">Ben  Burke</span>, <span class="hlFld-ContribAuthor ">Jeff  Wang</span>, <span class="hlFld-ContribAuthor ">Karen  Maegley</span>, <span class="hlFld-ContribAuthor ">Pramod P.  Mehta</span>, <span class="hlFld-ContribAuthor ">Min-Jean  Yin</span>, <span class="hlFld-ContribAuthor ">Ketan S.  Gajiwala</span>, <span class="hlFld-ContribAuthor ">Michael J.  Hickey</span>, <span class="hlFld-ContribAuthor ">Shinji  Yamazaki</span>, <span class="hlFld-ContribAuthor ">Evan  Smith</span>, <span class="hlFld-ContribAuthor ">Ping  Kang</span>, <span class="hlFld-ContribAuthor ">Anand  Sistla</span>, <span class="hlFld-ContribAuthor ">Elena  Dovalsantos</span>, <span class="hlFld-ContribAuthor ">Michael R.  Gehring</span>, <span class="hlFld-ContribAuthor ">Robert  Kania</span>, <span class="hlFld-ContribAuthor ">Martin  Wythes</span>, and <span class="hlFld-ContribAuthor ">Pei-Pei  Kung</span>  . </span><span class="cited-content_cbyCitation_article-title">Optimization of Potent, Selective, and Orally Bioavailable Pyrrolodinopyrimidine-Containing Inhibitors of Heat Shock Protein 90. Identification of Development Candidate 2-Amino-4-{4-chloro-2-[2-(4-fluoro-1H-pyrazol-1-yl)ethoxy]-6-methylphenyl}-N-(2,2-difluoropropyl)-5,7-dihydro-6H-pyrrolo[3,4-d]pyrimidine-6-carboxamide. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2011,</strong> <em>54 </em>
                                    (9)
                                     , 3368-3385. <a href="https://doi.org/10.1021/jm200128m" title="DOI URL">https://doi.org/10.1021/jm200128m</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm200128m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm200128m%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DOptimization%252Bof%252BPotent%25252C%252BSelective%25252C%252Band%252BOrally%252BBioavailable%252BPyrrolodinopyrimidine-Containing%252BInhibitors%252Bof%252BHeat%252BShock%252BProtein%252B90.%252BIdentification%252Bof%252BDevelopment%252BCandidate%252B2-Amino-4-%25257B4-chloro-2-%25255B2-%2525284-fluoro-1H-pyrazol-1-yl%252529ethoxy%25255D-6-methylphenyl%25257D-N-%2525282%25252C2-difluoropropyl%252529-5%25252C7-dihydro-6H-pyrrolo%25255B3%25252C4-d%25255Dpyrimidine-6-carboxamide%26aulast%3DZehnder%26aufirst%3DLuke%26date%3D2011%26date%3D2011%26date%3D2011%26date%3D05022011%26date%3D20042011%26date%3D12052011%26date%3D25032011%26volume%3D54%26issue%3D9%26spage%3D3368%26epage%3D3385" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andrew J.  Massey</span>. </span><span class="cited-content_cbyCitation_article-title">ATPases as Drug Targets: Insights from Heat Shock Proteins 70 and 90. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2010,</strong> <em>53 </em>
                                    (20)
                                     , 7280-7286. <a href="https://doi.org/10.1021/jm100342z" title="DOI URL">https://doi.org/10.1021/jm100342z</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm100342z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm100342z%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DATPases%252Bas%252BDrug%252BTargets%25253A%252BInsights%252Bfrom%252BHeat%252BShock%252BProteins%252B70%252Band%252B90%26aulast%3DMassey%26aufirst%3DAndrew%2BJ.%26date%3D2010%26date%3D2010%26date%3D2010%26date%3D16032010%26date%3D07072010%26date%3D28102010%26volume%3D53%26issue%3D20%26spage%3D7280%26epage%3D7286" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christopher W.  Murray</span>, <span class="hlFld-ContribAuthor ">Maria G.  Carr</span>, <span class="hlFld-ContribAuthor ">Owen  Callaghan</span>, <span class="hlFld-ContribAuthor ">Gianni  Chessari</span>, <span class="hlFld-ContribAuthor ">Miles  Congreve</span>, <span class="hlFld-ContribAuthor ">Suzanna  Cowan</span>, <span class="hlFld-ContribAuthor ">Joseph E.  Coyle</span>, <span class="hlFld-ContribAuthor ">Robert  Downham</span>, <span class="hlFld-ContribAuthor ">Eva  Figueroa</span>, <span class="hlFld-ContribAuthor ">Martyn  Frederickson</span>, <span class="hlFld-ContribAuthor ">Brent  Graham</span>, <span class="hlFld-ContribAuthor ">Rachel  McMenamin</span>, <span class="hlFld-ContribAuthor ">M. Alistair  O’Brien</span>, <span class="hlFld-ContribAuthor ">Sahil  Patel</span>, <span class="hlFld-ContribAuthor ">Theresa R.  Phillips</span>, <span class="hlFld-ContribAuthor ">Glyn  Williams</span>, <span class="hlFld-ContribAuthor ">Andrew J.  Woodhead</span> and <span class="hlFld-ContribAuthor ">Alison J.-A.  Woolford</span>. </span><span class="cited-content_cbyCitation_article-title">Fragment-Based Drug Discovery Applied to Hsp90. Discovery of Two Lead Series with High Ligand Efficiency. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2010,</strong> <em>53 </em>
                                    (16)
                                     , 5942-5955. <a href="https://doi.org/10.1021/jm100059d" title="DOI URL">https://doi.org/10.1021/jm100059d</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm100059d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm100059d%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DFragment-Based%252BDrug%252BDiscovery%252BApplied%252Bto%252BHsp90.%252BDiscovery%252Bof%252BTwo%252BLead%252BSeries%252Bwith%252BHigh%252BLigand%252BEfficiency%26aulast%3DMurray%26aufirst%3DChristopher%2BW.%26date%3D2010%26date%3D2010%26date%3D2010%26date%3D15012010%26date%3D27072010%26date%3D26082010%26volume%3D53%26issue%3D16%26spage%3D5942%26epage%3D5955" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andrew J.  Woodhead</span>, <span class="hlFld-ContribAuthor ">Hayley  Angove</span>, <span class="hlFld-ContribAuthor ">Maria G.  Carr</span>, <span class="hlFld-ContribAuthor ">Gianni  Chessari</span>, <span class="hlFld-ContribAuthor ">Miles  Congreve</span>, <span class="hlFld-ContribAuthor ">Joseph E.  Coyle</span>, <span class="hlFld-ContribAuthor ">Jose  Cosme</span>, <span class="hlFld-ContribAuthor ">Brent  Graham</span>, <span class="hlFld-ContribAuthor ">Philip J.  Day</span>, <span class="hlFld-ContribAuthor ">Robert  Downham</span>, <span class="hlFld-ContribAuthor ">Lynsey  Fazal</span>, <span class="hlFld-ContribAuthor ">Ruth  Feltell</span>, <span class="hlFld-ContribAuthor ">Eva  Figueroa</span>, <span class="hlFld-ContribAuthor ">Martyn  Frederickson</span>, <span class="hlFld-ContribAuthor ">Jonathan  Lewis</span>, <span class="hlFld-ContribAuthor ">Rachel  McMenamin</span>, <span class="hlFld-ContribAuthor ">Christopher W.  Murray</span>, <span class="hlFld-ContribAuthor ">M. Alistair  O’Brien</span>, <span class="hlFld-ContribAuthor ">Lina  Parra</span>, <span class="hlFld-ContribAuthor ">Sahil  Patel</span>, <span class="hlFld-ContribAuthor ">Theresa  Phillips</span>, <span class="hlFld-ContribAuthor ">David C.  Rees</span>, <span class="hlFld-ContribAuthor ">Sharna  Rich</span>, <span class="hlFld-ContribAuthor ">Donna-Michelle  Smith</span>, <span class="hlFld-ContribAuthor ">Gary  Trewartha</span>, <span class="hlFld-ContribAuthor ">Mladen  Vinkovic</span>, <span class="hlFld-ContribAuthor ">Brian  Williams</span> and <span class="hlFld-ContribAuthor ">Alison J.-A.  Woolford</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of (2,4-Dihydroxy-5-isopropylphenyl)-[5-(4-methylpiperazin-1-ylmethyl)-1,3-dihydroisoindol-2-yl]methanone (AT13387), a Novel Inhibitor of the Molecular Chaperone Hsp90 by Fragment Based Drug Design. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2010,</strong> <em>53 </em>
                                    (16)
                                     , 5956-5969. <a href="https://doi.org/10.1021/jm100060b" title="DOI URL">https://doi.org/10.1021/jm100060b</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm100060b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm100060b%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252B%2525282%25252C4-Dihydroxy-5-isopropylphenyl%252529-%25255B5-%2525284-methylpiperazin-1-ylmethyl%252529-1%25252C3-dihydroisoindol-2-yl%25255Dmethanone%252B%252528AT13387%252529%25252C%252Ba%252BNovel%252BInhibitor%252Bof%252Bthe%252BMolecular%252BChaperone%252BHsp90%252Bby%252BFragment%252BBased%252BDrug%252BDesign%26aulast%3DWoodhead%26aufirst%3DAndrew%2BJ.%26date%3D2010%26date%3D2010%26date%3D2010%26date%3D15012010%26date%3D28072010%26date%3D26082010%26volume%3D53%26issue%3D16%26spage%3D5956%26epage%3D5969" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Saba  Rezvani</span>, <span class="hlFld-ContribAuthor ">Ahmad  Ebadi</span>, <span class="hlFld-ContribAuthor ">Nima  Razzaghi-Asl</span>. </span><span class="cited-content_cbyCitation_article-title">In silico identification of potential Hsp90 inhibitors via ensemble docking, DFT and molecular dynamics simulations. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biomolecular Structure and Dynamics</span><span> <strong>2021,</strong> <em>26 </em>, 1-12. <a href="https://doi.org/10.1080/07391102.2021.1947383" title="DOI URL">https://doi.org/10.1080/07391102.2021.1947383</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/07391102.2021.1947383&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F07391102.2021.1947383%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biomolecular%2520Structure%2520and%2520Dynamics%26atitle%3DIn%252Bsilico%252Bidentification%252Bof%252Bpotential%252BHsp90%252Binhibitors%252Bvia%252Bensemble%252Bdocking%25252C%252BDFT%252Band%252Bmolecular%252Bdynamics%252Bsimulations%26aulast%3DRezvani%26aufirst%3DSaba%26date%3D2021%26date%3D2021%26volume%3D26%26spage%3D1%26epage%3D12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Roderick E.  Hubbard</span>. </span><span class="cited-content_cbyCitation_article-title">Fragment‐Based Lead Discovery. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 1-35. <a href="https://doi.org/10.1002/0471266949.bmc265" title="DOI URL">https://doi.org/10.1002/0471266949.bmc265</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/0471266949.bmc265&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F0471266949.bmc265%26sid%3Dliteratum%253Aachs%26atitle%3DFragment%2525E2%252580%252590Based%252BLead%252BDiscovery%26aulast%3DHubbard%26aufirst%3DRoderick%2BE.%26date%3D2021%26date%3D2021%26spage%3D1%26epage%3D35%26pub%3DWiley%26atitle%3DBurger%252527s%252BMedicinal%252BChemistry%252Band%252BDrug%252BDiscovery%26aulast%3DAbraham%26aufirst%3DDonald%2BJ.%26date%3D2003%26date%3D2003%26volume%3D214" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rony  Mshaik</span>, <span class="hlFld-ContribAuthor ">John  Simonet</span>, <span class="hlFld-ContribAuthor ">Aleksandra  Georgievski</span>, <span class="hlFld-ContribAuthor ">Layla  Jamal</span>, <span class="hlFld-ContribAuthor ">Shaliha  Bechoua</span>, <span class="hlFld-ContribAuthor ">Paola  Ballerini</span>, <span class="hlFld-ContribAuthor ">Pierre-Simon  Bellaye</span>, <span class="hlFld-ContribAuthor ">Zandile  Mlamla</span>, <span class="hlFld-ContribAuthor ">Jean-Paul  Pais de Barros</span>, <span class="hlFld-ContribAuthor ">Audrey  Geissler</span>, <span class="hlFld-ContribAuthor ">Pierre-Jean  Francin</span>, <span class="hlFld-ContribAuthor ">François  Girodon</span>, <span class="hlFld-ContribAuthor ">Carmen  Garrido</span>, <span class="hlFld-ContribAuthor ">Ronan  Quéré</span>. </span><span class="cited-content_cbyCitation_article-title">HSP90 inhibitor NVP-BEP800 affects stability of SRC kinases and growth of T-cell and B-cell acute lymphoblastic leukemias. </span><span class="cited-content_cbyCitation_journal-name">Blood Cancer Journal</span><span> <strong>2021,</strong> <em>11 </em>
                                    (3)
                                     <a href="https://doi.org/10.1038/s41408-021-00450-2" title="DOI URL">https://doi.org/10.1038/s41408-021-00450-2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41408-021-00450-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41408-021-00450-2%26sid%3Dliteratum%253Aachs%26jtitle%3DBlood%2520Cancer%2520Journal%26atitle%3DHSP90%252Binhibitor%252BNVP-BEP800%252Baffects%252Bstability%252Bof%252BSRC%252Bkinases%252Band%252Bgrowth%252Bof%252BT-cell%252Band%252BB-cell%252Bacute%252Blymphoblastic%252Bleukemias%26aulast%3DMshaik%26aufirst%3DRony%26date%3D2021%26date%3D2021%26volume%3D11%26issue%3D3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ben J.  Davis</span>. </span><span class="cited-content_cbyCitation_article-title">Fragment Screening by NMR. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 247-270. <a href="https://doi.org/10.1007/978-1-0716-1197-5_11" title="DOI URL">https://doi.org/10.1007/978-1-0716-1197-5_11</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-1-0716-1197-5_11&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-1-0716-1197-5_11%26sid%3Dliteratum%253Aachs%26atitle%3DFragment%252BScreening%252Bby%252BNMR%26aulast%3DDavis%26aufirst%3DBen%2BJ.%26date%3D2021%26date%3D2021%26spage%3D247%26epage%3D270%26pub%3DSpringer%2520US%26atitle%3DProtein-Ligand%252BInteractions%26aulast%3DDaviter%26aufirst%3DTina%26date%3D2021%26volume%3D2263" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lisa M.  Baker</span>, <span class="hlFld-ContribAuthor ">Anthony  Aimon</span>, <span class="hlFld-ContribAuthor ">James B.  Murray</span>, <span class="hlFld-ContribAuthor ">Allan E.  Surgenor</span>, <span class="hlFld-ContribAuthor ">Natalia  Matassova</span>, <span class="hlFld-ContribAuthor ">Stephen D.  Roughley</span>, <span class="hlFld-ContribAuthor ">Patrick M.  Collins</span>, <span class="hlFld-ContribAuthor ">Tobias  Krojer</span>, <span class="hlFld-ContribAuthor ">Frank  von Delft</span>, <span class="hlFld-ContribAuthor ">Roderick E.  Hubbard</span>. </span><span class="cited-content_cbyCitation_article-title">Rapid optimisation of fragments and hits to lead compounds from screening of crude reaction mixtures. </span><span class="cited-content_cbyCitation_journal-name">Communications Chemistry</span><span> <strong>2020,</strong> <em>3 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s42004-020-00367-0" title="DOI URL">https://doi.org/10.1038/s42004-020-00367-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s42004-020-00367-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs42004-020-00367-0%26sid%3Dliteratum%253Aachs%26jtitle%3DCommunications%2520Chemistry%26atitle%3DRapid%252Boptimisation%252Bof%252Bfragments%252Band%252Bhits%252Bto%252Blead%252Bcompounds%252Bfrom%252Bscreening%252Bof%252Bcrude%252Breaction%252Bmixtures%26aulast%3DBaker%26aufirst%3DLisa%2BM.%26date%3D2020%26date%3D2020%26volume%3D3%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Stephen D.  Roughley</span>. </span><span class="cited-content_cbyCitation_article-title">Five Years of the KNIME Vernalis Cheminformatics Community Contribution. </span><span class="cited-content_cbyCitation_journal-name">Current Medicinal Chemistry</span><span> <strong>2020,</strong> <em>27 </em>
                                    (38)
                                     , 6495-6522. <a href="https://doi.org/10.2174/0929867325666180904113616" title="DOI URL">https://doi.org/10.2174/0929867325666180904113616</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/0929867325666180904113616&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F0929867325666180904113616%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Medicinal%2520Chemistry%26atitle%3DFive%252BYears%252Bof%252Bthe%252BKNIME%252BVernalis%252BCheminformatics%252BCommunity%252BContribution%26aulast%3DRoughley%26aufirst%3DStephen%2BD.%26date%3D2020%26volume%3D27%26issue%3D38%26spage%3D6495%26epage%3D6522" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Matja  Zalar</span>, <span class="hlFld-ContribAuthor ">Hristo L.  Svilenov</span>, <span class="hlFld-ContribAuthor ">Alexander P.  Golovanov</span>. </span><span class="cited-content_cbyCitation_article-title">Binding of excipients is a poor predictor for aggregation kinetics of biopharmaceutical proteins. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Pharmaceutics and Biopharmaceutics</span><span> <strong>2020,</strong> <em>151 </em>, 127-136. <a href="https://doi.org/10.1016/j.ejpb.2020.04.002" title="DOI URL">https://doi.org/10.1016/j.ejpb.2020.04.002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejpb.2020.04.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejpb.2020.04.002%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Pharmaceutics%2520and%2520Biopharmaceutics%26atitle%3DBinding%252Bof%252Bexcipients%252Bis%252Ba%252Bpoor%252Bpredictor%252Bfor%252Baggregation%252Bkinetics%252Bof%252Bbiopharmaceutical%252Bproteins%26aulast%3DZalar%26aufirst%3DMatja%26date%3D2020%26volume%3D151%26spage%3D127%26epage%3D136" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ben J.  Davis</span>, <span class="hlFld-ContribAuthor ">Roderick E.  Hubbard</span>. </span><span class="cited-content_cbyCitation_article-title">Fragment‐Based Ligand Discovery. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,, 79-98. <a href="https://doi.org/10.1002/9781118681121.ch4" title="DOI URL">https://doi.org/10.1002/9781118681121.ch4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9781118681121.ch4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9781118681121.ch4%26sid%3Dliteratum%253Aachs%26atitle%3DFragment%2525E2%252580%252590Based%252BLigand%252BDiscovery%26aulast%3DDavis%26aufirst%3DBen%2BJ.%26date%3D2020%26date%3D2020%26spage%3D79%26epage%3D98%26pub%3DWiley%26atitle%3DStructural%252BBiology%252Bin%252BDrug%252BDiscovery%26aulast%3DRenaud%26aufirst%3DJean%25E2%2580%2590Paul%26date%3D2020%26date%3D2020%26volume%3D10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Daniela  Tomaselli</span>, <span class="hlFld-ContribAuthor ">Alessia  Lucidi</span>, <span class="hlFld-ContribAuthor ">Dante  Rotili</span>, <span class="hlFld-ContribAuthor ">Antonello  Mai</span>. </span><span class="cited-content_cbyCitation_article-title">Epigenetic polypharmacology: A new frontier for epi‐drug discovery. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Research Reviews</span><span> <strong>2020,</strong> <em>40 </em>
                                    (1)
                                     , 190-244. <a href="https://doi.org/10.1002/med.21600" title="DOI URL">https://doi.org/10.1002/med.21600</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/med.21600&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fmed.21600%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Research%2520Reviews%26atitle%3DEpigenetic%252Bpolypharmacology%25253A%252BA%252Bnew%252Bfrontier%252Bfor%252Bepi%2525E2%252580%252590drug%252Bdiscovery%26aulast%3DTomaselli%26aufirst%3DDaniela%26date%3D2020%26date%3D2019%26volume%3D40%26issue%3D1%26spage%3D190%26epage%3D244" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christopher A.  Waudby</span>, <span class="hlFld-ContribAuthor ">Margaux  Ouvry</span>, <span class="hlFld-ContribAuthor ">Ben  Davis</span>, <span class="hlFld-ContribAuthor ">John  Christodoulou</span>. </span><span class="cited-content_cbyCitation_article-title">Two-dimensional NMR lineshape analysis of single, multiple, zero and double quantum correlation experiments. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biomolecular NMR</span><span> <strong>2020,</strong> <em>74 </em>
                                    (1)
                                     , 95-109. <a href="https://doi.org/10.1007/s10858-019-00297-7" title="DOI URL">https://doi.org/10.1007/s10858-019-00297-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10858-019-00297-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10858-019-00297-7%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biomolecular%2520NMR%26atitle%3DTwo-dimensional%252BNMR%252Blineshape%252Banalysis%252Bof%252Bsingle%25252C%252Bmultiple%25252C%252Bzero%252Band%252Bdouble%252Bquantum%252Bcorrelation%252Bexperiments%26aulast%3DWaudby%26aufirst%3DChristopher%2BA.%26date%3D2020%26date%3D2020%26volume%3D74%26issue%3D1%26spage%3D95%26epage%3D109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fangfang  Yan</span>, <span class="hlFld-ContribAuthor ">Xinguo  Liu</span>, <span class="hlFld-ContribAuthor ">Shaolong  Zhang</span>, <span class="hlFld-ContribAuthor ">Qinggang  Zhang</span>, <span class="hlFld-ContribAuthor ">Jianzhong  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Understanding conformational diversity of heat shock protein 90 (HSP90) and binding features of inhibitors to HSP90 via molecular dynamics simulations. </span><span class="cited-content_cbyCitation_journal-name">Chemical Biology & Drug Design</span><span> <strong>2020,</strong> <em>95 </em>
                                    (1)
                                     , 87-103. <a href="https://doi.org/10.1111/cbdd.13623" title="DOI URL">https://doi.org/10.1111/cbdd.13623</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/cbdd.13623&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fcbdd.13623%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Biology%2520%2526%2520Drug%2520Design%26atitle%3DUnderstanding%252Bconformational%252Bdiversity%252Bof%252Bheat%252Bshock%252Bprotein%252B90%252B%252528HSP90%252529%252Band%252Bbinding%252Bfeatures%252Bof%252Binhibitors%252Bto%252BHSP90%252Bvia%252Bmolecular%252Bdynamics%252Bsimulations%26aulast%3DYan%26aufirst%3DFangfang%26date%3D2020%26date%3D2019%26volume%3D95%26issue%3D1%26spage%3D87%26epage%3D103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rajeev  Kumar</span>, <span class="hlFld-ContribAuthor ">Neeraj  Kumar</span>, <span class="hlFld-ContribAuthor ">Ram Kumar  Roy</span>, <span class="hlFld-ContribAuthor ">Anita  Singh</span>. </span><span class="cited-content_cbyCitation_article-title">1,3,5-Triazine Analogs: A Potent Anticancer Scaffold. </span><span class="cited-content_cbyCitation_journal-name">Current Signal Transduction Therapy</span><span> <strong>2019,</strong> <em>14 </em>
                                    (2)
                                     , 87-106. <a href="https://doi.org/10.2174/1574362413666180221113805" title="DOI URL">https://doi.org/10.2174/1574362413666180221113805</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1574362413666180221113805&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1574362413666180221113805%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Signal%2520Transduction%2520Therapy%26atitle%3D1%25252C3%25252C5-Triazine%252BAnalogs%25253A%252BA%252BPotent%252BAnticancer%252BScaffold%26aulast%3DKumar%26aufirst%3DRajeev%26date%3D2019%26volume%3D14%26issue%3D2%26spage%3D87%26epage%3D106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dario  Valenti</span>, <span class="hlFld-ContribAuthor ">Stanimira  Hristeva</span>, <span class="hlFld-ContribAuthor ">Dimitrios  Tzalis</span>, <span class="hlFld-ContribAuthor ">Christian  Ottmann</span>. </span><span class="cited-content_cbyCitation_article-title">Clinical candidates modulating protein-protein interactions: The fragment-based experience. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>167 </em>, 76-95. <a href="https://doi.org/10.1016/j.ejmech.2019.01.084" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.01.084</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.01.084&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.01.084%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DClinical%252Bcandidates%252Bmodulating%252Bprotein-protein%252Binteractions%25253A%252BThe%252Bfragment-based%252Bexperience%26aulast%3DValenti%26aufirst%3DDario%26date%3D2019%26volume%3D167%26spage%3D76%26epage%3D95" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tai  Wang</span>, <span class="hlFld-ContribAuthor ">Anna  Rodina</span>, <span class="hlFld-ContribAuthor ">Mark P.  Dunphy</span>, <span class="hlFld-ContribAuthor ">Adriana  Corben</span>, <span class="hlFld-ContribAuthor ">Shanu  Modi</span>, <span class="hlFld-ContribAuthor ">Monica L.  Guzman</span>, <span class="hlFld-ContribAuthor ">Daniel T.  Gewirth</span>, <span class="hlFld-ContribAuthor ">Gabriela  Chiosis</span>. </span><span class="cited-content_cbyCitation_article-title">Chaperome heterogeneity and its implications for cancer study and treatment. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biological Chemistry</span><span> <strong>2019,</strong> <em>294 </em>
                                    (6)
                                     , 2162-2179. <a href="https://doi.org/10.1074/jbc.REV118.002811" title="DOI URL">https://doi.org/10.1074/jbc.REV118.002811</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1074/jbc.REV118.002811&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1074%2Fjbc.REV118.002811%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biological%2520Chemistry%26atitle%3DChaperome%252Bheterogeneity%252Band%252Bits%252Bimplications%252Bfor%252Bcancer%252Bstudy%252Band%252Btreatment%26aulast%3DWang%26aufirst%3DTai%26date%3D2019%26volume%3D294%26issue%3D6%26spage%3D2162%26epage%3D2179" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Robert  Kuhnert</span>, <span class="hlFld-ContribAuthor ">Menyhárt-Botond  Sárosi</span>, <span class="hlFld-ContribAuthor ">Sven  George</span>, <span class="hlFld-ContribAuthor ">Peter  Lönnecke</span>, <span class="hlFld-ContribAuthor ">Bettina  Hofmann</span>, <span class="hlFld-ContribAuthor ">Dieter  Steinhilber</span>, <span class="hlFld-ContribAuthor ">Sara  Steinmann</span>, <span class="hlFld-ContribAuthor ">Regine  Schneider-Stock</span>, <span class="hlFld-ContribAuthor ">Blagoje  Murganić</span>, <span class="hlFld-ContribAuthor ">Sanja  Mijatović</span>, <span class="hlFld-ContribAuthor ">Danijela  Maksimović-Ivanić</span>, <span class="hlFld-ContribAuthor ">Evamarie  Hey-Hawkins</span>. </span><span class="cited-content_cbyCitation_article-title">Carborane-Based Analogues of 5-Lipoxygenase Inhibitors Co-inhibit Heat Shock Protein 90 in HCT116 Cells. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2019,</strong> <em>14 </em>
                                    (2)
                                     , 255-261. <a href="https://doi.org/10.1002/cmdc.201800651" title="DOI URL">https://doi.org/10.1002/cmdc.201800651</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201800651&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201800651%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DCarborane-Based%252BAnalogues%252Bof%252B5-Lipoxygenase%252BInhibitors%252BCo-inhibit%252BHeat%252BShock%252BProtein%252B90%252Bin%252BHCT116%252BCells%26aulast%3DKuhnert%26aufirst%3DRobert%26date%3D2019%26date%3D2018%26volume%3D14%26issue%3D2%26spage%3D255%26epage%3D261" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yue  Hu</span>, <span class="hlFld-ContribAuthor ">Xiao J.  Zhang</span>, <span class="hlFld-ContribAuthor ">Xiao T.  Yang</span>, <span class="hlFld-ContribAuthor ">Ying Y.  Tang</span>, <span class="hlFld-ContribAuthor ">Lin Y.  Hu</span>, <span class="hlFld-ContribAuthor ">Dong  Zhu</span>. </span><span class="cited-content_cbyCitation_article-title">Screening Technique for Heat Shock Protein 90 Inhibitors from Natural Products. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2019,</strong>,, 411-439. <a href="https://doi.org/10.1007/978-3-030-23158-3_19" title="DOI URL">https://doi.org/10.1007/978-3-030-23158-3_19</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-3-030-23158-3_19&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-3-030-23158-3_19%26sid%3Dliteratum%253Aachs%26atitle%3DScreening%252BTechnique%252Bfor%252BHeat%252BShock%252BProtein%252B90%252BInhibitors%252Bfrom%252BNatural%252BProducts%26aulast%3DHu%26aufirst%3DYue%26date%3D2019%26date%3D2019%26spage%3D411%26epage%3D439%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DHeat%252BShock%252BProtein%252B90%252Bin%252BHuman%252BDiseases%252Band%252BDisorders%26aulast%3DAsea%26aufirst%3DAlexzander%2BA.%2BA.%26date%3D2019%26volume%3D19" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Abdelreheem Abdelfatah  Saddik</span>, <span class="hlFld-ContribAuthor ">Adel Mohamed  Kamal El-Dean</span>, <span class="hlFld-ContribAuthor ">Waleed Ahmed  El-Said</span>, <span class="hlFld-ContribAuthor ">Khairy Mohamed  Hassan</span>, <span class="hlFld-ContribAuthor ">Mohamed Saad  Abbady</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, Antimicrobial, and Anticancer Activities of a New Series of Thieno[2,3-
              d
              ] Pyrimidine Derivatives. </span><span class="cited-content_cbyCitation_journal-name">Journal of Heterocyclic Chemistry</span><span> <strong>2018,</strong> <em>55 </em>
                                    (9)
                                     , 2111-2122. <a href="https://doi.org/10.1002/jhet.3256" title="DOI URL">https://doi.org/10.1002/jhet.3256</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/jhet.3256&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fjhet.3256%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Heterocyclic%2520Chemistry%26atitle%3DSynthesis%25252C%252BAntimicrobial%25252C%252Band%252BAnticancer%252BActivities%252Bof%252Ba%252BNew%252BSeries%252Bof%252BThieno%25255B2%25252C3-%252Bd%252B%25255D%252BPyrimidine%252BDerivatives%26aulast%3DSaddik%26aufirst%3DAbdelreheem%2BAbdelfatah%26date%3D2018%26date%3D2018%26volume%3D55%26issue%3D9%26spage%3D2111%26epage%3D2122" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Luca  Pinzi</span>, <span class="hlFld-ContribAuthor ">Andrew  Anighoro</span>, <span class="hlFld-ContribAuthor ">Jürgen  Bajorath</span>, <span class="hlFld-ContribAuthor ">Giulio  Rastelli</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of 4-aryl-1
              H
              -pyrrole[2,3-b]pyridine derivatives for the development of new B-Raf inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Chemical Biology & Drug Design</span><span> <strong>2018,</strong> <em>92 </em>
                                    (1)
                                     , 1382-1386. <a href="https://doi.org/10.1111/cbdd.13185" title="DOI URL">https://doi.org/10.1111/cbdd.13185</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/cbdd.13185&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fcbdd.13185%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Biology%2520%2526%2520Drug%2520Design%26atitle%3DIdentification%252Bof%252B4-aryl-1%252BH%252B-pyrrole%25255B2%25252C3-b%25255Dpyridine%252Bderivatives%252Bfor%252Bthe%252Bdevelopment%252Bof%252Bnew%252BB-Raf%252Binhibitors%26aulast%3DPinzi%26aufirst%3DLuca%26date%3D2018%26date%3D2018%26volume%3D92%26issue%3D1%26spage%3D1382%26epage%3D1386" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lianbin  Yao</span>, <span class="hlFld-ContribAuthor ">Sten  Ohlson</span>, <span class="hlFld-ContribAuthor ">Brian W.  Dymock</span>. </span><span class="cited-content_cbyCitation_article-title">Design and synthesis of triple inhibitors of janus kinase (JAK), histone deacetylase (HDAC) and Heat Shock Protein 90 (HSP90). </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2018,</strong> <em>28 </em>
                                    (8)
                                     , 1357-1362. <a href="https://doi.org/10.1016/j.bmcl.2018.03.009" title="DOI URL">https://doi.org/10.1016/j.bmcl.2018.03.009</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2018.03.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2018.03.009%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDesign%252Band%252Bsynthesis%252Bof%252Btriple%252Binhibitors%252Bof%252Bjanus%252Bkinase%252B%252528JAK%252529%25252C%252Bhistone%252Bdeacetylase%252B%252528HDAC%252529%252Band%252BHeat%252BShock%252BProtein%252B90%252B%252528HSP90%252529%26aulast%3DYao%26aufirst%3DLianbin%26date%3D2018%26volume%3D28%26issue%3D8%26spage%3D1357%26epage%3D1362" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Akira R.  Kinjo</span>. </span><span class="cited-content_cbyCitation_article-title">Cooperative “folding transition” in the sequence space facilitates function-driven evolution of protein families. </span><span class="cited-content_cbyCitation_journal-name">Journal of Theoretical Biology</span><span> <strong>2018,</strong> <em>443 </em>, 18-27. <a href="https://doi.org/10.1016/j.jtbi.2018.01.019" title="DOI URL">https://doi.org/10.1016/j.jtbi.2018.01.019</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jtbi.2018.01.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jtbi.2018.01.019%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Theoretical%2520Biology%26atitle%3DCooperative%252B%2525E2%252580%25259Cfolding%252Btransition%2525E2%252580%25259D%252Bin%252Bthe%252Bsequence%252Bspace%252Bfacilitates%252Bfunction-driven%252Bevolution%252Bof%252Bprotein%252Bfamilies%26aulast%3DKinjo%26aufirst%3DAkira%2BR.%26date%3D2018%26volume%3D443%26spage%3D18%26epage%3D27" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pierfausto  Seneci</span>. </span><span class="cited-content_cbyCitation_article-title">Step IIIb: The Drug-Like Chemical Diversity Pool: Diverse and Targeted Compound Collections. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2018,</strong>,, 115-177. <a href="https://doi.org/10.1016/B978-0-08-099420-8.00004-3" title="DOI URL">https://doi.org/10.1016/B978-0-08-099420-8.00004-3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-08-099420-8.00004-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-08-099420-8.00004-3%26sid%3Dliteratum%253Aachs%26atitle%3DStep%252BIIIb%25253A%252BThe%252BDrug-Like%252BChemical%252BDiversity%252BPool%25253A%252BDiverse%252Band%252BTargeted%252BCompound%252BCollections%26aulast%3DSeneci%26aufirst%3DPierfausto%26date%3D2018%26spage%3D115%26epage%3D177%26pub%3DElsevier%26atitle%3DChemical%252BSciences%252Bin%252BEarly%252BDrug%252BDiscovery%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Grace Q.  Gong</span>, <span class="hlFld-ContribAuthor ">Jackie D.  Kendall</span>, <span class="hlFld-ContribAuthor ">James M.J.  Dickson</span>, <span class="hlFld-ContribAuthor ">Gordon W.  Rewcastle</span>, <span class="hlFld-ContribAuthor ">Christina M.  Buchanan</span>, <span class="hlFld-ContribAuthor ">William A.  Denny</span>, <span class="hlFld-ContribAuthor ">Peter R.  Shepherd</span>, <span class="hlFld-ContribAuthor ">Jack U.  Flanagan</span>. </span><span class="cited-content_cbyCitation_article-title">Combining properties of different classes of PI3Kα inhibitors to understand the molecular features that confer selectivity. </span><span class="cited-content_cbyCitation_journal-name">Biochemical Journal</span><span> <strong>2017,</strong> <em>474 </em>
                                    (13)
                                     , 2261-2276. <a href="https://doi.org/10.1042/BCJ20161098" title="DOI URL">https://doi.org/10.1042/BCJ20161098</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1042/BCJ20161098&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1042%2FBCJ20161098%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemical%2520Journal%26atitle%3DCombining%252Bproperties%252Bof%252Bdifferent%252Bclasses%252Bof%252BPI3K%2525CE%2525B1%252Binhibitors%252Bto%252Bunderstand%252Bthe%252Bmolecular%252Bfeatures%252Bthat%252Bconfer%252Bselectivity%26aulast%3DGong%26aufirst%3DGrace%2BQ.%26date%3D2017%26date%3D2017%26volume%3D474%26issue%3D13%26spage%3D2261%26epage%3D2276" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">B.  Wilding</span>, <span class="hlFld-ContribAuthor ">N.  Klempier</span>. </span><span class="cited-content_cbyCitation_article-title">Newest Developments in the Preparation of Thieno[2,3-
              d
              ]pyrimidines. </span><span class="cited-content_cbyCitation_journal-name">Organic Preparations and Procedures International</span><span> <strong>2017,</strong> <em>49 </em>
                                    (3)
                                     , 183-215. <a href="https://doi.org/10.1080/00304948.2017.1320513" title="DOI URL">https://doi.org/10.1080/00304948.2017.1320513</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/00304948.2017.1320513&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F00304948.2017.1320513%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Preparations%2520and%2520Procedures%2520International%26atitle%3DNewest%252BDevelopments%252Bin%252Bthe%252BPreparation%252Bof%252BThieno%25255B2%25252C3-%252Bd%252B%25255Dpyrimidines%26aulast%3DWilding%26aufirst%3DB.%26date%3D2017%26date%3D2017%26volume%3D49%26issue%3D3%26spage%3D183%26epage%3D215" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sergio  Ruiz-Carmona</span>, <span class="hlFld-ContribAuthor ">Peter  Schmidtke</span>, <span class="hlFld-ContribAuthor ">F. Javier  Luque</span>, <span class="hlFld-ContribAuthor ">Lisa  Baker</span>, <span class="hlFld-ContribAuthor ">Natalia  Matassova</span>, <span class="hlFld-ContribAuthor ">Ben  Davis</span>, <span class="hlFld-ContribAuthor ">Stephen  Roughley</span>, <span class="hlFld-ContribAuthor ">James  Murray</span>, <span class="hlFld-ContribAuthor ">Rod  Hubbard</span>, <span class="hlFld-ContribAuthor ">Xavier  Barril</span>. </span><span class="cited-content_cbyCitation_article-title">Dynamic undocking and the quasi-bound state as tools for drug discovery. </span><span class="cited-content_cbyCitation_journal-name">Nature Chemistry</span><span> <strong>2017,</strong> <em>9 </em>
                                    (3)
                                     , 201-206. <a href="https://doi.org/10.1038/nchem.2660" title="DOI URL">https://doi.org/10.1038/nchem.2660</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/nchem.2660&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fnchem.2660%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Chemistry%26atitle%3DDynamic%252Bundocking%252Band%252Bthe%252Bquasi-bound%252Bstate%252Bas%252Btools%252Bfor%252Bdrug%252Bdiscovery%26aulast%3DRuiz-Carmona%26aufirst%3DSergio%26date%3D2017%26date%3D2016%26volume%3D9%26issue%3D3%26spage%3D201%26epage%3D206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ben J.  Davis</span>, <span class="hlFld-ContribAuthor ">Stephen D.  Roughley</span>. </span><span class="cited-content_cbyCitation_article-title">Fragment-Based Lead Discovery. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 371-439. <a href="https://doi.org/10.1016/bs.armc.2017.07.002" title="DOI URL">https://doi.org/10.1016/bs.armc.2017.07.002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/bs.armc.2017.07.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fbs.armc.2017.07.002%26sid%3Dliteratum%253Aachs%26atitle%3DFragment-Based%252BLead%252BDiscovery%26aulast%3DDavis%26aufirst%3DBen%2BJ.%26date%3D2017%26spage%3D371%26epage%3D439%26pub%3DElsevier%26atitle%3DPlatform%252BTechnologies%252Bin%252BDrug%252BDiscovery%252Band%252BValidation%26date%3D2017%26volume%3D50" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">A.  Anighoro</span>, <span class="hlFld-ContribAuthor ">L.  Pinzi</span>, <span class="hlFld-ContribAuthor ">G.  Marverti</span>, <span class="hlFld-ContribAuthor ">J.  Bajorath</span>, <span class="hlFld-ContribAuthor ">G.  Rastelli</span>. </span><span class="cited-content_cbyCitation_article-title">Heat shock protein 90 and serine/threonine kinase B-Raf inhibitors have overlapping chemical space. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2017,</strong> <em>7 </em>
                                    (49)
                                     , 31069-31074. <a href="https://doi.org/10.1039/C7RA05889F" title="DOI URL">https://doi.org/10.1039/C7RA05889F</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C7RA05889F&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC7RA05889F%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DHeat%252Bshock%252Bprotein%252B90%252Band%252Bserine%25252Fthreonine%252Bkinase%252BB-Raf%252Binhibitors%252Bhave%252Boverlapping%252Bchemical%252Bspace%26aulast%3DAnighoro%26aufirst%3DA.%26date%3D2017%26date%3D2017%26volume%3D7%26issue%3D49%26spage%3D31069%26epage%3D31074" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jianping  Hua</span>, <span class="hlFld-ContribAuthor ">Chao  Sima</span>, <span class="hlFld-ContribAuthor ">Milana  Cypert</span>, <span class="hlFld-ContribAuthor ">Edward R.  Dougherty</span>, <span class="hlFld-ContribAuthor ">Jeffery M.  Trent</span>, <span class="hlFld-ContribAuthor ">Michael L.  Bittner</span>. </span><span class="cited-content_cbyCitation_article-title">Dynamical Analysis of Drug Efficacy and Mechanism of Action Using GFP Reporters. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 1145-1174. <a href="https://doi.org/10.4018/978-1-5225-0983-7.ch045" title="DOI URL">https://doi.org/10.4018/978-1-5225-0983-7.ch045</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4018/978-1-5225-0983-7.ch045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4018%2F978-1-5225-0983-7.ch045%26sid%3Dliteratum%253Aachs%26atitle%3DDynamical%252BAnalysis%252Bof%252BDrug%252BEfficacy%252Band%252BMechanism%252Bof%252BAction%252BUsing%252BGFP%252BReporters%26aulast%3DHua%26aufirst%3DJianping%26date%3D2017%26spage%3D1145%26epage%3D1174%26pub%3DIGI%2520Global%26atitle%3DBiometrics%26aulast%3DManagement%2BAssociation%26aufirst%3DInformation%2BResources%26date%3D2017%26volume%3D78" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jean-Paul  Renaud</span>, <span class="hlFld-ContribAuthor ">Chun-wa  Chung</span>, <span class="hlFld-ContribAuthor ">U. Helena  Danielson</span>, <span class="hlFld-ContribAuthor ">Ursula  Egner</span>, <span class="hlFld-ContribAuthor ">Michael  Hennig</span>, <span class="hlFld-ContribAuthor ">Roderick E.  Hubbard</span>, <span class="hlFld-ContribAuthor ">Herbert  Nar</span>. </span><span class="cited-content_cbyCitation_article-title">Biophysics in drug discovery: impact, challenges and opportunities. </span><span class="cited-content_cbyCitation_journal-name">Nature Reviews Drug Discovery</span><span> <strong>2016,</strong> <em>15 </em>
                                    (10)
                                     , 679-698. <a href="https://doi.org/10.1038/nrd.2016.123" title="DOI URL">https://doi.org/10.1038/nrd.2016.123</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/nrd.2016.123&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fnrd.2016.123%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Reviews%2520Drug%2520Discovery%26atitle%3DBiophysics%252Bin%252Bdrug%252Bdiscovery%25253A%252Bimpact%25252C%252Bchallenges%252Band%252Bopportunities%26aulast%3DRenaud%26aufirst%3DJean-Paul%26date%3D2016%26date%3D2016%26volume%3D15%26issue%3D10%26spage%3D679%26epage%3D698" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dhanaji V.  Jawale</span>, <span class="hlFld-ContribAuthor ">Umesh R.  Pratap</span>, <span class="hlFld-ContribAuthor ">Manisha R.  Bhosale</span>, <span class="hlFld-ContribAuthor ">Ramrao A.  Mane</span>. </span><span class="cited-content_cbyCitation_article-title">One-Pot Three-Component Synthesis of 2-Amino Pyrimidines in Aqueous PEG-400 at Ambient Temperature. </span><span class="cited-content_cbyCitation_journal-name">Journal of Heterocyclic Chemistry</span><span> <strong>2016,</strong> <em>53 </em>
                                    (5)
                                     , 1626-1630. <a href="https://doi.org/10.1002/jhet.673" title="DOI URL">https://doi.org/10.1002/jhet.673</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/jhet.673&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fjhet.673%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Heterocyclic%2520Chemistry%26atitle%3DOne-Pot%252BThree-Component%252BSynthesis%252Bof%252B2-Amino%252BPyrimidines%252Bin%252BAqueous%252BPEG-400%252Bat%252BAmbient%252BTemperature%26aulast%3DJawale%26aufirst%3DDhanaji%2BV.%26date%3D2016%26date%3D2016%26volume%3D53%26issue%3D5%26spage%3D1626%26epage%3D1630" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Majda  Misini Ignjatović</span>, <span class="hlFld-ContribAuthor ">Octav  Caldararu</span>, <span class="hlFld-ContribAuthor ">Geng  Dong</span>, <span class="hlFld-ContribAuthor ">Camila  Muñoz-Gutierrez</span>, <span class="hlFld-ContribAuthor ">Francisco  Adasme-Carreño</span>, <span class="hlFld-ContribAuthor ">Ulf  Ryde</span>. </span><span class="cited-content_cbyCitation_article-title">Binding-affinity predictions of HSP90 in the D3R Grand Challenge 2015 with docking, MM/GBSA, QM/MM, and free-energy simulations. </span><span class="cited-content_cbyCitation_journal-name">Journal of Computer-Aided Molecular Design</span><span> <strong>2016,</strong> <em>30 </em>
                                    (9)
                                     , 707-730. <a href="https://doi.org/10.1007/s10822-016-9942-z" title="DOI URL">https://doi.org/10.1007/s10822-016-9942-z</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10822-016-9942-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10822-016-9942-z%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Computer-Aided%2520Molecular%2520Design%26atitle%3DBinding-affinity%252Bpredictions%252Bof%252BHSP90%252Bin%252Bthe%252BD3R%252BGrand%252BChallenge%252B2015%252Bwith%252Bdocking%25252C%252BMM%25252FGBSA%25252C%252BQM%25252FMM%25252C%252Band%252Bfree-energy%252Bsimulations%26aulast%3DMisini%2BIgnjatovi%25C4%2587%26aufirst%3DMajda%26date%3D2016%26date%3D2016%26volume%3D30%26issue%3D9%26spage%3D707%26epage%3D730" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Veronica  Salmaso</span>, <span class="hlFld-ContribAuthor ">Mattia  Sturlese</span>, <span class="hlFld-ContribAuthor ">Alberto  Cuzzolin</span>, <span class="hlFld-ContribAuthor ">Stefano  Moro</span>. </span><span class="cited-content_cbyCitation_article-title">DockBench as docking selector tool: the lesson learned from D3R Grand Challenge 2015. </span><span class="cited-content_cbyCitation_journal-name">Journal of Computer-Aided Molecular Design</span><span> <strong>2016,</strong> <em>30 </em>
                                    (9)
                                     , 773-789. <a href="https://doi.org/10.1007/s10822-016-9966-4" title="DOI URL">https://doi.org/10.1007/s10822-016-9966-4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10822-016-9966-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10822-016-9966-4%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Computer-Aided%2520Molecular%2520Design%26atitle%3DDockBench%252Bas%252Bdocking%252Bselector%252Btool%25253A%252Bthe%252Blesson%252Blearned%252Bfrom%252BD3R%252BGrand%252BChallenge%252B2015%26aulast%3DSalmaso%26aufirst%3DVeronica%26date%3D2016%26date%3D2016%26volume%3D30%26issue%3D9%26spage%3D773%26epage%3D789" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Arun  Chandramohan</span>, <span class="hlFld-ContribAuthor ">Srinath  Krishnamurthy</span>, <span class="hlFld-ContribAuthor ">Andreas  Larsson</span>, <span class="hlFld-ContribAuthor ">Paer  Nordlund</span>, <span class="hlFld-ContribAuthor ">Anna  Jansson</span>, <span class="hlFld-ContribAuthor ">Ganesh S.  Anand</span>, . </span><span class="cited-content_cbyCitation_article-title">Predicting Allosteric Effects from Orthosteric Binding in Hsp90-Ligand Interactions: Implications for Fragment-Based Drug Design. </span><span class="cited-content_cbyCitation_journal-name">PLOS Computational Biology</span><span> <strong>2016,</strong> <em>12 </em>
                                    (6)
                                     , e1004840. <a href="https://doi.org/10.1371/journal.pcbi.1004840" title="DOI URL">https://doi.org/10.1371/journal.pcbi.1004840</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1371/journal.pcbi.1004840&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1371%2Fjournal.pcbi.1004840%26sid%3Dliteratum%253Aachs%26jtitle%3DPLOS%2520Computational%2520Biology%26atitle%3DPredicting%252BAllosteric%252BEffects%252Bfrom%252BOrthosteric%252BBinding%252Bin%252BHsp90-Ligand%252BInteractions%25253A%252BImplications%252Bfor%252BFragment-Based%252BDrug%252BDesign%26aulast%3DChandramohan%26aufirst%3DArun%26date%3D2016%26date%3D2016%26volume%3D12%26issue%3D6%26spage%3De1004840" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Roderick E.  Hubbard</span>. </span><span class="cited-content_cbyCitation_article-title">The Role of Fragment-based Discovery in Lead Finding. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2016,</strong>,, 1-36. <a href="https://doi.org/10.1002/9783527683604.ch01" title="DOI URL">https://doi.org/10.1002/9783527683604.ch01</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9783527683604.ch01&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9783527683604.ch01%26sid%3Dliteratum%253Aachs%26atitle%3DThe%252BRole%252Bof%252BFragment-based%252BDiscovery%252Bin%252BLead%252BFinding%26aulast%3DHubbard%26aufirst%3DRoderick%2BE.%26date%3D2016%26date%3D2016%26spage%3D1%26epage%3D36%26pub%3DWiley-VCH%2520Verlag%2520GmbH%2520%2526%2520Co.%2520KGaA%26atitle%3DFragment-based%252BDrug%252BDiscovery%252BLessons%252Band%252BOutlook%26aulast%3DErlanson%26aufirst%3DDaniel%2BA.%26date%3D2016%26volume%3D11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">A V  Jacobsen</span>, <span class="hlFld-ContribAuthor ">K N  Lowes</span>, <span class="hlFld-ContribAuthor ">M C  Tanzer</span>, <span class="hlFld-ContribAuthor ">I S  Lucet</span>, <span class="hlFld-ContribAuthor ">J M  Hildebrand</span>, <span class="hlFld-ContribAuthor ">E J  Petrie</span>, <span class="hlFld-ContribAuthor ">M F  van Delft</span>, <span class="hlFld-ContribAuthor ">Z  Liu</span>, <span class="hlFld-ContribAuthor ">S A  Conos</span>, <span class="hlFld-ContribAuthor ">J-G  Zhang</span>, <span class="hlFld-ContribAuthor ">D C S  Huang</span>, <span class="hlFld-ContribAuthor ">J  Silke</span>, <span class="hlFld-ContribAuthor ">G  Lessene</span>, <span class="hlFld-ContribAuthor ">J M  Murphy</span>. </span><span class="cited-content_cbyCitation_article-title">HSP90 activity is required for MLKL oligomerisation and membrane translocation and the induction of necroptotic cell death. </span><span class="cited-content_cbyCitation_journal-name">Cell Death & Disease</span><span> <strong>2016,</strong> <em>7 </em>
                                    (1)
                                     , e2051-e2051. <a href="https://doi.org/10.1038/cddis.2015.386" title="DOI URL">https://doi.org/10.1038/cddis.2015.386</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/cddis.2015.386&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fcddis.2015.386%26sid%3Dliteratum%253Aachs%26jtitle%3DCell%2520Death%2520%2526%2520Disease%26atitle%3DHSP90%252Bactivity%252Bis%252Brequired%252Bfor%252BMLKL%252Boligomerisation%252Band%252Bmembrane%252Btranslocation%252Band%252Bthe%252Binduction%252Bof%252Bnecroptotic%252Bcell%252Bdeath%26aulast%3DJacobsen%26aufirst%3DA%2BV%26date%3D2016%26date%3D2016%26volume%3D7%26issue%3D1%26spage%3De2051%26epage%3De2051" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Stefano  Forli</span>. </span><span class="cited-content_cbyCitation_article-title">Charting a Path to Success in Virtual Screening. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2015,</strong> <em>20 </em>
                                    (10)
                                     , 18732-18758. <a href="https://doi.org/10.3390/molecules201018732" title="DOI URL">https://doi.org/10.3390/molecules201018732</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules201018732&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules201018732%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DCharting%252Ba%252BPath%252Bto%252BSuccess%252Bin%252BVirtual%252BScreening%26aulast%3DForli%26aufirst%3DStefano%26date%3D2015%26date%3D2015%26volume%3D20%26issue%3D10%26spage%3D18732%26epage%3D18758" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Khurshed  Bozorov</span>, <span class="hlFld-ContribAuthor ">Jiang-Yu  Zhao</span>, <span class="hlFld-ContribAuthor ">Burkhon  Elmuradov</span>, <span class="hlFld-ContribAuthor ">Apar  Pataer</span>, <span class="hlFld-ContribAuthor ">Haji A.  Aisa</span>. </span><span class="cited-content_cbyCitation_article-title">Recent developments regarding the use of thieno[2,3-d]pyrimidin-4-one derivatives in medicinal chemistry, with a focus on their synthesis and anticancer properties. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>102 </em>, 552-573. <a href="https://doi.org/10.1016/j.ejmech.2015.08.018" title="DOI URL">https://doi.org/10.1016/j.ejmech.2015.08.018</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2015.08.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2015.08.018%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DRecent%252Bdevelopments%252Bregarding%252Bthe%252Buse%252Bof%252Bthieno%25255B2%25252C3-d%25255Dpyrimidin-4-one%252Bderivatives%252Bin%252Bmedicinal%252Bchemistry%25252C%252Bwith%252Ba%252Bfocus%252Bon%252Btheir%252Bsynthesis%252Band%252Banticancer%252Bproperties%26aulast%3DBozorov%26aufirst%3DKhurshed%26date%3D2015%26volume%3D102%26spage%3D552%26epage%3D573" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Maria E.  Chizhova</span>, <span class="hlFld-ContribAuthor ">Olga Yu.  Bakulina</span>, <span class="hlFld-ContribAuthor ">Alexander Yu.  Ivanov</span>, <span class="hlFld-ContribAuthor ">Pavel S.  Lobanov</span>, <span class="hlFld-ContribAuthor ">Dmitrii V.  Dar'in</span>. </span><span class="cited-content_cbyCitation_article-title">Facile synthesis of pyrido[2,3-d]pyrimidines via cyclocondensation of 4,6-dichloro-2-methylsulfanylpyrimidine-5-carbaldehyde with β-substituted β-aminoacrylic esters. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2015,</strong> <em>71 </em>
                                    (36)
                                     , 6196-6203. <a href="https://doi.org/10.1016/j.tet.2015.06.085" title="DOI URL">https://doi.org/10.1016/j.tet.2015.06.085</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2015.06.085&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2015.06.085%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DFacile%252Bsynthesis%252Bof%252Bpyrido%25255B2%25252C3-d%25255Dpyrimidines%252Bvia%252Bcyclocondensation%252Bof%252B4%25252C6-dichloro-2-methylsulfanylpyrimidine-5-carbaldehyde%252Bwith%252B%2525CE%2525B2-substituted%252B%2525CE%2525B2-aminoacrylic%252Besters%26aulast%3DChizhova%26aufirst%3DMaria%2BE.%26date%3D2015%26volume%3D71%26issue%3D36%26spage%3D6196%26epage%3D6203" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ola  Fjellström</span>, <span class="hlFld-ContribAuthor ">Sibel  Akkaya</span>, <span class="hlFld-ContribAuthor ">Hans-Georg  Beisel</span>, <span class="hlFld-ContribAuthor ">Per-Olof  Eriksson</span>, <span class="hlFld-ContribAuthor ">Karl  Erixon</span>, <span class="hlFld-ContribAuthor ">David  Gustafsson</span>, <span class="hlFld-ContribAuthor ">Ulrik  Jurva</span>, <span class="hlFld-ContribAuthor ">Daiwu  Kang</span>, <span class="hlFld-ContribAuthor ">David  Karis</span>, <span class="hlFld-ContribAuthor ">Wolfgang  Knecht</span>, <span class="hlFld-ContribAuthor ">Viveca  Nerme</span>, <span class="hlFld-ContribAuthor ">Ingemar  Nilsson</span>, <span class="hlFld-ContribAuthor ">Thomas  Olsson</span>, <span class="hlFld-ContribAuthor ">Alma  Redzic</span>, <span class="hlFld-ContribAuthor ">Robert  Roth</span>, <span class="hlFld-ContribAuthor ">Jenny  Sandmark</span>, <span class="hlFld-ContribAuthor ">Anna  Tigerström</span>, <span class="hlFld-ContribAuthor ">Linda  Öster</span>, . </span><span class="cited-content_cbyCitation_article-title">Creating Novel Activated Factor XI Inhibitors through Fragment Based Lead Generation and Structure Aided Drug Design. </span><span class="cited-content_cbyCitation_journal-name">PLOS ONE</span><span> <strong>2015,</strong> <em>10 </em>
                                    (1)
                                     , e0113705. <a href="https://doi.org/10.1371/journal.pone.0113705" title="DOI URL">https://doi.org/10.1371/journal.pone.0113705</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1371/journal.pone.0113705&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1371%2Fjournal.pone.0113705%26sid%3Dliteratum%253Aachs%26jtitle%3DPLOS%2520ONE%26atitle%3DCreating%252BNovel%252BActivated%252BFactor%252BXI%252BInhibitors%252Bthrough%252BFragment%252BBased%252BLead%252BGeneration%252Band%252BStructure%252BAided%252BDrug%252BDesign%26aulast%3DFjellstr%25C3%25B6m%26aufirst%3DOla%26date%3D2015%26date%3D2015%26volume%3D10%26issue%3D1%26spage%3De0113705" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chunquan  Sheng</span>, <span class="hlFld-ContribAuthor ">Guoqiang  Dong</span>, <span class="hlFld-ContribAuthor ">Chen  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Computational Fragment-Based Drug Design. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2015,</strong>,, 189-215. <a href="https://doi.org/10.1007/7653_2015_51" title="DOI URL">https://doi.org/10.1007/7653_2015_51</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/7653_2015_51&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F7653_2015_51%26sid%3Dliteratum%253Aachs%26atitle%3DComputational%252BFragment-Based%252BDrug%252BDesign%26aulast%3DSheng%26aufirst%3DChunquan%26date%3D2015%26date%3D2016%26spage%3D189%26epage%3D215%26pub%3DSpringer%2520New%2520York%26atitle%3DComputer-Aided%252BDrug%252BDiscovery%26aulast%3DZhang%26aufirst%3DWei%26date%3D2016%26volume%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Venkata  Velvadapu</span>, <span class="hlFld-ContribAuthor ">Bennett T.  Farmer</span>, <span class="hlFld-ContribAuthor ">Allen B.  Reitz</span>. </span><span class="cited-content_cbyCitation_article-title">Fragment-Based Drug Discovery. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2015,</strong>,, 161-180. <a href="https://doi.org/10.1016/B978-0-12-417205-0.00007-9" title="DOI URL">https://doi.org/10.1016/B978-0-12-417205-0.00007-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-417205-0.00007-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-417205-0.00007-9%26sid%3Dliteratum%253Aachs%26atitle%3DFragment-Based%252BDrug%252BDiscovery%26aulast%3DVelvadapu%26aufirst%3DVenkata%26date%3D2015%26spage%3D161%26epage%3D180%26pub%3DElsevier%26atitle%3DThe%252BPractice%252Bof%252BMedicinal%252BChemistry%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">JIANYUE  WU</span>, <span class="hlFld-ContribAuthor ">WEIMIN  WANG</span>, <span class="hlFld-ContribAuthor ">QIN  SHAO</span>, <span class="hlFld-ContribAuthor ">GUOMIN  XIAO</span>, <span class="hlFld-ContribAuthor ">JUN  CHENG</span>, <span class="hlFld-ContribAuthor ">YUNPENG  YUAN</span>, <span class="hlFld-ContribAuthor ">MEI  ZHANG</span>. </span><span class="cited-content_cbyCitation_article-title">Irradiation facilitates the inhibitory effect of the heat shock protein 90 inhibitor NVP-BEP800 on the proliferation of malignant glioblastoma cells through attenuation of the upregulation of heat shock protein 70. </span><span class="cited-content_cbyCitation_journal-name">Experimental and Therapeutic Medicine</span><span> <strong>2014,</strong> <em>8 </em>
                                    (3)
                                     , 893-898. <a href="https://doi.org/10.3892/etm.2014.1800" title="DOI URL">https://doi.org/10.3892/etm.2014.1800</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3892/etm.2014.1800&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3892%2Fetm.2014.1800%26sid%3Dliteratum%253Aachs%26jtitle%3DExperimental%2520and%2520Therapeutic%2520Medicine%26atitle%3DIrradiation%252Bfacilitates%252Bthe%252Binhibitory%252Beffect%252Bof%252Bthe%252Bheat%252Bshock%252Bprotein%252B90%252Binhibitor%252BNVP-BEP800%252Bon%252Bthe%252Bproliferation%252Bof%252Bmalignant%252Bglioblastoma%252Bcells%252Bthrough%252Battenuation%252Bof%252Bthe%252Bupregulation%252Bof%252Bheat%252Bshock%252Bprotein%252B70%26aulast%3DWU%26aufirst%3DJIANYUE%26date%3D2014%26date%3D2014%26volume%3D8%26issue%3D3%26spage%3D893%26epage%3D898" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Valentina  Abet</span>, <span class="hlFld-ContribAuthor ">Angelica  Mariani</span>, <span class="hlFld-ContribAuthor ">Fiona R.  Truscott</span>, <span class="hlFld-ContribAuthor ">Sébastien  Britton</span>, <span class="hlFld-ContribAuthor ">Raphaël  Rodriguez</span>. </span><span class="cited-content_cbyCitation_article-title">Biased and unbiased strategies to identify biologically active small molecules. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2014,</strong> <em>22 </em>
                                    (16)
                                     , 4474-4489. <a href="https://doi.org/10.1016/j.bmc.2014.04.019" title="DOI URL">https://doi.org/10.1016/j.bmc.2014.04.019</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2014.04.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2014.04.019%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DBiased%252Band%252Bunbiased%252Bstrategies%252Bto%252Bidentify%252Bbiologically%252Bactive%252Bsmall%252Bmolecules%26aulast%3DAbet%26aufirst%3DValentina%26date%3D2014%26volume%3D22%26issue%3D16%26spage%3D4474%26epage%3D4489" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Elena  Casale</span>, <span class="hlFld-ContribAuthor ">Nadia  Amboldi</span>, <span class="hlFld-ContribAuthor ">Maria Gabriella  Brasca</span>, <span class="hlFld-ContribAuthor ">Dannica  Caronni</span>, <span class="hlFld-ContribAuthor ">Nicoletta  Colombo</span>, <span class="hlFld-ContribAuthor ">Claudio  Dalvit</span>, <span class="hlFld-ContribAuthor ">Eduard R.  Felder</span>, <span class="hlFld-ContribAuthor ">Gianpaolo  Fogliatto</span>, <span class="hlFld-ContribAuthor ">Arturo  Galvani</span>, <span class="hlFld-ContribAuthor ">Antonella  Isacchi</span>, <span class="hlFld-ContribAuthor ">Paolo  Polucci</span>, <span class="hlFld-ContribAuthor ">Laura  Riceputi</span>, <span class="hlFld-ContribAuthor ">Francesco  Sola</span>, <span class="hlFld-ContribAuthor ">Carlo  Visco</span>, <span class="hlFld-ContribAuthor ">Fabio  Zuccotto</span>, <span class="hlFld-ContribAuthor ">Francesco  Casuscelli</span>. </span><span class="cited-content_cbyCitation_article-title">Fragment-based hit discovery and structure-based optimization of aminotriazoloquinazolines as novel Hsp90 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2014,</strong> <em>22 </em>
                                    (15)
                                     , 4135-4150. <a href="https://doi.org/10.1016/j.bmc.2014.05.056" title="DOI URL">https://doi.org/10.1016/j.bmc.2014.05.056</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2014.05.056&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2014.05.056%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DFragment-based%252Bhit%252Bdiscovery%252Band%252Bstructure-based%252Boptimization%252Bof%252Baminotriazoloquinazolines%252Bas%252Bnovel%252BHsp90%252Binhibitors%26aulast%3DCasale%26aufirst%3DElena%26date%3D2014%26volume%3D22%26issue%3D15%26spage%3D4135%26epage%3D4150" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mohamed  Hassan</span>, <span class="hlFld-ContribAuthor ">Hidemichi  Watari</span>, <span class="hlFld-ContribAuthor ">Ali  AbuAlmaaty</span>, <span class="hlFld-ContribAuthor ">Yusuke  Ohba</span>, <span class="hlFld-ContribAuthor ">Noriaki  Sakuragi</span>. </span><span class="cited-content_cbyCitation_article-title">Apoptosis and Molecular Targeting Therapy in Cancer. </span><span class="cited-content_cbyCitation_journal-name">BioMed Research International</span><span> <strong>2014,</strong> <em>2014 </em>, 1-23. <a href="https://doi.org/10.1155/2014/150845" title="DOI URL">https://doi.org/10.1155/2014/150845</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1155/2014/150845&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1155%2F2014%2F150845%26sid%3Dliteratum%253Aachs%26jtitle%3DBioMed%2520Research%2520International%26atitle%3DApoptosis%252Band%252BMolecular%252BTargeting%252BTherapy%252Bin%252BCancer%26aulast%3DHassan%26aufirst%3DMohamed%26date%3D2014%26volume%3D2014%26spage%3D1%26epage%3D23" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tony  Taldone</span>, <span class="hlFld-ContribAuthor ">Hardik J  Patel</span>, <span class="hlFld-ContribAuthor ">Alexander  Bolaender</span>, <span class="hlFld-ContribAuthor ">Maulik R  Patel</span>, <span class="hlFld-ContribAuthor ">Gabriela  Chiosis</span>. </span><span class="cited-content_cbyCitation_article-title">Protein chaperones: a composition of matter review (2008 – 2013). </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2014,</strong> <em>24 </em>
                                    (5)
                                     , 501-518. <a href="https://doi.org/10.1517/13543776.2014.887681" title="DOI URL">https://doi.org/10.1517/13543776.2014.887681</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/13543776.2014.887681&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F13543776.2014.887681%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DProtein%252Bchaperones%25253A%252Ba%252Bcomposition%252Bof%252Bmatter%252Breview%252B%2525282008%252B%2525E2%252580%252593%252B2013%252529%26aulast%3DTaldone%26aufirst%3DTony%26date%3D2014%26date%3D2014%26volume%3D24%26issue%3D5%26spage%3D501%26epage%3D518" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sergio  Ruiz-Carmona</span>, <span class="hlFld-ContribAuthor ">Daniel  Alvarez-Garcia</span>, <span class="hlFld-ContribAuthor ">Nicolas  Foloppe</span>, <span class="hlFld-ContribAuthor ">A. Beatriz  Garmendia-Doval</span>, <span class="hlFld-ContribAuthor ">Szilveszter  Juhos</span>, <span class="hlFld-ContribAuthor ">Peter  Schmidtke</span>, <span class="hlFld-ContribAuthor ">Xavier  Barril</span>, <span class="hlFld-ContribAuthor ">Roderick E.  Hubbard</span>, <span class="hlFld-ContribAuthor ">S. David  Morley</span>, . </span><span class="cited-content_cbyCitation_article-title">rDock: A Fast, Versatile and Open Source Program for Docking Ligands to Proteins and Nucleic Acids. </span><span class="cited-content_cbyCitation_journal-name">PLoS Computational Biology</span><span> <strong>2014,</strong> <em>10 </em>
                                    (4)
                                     , e1003571. <a href="https://doi.org/10.1371/journal.pcbi.1003571" title="DOI URL">https://doi.org/10.1371/journal.pcbi.1003571</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1371/journal.pcbi.1003571&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1371%2Fjournal.pcbi.1003571%26sid%3Dliteratum%253Aachs%26jtitle%3DPLoS%2520Computational%2520Biology%26atitle%3DrDock%25253A%252BA%252BFast%25252C%252BVersatile%252Band%252BOpen%252BSource%252BProgram%252Bfor%252BDocking%252BLigands%252Bto%252BProteins%252Band%252BNucleic%252BAcids%26aulast%3DRuiz-Carmona%26aufirst%3DSergio%26date%3D2014%26date%3D2014%26volume%3D10%26issue%3D4%26spage%3De1003571" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tim ten  Brink</span>, <span class="hlFld-ContribAuthor ">Clementine  Aguirre</span>, <span class="hlFld-ContribAuthor ">Isabelle  Krimm</span>. </span><span class="cited-content_cbyCitation_article-title">Fragment docking supported by NMR shift perturbations. </span><span class="cited-content_cbyCitation_journal-name">Journal of Cheminformatics</span><span> <strong>2014,</strong> <em>6 </em>
                                    (S1)
                                     <a href="https://doi.org/10.1186/1758-2946-6-S1-P18" title="DOI URL">https://doi.org/10.1186/1758-2946-6-S1-P18</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/1758-2946-6-S1-P18&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2F1758-2946-6-S1-P18%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Cheminformatics%26atitle%3DFragment%252Bdocking%252Bsupported%252Bby%252BNMR%252Bshift%252Bperturbations%26aulast%3DBrink%26aufirst%3DTim%2Bten%26date%3D2014%26date%3D2014%26volume%3D6%26issue%3DS1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Swee  Sharp</span>, <span class="hlFld-ContribAuthor ">Keith  Jones</span>, <span class="hlFld-ContribAuthor ">Paul  Workman</span>. </span><span class="cited-content_cbyCitation_article-title">Exploiting Cancer Dependence on Molecular Chaperones. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2014,</strong>,, 239-274. <a href="https://doi.org/10.1016/B978-0-12-396521-9.00009-7" title="DOI URL">https://doi.org/10.1016/B978-0-12-396521-9.00009-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-396521-9.00009-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-396521-9.00009-7%26sid%3Dliteratum%253Aachs%26atitle%3DExploiting%252BCancer%252BDependence%252Bon%252BMolecular%252BChaperones%26aulast%3DSharp%26aufirst%3DSwee%26date%3D2014%26spage%3D239%26epage%3D274%26pub%3DElsevier%26atitle%3DCancer%252BDrug%252BDesign%252Band%252BDiscovery%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Justin T.  Ernst</span>, <span class="hlFld-ContribAuthor ">Michael  Liu</span>, <span class="hlFld-ContribAuthor ">Harmon  Zuccola</span>, <span class="hlFld-ContribAuthor ">Timothy  Neubert</span>, <span class="hlFld-ContribAuthor ">Kevin  Beaumont</span>, <span class="hlFld-ContribAuthor ">Amy  Turnbull</span>, <span class="hlFld-ContribAuthor ">Adam  Kallel</span>, <span class="hlFld-ContribAuthor ">Bryan  Vought</span>, <span class="hlFld-ContribAuthor ">Dean  Stamos</span>. </span><span class="cited-content_cbyCitation_article-title">Correlation between chemotype-dependent binding conformations of HSP90α/β and isoform selectivity—Implications for the structure-based design of HSP90α/β selective inhibitors for treating neurodegenerative diseases. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2014,</strong> <em>24 </em>
                                    (1)
                                     , 204-208. <a href="https://doi.org/10.1016/j.bmcl.2013.11.036" title="DOI URL">https://doi.org/10.1016/j.bmcl.2013.11.036</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2013.11.036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2013.11.036%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DCorrelation%252Bbetween%252Bchemotype-dependent%252Bbinding%252Bconformations%252Bof%252BHSP90%2525CE%2525B1%25252F%2525CE%2525B2%252Band%252Bisoform%252Bselectivity%2525E2%252580%252594Implications%252Bfor%252Bthe%252Bstructure-based%252Bdesign%252Bof%252BHSP90%2525CE%2525B1%25252F%2525CE%2525B2%252Bselective%252Binhibitors%252Bfor%252Btreating%252Bneurodegenerative%252Bdiseases%26aulast%3DErnst%26aufirst%3DJustin%2BT.%26date%3D2014%26volume%3D24%26issue%3D1%26spage%3D204%26epage%3D208" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bo  Li</span>, <span class="hlFld-ContribAuthor ">Zhizhou  Yue</span>, <span class="hlFld-ContribAuthor ">Haoyue  Xiang</span>, <span class="hlFld-ContribAuthor ">Linlin  Lv</span>, <span class="hlFld-ContribAuthor ">Shanshan  Song</span>, <span class="hlFld-ContribAuthor ">Zehong  Miao</span>, <span class="hlFld-ContribAuthor ">Chunhao  Yang</span>. </span><span class="cited-content_cbyCitation_article-title">Catalyst-free synthesis of benzofuran-fused pyrido[4,3-d]pyrimidines from 2-(2-hydroxyaryl)acetonitrile and 4,6-dichloropyrimidine-5-carbaldehyde through domino condensation reactions. </span><span class="cited-content_cbyCitation_journal-name">RSC Adv.</span><span> <strong>2014,</strong> <em>4 </em>
                                    (1)
                                     , 358-364. <a href="https://doi.org/10.1039/C3RA44828B" title="DOI URL">https://doi.org/10.1039/C3RA44828B</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C3RA44828B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC3RA44828B%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Adv.%26atitle%3DCatalyst-free%252Bsynthesis%252Bof%252Bbenzofuran-fused%252Bpyrido%25255B4%25252C3-d%25255Dpyrimidines%252Bfrom%252B2-%2525282-hydroxyaryl%252529acetonitrile%252Band%252B4%25252C6-dichloropyrimidine-5-carbaldehyde%252Bthrough%252Bdomino%252Bcondensation%252Breactions%26aulast%3DLi%26aufirst%3DBo%26date%3D2014%26date%3D2014%26volume%3D4%26issue%3D1%26spage%3D358%26epage%3D364" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Galal H.  Elgemeie</span>, <span class="hlFld-ContribAuthor ">Reham A.  Mohamed</span>. </span><span class="cited-content_cbyCitation_article-title">Application of dimethyl N-cyanodithioiminocarbonate in synthesis of fused heterocycles and in biological chemistry. </span><span class="cited-content_cbyCitation_journal-name">Heterocyclic Communications</span><span> <strong>2014,</strong> <em>20 </em>
                                    (6)
                                     <a href="https://doi.org/10.1515/hc-2014-0156" title="DOI URL">https://doi.org/10.1515/hc-2014-0156</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1515/hc-2014-0156&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1515%2Fhc-2014-0156%26sid%3Dliteratum%253Aachs%26jtitle%3DHeterocyclic%2520Communications%26atitle%3DApplication%252Bof%252Bdimethyl%252BN-cyanodithioiminocarbonate%252Bin%252Bsynthesis%252Bof%252Bfused%252Bheterocycles%252Band%252Bin%252Bbiological%252Bchemistry%26aulast%3DElgemeie%26aufirst%3DGalal%2BH.%26date%3D2014%26volume%3D20%26issue%3D6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Juan Carlos  Pizarro</span>, <span class="hlFld-ContribAuthor ">Tanya  Hills</span>, <span class="hlFld-ContribAuthor ">Guillermo  Senisterra</span>, <span class="hlFld-ContribAuthor ">Amy K.  Wernimont</span>, <span class="hlFld-ContribAuthor ">Claire  Mackenzie</span>, <span class="hlFld-ContribAuthor ">Neil R.  Norcross</span>, <span class="hlFld-ContribAuthor ">Michael A. J.  Ferguson</span>, <span class="hlFld-ContribAuthor ">Paul G.  Wyatt</span>, <span class="hlFld-ContribAuthor ">Ian H.  Gilbert</span>, <span class="hlFld-ContribAuthor ">Raymond  Hui</span>, . </span><span class="cited-content_cbyCitation_article-title">Exploring the Trypanosoma brucei Hsp83 Potential as a Target for Structure Guided Drug Design. </span><span class="cited-content_cbyCitation_journal-name">PLoS Neglected Tropical Diseases</span><span> <strong>2013,</strong> <em>7 </em>
                                    (10)
                                     , e2492. <a href="https://doi.org/10.1371/journal.pntd.0002492" title="DOI URL">https://doi.org/10.1371/journal.pntd.0002492</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1371/journal.pntd.0002492&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1371%2Fjournal.pntd.0002492%26sid%3Dliteratum%253Aachs%26jtitle%3DPLoS%2520Neglected%2520Tropical%2520Diseases%26atitle%3DExploring%252Bthe%252BTrypanosoma%252Bbrucei%252BHsp83%252BPotential%252Bas%252Ba%252BTarget%252Bfor%252BStructure%252BGuided%252BDrug%252BDesign%26aulast%3DPizarro%26aufirst%3DJuan%2BCarlos%26date%3D2013%26date%3D2013%26volume%3D7%26issue%3D10%26spage%3De2492" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jacob D.  Durrant</span>, <span class="hlFld-ContribAuthor ">Rommie E.  Amaro</span>. </span><span class="cited-content_cbyCitation_article-title">De Novo
              Design by Fragment Growing and Docking. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2013,</strong>,, 125-142. <a href="https://doi.org/10.1002/9783527677016.ch5" title="DOI URL">https://doi.org/10.1002/9783527677016.ch5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9783527677016.ch5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9783527677016.ch5%26sid%3Dliteratum%253Aachs%26atitle%3DDe%252BNovo%252BDesign%252Bby%252BFragment%252BGrowing%252Band%252BDocking%26aulast%3DDurrant%26aufirst%3DJacob%2BD.%26date%3D2013%26date%3D2013%26spage%3D125%26epage%3D142%26pub%3DWiley-VCH%2520Verlag%2520GmbH%2520%2526%2520Co.%2520KGaA%26atitle%3DDe%252Bnovo%252BMolecular%252BDesign%26aulast%3DSchneider%26aufirst%3DGisbert%26date%3D2013%26volume%3D14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michael  Mazanetz</span>, <span class="hlFld-ContribAuthor ">Richard  Law</span>, <span class="hlFld-ContribAuthor ">Mark  Whittaker</span>. </span><span class="cited-content_cbyCitation_article-title">Hit and Lead Identification from Fragments. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2013,</strong>,, 143-200. <a href="https://doi.org/10.1002/9783527677016.ch6" title="DOI URL">https://doi.org/10.1002/9783527677016.ch6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9783527677016.ch6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9783527677016.ch6%26sid%3Dliteratum%253Aachs%26atitle%3DHit%252Band%252BLead%252BIdentification%252Bfrom%252BFragments%26aulast%3DMazanetz%26aufirst%3DMichael%26date%3D2013%26date%3D2013%26spage%3D143%26epage%3D200%26pub%3DWiley-VCH%2520Verlag%2520GmbH%2520%2526%2520Co.%2520KGaA%26atitle%3DDe%252Bnovo%252BMolecular%252BDesign%26aulast%3DSchneider%26aufirst%3DGisbert%26date%3D2013%26volume%3D8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sean A.  Hudson</span>, <span class="hlFld-ContribAuthor ">Sachin  Surade</span>, <span class="hlFld-ContribAuthor ">Anthony G.  Coyne</span>, <span class="hlFld-ContribAuthor ">Kirsty J.  McLean</span>, <span class="hlFld-ContribAuthor ">David  Leys</span>, <span class="hlFld-ContribAuthor ">Andrew W.  Munro</span>, <span class="hlFld-ContribAuthor ">Chris  Abell</span>. </span><span class="cited-content_cbyCitation_article-title">Overcoming the Limitations of Fragment Merging: Rescuing a Strained Merged Fragment Series Targeting
              Mycobacterium tuberculosis
              CYP121. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2013,</strong> <em>8 </em>
                                    (9)
                                     , 1451-1456. <a href="https://doi.org/10.1002/cmdc.201300219" title="DOI URL">https://doi.org/10.1002/cmdc.201300219</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201300219&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201300219%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DOvercoming%252Bthe%252BLimitations%252Bof%252BFragment%252BMerging%25253A%252BRescuing%252Ba%252BStrained%252BMerged%252BFragment%252BSeries%252BTargeting%252BMycobacterium%252Btuberculosis%252BCYP121%26aulast%3DHudson%26aufirst%3DSean%2BA.%26date%3D2013%26date%3D2013%26volume%3D8%26issue%3D9%26spage%3D1451%26epage%3D1456" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rocco  Caliandro</span>, <span class="hlFld-ContribAuthor ">Danilo Benny  Belviso</span>, <span class="hlFld-ContribAuthor ">Brunella Maria  Aresta</span>, <span class="hlFld-ContribAuthor ">Modesto  de Candia</span>, <span class="hlFld-ContribAuthor ">Cosimo Damiano  Altomare</span>. </span><span class="cited-content_cbyCitation_article-title">Protein crystallography and fragment-based drug design. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2013,</strong> <em>5 </em>
                                    (10)
                                     , 1121-1140. <a href="https://doi.org/10.4155/fmc.13.84" title="DOI URL">https://doi.org/10.4155/fmc.13.84</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc.13.84&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc.13.84%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DProtein%252Bcrystallography%252Band%252Bfragment-based%252Bdrug%252Bdesign%26aulast%3DCaliandro%26aufirst%3DRocco%26date%3D2013%26volume%3D5%26issue%3D10%26spage%3D1121%26epage%3D1140" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chunquan  Sheng</span>, <span class="hlFld-ContribAuthor ">Wannian  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Fragment Informatics and Computational Fragment-Based Drug Design: An Overview and Update. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Research Reviews</span><span> <strong>2013,</strong> <em>33 </em>
                                    (3)
                                     , 554-598. <a href="https://doi.org/10.1002/med.21255" title="DOI URL">https://doi.org/10.1002/med.21255</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/med.21255&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fmed.21255%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Research%2520Reviews%26atitle%3DFragment%252BInformatics%252Band%252BComputational%252BFragment-Based%252BDrug%252BDesign%25253A%252BAn%252BOverview%252Band%252BUpdate%26aulast%3DSheng%26aufirst%3DChunquan%26date%3D2013%26date%3D2012%26volume%3D33%26issue%3D3%26spage%3D554%26epage%3D598" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Susanne  Hartmann</span>, <span class="hlFld-ContribAuthor ">Nadine  Günther</span>, <span class="hlFld-ContribAuthor ">Marlene  Biehl</span>, <span class="hlFld-ContribAuthor ">Astrid  Katzer</span>, <span class="hlFld-ContribAuthor ">Sebastian  Kuger</span>, <span class="hlFld-ContribAuthor ">Eike  Worschech</span>, <span class="hlFld-ContribAuthor ">Vladimir L.  Sukhorukov</span>, <span class="hlFld-ContribAuthor ">Georg  Krohne</span>, <span class="hlFld-ContribAuthor ">Heiko  Zimmermann</span>, <span class="hlFld-ContribAuthor ">Michael  Flentje</span>, <span class="hlFld-ContribAuthor ">Cholpon S.  Djuzenova</span>. </span><span class="cited-content_cbyCitation_article-title">Hsp90 inhibition by NVP-AUY922 and NVP-BEP800 decreases migration and invasion of irradiated normoxic and hypoxic tumor cell lines. </span><span class="cited-content_cbyCitation_journal-name">Cancer Letters</span><span> <strong>2013,</strong> <em>331 </em>
                                    (2)
                                     , 200-210. <a href="https://doi.org/10.1016/j.canlet.2012.12.027" title="DOI URL">https://doi.org/10.1016/j.canlet.2012.12.027</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.canlet.2012.12.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.canlet.2012.12.027%26sid%3Dliteratum%253Aachs%26jtitle%3DCancer%2520Letters%26atitle%3DHsp90%252Binhibition%252Bby%252BNVP-AUY922%252Band%252BNVP-BEP800%252Bdecreases%252Bmigration%252Band%252Binvasion%252Bof%252Birradiated%252Bnormoxic%252Band%252Bhypoxic%252Btumor%252Bcell%252Blines%26aulast%3DHartmann%26aufirst%3DSusanne%26date%3D2013%26volume%3D331%26issue%3D2%26spage%3D200%26epage%3D210" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">JianMin  Jia</span>, <span class="hlFld-ContribAuthor ">XiaoLi  Xu</span>, <span class="hlFld-ContribAuthor ">Fang  Liu</span>, <span class="hlFld-ContribAuthor ">XiaoKe  Guo</span>, <span class="hlFld-ContribAuthor ">MingYe  Zhang</span>, <span class="hlFld-ContribAuthor ">MengChen  Lu</span>, <span class="hlFld-ContribAuthor ">LiLi  Xu</span>, <span class="hlFld-ContribAuthor ">JinLian  Wei</span>, <span class="hlFld-ContribAuthor ">Jia  Zhu</span>, <span class="hlFld-ContribAuthor ">ShengLie  Zhang</span>, <span class="hlFld-ContribAuthor ">ShengMiao  Zhang</span>, <span class="hlFld-ContribAuthor ">HaoPeng  Sun</span>, <span class="hlFld-ContribAuthor ">QiDong  You</span>, . </span><span class="cited-content_cbyCitation_article-title">Identification, Design and Bio-Evaluation of Novel Hsp90 Inhibitors by Ligand-Based Virtual Screening. </span><span class="cited-content_cbyCitation_journal-name">PLoS ONE</span><span> <strong>2013,</strong> <em>8 </em>
                                    (4)
                                     , e59315. <a href="https://doi.org/10.1371/journal.pone.0059315" title="DOI URL">https://doi.org/10.1371/journal.pone.0059315</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1371/journal.pone.0059315&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1371%2Fjournal.pone.0059315%26sid%3Dliteratum%253Aachs%26jtitle%3DPLoS%2520ONE%26atitle%3DIdentification%25252C%252BDesign%252Band%252BBio-Evaluation%252Bof%252BNovel%252BHsp90%252BInhibitors%252Bby%252BLigand-Based%252BVirtual%252BScreening%26aulast%3DJia%26aufirst%3DJianMin%26date%3D2013%26date%3D2013%26volume%3D8%26issue%3D4%26spage%3De59315" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Duncan E.  Scott</span>, <span class="hlFld-ContribAuthor ">Matthias T.  Ehebauer</span>, <span class="hlFld-ContribAuthor ">Tara  Pukala</span>, <span class="hlFld-ContribAuthor ">May  Marsh</span>, <span class="hlFld-ContribAuthor ">Tom L.  Blundell</span>, <span class="hlFld-ContribAuthor ">Ashok R.  Venkitaraman</span>, <span class="hlFld-ContribAuthor ">Chris  Abell</span>, <span class="hlFld-ContribAuthor ">Marko  Hyvönen</span>. </span><span class="cited-content_cbyCitation_article-title">Using a Fragment-Based Approach To Target Protein-Protein Interactions. </span><span class="cited-content_cbyCitation_journal-name">ChemBioChem</span><span> <strong>2013,</strong> <em>14 </em>
                                    (3)
                                     , 332-342. <a href="https://doi.org/10.1002/cbic.201200521" title="DOI URL">https://doi.org/10.1002/cbic.201200521</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cbic.201200521&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcbic.201200521%26sid%3Dliteratum%253Aachs%26jtitle%3DChemBioChem%26atitle%3DUsing%252Ba%252BFragment-Based%252BApproach%252BTo%252BTarget%252BProtein-Protein%252BInteractions%26aulast%3DScott%26aufirst%3DDuncan%2BE.%26date%3D2013%26date%3D2013%26volume%3D14%26issue%3D3%26spage%3D332%26epage%3D342" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Martin J.  Drysdale</span>. </span><span class="cited-content_cbyCitation_article-title">Fragment-based Drug Discovery: the Shape of Things to Come. </span><span class="cited-content_cbyCitation_journal-name">Australian Journal of Chemistry</span><span> <strong>2013,</strong> <em>66 </em>
                                    (12)
                                     , 1544. <a href="https://doi.org/10.1071/CH13255" title="DOI URL">https://doi.org/10.1071/CH13255</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1071/CH13255&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1071%2FCH13255%26sid%3Dliteratum%253Aachs%26jtitle%3DAustralian%2520Journal%2520of%2520Chemistry%26atitle%3DFragment-based%252BDrug%252BDiscovery%25253A%252Bthe%252BShape%252Bof%252BThings%252Bto%252BCome%26aulast%3DDrysdale%26aufirst%3DMartin%2BJ.%26date%3D2013%26volume%3D66%26issue%3D12%26spage%3D1544" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Leah N.  Makley</span>, <span class="hlFld-ContribAuthor ">Jason E.  Gestwicki</span>. </span><span class="cited-content_cbyCitation_article-title">Expanding the Number of ‘Druggable’ Targets: Non-Enzymes and Protein-Protein Interactions. </span><span class="cited-content_cbyCitation_journal-name">Chemical Biology & Drug Design</span><span> <strong>2013,</strong> <em>81 </em>
                                    (1)
                                     , 22-32. <a href="https://doi.org/10.1111/cbdd.12066" title="DOI URL">https://doi.org/10.1111/cbdd.12066</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/cbdd.12066&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fcbdd.12066%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Biology%2520%2526%2520Drug%2520Design%26atitle%3DExpanding%252Bthe%252BNumber%252Bof%252B%2525E2%252580%252598Druggable%2525E2%252580%252599%252BTargets%25253A%252BNon-Enzymes%252Band%252BProtein-Protein%252BInteractions%26aulast%3DMakley%26aufirst%3DLeah%2BN.%26date%3D2013%26date%3D2012%26volume%3D81%26issue%3D1%26spage%3D22%26epage%3D32" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nicholas G.M.  Davies</span>, <span class="hlFld-ContribAuthor ">Helen  Browne</span>, <span class="hlFld-ContribAuthor ">Ben  Davis</span>, <span class="hlFld-ContribAuthor ">Martin J.  Drysdale</span>, <span class="hlFld-ContribAuthor ">Nicolas  Foloppe</span>, <span class="hlFld-ContribAuthor ">Stephanie  Geoffrey</span>, <span class="hlFld-ContribAuthor ">Ben  Gibbons</span>, <span class="hlFld-ContribAuthor ">Terance  Hart</span>, <span class="hlFld-ContribAuthor ">Roderick  Hubbard</span>, <span class="hlFld-ContribAuthor ">Michael Rugaard  Jensen</span>, <span class="hlFld-ContribAuthor ">Howard  Mansell</span>, <span class="hlFld-ContribAuthor ">Andrew  Massey</span>, <span class="hlFld-ContribAuthor ">Natalia  Matassova</span>, <span class="hlFld-ContribAuthor ">Jonathan D.  Moore</span>, <span class="hlFld-ContribAuthor ">James  Murray</span>, <span class="hlFld-ContribAuthor ">Robert  Pratt</span>, <span class="hlFld-ContribAuthor ">Stuart  Ray</span>, <span class="hlFld-ContribAuthor ">Alan  Robertson</span>, <span class="hlFld-ContribAuthor ">Stephen D.  Roughley</span>, <span class="hlFld-ContribAuthor ">Joseph  Schoepfer</span>, <span class="hlFld-ContribAuthor ">Kirsten  Scriven</span>, <span class="hlFld-ContribAuthor ">Heather  Simmonite</span>, <span class="hlFld-ContribAuthor ">Stephen  Stokes</span>, <span class="hlFld-ContribAuthor ">Allan  Surgenor</span>, <span class="hlFld-ContribAuthor ">Paul  Webb</span>, <span class="hlFld-ContribAuthor ">Mike  Wood</span>, <span class="hlFld-ContribAuthor ">Lisa  Wright</span>, <span class="hlFld-ContribAuthor ">Paul  Brough</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting conserved water molecules: Design of 4-aryl-5-cyanopyrrolo[2,3-d]pyrimidine Hsp90 inhibitors using fragment-based screening and structure-based optimization. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2012,</strong> <em>20 </em>
                                    (22)
                                     , 6770-6789. <a href="https://doi.org/10.1016/j.bmc.2012.08.050" title="DOI URL">https://doi.org/10.1016/j.bmc.2012.08.050</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2012.08.050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2012.08.050%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DTargeting%252Bconserved%252Bwater%252Bmolecules%25253A%252BDesign%252Bof%252B4-aryl-5-cyanopyrrolo%25255B2%25252C3-d%25255Dpyrimidine%252BHsp90%252Binhibitors%252Busing%252Bfragment-based%252Bscreening%252Band%252Bstructure-based%252Boptimization%26aulast%3DDavies%26aufirst%3DNicholas%2BG.M.%26date%3D2012%26volume%3D20%26issue%3D22%26spage%3D6770%26epage%3D6789" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Maurizio  Scaltriti</span>, <span class="hlFld-ContribAuthor ">Shaheenah  Dawood</span>, <span class="hlFld-ContribAuthor ">Javier  Cortes</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular Pathways: Targeting Hsp90—Who Benefits and Who Does Not: Figure 1.. </span><span class="cited-content_cbyCitation_journal-name">Clinical Cancer Research</span><span> <strong>2012,</strong> <em>18 </em>
                                    (17)
                                     , 4508-4513. <a href="https://doi.org/10.1158/1078-0432.CCR-11-2138" title="DOI URL">https://doi.org/10.1158/1078-0432.CCR-11-2138</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/1078-0432.CCR-11-2138&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F1078-0432.CCR-11-2138%26sid%3Dliteratum%253Aachs%26jtitle%3DClinical%2520Cancer%2520Research%26atitle%3DMolecular%252BPathways%25253A%252BTargeting%252BHsp90%2525E2%252580%252594Who%252BBenefits%252Band%252BWho%252BDoes%252BNot%25253A%252BFigure%252B1.%26aulast%3DScaltriti%26aufirst%3DMaurizio%26date%3D2012%26date%3D2012%26volume%3D18%26issue%3D17%26spage%3D4508%26epage%3D4513" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Carol  Austin</span>, <span class="hlFld-ContribAuthor ">Simon N.  Pettit</span>, <span class="hlFld-ContribAuthor ">Sharon K.  Magnolo</span>, <span class="hlFld-ContribAuthor ">Jonathan  Sanvoisin</span>, <span class="hlFld-ContribAuthor ">WenJie  Chen</span>, <span class="hlFld-ContribAuthor ">Stephen P.  Wood</span>, <span class="hlFld-ContribAuthor ">Lauren D.  Freeman</span>, <span class="hlFld-ContribAuthor ">Reuben J.  Pengelly</span>, <span class="hlFld-ContribAuthor ">Dallas E.  Hughes</span>. </span><span class="cited-content_cbyCitation_article-title">Fragment Screening Using Capillary Electrophoresis (CEfrag) for Hit Identification of Heat Shock Protein 90 ATPase Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biomolecular Screening</span><span> <strong>2012,</strong> <em>17 </em>
                                    (7)
                                     , 868-876. <a href="https://doi.org/10.1177/1087057112445785" title="DOI URL">https://doi.org/10.1177/1087057112445785</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1177/1087057112445785&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1177%2F1087057112445785%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biomolecular%2520Screening%26atitle%3DFragment%252BScreening%252BUsing%252BCapillary%252BElectrophoresis%252B%252528CEfrag%252529%252Bfor%252BHit%252BIdentification%252Bof%252BHeat%252BShock%252BProtein%252B90%252BATPase%252BInhibitors%26aulast%3DAustin%26aufirst%3DCarol%26date%3D2012%26date%3D2012%26volume%3D17%26issue%3D7%26spage%3D868%26epage%3D876" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Robert B.  Den</span>, <span class="hlFld-ContribAuthor ">Bo  Lu</span>. </span><span class="cited-content_cbyCitation_article-title">Heat shock protein 90 inhibition: rationale and clinical potential. </span><span class="cited-content_cbyCitation_journal-name">Therapeutic Advances in Medical Oncology</span><span> <strong>2012,</strong> <em>4 </em>
                                    (4)
                                     , 211-218. <a href="https://doi.org/10.1177/1758834012445574" title="DOI URL">https://doi.org/10.1177/1758834012445574</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1177/1758834012445574&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1177%2F1758834012445574%26sid%3Dliteratum%253Aachs%26jtitle%3DTherapeutic%2520Advances%2520in%2520Medical%2520Oncology%26atitle%3DHeat%252Bshock%252Bprotein%252B90%252Binhibition%25253A%252Brationale%252Band%252Bclinical%252Bpotential%26aulast%3DDen%26aufirst%3DRobert%2BB.%26date%3D2012%26date%3D2012%26volume%3D4%26issue%3D4%26spage%3D211%26epage%3D218" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lisheng  Wang</span>, <span class="hlFld-ContribAuthor ">Yejun  You</span>, <span class="hlFld-ContribAuthor ">Songqing  Wang</span>, <span class="hlFld-ContribAuthor ">Xu  Liu</span>, <span class="hlFld-ContribAuthor ">Buming  Liu</span>, <span class="hlFld-ContribAuthor ">Jinni  Wang</span>, <span class="hlFld-ContribAuthor ">Xiao  Lin</span>, <span class="hlFld-ContribAuthor ">Mingsheng  Chen</span>, <span class="hlFld-ContribAuthor ">Gang  Liang</span>, <span class="hlFld-ContribAuthor ">Hua  Yang</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, characterization and in vitro anti-tumor activities of matrine derivatives. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2012,</strong> <em>22 </em>
                                    (12)
                                     , 4100-4102. <a href="https://doi.org/10.1016/j.bmcl.2012.04.069" title="DOI URL">https://doi.org/10.1016/j.bmcl.2012.04.069</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2012.04.069&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2012.04.069%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSynthesis%25252C%252Bcharacterization%252Band%252Bin%252Bvitro%252Banti-tumor%252Bactivities%252Bof%252Bmatrine%252Bderivatives%26aulast%3DWang%26aufirst%3DLisheng%26date%3D2012%26volume%3D22%26issue%3D12%26spage%3D4100%26epage%3D4102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Egidijus  Kazlauskas</span>, <span class="hlFld-ContribAuthor ">Vilma  Petrikaitė</span>, <span class="hlFld-ContribAuthor ">Vilma  Michailovienė</span>, <span class="hlFld-ContribAuthor ">Jurgita  Revuckienė</span>, <span class="hlFld-ContribAuthor ">Jurgita  Matulienė</span>, <span class="hlFld-ContribAuthor ">Leonas  Grinius</span>, <span class="hlFld-ContribAuthor ">Daumantas  Matulis</span>, . </span><span class="cited-content_cbyCitation_article-title">Thermodynamics of Aryl-Dihydroxyphenyl-Thiadiazole Binding to Human Hsp90. </span><span class="cited-content_cbyCitation_journal-name">PLoS ONE</span><span> <strong>2012,</strong> <em>7 </em>
                                    (5)
                                     , e36899. <a href="https://doi.org/10.1371/journal.pone.0036899" title="DOI URL">https://doi.org/10.1371/journal.pone.0036899</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1371/journal.pone.0036899&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1371%2Fjournal.pone.0036899%26sid%3Dliteratum%253Aachs%26jtitle%3DPLoS%2520ONE%26atitle%3DThermodynamics%252Bof%252BAryl-Dihydroxyphenyl-Thiadiazole%252BBinding%252Bto%252BHuman%252BHsp90%26aulast%3DKazlauskas%26aufirst%3DEgidijus%26date%3D2012%26date%3D2012%26volume%3D7%26issue%3D5%26spage%3De36899" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Swen  Hoelder</span>, <span class="hlFld-ContribAuthor ">Paul A.  Clarke</span>, <span class="hlFld-ContribAuthor ">Paul  Workman</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of small molecule cancer drugs: Successes, challenges and opportunities. </span><span class="cited-content_cbyCitation_journal-name">Molecular Oncology</span><span> <strong>2012,</strong> <em>6 </em>
                                    (2)
                                     , 155-176. <a href="https://doi.org/10.1016/j.molonc.2012.02.004" title="DOI URL">https://doi.org/10.1016/j.molonc.2012.02.004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.molonc.2012.02.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.molonc.2012.02.004%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Oncology%26atitle%3DDiscovery%252Bof%252Bsmall%252Bmolecule%252Bcancer%252Bdrugs%25253A%252BSuccesses%25252C%252Bchallenges%252Band%252Bopportunities%26aulast%3DHoelder%26aufirst%3DSwen%26date%3D2012%26date%3D2012%26volume%3D6%26issue%3D2%26spage%3D155%26epage%3D176" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Cholpon S.  Djuzenova</span>, <span class="hlFld-ContribAuthor ">Christina  Blassl</span>, <span class="hlFld-ContribAuthor ">Konstanze  Roloff</span>, <span class="hlFld-ContribAuthor ">Sebastian  Kuger</span>, <span class="hlFld-ContribAuthor ">Astrid  Katzer</span>, <span class="hlFld-ContribAuthor ">Natalia  Niewidok</span>, <span class="hlFld-ContribAuthor ">Nadine  Günther</span>, <span class="hlFld-ContribAuthor ">Bülent  Polat</span>, <span class="hlFld-ContribAuthor ">Vladimir L.  Sukhorukov</span>, <span class="hlFld-ContribAuthor ">Michael  Flentje</span>. </span><span class="cited-content_cbyCitation_article-title">Hsp90 inhibitor NVP-AUY922 enhances radiation sensitivity of tumor cell lines under hypoxia. </span><span class="cited-content_cbyCitation_journal-name">Cancer Biology & Therapy</span><span> <strong>2012,</strong> <em>13 </em>
                                    (6)
                                     , 425-434. <a href="https://doi.org/10.4161/cbt.19294" title="DOI URL">https://doi.org/10.4161/cbt.19294</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4161/cbt.19294&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4161%2Fcbt.19294%26sid%3Dliteratum%253Aachs%26jtitle%3DCancer%2520Biology%2520%2526%2520Therapy%26atitle%3DHsp90%252Binhibitor%252BNVP-AUY922%252Benhances%252Bradiation%252Bsensitivity%252Bof%252Btumor%252Bcell%252Blines%252Bunder%252Bhypoxia%26aulast%3DDjuzenova%26aufirst%3DCholpon%2BS.%26date%3D2012%26date%3D2014%26volume%3D13%26issue%3D6%26spage%3D425%26epage%3D434" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jon  Travers</span>, <span class="hlFld-ContribAuthor ">Swee  Sharp</span>, <span class="hlFld-ContribAuthor ">Paul  Workman</span>. </span><span class="cited-content_cbyCitation_article-title">HSP90 inhibition: two-pronged exploitation of cancer dependencies. </span><span class="cited-content_cbyCitation_journal-name">Drug Discovery Today</span><span> <strong>2012,</strong> <em>17 </em>
                                    (5-6)
                                     , 242-252. <a href="https://doi.org/10.1016/j.drudis.2011.12.021" title="DOI URL">https://doi.org/10.1016/j.drudis.2011.12.021</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.drudis.2011.12.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.drudis.2011.12.021%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Discovery%2520Today%26atitle%3DHSP90%252Binhibition%25253A%252Btwo-pronged%252Bexploitation%252Bof%252Bcancer%252Bdependencies%26aulast%3DTravers%26aufirst%3DJon%26date%3D2012%26volume%3D17%26issue%3D5-6%26spage%3D242%26epage%3D252" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ewald  Edink</span>, <span class="hlFld-ContribAuthor ">Atilla  Akdemir</span>, <span class="hlFld-ContribAuthor ">Chimed  Jansen</span>, <span class="hlFld-ContribAuthor ">René van  Elk</span>, <span class="hlFld-ContribAuthor ">Obbe  Zuiderveld</span>, <span class="hlFld-ContribAuthor ">Frans J.J.  de Kanter</span>, <span class="hlFld-ContribAuthor ">Jacqueline E.  van Muijlwijk-Koezen</span>, <span class="hlFld-ContribAuthor ">August B.  Smit</span>, <span class="hlFld-ContribAuthor ">Rob  Leurs</span>, <span class="hlFld-ContribAuthor ">Iwan J.P.  de Esch</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-based design, synthesis and structure–activity relationships of dibenzosuberyl- and benzoate-substituted tropines as ligands for acetylcholine-binding protein. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2012,</strong> <em>22 </em>
                                    (3)
                                     , 1448-1454. <a href="https://doi.org/10.1016/j.bmcl.2011.12.008" title="DOI URL">https://doi.org/10.1016/j.bmcl.2011.12.008</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2011.12.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2011.12.008%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DStructure-based%252Bdesign%25252C%252Bsynthesis%252Band%252Bstructure%2525E2%252580%252593activity%252Brelationships%252Bof%252Bdibenzosuberyl-%252Band%252Bbenzoate-substituted%252Btropines%252Bas%252Bligands%252Bfor%252Bacetylcholine-binding%252Bprotein%26aulast%3DEdink%26aufirst%3DEwald%26date%3D2012%26volume%3D22%26issue%3D3%26spage%3D1448%26epage%3D1454" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div><a href="#" data-source="/pb/widgets/cited-by?doi=10.1021%2Fjm900357y&amp;widgetId=9cf770f4-a9a2-46e0-bd29-3da15bcf4ae0&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Barticle%3Aarticle%3A10.1021%2Fjm900357y%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2009.52.issue-15%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text&amp;citedByCount=127&amp;pagesCount=2&amp;pageNumber=-1" title="Load all citations" class="button_primary float-right cited-by__see-more mb-5"><i aria-hidden="”true”" class="icon-angle-double-down"></i><span>Load all citations</span></a></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900357y/production/images/medium/jm-2009-00357y_0015.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900357y/production/images/large/jm-2009-00357y_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900357y&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900357y/production/images/medium/jm-2009-00357y_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900357y/production/images/large/jm-2009-00357y_0004.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Natural product derived Hsp90 inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900357y/production/images/large/jm-2009-00357y_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900357y&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900357y/production/images/medium/jm-2009-00357y_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900357y/production/images/large/jm-2009-00357y_0005.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Purine, benzamide, and resorcinol scaffold Hsp90 inhibitors progressed to phase I trials.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900357y/production/images/large/jm-2009-00357y_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900357y&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900357y/production/images/medium/jm-2009-00357y_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900357y/production/images/large/jm-2009-00357y_0006.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Structures of Hsp90α ATP site binding fragments identified by 1D NMR experiments.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900357y/production/images/large/jm-2009-00357y_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900357y&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900357y/production/images/medium/jm-2009-00357y_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900357y/production/images/large/jm-2009-00357y_0007.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Structures of Hsp90 ligands identified by virtual screening.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900357y/production/images/large/jm-2009-00357y_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900357y&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900357y/production/images/medium/jm-2009-00357y_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900357y/production/images/large/jm-2009-00357y_0008.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Detail of the X-ray crystal structures of N-terminal-Hsp90α in complex with a series of fragments and ligands, highlighting key protein amino acids and water molecules (red spheres).<a onclick="showRef(event, 'ref80'); return false;" href="javascript:void(0);" class="ref ref80">(80)</a> The structures were overlapped on the main chains of residues T109-D102 and T115-G215, which omit the flexible helix and N and C termini. The rmsd was between 0.22 and 0.40 Å across the data set. Protein carbon atoms in gray (bond types not shown), oxygen in red, nitrogen in blue, chlorine in green, sulfur in yellow. Electron density for <b>10</b> is 2<i>F</i><sub>o</sub> − <i>F</i><sub>c</sub> map, contoured at 3σ. All structures are from ligand soaks except where stated.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900357y/production/images/large/jm-2009-00357y_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900357y&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900357y/production/images/medium/jm-2009-00357y_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900357y/production/images/large/jm-2009-00357y_0017.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Close Analogues of the Fragment Hits <b>10</b> and <b>11</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900357y/production/images/large/jm-2009-00357y_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900357y&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) diisopropylamine, EtOH, 65 °C, 3.5 h, 30%. (b) MeOH, Et<sub>3</sub>N, microwave, 120 °C, 10 min, 14%.</p></p></figure><figure data-id="sch2" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900357y/production/images/medium/jm-2009-00357y_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900357y/production/images/large/jm-2009-00357y_0018.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of the 2,4-Diaminothieno[2,3-<i>d</i>]pyrimidine Scaffold<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900357y/production/images/large/jm-2009-00357y_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900357y&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) ethyl-2-mercaptoacetate, K<sub>2</sub>CO<sub>3</sub>, MeCN, 85 °C, 5 h, 82%. (b) aq NH<sub>3</sub>, microwave 130 °C, 15 min, 22%.</p></p></figure><figure data-id="sch3" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900357y/production/images/medium/jm-2009-00357y_0019.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900357y/production/images/large/jm-2009-00357y_0019.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of 4-Aryl 2-Aminothieno[2,3-<i>d</i>]pyrimidines <b>21a</b>−<b>21e</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900357y/production/images/large/jm-2009-00357y_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900357y&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 2X,4Y-phenylboronic acid, DMF, H<sub>2</sub>O, Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub>, NaHCO<sub>3</sub>, Δ. (b) EtNH<sub>2</sub>, MeOH, 85 °C (sealed tube), 18 h. (c) NaOH, H<sub>2</sub>O, EtOH, Δ. (d) HATU, diisopropylamine, EtNH<sub>2</sub>·HCl, DMF, 100 °C.</p></p></figure><figure data-id="sch4" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900357y/production/images/medium/jm-2009-00357y_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900357y/production/images/large/jm-2009-00357y_0001.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of 5′-Alkyloxy-2-aminothieno[2,3-<i>d</i>]pyrimidine Hsp90 Inhibitors <b>34a</b>−<b>i</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900357y/production/images/large/jm-2009-00357y_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900357y&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) BnBr, K<sub>2</sub>CO<sub>3</sub>, MeCN, Δ, 18 h, 96%. (b) Iron powder, AcOH, H<sub>2</sub>O, 85 °C, 1.5 h, 96%. (c) (i) NaNO<sub>2</sub>, HCl, H<sub>2</sub>O, AcOH, 0 to 5 °C, 30 min; (ii) I<sub>2</sub>, KI, H<sub>2</sub>O, rt,1.5 h, 90%. (d) (i) KOAc, bis(pinacolato)diboron, Pd(OAc)<sub>2</sub>, DMF, 90 °C, 18 h; (ii) <b>18</b>, K<sub>3</sub>PO<sub>4</sub>, 1,4-dioxane, Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub>, 100 °C, 3 h, 45%. (e) EtNH<sub>2</sub>, MeOH, Δ, 18 h, 84%. (f) NaOH, H<sub>2</sub>O, EtOH, D, 50 min, quant. (g) HATU, RNH<sub>2</sub>, DMF, diisopropylamine; 50 °C, 1 h. (h) BCl<sub>3</sub>, CH<sub>2</sub>Cl<sub>2</sub>, −78 °C to rt, 3 h, 87%. (i) R<sub>1</sub>Br/Cl, Cs<sub>2</sub>CO<sub>3</sub>, DMF, 100−140 °C, 1−2 h. (j) R<sub>1</sub>OH, DIAD, PPh<sub>3</sub>, THF, rt, 4 h.</p></p></figure><figure data-id="sch5" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900357y/production/images/medium/jm-2009-00357y_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900357y/production/images/large/jm-2009-00357y_0002.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthesis of Aminothieno[2,3-<i>d</i>]pyrimidine Hsp90 inhibitors <b>34j</b>−<b>m</b> via Reductive Amination<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900357y/production/images/large/jm-2009-00357y_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900357y&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 2-Bromoethylacetaldehyde diethyl acetal, Cs<sub>2</sub>CO<sub>3</sub>, DMF, 125 °C, 4 h, 71%. (b) (i) HCl (aq), THF, 48 h; (ii) amine, DCM, NaB(OAc)<sub>3</sub>H, 1.5 h.</p></p></figure><figure data-id="fig6" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900357y/production/images/medium/jm-2009-00357y_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900357y/production/images/large/jm-2009-00357y_0009.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Combining fragment and virtual screening hits; evolution to the 2-aminothieno[2,3-<i>d</i>]pyrimidine scaffold.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900357y/production/images/large/jm-2009-00357y_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900357y&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900357y/production/images/medium/jm-2009-00357y_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900357y/production/images/large/jm-2009-00357y_0010.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Effects of <b>34a</b> on expression of HER2, Hsp72, CRAF, and CDK4 in BT474 and HCT116 cells as determined by Western blot after 24 h. Compounds concentrations were 25, 50, 100, 200, and 400 nM concentrations. GAPDH was used as a loading control. Expression levels of HER2 in HCT116 cells are too low to be detected (consistent with etiology of this cell line).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900357y/production/images/large/jm-2009-00357y_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900357y&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900357y/production/images/medium/jm-2009-00357y_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900357y/production/images/large/jm-2009-00357y_0011.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Response of established WM266.4 human melanoma xenografts to <b>34a</b> therapy (50 and 100 mg/kg, qd, po). (A) Relative tumor volumes (compared with volumes at start of therapy). Key: black squares, vehicle controls; red triangles, <b>34a</b> at 50 mg/kg po; green inverted triangles, <b>34a</b> at 100 mg/kg po. (B) Mean weights of excised tumors after 21 days therapy. (C) Mean mouse body weights during therapy. (D) Pharmacodynamic biomarker changes assessed by Western blotting (24 h after final dose).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900357y/production/images/large/jm-2009-00357y_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900357y&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900357y/production/images/medium/jm-2009-00357y_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900357y/production/images/large/jm-2009-00357y_0013.jpeg" id="rightTab-gr14" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Effects of thienopyrimidines <b>34a</b>−<b>d</b> and <b>34i</b>−<b>j</b> on expression of HER2, pAKT, and Hsp72 in BT474 cells as determined by Western blot at 24 h. Cells were exposed to compounds <b>34a</b>−<b>d</b> and <b>34j</b> at 4 and 2 times GI<sub>50</sub>, and compound <b>34i</b> was used at 8 and 4 times GI<sub>50</sub>. GAPDH was used as a loading control.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900357y/production/images/large/jm-2009-00357y_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900357y&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig10" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900357y/production/images/medium/jm-2009-00357y_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900357y/production/images/large/jm-2009-00357y_0012.jpeg" id="rightTab-gr15" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Response of established BT474 human breast cancer xenografts to therapy with thienopyrimidines <b>34a</b>−<b>d</b> and <b>34i</b>−<b>j</b> (30 mg/kg, qd, po). (A) Mean relative tumor volumes. (B) Mean body weight changes in % during therapy. Bars represent SEM * <i>p</i> < 0.05, one-way ANOVA post hoc Dunnet’s.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900357y/production/images/large/jm-2009-00357y_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900357y&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig11" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900357y/production/images/medium/jm-2009-00357y_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900357y/production/images/large/jm-2009-00357y_0014.jpeg" id="rightTab-gr16" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Tumor pharmacodynamic biomarker changes in nude mice bearing established BT474 human breast cancer xenografts following daily dosing of at 30 mg/kg of <b>34a</b>, <b>34b</b>, <b>34d</b>, <b>34j</b> or <b>34i</b>. BT474 tumors were collected from treated nude mice at the end of the efficacy experiment and assayed for either dissociation of p23 from Hsp90α or for client protein degradation (6 h after final dose).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900357y/production/images/large/jm-2009-00357y_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900357y&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig12" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900357y/production/images/medium/jm-2009-00357y_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900357y/production/images/large/jm-2009-00357y_0016.jpeg" id="rightTab-gr17" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. Detail of the X-ray structure of compound <b>34d</b> bound to the ATP binding site of the N-terminal domain of human Hsp90α (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2WI7">2WI7</a>), showing selected amino acids and listing key ligand−protein interactions (note main chain atoms of N51 removed for clarity). Red spheres represent structurally conserved water molecules with key hydrogen bonding network shown as dotted lines. (A) Key H-bonds (to water and D93); (B) thieno-ring stacking with M98; (C) chlorine filling small amphiphilic pocket; (D) H-bond interaction with G97; (E) lipophilic interaction with L107/F138 and stacking with N51; (F) solvent exposed; (G) water-mediated H-bond to F138.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900357y/production/images/large/jm-2009-00357y_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900357y&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i55">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_76383" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_76383" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 82 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Mosser, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morimoto, R. I.</span><span> </span><span class="NLM_article-title">Molecular chaperones and the stress of oncogenesis</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">2907</span><span class="NLM_x">–</span> <span class="NLM_lpage">2918</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm900357y&amp;key=10.1038%2Fsj.onc.1207529" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm900357y&amp;key=15077153" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm900357y&amp;key=1%3ACAS%3A528%3ADC%252BD2cXivFKmsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2004&pages=2907-2918&author=D.+D.+Mosserauthor=R.+I.+Morimoto&title=Molecular+chaperones+and+the+stress+of+oncogenesis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular chaperones and the stress of oncogenesis</span></div><div class="casAuthors">Mosser, Dick D.; Morimoto, Richard I.</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">2907-2918</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Protein-damaging stresses induce the expression of heat-shock proteins', which have essential roles in protecting cells from the potentially lethal effects of stress and proteotoxicity.  These stress-protective heat-shock proteins are often overexpressed in cells of various cancers and have been suggested to be contributing factors in tumorigenesis.  An underlying basis of oncogenesis is the acquisition and accumulation of mutations that provide the transformed cell with the combined characteristics of deregulated cell proliferation and suppressed cell death.  Heat-shock proteins with dual roles as regulators of protein conformation and stress sensors may therefore have intriguing and central roles in both cell proliferation and apoptosis.  It has been established that heat-shock proteins exhibit specificity to particular classes of polypeptide substrates and client proteins in vivo, and that chaperones can stabilize mutations that affect the folded conformation.  Likewise, overexpression of chaperones has also been shown to protect cells against apoptotic cell death.  The involvement of chaperones, therefore, in such diverse roles might suggest novel anticancer therapeutic approaches targeting heat-shock protein function for a broad spectrum of tumor types.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXglApcXUKQrVg90H21EOLACvtfcHk0liHiXZxXhgIeA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXivFKmsLs%253D&md5=535effb8bca3679c2e29bffcb0077cc3</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fsj.onc.1207529&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.onc.1207529%26sid%3Dliteratum%253Aachs%26aulast%3DMosser%26aufirst%3DD.%2BD.%26aulast%3DMorimoto%26aufirst%3DR.%2BI.%26atitle%3DMolecular%2520chaperones%2520and%2520the%2520stress%2520of%2520oncogenesis%26jtitle%3DOncogene%26date%3D2004%26volume%3D23%26spage%3D2907%26epage%3D2918" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Pearl, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prodromou, C.</span><span> </span><span class="NLM_article-title">Structure and mechanism of the hsp90 molecular chaperone machinery</span> <span class="citation_source-journal">Annu. Rev. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">75</span><span class="NLM_x">, </span> <span class="NLM_fpage">271</span><span class="NLM_x">–</span> <span class="NLM_lpage">294</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm900357y&amp;key=10.1146%2Fannurev.biochem.75.103004.142738" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm900357y&amp;key=16756493" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm900357y&amp;key=1%3ACAS%3A528%3ADC%252BD28XosVKhs78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2006&pages=271-294&author=L.+H.+Pearlauthor=C.+Prodromou&title=Structure+and+mechanism+of+the+hsp90+molecular+chaperone+machinery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Structure and mechanism of the Hsp90 molecular chaperone machinery</span></div><div class="casAuthors">Pearl, Laurence H.; Prodromou, Chrisostomos</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Biochemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">75</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">271-294</span>CODEN:
                <span class="NLM_cas:coden">ARBOAW</span>;
        ISSN:<span class="NLM_cas:issn">0066-4154</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  Heat-shock protein 90 (Hsp90) is a mol. chaperone essential for activating many signaling proteins in the eukaryotic cell.  Biochem. and structural anal. of Hsp90 has revealed a complex mechanism of ATPase-coupled conformational changes and interactions with cochaperone proteins, which facilitate activation of Hsp90's diverse "clientele.".  Despite recent progress, key aspects of the ATPase-coupled mechanism of Hsp90 remain controversial, and the nature of the changes, engendered by Hsp90 in client proteins, is largely unknown.  Here, the authors discuss present knowledge of Hsp90 structure and function gleaned from crystallog. studies of individual domains and recent progress in obtaining a structure for the ATP-bound conformation of the intact dimeric chaperone.  Addnl., the authors describe the roles of the plethora of cochaperones with which Hsp90 cooperates and growing insights into their biochem. mechanisms, which come from crystal structures of Hsp90-cochaperone complexes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1Aa7D8Mk_qbVg90H21EOLACvtfcHk0ljvl7l4REyq6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XosVKhs78%253D&md5=a954553202a2a81fce297ac6a8378c67</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1146%2Fannurev.biochem.75.103004.142738&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.biochem.75.103004.142738%26sid%3Dliteratum%253Aachs%26aulast%3DPearl%26aufirst%3DL.%2BH.%26aulast%3DProdromou%26aufirst%3DC.%26atitle%3DStructure%2520and%2520mechanism%2520of%2520the%2520hsp90%2520molecular%2520chaperone%2520machinery%26jtitle%3DAnnu.%2520Rev.%2520Biochem.%26date%3D2006%26volume%3D75%26spage%3D271%26epage%3D294" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Obermann, W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sondermann, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Russo, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pavletich, N. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartl, F. U.</span><span> </span><span class="NLM_article-title">In vivo function of Hsp90 is dependent on ATP binding and ATP hydrolysis</span> <span class="citation_source-journal">J. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">143</span><span class="NLM_x">, </span> <span class="NLM_fpage">901</span><span class="NLM_x">–</span> <span class="NLM_lpage">910</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=143&publication_year=1998&pages=901-910&author=W.+M.+Obermannauthor=H.+Sondermannauthor=A.+A.+Russoauthor=N.+P.+Pavletichauthor=F.+U.+Hartl&title=In+vivo+function+of+Hsp90+is+dependent+on+ATP+binding+and+ATP+hydrolysis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DObermann%26aufirst%3DW.%2BM.%26aulast%3DSondermann%26aufirst%3DH.%26aulast%3DRusso%26aufirst%3DA.%2BA.%26aulast%3DPavletich%26aufirst%3DN.%2BP.%26aulast%3DHartl%26aufirst%3DF.%2BU.%26atitle%3DIn%2520vivo%2520function%2520of%2520Hsp90%2520is%2520dependent%2520on%2520ATP%2520binding%2520and%2520ATP%2520hydrolysis%26jtitle%3DJ.%2520Cell%2520Biol.%26date%3D1998%26volume%3D143%26spage%3D901%26epage%3D910" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Panaretou, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prodromou, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roe, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O'Brien, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ladbury, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piper, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pearl, L. H.</span><span> </span><span class="NLM_article-title">ATP binding and hydrolysis are essential to the function of the Hsp90 molecular chaperone in vivo</span> <span class="citation_source-journal">EMBO J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">4829</span><span class="NLM_x">–</span> <span class="NLM_lpage">4836</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1998&pages=4829-4836&author=B.+Panaretouauthor=C.+Prodromouauthor=S.+M.+Roeauthor=R.+O%27Brienauthor=J.+E.+Ladburyauthor=P.+W.+Piperauthor=L.+H.+Pearl&title=ATP+binding+and+hydrolysis+are+essential+to+the+function+of+the+Hsp90+molecular+chaperone+in+vivo"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPanaretou%26aufirst%3DB.%26aulast%3DProdromou%26aufirst%3DC.%26aulast%3DRoe%26aufirst%3DS.%2BM.%26aulast%3DO%2527Brien%26aufirst%3DR.%26aulast%3DLadbury%26aufirst%3DJ.%2BE.%26aulast%3DPiper%26aufirst%3DP.%2BW.%26aulast%3DPearl%26aufirst%3DL.%2BH.%26atitle%3DATP%2520binding%2520and%2520hydrolysis%2520are%2520essential%2520to%2520the%2520function%2520of%2520the%2520Hsp90%2520molecular%2520chaperone%2520in%2520vivo%26jtitle%3DEMBO%2520J.%26date%3D1998%26volume%3D17%26spage%3D4829%26epage%3D4836" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Pearl, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prodromou, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Workman, P.</span><span> </span><span class="NLM_article-title">The Hsp90 molecular chaperone: an open and shut case for treatment</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">410</span><span class="NLM_x">, </span> <span class="NLM_fpage">439</span><span class="NLM_x">–</span> <span class="NLM_lpage">453</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm900357y&amp;key=10.1042%2FBJ20071640" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm900357y&amp;key=18290764" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm900357y&amp;key=1%3ACAS%3A528%3ADC%252BD1cXisVWgtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=410&publication_year=2008&pages=439-453&author=L.+H.+Pearlauthor=C.+Prodromouauthor=P.+Workman&title=The+Hsp90+molecular+chaperone%3A+an+open+and+shut+case+for+treatment"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">The Hsp90 molecular chaperone: an open and shut case for treatment</span></div><div class="casAuthors">Pearl, Laurence H.; Prodromou, Chrisostomos; Workman, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">410</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">439-453</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">A review.  The mol. chaperone Hsp90 (90 kDa heat-shock protein) is a remarkably versatile protein involved in the stress response and in normal homeostatic control mechanisms.  It interacts with 'client proteins', including protein kinases, transcription factors and others, and either facilitates their stabilization and activation or directs them for proteasomal degrdn.  By this means, Hsp90 displays a multifaceted ability to influence signal transduction, chromatin remodelling and epigenetic regulation, development and morphol. evolution.  Hsp90 operates as a dimer in a conformational cycle driven by ATP binding and hydrolysis at the N-terminus.  The cycle is also regulated by a group of co-chaperones and accessory proteins.  Here the authors review the biol. of the Hsp90 mol. chaperone, emphasizing recent progress in the understanding of structure-function relationships and the identification of new client proteins.  In addn. we describe the exciting progress that has been made in the development of Hsp90 inhibitors, which are now showing promise in the clinic for cancer treatment.  The authors also identify the gaps in the current understanding and highlight important topics for future research.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6x-AH695RgrVg90H21EOLACvtfcHk0ljvl7l4REyq6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXisVWgtrs%253D&md5=2623a81947643815e7b314e4859ef057</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1042%2FBJ20071640&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBJ20071640%26sid%3Dliteratum%253Aachs%26aulast%3DPearl%26aufirst%3DL.%2BH.%26aulast%3DProdromou%26aufirst%3DC.%26aulast%3DWorkman%26aufirst%3DP.%26atitle%3DThe%2520Hsp90%2520molecular%2520chaperone%253A%2520an%2520open%2520and%2520shut%2520case%2520for%2520treatment%26jtitle%3DBiochem.%2520J.%26date%3D2008%26volume%3D410%26spage%3D439%26epage%3D453" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span>For a list, see the web page maintained by D. Picard: <a href="http://www.picard.ch/downloads/Hsp90interactors.pdf" class="extLink">http://www.picard.ch/downloads/Hsp90interactors.pdf</a>. Accessed on July 13, 2009</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=For+a+list%2C+see+the+web+page+maintained+by+D.+Picard%3A+http%3A%2F%2Fwww.picard.ch%2Fdownloads%2FHsp90interactors.pdf.+Accessed+on+July+13%2C+2009"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Whitesell, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindquist, S. L.</span><span> </span><span class="NLM_article-title">HSP90 and the chaperoning of cancer</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">761</span><span class="NLM_x">–</span> <span class="NLM_lpage">772</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm900357y&amp;key=10.1038%2Fnrc1716" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm900357y&amp;key=16175177" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm900357y&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVGjs7bF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=761-772&author=L.+Whitesellauthor=S.+L.+Lindquist&title=HSP90+and+the+chaperoning+of+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">HSP90 and the chaperoning of cancer</span></div><div class="casAuthors">Whitesell, Luke; Lindquist, Susan L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">761-772</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Standing watch over the proteome, mol. chaperones are an ancient and evolutionarily conserved class of proteins that guide the normal folding, intracellular disposition and proteolytic turnover of many of the key regulators of cell growth, differentiation and survival.  This essential guardian function is subverted during oncogenesis to allow malignant transformation and to facilitate rapid somatic evolution.  Pharmacol. 'bribing' the essential guard duty of the chaperone HSP90 (heat-shock protein of 90 kDa) seems to offer a unique anticancer strategy of considerable promise.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp4Vmb5bGXgDLVg90H21EOLACvtfcHk0ljvl7l4REyq6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVGjs7bF&md5=c418ec249a29c70047081cd241938931</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fnrc1716&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc1716%26sid%3Dliteratum%253Aachs%26aulast%3DWhitesell%26aufirst%3DL.%26aulast%3DLindquist%26aufirst%3DS.%2BL.%26atitle%3DHSP90%2520and%2520the%2520chaperoning%2520of%2520cancer%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2005%26volume%3D5%26spage%3D761%26epage%3D772" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Maloney, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Workman, P.</span><span> </span><span class="NLM_article-title">HSP90 as a new therapeutic target for cancer therapy: the story unfolds</span> <span class="citation_source-journal">Expert Opin. Biol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">3</span><span class="NLM_x">–</span> <span class="NLM_lpage">24</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm900357y&amp;key=10.1517%2F14712598.2.1.3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm900357y&amp;key=11772336" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm900357y&amp;key=1%3ACAS%3A528%3ADC%252BD38XnsVaksw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2002&pages=3-24&author=A.+Maloneyauthor=P.+Workman&title=HSP90+as+a+new+therapeutic+target+for+cancer+therapy%3A+the+story+unfolds"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">HSP90 as a new therapeutic target for cancer therapy: the story unfolds</span></div><div class="casAuthors">Maloney, Alison; Workman, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Biological Therapy</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">3-24</span>CODEN:
                <span class="NLM_cas:coden">EOBTA2</span>;
        ISSN:<span class="NLM_cas:issn">1471-2598</span>.
    
            (<span class="NLM_cas:orgname">Ashley Publications Ltd.</span>)
        </div><div class="casAbstract">A review. Current anticancer drug-development strategies involve identifying novel mol. targets which are crucial for tumorigenesis.  The mol. chaperone heat-shock protein (HSP) 90 is of interest as an anticancer drug target because of its importance in maintaining the conformation, stability and function of key oncogenic client proteins involved in signal transduction pathways leading to proliferation, cell cycle progression, and apoptosis, as well as other features of the malignant phenotype such as invasion, angiogenesis and metastasis.  The natural-product HSP90 inhibitors geldanamycin and radicicol exert their antitumor effect by inhibiting the intrinsic ATPase activity of HSP90, resulting in degrdn. of HSP90 client proteins via the ubiquitin proteosome pathway.  Anticancer selectivity may derive from the simultaneous combinatorial effects of HSP90 inhibitors on multiple cancer targets and pathways. 17-Allylamino-17-demethoxygeldanamycin (17AAG) showed good activity and cancer selectivity in preclin. models and has now progressed to Phase I clin. trials in cancer patients with encouraging initial results.  Phase II trials including combination studies with cytotoxic agents are now being planned and these should allow the therapeutic activity of 17AAG to be detd.  Second-generation HSP90 inhibitors may be designed to overcome some of the drawbacks of 17AAG, including limited oral bioavailability and soly.  They could also be engineered to target specific functions of HSP90, which may not only provide greater mol. selectivity and clin. benefit but may also increase understanding of the complex functions of this mol. chaperone.  HSP90 inhibitors provide proof of concept for drugs directed at HSP90 and protein folding and this principle may be applicable to other medical conditions involving protein aggregation and stability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxpya4HhGPu7Vg90H21EOLACvtfcHk0lgrtGY2Dv6apg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XnsVaksw%253D%253D&md5=b0542acde22286a95578e3ef4dac0d8e</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1517%2F14712598.2.1.3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14712598.2.1.3%26sid%3Dliteratum%253Aachs%26aulast%3DMaloney%26aufirst%3DA.%26aulast%3DWorkman%26aufirst%3DP.%26atitle%3DHSP90%2520as%2520a%2520new%2520therapeutic%2520target%2520for%2520cancer%2520therapy%253A%2520the%2520story%2520unfolds%26jtitle%3DExpert%2520Opin.%2520Biol.%2520Ther.%26date%3D2002%26volume%3D2%26spage%3D3%26epage%3D24" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Kamal, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boehm, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burrows, F. J.</span><span> </span><span class="NLM_article-title">Therapeutic and diagnostic implications of Hsp90 activation</span> <span class="citation_source-journal">Trends Mol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">283</span><span class="NLM_x">–</span> <span class="NLM_lpage">290</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2004&pages=283-290&author=A.+Kamalauthor=M.+F.+Boehmauthor=F.+J.+Burrows&title=Therapeutic+and+diagnostic+implications+of+Hsp90+activation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKamal%26aufirst%3DA.%26aulast%3DBoehm%26aufirst%3DM.%2BF.%26aulast%3DBurrows%26aufirst%3DF.%2BJ.%26atitle%3DTherapeutic%2520and%2520diagnostic%2520implications%2520of%2520Hsp90%2520activation%26jtitle%3DTrends%2520Mol.%2520Med.%26date%3D2004%26volume%3D10%26spage%3D283%26epage%3D290" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Chiosis, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vilenchik, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Solit, D.</span><span> </span><span class="NLM_article-title">Hsp90: the vulnerable chaperone</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">881</span><span class="NLM_x">–</span> <span class="NLM_lpage">888</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2004&pages=881-888&author=G.+Chiosisauthor=M.+Vilenchikauthor=J.+Kimauthor=D.+Solit&title=Hsp90%3A+the+vulnerable+chaperone"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChiosis%26aufirst%3DG.%26aulast%3DVilenchik%26aufirst%3DM.%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DSolit%26aufirst%3DD.%26atitle%3DHsp90%253A%2520the%2520vulnerable%2520chaperone%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2004%26volume%3D9%26spage%3D881%26epage%3D888" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Hanahan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinberg, R. A.</span><span> </span><span class="NLM_article-title">The hallmarks of cancer</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">100</span><span class="NLM_x">, </span> <span class="NLM_fpage">57</span><span class="NLM_x">–</span> <span class="NLM_lpage">70</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm900357y&amp;key=10.1016%2FS0092-8674%2800%2981683-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm900357y&amp;key=10647931" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm900357y&amp;key=1%3ACAS%3A528%3ADC%252BD3cXks1CktA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2000&pages=57-70&author=D.+Hanahanauthor=R.+A.+Weinberg&title=The+hallmarks+of+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">The hallmarks of cancer</span></div><div class="casAuthors">Hanahan, Douglas; Weinberg, Robert A.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, Massachusetts)</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">100</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">57-70</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review is given with many refs. on principles governing the transformation of normal human cells into malignant cancers.  The authors suggest that research over the past decades has revealed a small no. of mol., biochem., and cellular traits (acquired capabilities) shared by most and perhaps all types of cancer.  Topics included are the acquired capabilities self-sufficiency in growth signals, insensitivity to antigrowth signals, evading apoptosis, limitless replicative potential, sustained angiogenesis, and tissue invasion and metastasis followed by genome instability as an enabling characteristic and alternative pathways to cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGooXmGqKjM1C7Vg90H21EOLACvtfcHk0lgrtGY2Dv6apg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXks1CktA%253D%253D&md5=1d23c4400dad34c7f32d4a0c41890349</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2FS0092-8674%2800%2981683-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0092-8674%252800%252981683-9%26sid%3Dliteratum%253Aachs%26aulast%3DHanahan%26aufirst%3DD.%26aulast%3DWeinberg%26aufirst%3DR.%2BA.%26atitle%3DThe%2520hallmarks%2520of%2520cancer%26jtitle%3DCell%26date%3D2000%26volume%3D100%26spage%3D57%26epage%3D70" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Workman, P.</span><span> </span><span class="NLM_article-title">Combinatorial attack on multistep oncogenesis by inhibiting the Hsp90 molecular chaperone</span> <span class="citation_source-journal">Cancer Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">206</span><span class="NLM_x">, </span> <span class="NLM_fpage">149</span><span class="NLM_x">–</span> <span class="NLM_lpage">157</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm900357y&amp;key=10.1016%2Fj.canlet.2003.08.032" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm900357y&amp;key=15013520" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm900357y&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhvFaiu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=206&publication_year=2004&pages=149-157&author=P.+Workman&title=Combinatorial+attack+on+multistep+oncogenesis+by+inhibiting+the+Hsp90+molecular+chaperone"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Combinatorial attack on multistep oncogenesis by inhibiting the Hsp90 molecular chaperone</span></div><div class="casAuthors">Workman, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">206</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">149-157</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  The mol. chaperone Hsp90 is not only of major current interest in fundamental biol. research but also recognized as an exciting new target for the treatment of cancer and other diseases.  In addn. to playing an important role in response to proteotoxic heat shock and others stresses, Hsp90 is also crit. for maintaining normal cellular homeostasis.  Hsp90 is responsible for ensuring the conformational stability, shape and function of a selected range of key proteins, including many kinases and transcription factors.  Furthermore, recent studies show that Hsp90 plays a key role in development and evolution.  Hsp90 is overexpressed in cancer cells and is thought to be involved in dealing with the cellular stress assocd. with malignancy, as well as being essential for a range of key oncogenic proteins, including ErbB2, Raf-1, Akt/PKB, mutant p53 and many others.  A major attraction of Hsp90 inhibitors is their potential to inhibit a range of 'mission crit.' cancer pathways, thereby blocking all of the hallmark traits' of malignancy and exhibiting broad-spectrum antitumor activity.  The first-in-class Hsp90 inhibitor 17AAG has entered clin. trials with promising early results and a range of other agents is under investigation and preclin. development.  This article reviews the current status and future prospects for the exploitation of Hsp90 as a new mol. target for cancer treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVh9SsuC7uE7Vg90H21EOLACvtfcHk0lg5P11-jGxFtg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhvFaiu7s%253D&md5=082cb68ad7ccf630d7f1ccedde160744</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2003.08.032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2003.08.032%26sid%3Dliteratum%253Aachs%26aulast%3DWorkman%26aufirst%3DP.%26atitle%3DCombinatorial%2520attack%2520on%2520multistep%2520oncogenesis%2520by%2520inhibiting%2520the%2520Hsp90%2520molecular%2520chaperone%26jtitle%3DCancer%2520Lett.%26date%3D2004%26volume%3D206%26spage%3D149%26epage%3D157" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">DeBoer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meulman, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wnuk, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peterson, D. H.</span><span> </span><span class="NLM_article-title">Geldanamycin, a new antibiotic</span> <span class="citation_source-journal">J. Antibiot. (Tokyo)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1970</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">442</span><span class="NLM_x">–</span> <span class="NLM_lpage">447</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm900357y&amp;key=10.7164%2Fantibiotics.23.442" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm900357y&amp;key=5459626" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm900357y&amp;key=1%3ACAS%3A528%3ADyaE3MXhtFyltQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=1970&pages=442-447&author=C.+DeBoerauthor=P.+A.+Meulmanauthor=R.+J.+Wnukauthor=D.+H.+Peterson&title=Geldanamycin%2C+a+new+antibiotic"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Geldanamycin, a new antibiotic</span></div><div class="casAuthors">De Boer, Clarence; Meulman, P. A.; Wnuk, R. J.; Peterson, Durey Harold</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Antibiotics</span>
        (<span class="NLM_cas:date">1970</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">442-7</span>CODEN:
                <span class="NLM_cas:coden">JANTAJ</span>;
        ISSN:<span class="NLM_cas:issn">0021-8820</span>.
    </div><div class="casAbstract">Geldanamycin, an antibiotic isolated in cryst. form from culture filtrates of Streptomyces hygroscopicus, was moderately active in vitro against protozoa, bacteria, and fungi.  Geldanamycin was also active against L-1210 and KB tumor cells growing in culture and against the parasite Syphacia obvelata in vivo.  Phys. and chem. properties indicated that geldanamycin is a complex mol. consisting of an unsatd. moiety attached to a quinone.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpu-1yq8CsQ5bVg90H21EOLACvtfcHk0lg5P11-jGxFtg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE3MXhtFyltQ%253D%253D&md5=c3b43c17ee1cdafdf44ffbe0ae1348f7</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.7164%2Fantibiotics.23.442&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7164%252Fantibiotics.23.442%26sid%3Dliteratum%253Aachs%26aulast%3DDeBoer%26aufirst%3DC.%26aulast%3DMeulman%26aufirst%3DP.%2BA.%26aulast%3DWnuk%26aufirst%3DR.%2BJ.%26aulast%3DPeterson%26aufirst%3DD.%2BH.%26atitle%3DGeldanamycin%252C%2520a%2520new%2520antibiotic%26jtitle%3DJ.%2520Antibiot.%2520%2528Tokyo%2529%26date%3D1970%26volume%3D23%26spage%3D442%26epage%3D447" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Supko, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickman, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grever, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malspeis, L.</span><span> </span><span class="NLM_article-title">Preclinical pharmacologic evaluation of geldanamycin as an antitumor agent</span> <span class="citation_source-journal">Cancer Chemother. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">305</span><span class="NLM_x">–</span> <span class="NLM_lpage">315</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm900357y&amp;key=10.1007%2FBF00689048" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm900357y&amp;key=7628050" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm900357y&amp;key=1%3ACAS%3A528%3ADyaK2MXnsFShtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=1995&pages=305-315&author=J.+G.+Supkoauthor=R.+L.+Hickmanauthor=M.+R.+Greverauthor=L.+Malspeis&title=Preclinical+pharmacologic+evaluation+of+geldanamycin+as+an+antitumor+agent"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Preclinical pharmacologic evaluation of geldanamycin as an antitumor agent</span></div><div class="casAuthors">Supko, Jeffrey G.; Hickman, Robert L.; Grever, Michael R.; Malspeis, Louis</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Chemotherapy and Pharmacology</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">305-15</span>CODEN:
                <span class="NLM_cas:coden">CCPHDZ</span>;
        ISSN:<span class="NLM_cas:issn">0344-5704</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">The plasma pharmacokinetics of the antitumor antibiotic geldanamycin (GM; NSC 122750), a naturally occurring benzoquinoid ansamycin, were characterized in mice and a beagle dog.  Concns. of GM well above 0.1 μg/mL, which were typically effective against neoplastic cell lines responsive to the drug in vitro, were achieved in the plasma of the mice and the dog treated by i.v. injection.  However, the systemic duration of the drug was relatively short.  Plasma levels decayed to <0.1 μg/mL within 3-4 h after administration of the apparent max. tolerated doses, which were approx. 20 mg/kg for the mice and 4 mg/kg for the dog.  The drug exhibited linear pharmacokinetic behavior within the dose ranges studied.  However, there were significant interspecies differences in its disposition.  Whereas the mean biol. half-life of GM was slightly longer in the mice (77.7 min) than in the dog (57.9 min), its mean residence time in the dog (46.6 min) was >2-fold greater than that in the mice (20.7 min).  Nevertheless, the drug was cleared from plasma much faster by the dog (49.4 mL/min/kg) than by the mice (30.5 mL/min/kg).  These apparent anomalies were principally assocd. with differences in the relative significance of the terminal phase upon overall drug disposition.  The liver appeared to be the principal target organ of acute drug toxicity in the dog.  Doses of 2.0 and 4.2 mg/kg both produced elevations in serum levels of the transaminases and other indicators of liver function characteristic of acute hepatic necrosis.  Addnl. effects included symptoms of minor gastrointestinal toxicity and alterations in serum chem. parameters consistent with less severe nephrotoxicity.  The drug-related toxicity appeared to be reversible.  In consideration of the potential for acute hepatotoxic reactions to GM, as well as to the other benzoquinoid ansamycins based upon structural analogy, addnl. pharmacol. and therapeutic information is required to ascertain whether these compds. are viable candidates for clin. development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9-P4wBmA1f7Vg90H21EOLACvtfcHk0lg5P11-jGxFtg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXnsFShtLs%253D&md5=cde4aa9e616ff38b67dafed67b05d174</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1007%2FBF00689048&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF00689048%26sid%3Dliteratum%253Aachs%26aulast%3DSupko%26aufirst%3DJ.%2BG.%26aulast%3DHickman%26aufirst%3DR.%2BL.%26aulast%3DGrever%26aufirst%3DM.%2BR.%26aulast%3DMalspeis%26aufirst%3DL.%26atitle%3DPreclinical%2520pharmacologic%2520evaluation%2520of%2520geldanamycin%2520as%2520an%2520antitumor%2520agent%26jtitle%3DCancer%2520Chemother.%2520Pharmacol.%26date%3D1995%26volume%3D36%26spage%3D305%26epage%3D315" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Neckers, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schulte, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mimnaugh, E.</span><span> </span><span class="NLM_article-title">Geldanamycin as a potential anticancer agent: its molecular target and biochemical activity</span> <span class="citation_source-journal">Invest. New Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">361</span><span class="NLM_x">–</span> <span class="NLM_lpage">373</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1999&pages=361-373&author=L.+Neckersauthor=T.+W.+Schulteauthor=E.+Mimnaugh&title=Geldanamycin+as+a+potential+anticancer+agent%3A+its+molecular+target+and+biochemical+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNeckers%26aufirst%3DL.%26aulast%3DSchulte%26aufirst%3DT.%2BW.%26aulast%3DMimnaugh%26aufirst%3DE.%26atitle%3DGeldanamycin%2520as%2520a%2520potential%2520anticancer%2520agent%253A%2520its%2520molecular%2520target%2520and%2520biochemical%2520activity%26jtitle%3DInvest.%2520New%2520Drugs%26date%3D1999%26volume%3D17%26spage%3D361%26epage%3D373" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Delmotte, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delmotte-Plaque, J.</span><span> </span><span class="NLM_article-title">A new antifungal substance of fungal origin</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1953</span><span class="NLM_x">, </span> <span class="NLM_volume">171</span><span class="NLM_x">, </span> <span class="NLM_fpage">344</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=171&publication_year=1953&pages=344&author=P.+Delmotteauthor=J.+Delmotte-Plaque&title=A+new+antifungal+substance+of+fungal+origin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDelmotte%26aufirst%3DP.%26aulast%3DDelmotte-Plaque%26aufirst%3DJ.%26atitle%3DA%2520new%2520antifungal%2520substance%2520of%2520fungal%2520origin%26jtitle%3DNature%26date%3D1953%26volume%3D171%26spage%3D344" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Soga, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiotsu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akinaga, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharma, S. V.</span><span> </span><span class="NLM_article-title">Development of radicicol analogues</span> <span class="citation_source-journal">Curr. Cancer Drug Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">359</span><span class="NLM_x">–</span> <span class="NLM_lpage">369</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm900357y&amp;key=10.2174%2F1568009033481859" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm900357y&amp;key=14529387" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm900357y&amp;key=1%3ACAS%3A528%3ADC%252BD3sXnsV2is74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2003&pages=359-369&author=S.+Sogaauthor=Y.+Shiotsuauthor=S.+Akinagaauthor=S.+V.+Sharma&title=Development+of+radicicol+analogues"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Development of radicicol analogues</span></div><div class="casAuthors">Soga, Shiro; Shiotsu, Yukimasa; Akinaga, Shiro; Sharma, Sreenath V.</div><div class="citationInfo"><span class="NLM_cas:title">Current Cancer Drug Targets</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">359-369</span>CODEN:
                <span class="NLM_cas:coden">CCDTB9</span>;
        ISSN:<span class="NLM_cas:issn">1568-0096</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Radicicol, a macrocyclic antibiotic produced by fungi, was originally isolated many years ago, and was described as tyrosine kinase inhibitor.  We also rediscovered radicicol as an inhibitor of signal transduction of oncogene products, such as K-ras and v-Src, using yeast and mammalian cell-based assays.  In a study of mechanisms of action, it was revealed that radicicol depletes the Hsp90 client signaling mols. in cells, and thus inhibit the signal transduction pathway.  In addn., direct binding of radicicol to the N-terminal ATP/ADP binding site of Hsp90 was shown, and thus radicicol has been recognized as a structurally unique antibiotic that binds and inhibits the mol. chaperone Hsp90.  Although radicicol itself has little or no activity in animals because of instability in animals, its oxime derivs. showed potent antitumor activities against human tumor xenograft models.  Hsp90 client proteins were depleted and apoptosis was induced in the tumor specimen treated with radicicol oxime derivs.  Taken together, these results suggest that the antitumor activity of radicicol oxime derivs. is mediated by binding to Hsp90 and destabilization of Hsp90 client proteins in the tumor.  Among Hsp90 clients, we focused on ErbB2 and Bcr-Abl as examples of important targets of Hsp90 inhibitors.  Radicicol oxime showed potent antitumor activity against ER neg./ErbB2 overexpressing breast cancer and Bcr-Abl expressing CML.  Putative mechanisms of action and future directions of radicicol oxime against these kinds of tumor are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-uapkd0TYQrVg90H21EOLACvtfcHk0ljuoaFn_ZNIkw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXnsV2is74%253D&md5=59ef4ec5535cec06665a164be0b12305</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.2174%2F1568009033481859&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568009033481859%26sid%3Dliteratum%253Aachs%26aulast%3DSoga%26aufirst%3DS.%26aulast%3DShiotsu%26aufirst%3DY.%26aulast%3DAkinaga%26aufirst%3DS.%26aulast%3DSharma%26aufirst%3DS.%2BV.%26atitle%3DDevelopment%2520of%2520radicicol%2520analogues%26jtitle%3DCurr.%2520Cancer%2520Drug%2520Targets%26date%3D2003%26volume%3D3%26spage%3D359%26epage%3D369" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Roe, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prodromou, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O'Brien, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ladbury, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piper, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pearl, L. H.</span><span> </span><span class="NLM_article-title">Structural basis for inhibition of the Hsp90 molecular chaperone by the antitumor antibiotics radicicol and geldanamycin</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">260</span><span class="NLM_x">–</span> <span class="NLM_lpage">266</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm980403y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1999&pages=260-266&author=S.+M.+Roeauthor=C.+Prodromouauthor=R.+O%27Brienauthor=J.+E.+Ladburyauthor=P.+W.+Piperauthor=L.+H.+Pearl&title=Structural+basis+for+inhibition+of+the+Hsp90+molecular+chaperone+by+the+antitumor+antibiotics+radicicol+and+geldanamycin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fjm980403y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm980403y%26sid%3Dliteratum%253Aachs%26aulast%3DRoe%26aufirst%3DS.%2BM.%26aulast%3DProdromou%26aufirst%3DC.%26aulast%3DO%2527Brien%26aufirst%3DR.%26aulast%3DLadbury%26aufirst%3DJ.%2BE.%26aulast%3DPiper%26aufirst%3DP.%2BW.%26aulast%3DPearl%26aufirst%3DL.%2BH.%26atitle%3DStructural%2520basis%2520for%2520inhibition%2520of%2520the%2520Hsp90%2520molecular%2520chaperone%2520by%2520the%2520antitumor%2520antibiotics%2520radicicol%2520and%2520geldanamycin%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1999%26volume%3D42%26spage%3D260%26epage%3D266" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Hostein, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robertson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DiStefano, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Workman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clarke, P. A.</span><span> </span><span class="NLM_article-title">Inhibition of signal transduction by the Hsp90 inhibitor 17-allylamino-17-demethoxygeldanamycin results in cytostasis and apoptosis</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">4003</span><span class="NLM_x">–</span> <span class="NLM_lpage">4009</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2001&pages=4003-4009&author=I.+Hosteinauthor=D.+Robertsonauthor=F.+DiStefanoauthor=P.+Workmanauthor=P.+A.+Clarke&title=Inhibition+of+signal+transduction+by+the+Hsp90+inhibitor+17-allylamino-17-demethoxygeldanamycin+results+in+cytostasis+and+apoptosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHostein%26aufirst%3DI.%26aulast%3DRobertson%26aufirst%3DD.%26aulast%3DDiStefano%26aufirst%3DF.%26aulast%3DWorkman%26aufirst%3DP.%26aulast%3DClarke%26aufirst%3DP.%2BA.%26atitle%3DInhibition%2520of%2520signal%2520transduction%2520by%2520the%2520Hsp90%2520inhibitor%252017-allylamino-17-demethoxygeldanamycin%2520results%2520in%2520cytostasis%2520and%2520apoptosis%26jtitle%3DCancer%2520Res.%26date%3D2001%26volume%3D61%26spage%3D4003%26epage%3D4009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Schulte, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neckers, L. M.</span><span> </span><span class="NLM_article-title">The benzoquinone ansamycin 17-allylamino-17-demethoxygeldanamycin binds to HSP90 and shares important biologic activities with geldanamycin</span> <span class="citation_source-journal">Cancer Chemother. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">273</span><span class="NLM_x">–</span> <span class="NLM_lpage">279</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm900357y&amp;key=10.1007%2Fs002800050817" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm900357y&amp;key=9744771" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm900357y&amp;key=1%3ACAS%3A528%3ADyaK1cXls1Wlt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1998&pages=273-279&author=T.+W.+Schulteauthor=L.+M.+Neckers&title=The+benzoquinone+ansamycin+17-allylamino-17-demethoxygeldanamycin+binds+to+HSP90+and+shares+important+biologic+activities+with+geldanamycin"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">The benzoquinone ansamycin 17-allylamino-17-demethoxygeldanamycin binds to HSP90 and shares important biologic activities with geldanamycin</span></div><div class="casAuthors">Schulte, Theodor W.; Neckers, Leonard M.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Chemotherapy and Pharmacology</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">273-279</span>CODEN:
                <span class="NLM_cas:coden">CCPHDZ</span>;
        ISSN:<span class="NLM_cas:issn">0344-5704</span>.
    
            (<span class="NLM_cas:orgname">Springer-Verlag</span>)
        </div><div class="casAbstract">Binding of 17-allylamino-17-demethoxygeldanamycin (17-AG) to the heat-shock protein HSP90 was studied in vitro using a geldanamycin (GA)-affinity beads competition assay.  The drug-induced destabilization was studied of p185erbB2, Raf-1, and mutant p53 in SKBR3 breast cancer cells by Western blotting.  The antiproliferative activities of 17-AG and GA were compared using the MTT assay.  The 17-AG bound specifically to HSP90 in a similar manner as GA itself.  It also led to degrdn. of the receptor Tyr kinase p185erbB2, the Ser/Thr kinase Raf-1, and mutant p53.  GA and 17-AG displayed comparable antiproliferative effects in SKBR3 and MCF7 cells.  Even though HSP90 binding with 17-AG was weaker than by GA, 17-AG and GA caused biol. effects in tumor cells at similar doses.  Since 17-AG had a better toxicity profile than GA, it was suggested as benzoquinone ansamycin candidate for clin. development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGouj3pMDUB7kLVg90H21EOLACvtfcHk0ljuoaFn_ZNIkw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXls1Wlt7Y%253D&md5=3d6ac0592b10d66b391f824272523de2</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1007%2Fs002800050817&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs002800050817%26sid%3Dliteratum%253Aachs%26aulast%3DSchulte%26aufirst%3DT.%2BW.%26aulast%3DNeckers%26aufirst%3DL.%2BM.%26atitle%3DThe%2520benzoquinone%2520ansamycin%252017-allylamino-17-demethoxygeldanamycin%2520binds%2520to%2520HSP90%2520and%2520shares%2520important%2520biologic%2520activities%2520with%2520geldanamycin%26jtitle%3DCancer%2520Chemother.%2520Pharmacol.%26date%3D1998%26volume%3D42%26spage%3D273%26epage%3D279" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Banerji, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O'Donnell, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scurr, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pacey, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stapleton, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asad, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simmons, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maloney, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raynaud, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walton, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lakhani, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaye, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Workman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Judson, I.</span><span> </span><span class="NLM_article-title">Phase I pharmacokinetic and pharmacodynamic study of 17-allylamino, 17-demethoxygeldanamycin in patients with advanced malignancies</span> <span class="citation_source-journal">J. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">4152</span><span class="NLM_x">–</span> <span class="NLM_lpage">4161</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm900357y&amp;key=10.1200%2FJCO.2005.00.612" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm900357y&amp;key=15961763" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm900357y&amp;key=1%3ACAS%3A528%3ADC%252BD2MXmt1elsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2005&pages=4152-4161&author=U.+Banerjiauthor=A.+O%27Donnellauthor=M.+Scurrauthor=S.+Paceyauthor=S.+Stapletonauthor=Y.+Asadauthor=L.+Simmonsauthor=A.+Maloneyauthor=F.+Raynaudauthor=M.+Campbellauthor=M.+Waltonauthor=S.+Lakhaniauthor=S.+Kayeauthor=P.+Workmanauthor=I.+Judson&title=Phase+I+pharmacokinetic+and+pharmacodynamic+study+of+17-allylamino%2C+17-demethoxygeldanamycin+in+patients+with+advanced+malignancies"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Phase I pharmacokinetic and pharmacodynamic study of 17-allylamino, 17-demethoxygeldanamycin in patients with advanced malignancies</span></div><div class="casAuthors">Banerji, Udai; O'Donnell, Anne; Scurr, Michelle; Pacey, Simon; Stapleton, Sarah; Asad, Yasmin; Simmons, Laura; Maloney, Alison; Raynaud, Florence; Campbell, Maeli; Walton, Michael; Lakhani, Sunil; Kaye, Stanley; Workman, Paul; Judson, Ian</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Oncology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">4152-4161</span>CODEN:
                <span class="NLM_cas:coden">JCONDN</span>;
        ISSN:<span class="NLM_cas:issn">0732-183X</span>.
    
            (<span class="NLM_cas:orgname">American Society of Clinical Oncology</span>)
        </div><div class="casAbstract">Purpose: To study the toxicity and pharmacokinetic-pharmacodynamic profile of 17-allylamino, 17-demethoxygeldanamycin (17-AAG) and to recommend a dose for phase II trials.  Patients and Methods: This was a phase I study examg. a once-weekly dosing schedule of 17-AAG.  Thirty patients with advanced malignancies were treated.  Results: The highest dose level reached was 450 mg/m2/wk.  The dose-limiting toxicities (DLTs) encountered were grade 3 diarrhea in three patients (one at 320 mg/m2/wk and two at 450 mg/m2/wk) and grade 3 to 4 hepatotoxicity (AST/ALT) in one patient at 450 mg/m2/wk.  Two of nine DLTs were at the highest dose level.  Two patients with metastatic melanoma had stable disease and were treated for 15 and 41 mo, resp.  The dose vs. area under the curve-relationship for 17-AAG was linear (r2 = .71) over the dose range 10 to 450 mg/m2/wk, with peak plasma concns. of 8,998 μg/L (std. deviation, 2,881) at the highest dose level.  After the demonstration of pharmacodynamic changes in peripheral blood leukocytes, pre- and 24 h post-treatment, tumor biopsies were performed and demonstrated target inhibition (c-RAF-1 inhibition in four of six patients, CDK4 depletion in eight of nine patients and HSP70 induction in eight of nine patients) at the dose levels 320 and 450 mg/m2/wk.  It was not possible to reproducibly demonstrate these changes in biopsies taken 5 days after treatment.  Conclusion: It has been possible to demonstrate that 17-AAG exhibits a tolerable toxicity profile with therapeutic plasma concns. and target inhibition for 24 h after treatment and some indications of clin. activity at the dose level 450 mg/m2/wk.  We recommend this dose for phase II clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoaKgFbodgT_bVg90H21EOLACvtfcHk0ljuoaFn_ZNIkw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXmt1elsrY%253D&md5=6ba10e24a68a1d9bd09d87239eea1ca6</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1200%2FJCO.2005.00.612&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2005.00.612%26sid%3Dliteratum%253Aachs%26aulast%3DBanerji%26aufirst%3DU.%26aulast%3DO%2527Donnell%26aufirst%3DA.%26aulast%3DScurr%26aufirst%3DM.%26aulast%3DPacey%26aufirst%3DS.%26aulast%3DStapleton%26aufirst%3DS.%26aulast%3DAsad%26aufirst%3DY.%26aulast%3DSimmons%26aufirst%3DL.%26aulast%3DMaloney%26aufirst%3DA.%26aulast%3DRaynaud%26aufirst%3DF.%26aulast%3DCampbell%26aufirst%3DM.%26aulast%3DWalton%26aufirst%3DM.%26aulast%3DLakhani%26aufirst%3DS.%26aulast%3DKaye%26aufirst%3DS.%26aulast%3DWorkman%26aufirst%3DP.%26aulast%3DJudson%26aufirst%3DI.%26atitle%3DPhase%2520I%2520pharmacokinetic%2520and%2520pharmacodynamic%2520study%2520of%252017-allylamino%252C%252017-demethoxygeldanamycin%2520in%2520patients%2520with%2520advanced%2520malignancies%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2005%26volume%3D23%26spage%3D4152%26epage%3D4161" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Goetz, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toft, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reid, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ames, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stensgard, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Safgren, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adjei, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sloan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atherton, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vasile, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salazaar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adjei, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Croghan, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erlichman, C.</span><span> </span><span class="NLM_article-title">Phase I trial of 17-allylamino-17-demethoxygeldanamycin in patients with advanced cancer</span> <span class="citation_source-journal">J. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">1078</span><span class="NLM_x">–</span> <span class="NLM_lpage">1087</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm900357y&amp;key=10.1200%2FJCO.2005.09.119" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm900357y&amp;key=15718306" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm900357y&amp;key=1%3ACAS%3A528%3ADC%252BD2MXitl2gtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2005&pages=1078-1087&author=M.+P.+Goetzauthor=D.+Toftauthor=J.+Reidauthor=M.+Amesauthor=B.+Stensgardauthor=S.+Safgrenauthor=A.+A.+Adjeiauthor=J.+Sloanauthor=P.+Athertonauthor=V.+Vasileauthor=S.+Salazaarauthor=A.+Adjeiauthor=G.+Croghanauthor=C.+Erlichman&title=Phase+I+trial+of+17-allylamino-17-demethoxygeldanamycin+in+patients+with+advanced+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Phase I trial of 17-allylamino-17-demethoxygeldanamycin in patients with advanced cancer</span></div><div class="casAuthors">Goetz, Matthew P.; Toft, David; Reid, Joel; Ames, Matthew; Stensgard, Bridget; Safgren, Stephanie; Adjei, Araba A.; Sloan, Jeff; Atherton, Pamela; Vasile, Vlad; Salazaar, Sandra; Adjei, Alex; Croghan, Gary; Erlichman, Charles</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Oncology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1078-1087</span>CODEN:
                <span class="NLM_cas:coden">JCONDN</span>;
        ISSN:<span class="NLM_cas:issn">0732-183X</span>.
    
            (<span class="NLM_cas:orgname">American Society of Clinical Oncology</span>)
        </div><div class="casAbstract">Purpose We detd. the max.-tolerated dose (MTD) and the dose-limiting toxicities (DLT) of 17-allylamino-17-demethoxygeldanamycin (17-AAG) when infused on days 1, 8, and 15 of a 28-day cycle in advanced solid tumor patients.  We also characterized the pharmacokinetics of 17-AAG, its effect on chaperone and client proteins, and whether cytochrome P 450 (CYP) 3A5 and NAD(P)H:quinone oxidoreductase 1 (NQO1) polymorphisms affected 17-AAG disposition or toxicity.  Patients and Methods An accelerated titrn. design was used.  Biomarkers were measured in peripheral-blood mononuclear cells (PBMCs) at baseline and on days 1 and 15, and pharmacokinetic anal. was performed on day 1 of cycle 1.  CYP3A5*3 and NQO1*2 genotypes were detd. and correlated with pharmacokinetics and toxicity.  Results Twenty-one patients received 52 courses at 11 dose levels.  DLTs at 431 mg/m2 were grade 3 bilirubin (n = 1), AST (n = 1), anemia (n = 1), nausea (n = 1), vomiting (n = 1), and myalgias (n = 1).  No tumor responses were seen.  17-AAG consistently increased heat shock protein (Hsp) 70 levels in PBMCs.  At the MTD, the clearance and half-life (t1/2) of 17-AAG were 11.6 L/h/m2 and 4.15 h, resp.; whereas the active metabolite 17-aminogeldanamycin had a t1/2 of 7.63 h.  The CYP3A5*3 and NQO1*2 polymorphisms were not assocd. with 17-AAG toxicity.  The CYP3A5*3 polymorphism was assocd. with higher 17-AAG clearance.  Conclusion The MTD of weekly 17-AAG is 308 mg/m2.  17-AAG induced Hsp70 in PBMCs, indicating that Hsp90 has been affected.  Further evaluation of 17-AAG is ongoing using a twice-weekly regimen, and this schedule of 17-AAG is being tested in combination with chemotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFPRrruDVbcLVg90H21EOLACvtfcHk0lg3x-M3XQuY4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXitl2gtbw%253D&md5=b4ea280cb99c9977e6fa4bdb5f6efc06</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1200%2FJCO.2005.09.119&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2005.09.119%26sid%3Dliteratum%253Aachs%26aulast%3DGoetz%26aufirst%3DM.%2BP.%26aulast%3DToft%26aufirst%3DD.%26aulast%3DReid%26aufirst%3DJ.%26aulast%3DAmes%26aufirst%3DM.%26aulast%3DStensgard%26aufirst%3DB.%26aulast%3DSafgren%26aufirst%3DS.%26aulast%3DAdjei%26aufirst%3DA.%2BA.%26aulast%3DSloan%26aufirst%3DJ.%26aulast%3DAtherton%26aufirst%3DP.%26aulast%3DVasile%26aufirst%3DV.%26aulast%3DSalazaar%26aufirst%3DS.%26aulast%3DAdjei%26aufirst%3DA.%26aulast%3DCroghan%26aufirst%3DG.%26aulast%3DErlichman%26aufirst%3DC.%26atitle%3DPhase%2520I%2520trial%2520of%252017-allylamino-17-demethoxygeldanamycin%2520in%2520patients%2520with%2520advanced%2520cancer%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2005%26volume%3D23%26spage%3D1078%26epage%3D1087" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Weigel, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blaney, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reid, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Safgren, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bagatell, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kersey, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neglia, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ivy, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ingle, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whitesell, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilbertson, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krailo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ames, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adamson, P. C.</span><span> </span><span class="NLM_article-title">A Phase I Study of 17-Allylaminogeldanamycin in Relapsed/Refractory Pediatric Patients with Solid Tumors: A Children's Oncology Group Study</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">1789</span><span class="NLM_x">–</span> <span class="NLM_lpage">1793</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Fjm900357y&amp;key=10.1158%2F1078-0432.CCR-06-2270" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Fjm900357y&amp;key=17363534" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm900357y&amp;key=1%3ACAS%3A528%3ADC%252BD2sXivV2gtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2007&pages=1789-1793&author=B.+J.+Weigelauthor=S.+M.+Blaneyauthor=J.+M.+Reidauthor=S.+L.+Safgrenauthor=R.+Bagatellauthor=J.+Kerseyauthor=J.+P.+Negliaauthor=S.+P.+Ivyauthor=A.+M.+Ingleauthor=L.+Whitesellauthor=R.+J.+Gilbertsonauthor=M.+Krailoauthor=M.+Amesauthor=P.+C.+Adamson&title=A+Phase+I+Study+of+17-Allylaminogeldanamycin+in+Relapsed%2FRefractory+Pediatric+Patients+with+Solid+Tumors%3A+A+Children%27s+Oncology+Group+Study"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">A phase I study of 17-allylaminogeldanamycin in relapsed/refractory pediatric patients with solid tumors: a children's oncology group Study</span></div><div class="casAuthors">Weigel, Brenda J.; Blaney, Susan M.; Reid, Joel M.; Safgren, Stephanie L.; Bagatell, Rochelle; Kersey, John; Neglia, Joseph P.; Ivy, S. Percy; Ingle, Ashish M.; Whitesell, Luke; Gilbertson, Richard J.; Krailo, Mark; Ames, Matthew; Adamson, Peter C.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1789-1793</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">To det. the recommended phase 2 dose, dose-limiting toxicities (DLT), pharmacokinetic profile, and pharmacodynamics of the heat shock protein (Hsp) 90 inhibitor, 17-allylaminogeldanamycin (17-AAG).  17-AAG was administered as a 60-min infusion, on days 1, 4, 8, and 11 of a 21-day cycle at dose levels of 150, 200, 270, and 360 mg/m2/dose.  Pharmacokinetic studies and evaluations for Hsp72 and Akt levels in peripheral blood mononuclear cells were done during the first course of therapy.  Seventeen patients (7 males), median 7 years of age (range, 1-19 years), were enrolled using a std. dose escalation scheme.  No DLTs were obsd.  Although there were no objective responses, three patients remain on therapy at 6+, 7+, and 9+ months with stable disease.  One patient with hepatoblastoma had a redn. in α-fetoprotein and stable disease over three cycles.  At 270 mg/m2/dose, the Cmax and areas under the plasma concn.-time curves of 17-AAG were 5,303 ± 1,591 ng/mL and 13,656 ± 4,757 ng/mL h, resp., similar to the exposure in adults.  The mean terminal half-life for 17-AAG was 3.24 ± 0.80 h.  Induction of Hsp72, a surrogate marker for inhibition of Hsp90, was detected at the 270 mg/m2 dose level.  Drug exposures consistent with those required for anticancer activity in preclin. models were achieved without DLT.  Evidence for drug-induced modulation of Hsp90 systemically was also detected.  The recommended phase II dose of 17-AAG is 360 mg/m2/d.  Non-DMSO-contg. formulations may improve acceptance of this drug by children and their families.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5bX_5e9xYaLVg90H21EOLACvtfcHk0lg3x-M3XQuY4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXivV2gtLw%253D&md5=993461ceb86c7e6fa3c759a482eea16e</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-06-2270&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-06-2270%26sid%3Dliteratum%253Aachs%26aulast%3DWeigel%26aufirst%3DB.%2BJ.%26aulast%3DBlaney%26aufirst%3DS.%2BM.%26aulast%3DReid%26aufirst%3DJ.%2BM.%26aulast%3DSafgren%26aufirst%3DS.%2BL.%26aulast%3DBagatell%26aufirst%3DR.%26aulast%3DKersey%26aufirst%3DJ.%26aulast%3DNeglia%26aufirst%3DJ.%2BP.%26aulast%3DIvy%26aufirst%3DS.%2BP.%26aulast%3DIngle%26aufirst%3DA.%2BM.%26aulast%3DWhitesell%26aufirst%3DL.%26aulast%3DGilbertson%26aufirst%3DR.%2BJ.%26aulast%3DKrailo%26aufirst%3DM.%26aulast%3DAmes%26aufirst%3DM.%26aulast%3DAdamson%26aufirst%3DP.%2BC.%26atitle%3DA%2520Phase%2520I%2520Study%2520of%252017-Allylaminogeldanamycin%2520in%2520Relapsed%252FRefractory%2520Pediatric%2520Patients%2520with%2520Solid%2520Tumors%253A%2520A%2520Children%2527s%2520Oncology%2520Group%2520Study%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2007%26volume%3D13%26spage%3D1789%26epage%3D1793" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Solit, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Osman, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polsky, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panageas, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daud, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goydos, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teitcher, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolchok, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Germino, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krown, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coit, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chapman, P. B.</span><span> </span><span class="NLM_article-title">Phase II Trial of 17-Allylamino-17-Demethoxygeldanamycin in Patients with Metastatic Melanoma</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">8302</span><span class="NLM_x">–</span> <span class="NLM_lpage">8307</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Fjm900357y&amp;key=10.1158%2F1078-0432.CCR-08-1002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Fjm900357y&amp;key=19088048" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Fjm900357y&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsV2it7nP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2008&pages=8302-8307&author=D.+B.+Solitauthor=I.+Osmanauthor=D.+Polskyauthor=K.+S.+Panageasauthor=A.+Daudauthor=J.+S.+Goydosauthor=J.+Teitcherauthor=J.+D.+Wolchokauthor=F.+J.+Germinoauthor=S.+E.+Krownauthor=D.+Coitauthor=N.+Rosenauthor=P.+B.+Chapman&title=Phase+II+Trial+of+17-Allylamino-17-Demethoxygeldanamycin+in+Patients+with+Metastatic+Melanoma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Phase II Trial of 17-Allylamino-17-Demethoxygeldanamycin in Patients with Metastatic Melanoma</span></div><div class="casAuthors">Solit, David B.; Osman, Iman; Polsky, David; Panageas, Katherine S.; Daud, Adil; Goydos, James S.; Teitcher, Jerrold; Wolchok, Jedd D.; Germino, F. Joseph; Krown, Susan E.; Coit, Daniel; Rosen, Neal; Chapman, Paul B.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">8302-8307</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">PURPOSE: Activation of the mitogen-activated protein kinase (MAPK) pathway and the phosphatidylinositol 3-kinase/AKT pathway seems to be crit. for melanoma proliferation.  Components of these pathways are client proteins of heat-shock protein 90 (hsp90), suggesting that inhibition of hsp90 could have significant antimelanoma effects.  We conducted a phase II trial using the hsp90 inhibitor 17-allylamino-17-demethoxygeldanamycin (17-AAG) in melanoma patients.  The primary end points were clin. responses and whether treatment inhibited MAPK pathway activity.  Exptl. Design: Melanoma patients with measurable disease were stratified on the basis of whether or not their tumor harbored a V600E BRAF mutation.  The hsp90 inhibitor 17-AAG was administered i.v. once weekly x6 wk at 450 mg/m2.  Tumor biopsies were obtained pretreatment and 18 to 50 h after the first dose of 17-AAG, and were snap-frozen.  RESULTS: Fifteen evaluable patients were treated; nine had BRAF mutations and six were wild-type.  No objective responses were obsd.  Western blot anal. of tumor biopsies showed an increase in hsp70 and a decrease in cyclin D1 expression in the posttreatment biopsies but no significant effect on RAF kinases or phospho-extracellular signal-regulated kinase expression.  Plasma analyzed by mutant-specific PCR for V600E BRAF showed 86% sensitivity and 67% specificity in predicting tumor DNA sequencing results.  CONCLUSIONS: At this dose and schedule of 17-AAG, the effects of 17-AAG on RAF kinase expression were short-lived, and no objective antimelanoma responses were seen.  Future trials in melanoma should focus on a more potent hsp90 inhibitor or a formulation that can be administered chronically for a more prolonged suppression of the MAPK pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8xsVn1x3UJrVg90H21EOLACvtfcHk0lgJO3LpyYG1Fg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsV2it7nP&md5=aa8e989cf8bd0f198920bd08808e2627</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-08-1002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-08-1002%26sid%3Dliteratum%253Aachs%26aulast%3DSolit%26aufirst%3DD.%2BB.%26aulast%3DOsman%26aufirst%3DI.%26aulast%3DPolsky%26aufirst%3DD.%26aulast%3DPanageas%26aufirst%3DK.%2BS.%26aulast%3DDaud%26aufirst%3DA.%26aulast%3DGoydos%26aufirst%3DJ.%2BS.%26aulast%3DTeitcher%26aufirst%3DJ.%26aulast%3DWolchok%26aufirst%3DJ.%2BD.%26aulast%3DGermino%26aufirst%3DF.%2BJ.%26aulast%3DKrown%26aufirst%3DS.%2BE.%26aulast%3DCoit%26aufirst%3DD.%26aulast%3DRosen%26aufirst%3DN.%26aulast%3DChapman%26aufirst%3DP.%2BB.%26atitle%3DPhase%2520II%2520Trial%2520of%252017-Allylamino-17-Demethoxygeldanamycin%2520in%2520Patients%2520with%2520Metastatic%2520Melanoma%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2008%26volume%3D14%26spage%3D8302%26epage%3D8307" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Kamal, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thao, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sensintaffar, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boehm, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fritz, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burrows, F. J.</span><span> </span><span class="NLM_article-title">A high-affinity conformation of Hsp90 confers tumour selectivity on Hsp90 inhibitors</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">425</span><span class="NLM_x">, </span> <span class="NLM_fpage">407</span><span class="NLM_x">–</span> <span class="NLM_lpage">410</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Fjm900357y&amp;key=10.1038%2Fnature01913" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Fjm900357y&amp;key=14508491" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm900357y&amp;key=1%3ACAS%3A528%3ADC%252BD3sXnsV2kt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=425&publication_year=2003&pages=407-410&author=A.+Kamalauthor=L.+Thaoauthor=J.+Sensintaffarauthor=L.+Zhangauthor=M.+F.+Boehmauthor=L.+C.+Fritzauthor=F.+J.+Burrows&title=A+high-affinity+conformation+of+Hsp90+confers+tumour+selectivity+on+Hsp90+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">A high-affinity conformation of Hsp90 confers tumor selectivity on Hsp90 inhibitors</span></div><div class="casAuthors">Kamal, Adeela; Thao, Lia; Sensintaffar, John; Zhang, Lin; Boehm, Marcus F.; Fritz, Lawrence C.; Burrows, Francis J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">425</span>
        (<span class="NLM_cas:issue">6956</span>),
    <span class="NLM_cas:pages">407-410</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Heat shock protein 90 (Hsp90) is a mol. chaperone that plays a key role in the conformational maturation of oncogenic signaling proteins, including HER-2/ErbB2, Akt, Raf-1, Bcr-Abl and mutated p53.  Hsp90 inhibitors bind to Hsp90, and induce the proteasomal degrdn. of Hsp90 client proteins.  Although Hsp90 is highly expressed in most cells, Hsp90 inhibitors selectively kill cancer cells compared to normal cells, and the Hsp90 inhibitor 17-allylaminogeldanamycin (17-AAG) is currently in phase I clin. trials.  However, the mol. basis of the tumor selectivity of Hsp90 inhibitors is unknown.  Here we report that Hsp90 derived from tumor cells has a 100-fold higher binding affinity for 17-AAG than does Hsp90 from normal cells.  Tumor Hsp90 is present entirely in multi-chaperone complexes with high ATPase activity, whereas Hsp90 from normal tissues is in a latent, uncomplexed state.  In vitro reconstitution of chaperone complexes with Hsp90 resulted in increased binding affinity to 17-AAG, and increased ATPase activity.  These results suggest that tumor cells contain Hsp90 complexes in an activated, high-affinity conformation that facilitates malignant progression, and that may represent a unique target for cancer therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp0ozo1K3wfA7Vg90H21EOLACvtfcHk0lgJO3LpyYG1Fg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXnsV2kt7w%253D&md5=7c83fca7aaf685b589c4aef6e5f39b02</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1038%2Fnature01913&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature01913%26sid%3Dliteratum%253Aachs%26aulast%3DKamal%26aufirst%3DA.%26aulast%3DThao%26aufirst%3DL.%26aulast%3DSensintaffar%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DBoehm%26aufirst%3DM.%2BF.%26aulast%3DFritz%26aufirst%3DL.%2BC.%26aulast%3DBurrows%26aufirst%3DF.%2BJ.%26atitle%3DA%2520high-affinity%2520conformation%2520of%2520Hsp90%2520confers%2520tumour%2520selectivity%2520on%2520Hsp90%2520inhibitors%26jtitle%3DNature%26date%3D2003%26volume%3D425%26spage%3D407%26epage%3D410" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">da Rocha, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedlos, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Light, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Springer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Workman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marais, R.</span><span> </span><span class="NLM_article-title">Activated B-RAF is an Hsp90 client protein that is targeted by the anticancer drug 17-allylamino-17-demethoxygeldanamycin</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">10686</span><span class="NLM_x">–</span> <span class="NLM_lpage">10691</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2005&pages=10686-10691&author=D.+S.+da+Rochaauthor=F.+Friedlosauthor=Y.+Lightauthor=C.+Springerauthor=P.+Workmanauthor=R.+Marais&title=Activated+B-RAF+is+an+Hsp90+client+protein+that+is+targeted+by+the+anticancer+drug+17-allylamino-17-demethoxygeldanamycin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3Dda%2BRocha%26aufirst%3DD.%2BS.%26aulast%3DFriedlos%26aufirst%3DF.%26aulast%3DLight%26aufirst%3DY.%26aulast%3DSpringer%26aufirst%3DC.%26aulast%3DWorkman%26aufirst%3DP.%26aulast%3DMarais%26aufirst%3DR.%26atitle%3DActivated%2520B-RAF%2520is%2520an%2520Hsp90%2520client%2520protein%2520that%2520is%2520targeted%2520by%2520the%2520anticancer%2520drug%252017-allylamino-17-demethoxygeldanamycin%26jtitle%3DCancer%2520Res.%26date%3D2005%26volume%3D65%26spage%3D10686%26epage%3D10691" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Workman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burrows, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neckers, L.</span><span> </span><span class="NLM_article-title">Drugging the cancer chaperone HSP90: combinatorial therapeutic exploitation of oncogene addiction and tumor stress</span> <span class="citation_source-journal">Ann. N.Y. Acad. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">1113</span><span class="NLM_x">, </span> <span class="NLM_fpage">202</span><span class="NLM_x">–</span> <span class="NLM_lpage">216</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Fjm900357y&amp;key=10.1196%2Fannals.1391.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Fjm900357y&amp;key=17513464" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm900357y&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVanurfF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1113&publication_year=2007&pages=202-216&author=P.+Workmanauthor=F.+Burrowsauthor=L.+Neckers&title=Drugging+the+cancer+chaperone+HSP90%3A+combinatorial+therapeutic+exploitation+of+oncogene+addiction+and+tumor+stress"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Drugging the cancer chaperone HSP90: combinatorial therapeutic expolitation on oncogene addiction and tumor stress</span></div><div class="casAuthors">Workman, Paul; Burrows, Francis; Neckers, Len; Rosen, Neal</div><div class="citationInfo"><span class="NLM_cas:title">Annals of the New York Academy of Sciences</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">1113</span>
        (<span class="NLM_cas:issue">Stress Responses in Biology and Medicine</span>),
    <span class="NLM_cas:pages">202-216</span>CODEN:
                <span class="NLM_cas:coden">ANYAA9</span>;
        ISSN:<span class="NLM_cas:issn">0077-8923</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing, Inc.</span>)
        </div><div class="casAbstract">A review.  The mol. chaperone HSP90 has emerged as an exciting target for cancer treatment.  We review the potential advantages of HSP90 inhibitors, particularly the simultaneous combinatorial depletion of multiple oncogenic "client" proteins, leading to blockade of many cancer-causing pathways and the antagonism of all of the hallmark pathol. traits of malignancy.  Cancer selectivity is achieved by exploiting cancer "dependencies," including oncogene addiction and the stressed state of malignant cells.  The multiple downstream effects of HSP90 inhibitors should make the development of resistance more difficult than with agents having more restricted effects.  We review the various classes of HSP90 inhibitor that have been developed, including the natural products geldanamycin and radicicol and also the purine scaffold and pyrazole/isoxazole class of synthetic small mol. inhibitors.  A first-in-class HSP90 drug, the geldanamycin analog 17-AAG, has provided proof of concept for HSP90 inhibition in patients at well tolerated doses and therapeutic activity has been seen.  Other inhibitors show promise in preclin. and clin. development.  Opportunities and challenges for HSP90 inhibitors are discussed, including use in combination with other agents.  Most of the current HSP90 inhibitors act by blocking the essential nucleotide binding and ATPase activity required for chaperone function.  Potential new approaches are discussed, for example, interference with cochaperone binding and function in the superchaperone complex.  Biomarkers for use with HSP90 inhibitors are described.  We stress how basic and translational research has been mutually beneficial and indicate future directions to enhance our understanding of mol. chaperones and their exploitation in cancer and other diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoi_I-DGevqj7Vg90H21EOLACvtfcHk0lgJO3LpyYG1Fg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVanurfF&md5=a537c5d947847c6b3cdf613968214623</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1196%2Fannals.1391.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1196%252Fannals.1391.012%26sid%3Dliteratum%253Aachs%26aulast%3DWorkman%26aufirst%3DP.%26aulast%3DBurrows%26aufirst%3DF.%26aulast%3DNeckers%26aufirst%3DL.%26atitle%3DDrugging%2520the%2520cancer%2520chaperone%2520HSP90%253A%2520combinatorial%2520therapeutic%2520exploitation%2520of%2520oncogene%2520addiction%2520and%2520tumor%2520stress%26jtitle%3DAnn.%2520N.Y.%2520Acad.%2520Sci.%26date%3D2007%26volume%3D1113%26spage%3D202%26epage%3D216" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Egorin, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolff, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Callery, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Musser, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eiseman, J. L.</span><span> </span><span class="NLM_article-title">Metabolism of 17-(allylamino)-17-demethoxygeldanamycin (NSC 330507) by murine and human hepatic preparations</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">2385</span><span class="NLM_x">–</span> <span class="NLM_lpage">2396</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=1998&pages=2385-2396&author=M.+J.+Egorinauthor=D.+M.+Rosenauthor=J.+H.+Wolffauthor=P.+S.+Calleryauthor=S.+M.+Musserauthor=J.+L.+Eiseman&title=Metabolism+of+17-%28allylamino%29-17-demethoxygeldanamycin+%28NSC+330507%29+by+murine+and+human+hepatic+preparations"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEgorin%26aufirst%3DM.%2BJ.%26aulast%3DRosen%26aufirst%3DD.%2BM.%26aulast%3DWolff%26aufirst%3DJ.%2BH.%26aulast%3DCallery%26aufirst%3DP.%2BS.%26aulast%3DMusser%26aufirst%3DS.%2BM.%26aulast%3DEiseman%26aufirst%3DJ.%2BL.%26atitle%3DMetabolism%2520of%252017-%2528allylamino%2529-17-demethoxygeldanamycin%2520%2528NSC%2520330507%2529%2520by%2520murine%2520and%2520human%2520hepatic%2520preparations%26jtitle%3DCancer%2520Res.%26date%3D1998%26volume%3D58%26spage%3D2385%26epage%3D2396" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Kelland, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharp, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Myers, T. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Workman, P.</span><span> </span><span class="NLM_article-title">DT-Diaphorase expression and tumor cell sensitivity to 17-allylamino, 17-demethoxygeldanamycin, an inhibitor of heat shock protein 90</span> <span class="citation_source-journal">J. Natl. Cancer Inst.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">91</span><span class="NLM_x">, </span> <span class="NLM_fpage">1940</span><span class="NLM_x">–</span> <span class="NLM_lpage">1949</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Fjm900357y&amp;key=10.1093%2Fjnci%2F91.22.1940" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Fjm900357y&amp;key=10564678" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Fjm900357y&amp;key=1%3ACAS%3A528%3ADyaK1MXotVaitr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=1999&pages=1940-1949&author=L.+R.+Kellandauthor=S.+Y.+Sharpauthor=P.+M.+Rogersauthor=T.+G.+Myersauthor=P.+Workman&title=DT-Diaphorase+expression+and+tumor+cell+sensitivity+to+17-allylamino%2C+17-demethoxygeldanamycin%2C+an+inhibitor+of+heat+shock+protein+90"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">DT-diaphorase expression and tumor cell sensitivity to 17-allylamino-17-demethoxygeldanamycin, an inhibitor of heat shock protein 90</span></div><div class="casAuthors">Kelland, Lloyd R.; Sharp, Swee Y.; Rogers, Paul M.; Myers, Timothy G.; Workman, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the National Cancer Institute</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">91</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">1940-1949</span>CODEN:
                <span class="NLM_cas:coden">JNCIEQ</span>;
        ISSN:<span class="NLM_cas:issn">0027-8874</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Background: To our knowledge, 17-allylamino-17-demethoxygeldanamycin (17AAG) is the first inhibitor of heat shock protein 90 (Hsp90) to enter a phase I clin. trial in cancer.  Inhibition of Hsp90, a chaperone protein (a protein that helps other proteins avoid misfolding pathways that produce inactive or aggregated states), leads to depletion of important oncogenic proteins, including Raf-1 and mutant p53 (also known as TP53).  Given its ansamycin benzoquinone structure, we questioned whether the antitumor activity of 17AAG was affected by expression of the NQO1 gene, which encodes the quinone-metabolizing enzyme DT-diaphorase.  Methods: The antitumor activity of 17AAG and other Hsp90 inhibitors was detd. by use of a sulforhodamine B-based cell growth inhibition assay in culture and by the arrest of xenograft tumor growth in nude mice.  DT-diaphorase activity was detd. by use of a spectrophotometric assay, and protein expression was detd. by western immunoblotting.  Results: In two independent in vitro human tumor cell panels, we obsd. a pos. relation between DT-diaphorase expression level and growth inhibition by 17AAG.  Stable, high-level expression of the active NQO1 gene transfected into the DT-diaphorase-deficient (by NQO1 mutation) BE human colon carcinoma cell line resulted in a 32-fold increase in 17AAG growth-inhibition activity.  Increased sensitivity to 17AAG in the transfected cell line was also confirmed in xenografts.  The extent of depletion of Raf-1 and mutant p53 protein confirmed that the Hsp90 inhibition mechanism was maintained in cells with high and low levels of DT-diaphorase.  17AAG was shown to be a substrate for purified human DT-diaphorase.  Conclusion: These results suggest that the antitumor activity and possibly the toxicol. properties of 17AAG in humans may be influenced by the expression of DT-diaphorase.  Careful monitoring for NQO1 polymorphism and the level of tumor DT-diaphorase activity is therefore recommended in clin. trials with 17AAG.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5zBsj7Xagm7Vg90H21EOLACvtfcHk0lgMcEyQBApGCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXotVaitr8%253D&md5=508d5f614ce715ae495263171b286bff</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1093%2Fjnci%2F91.22.1940&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjnci%252F91.22.1940%26sid%3Dliteratum%253Aachs%26aulast%3DKelland%26aufirst%3DL.%2BR.%26aulast%3DSharp%26aufirst%3DS.%2BY.%26aulast%3DRogers%26aufirst%3DP.%2BM.%26aulast%3DMyers%26aufirst%3DT.%2BG.%26aulast%3DWorkman%26aufirst%3DP.%26atitle%3DDT-Diaphorase%2520expression%2520and%2520tumor%2520cell%2520sensitivity%2520to%252017-allylamino%252C%252017-demethoxygeldanamycin%252C%2520an%2520inhibitor%2520of%2520heat%2520shock%2520protein%252090%26jtitle%3DJ.%2520Natl.%2520Cancer%2520Inst.%26date%3D1999%26volume%3D91%26spage%3D1940%26epage%3D1949" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Meli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pennati, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daidone, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plescia, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toba, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Altieri, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zaffaroni, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colombo, G.</span><span> </span><span class="NLM_article-title">Small-Molecule Targeting of Heat Shock Protein 90 Chaperone Function: Rational Identification of a New Anticancer Lead</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">7721</span><span class="NLM_x">–</span> <span class="NLM_lpage">7730</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm060836y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=7721-7730&author=M.+Meliauthor=M.+Pennatiauthor=M.+Curtoauthor=M.+G.+Daidoneauthor=J.+Plesciaauthor=S.+Tobaauthor=D.+C.+Altieriauthor=N.+Zaffaroniauthor=G.+Colombo&title=Small-Molecule+Targeting+of+Heat+Shock+Protein+90+Chaperone+Function%3A+Rational+Identification+of+a+New+Anticancer+Lead"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fjm060836y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060836y%26sid%3Dliteratum%253Aachs%26aulast%3DMeli%26aufirst%3DM.%26aulast%3DPennati%26aufirst%3DM.%26aulast%3DCurto%26aufirst%3DM.%26aulast%3DDaidone%26aufirst%3DM.%2BG.%26aulast%3DPlescia%26aufirst%3DJ.%26aulast%3DToba%26aufirst%3DS.%26aulast%3DAltieri%26aufirst%3DD.%2BC.%26aulast%3DZaffaroni%26aufirst%3DN.%26aulast%3DColombo%26aufirst%3DG.%26atitle%3DSmall-Molecule%2520Targeting%2520of%2520Heat%2520Shock%2520Protein%252090%2520Chaperone%2520Function%253A%2520Rational%2520Identification%2520of%2520a%2520New%2520Anticancer%2520Lead%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D7721%26epage%3D7730" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Gaspar, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharp, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pacey, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walton, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vassal, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eccles, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pearson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Workman, P.</span><span> </span><span class="NLM_article-title">Acquired Resistance to 17-Allylamino-17-Demethoxygeldanamycin (Tanespimycin) in Glioblastoma Cells</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x">, </span> <span class="NLM_fpage">1966</span><span class="NLM_x">–</span> <span class="NLM_lpage">1975</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2009&pages=1966-1975&author=N.+Gasparauthor=S.+Y.+Sharpauthor=S.+Paceyauthor=D.+Jonesauthor=M.+Waltonauthor=G.+Vassalauthor=S.+Ecclesauthor=A.+Pearsonauthor=P.+Workman&title=Acquired+Resistance+to+17-Allylamino-17-Demethoxygeldanamycin+%28Tanespimycin%29+in+Glioblastoma+Cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGaspar%26aufirst%3DN.%26aulast%3DSharp%26aufirst%3DS.%2BY.%26aulast%3DPacey%26aufirst%3DS.%26aulast%3DJones%26aufirst%3DD.%26aulast%3DWalton%26aufirst%3DM.%26aulast%3DVassal%26aufirst%3DG.%26aulast%3DEccles%26aufirst%3DS.%26aulast%3DPearson%26aufirst%3DA.%26aulast%3DWorkman%26aufirst%3DP.%26atitle%3DAcquired%2520Resistance%2520to%252017-Allylamino-17-Demethoxygeldanamycin%2520%2528Tanespimycin%2529%2520in%2520Glioblastoma%2520Cells%26jtitle%3DCancer%2520Res.%26date%3D2009%26volume%3D69%26spage%3D1966%26epage%3D1975" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Kaur, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belotti, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burger, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher-Nielson, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borsotti, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riccardi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thillainathan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollingshead, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sausville, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giavazzi, R.</span><span> </span><span class="NLM_article-title">Antiangiogenic properties of 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin: an orally bioavailable heat shock protein 90 modulator</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">4813</span><span class="NLM_x">–</span> <span class="NLM_lpage">4821</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Fjm900357y&amp;key=10.1158%2F1078-0432.CCR-03-0795" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Fjm900357y&amp;key=15269157" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm900357y&amp;key=1%3ACAS%3A528%3ADC%252BD2cXlvVegs7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2004&pages=4813-4821&author=G.+Kaurauthor=D.+Belottiauthor=A.+M.+Burgerauthor=K.+Fisher-Nielsonauthor=P.+Borsottiauthor=E.+Riccardiauthor=J.+Thillainathanauthor=M.+Hollingsheadauthor=E.+A.+Sausvilleauthor=R.+Giavazzi&title=Antiangiogenic+properties+of+17-%28dimethylaminoethylamino%29-17-demethoxygeldanamycin%3A+an+orally+bioavailable+heat+shock+protein+90+modulator"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Antiangiogenic properties of 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin: an orally bioavailable heat shock protein 90 modulator</span></div><div class="casAuthors">Kaur, Gurmeet; Belotti, Dorina; Burger, Angelika M.; Fisher-Nielson, Kirsten; Borsotti, Patrizia; Riccardi, Elena; Thillainathan, Jagada; Hollingshead, Melinda; Sausville, Edward A.; Giavazzi, Raffaella</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">4813-4821</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The purpose of this study was to investigate the antiangiogenic properties of 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin (17-DMAG; NSC707545), a water-sol. benzoquinone ansamycin.  The activity of 17-DMAG, in vivo, was evaluated for inhibition of fibroblast growth factor (FGF)-2-induced angiogenesis in s.c. implanted Matrigel in mice.  In vitro, the activity of 17-DMAG on endothelial cells (human umbilical vein endothelial cells; HUVEC) was tested in FGF-2; and vascular endothelial growth factor (VEGF)-induced proliferation and apoptosis, motility, and extracellular matrix invasion; and on the alignment of capillary like structures in Matrigel.  The protein level of heat shock protein (Hsp)90 and client proteins was examd. by Western blot in FGF-2 and VEGF-stimulated HUVEC.  Daily oral administration of 17-DMAG affected the angiogenic response in Matrigel in a dose-dependent manner.  The Hb content in the Matrigel implants was significantly inhibited, and the histol. anal. confirmed a decrease of CD31+ endothelial cells and of structures organized in cord and erythrocyte-contg. vessels.  In vitro, the compd. inhibited dose-dependently the migration and the extracellular matrix-invasiveness of HUVEC and their capacity to form capillary like structures in Matrigel. 17-DMAG treatment also inhibited FGF-2 and VEGF-induced HUVEC proliferation and resulted in apoptosis.  Accordingly, the expression of Hsp90 direct client proteins (pAkt and c-Raf-1) or their downstream substrates including pERK was also affected. 17-DMAG consistently increased the expression of Hsp70.  Throughout the study similar results were obtained with 17-allylamino-17-demethoxygeldanamycin (17-AAG; NSC330507), the analog compd. currently undergoing clin. trials.  We show that the Hsp90 targeting agents 17-DMAG and 17-AAG inhibit angiogenesis.  The strong effects on endothelial cell functions, in vitro, indicate that the antiangiogenic activity of 17-DMAG/17-AAG could also be due to a direct effect on endothelial cells.  The oral bioavailability of 17-DMAG might be of advantage in investigating the potential of this compd. in clin. trials with antiangiogenic as well as antiproliferative endpoints.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrbGsLTxbCrQ7Vg90H21EOLACvtfcHk0lgkinU3k4PlbQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXlvVegs7s%253D&md5=e78331697485d2c1948adec2d4f124e6</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-03-0795&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-03-0795%26sid%3Dliteratum%253Aachs%26aulast%3DKaur%26aufirst%3DG.%26aulast%3DBelotti%26aufirst%3DD.%26aulast%3DBurger%26aufirst%3DA.%2BM.%26aulast%3DFisher-Nielson%26aufirst%3DK.%26aulast%3DBorsotti%26aufirst%3DP.%26aulast%3DRiccardi%26aufirst%3DE.%26aulast%3DThillainathan%26aufirst%3DJ.%26aulast%3DHollingshead%26aufirst%3DM.%26aulast%3DSausville%26aufirst%3DE.%2BA.%26aulast%3DGiavazzi%26aufirst%3DR.%26atitle%3DAntiangiogenic%2520properties%2520of%252017-%2528dimethylaminoethylamino%2529-17-demethoxygeldanamycin%253A%2520an%2520orally%2520bioavailable%2520heat%2520shock%2520protein%252090%2520modulator%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2004%26volume%3D10%26spage%3D4813%26epage%3D4821" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Ge, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Normant, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porter, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ali, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dembski, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Georges, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grenier, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pak, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patterson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sydor, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tibbitts, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tong, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palombella, V. J.</span><span> </span><span class="NLM_article-title">Design, synthesis, and biological evaluation of hydroquinone derivatives of 17-amino-17-demethoxygeldanamycin as potent, water-soluble inhibitors of Hsp90</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">4606</span><span class="NLM_x">–</span> <span class="NLM_lpage">4615</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0603116" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=4606-4615&author=J.+Geauthor=E.+Normantauthor=J.+R.+Porterauthor=J.+A.+Aliauthor=M.+S.+Dembskiauthor=Y.+Gaoauthor=A.+T.+Georgesauthor=L.+Grenierauthor=R.+H.+Pakauthor=J.+Pattersonauthor=J.+R.+Sydorauthor=T.+T.+Tibbittsauthor=J.+K.+Tongauthor=J.+Adamsauthor=V.+J.+Palombella&title=Design%2C+synthesis%2C+and+biological+evaluation+of+hydroquinone+derivatives+of+17-amino-17-demethoxygeldanamycin+as+potent%2C+water-soluble+inhibitors+of+Hsp90"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fjm0603116&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0603116%26sid%3Dliteratum%253Aachs%26aulast%3DGe%26aufirst%3DJ.%26aulast%3DNormant%26aufirst%3DE.%26aulast%3DPorter%26aufirst%3DJ.%2BR.%26aulast%3DAli%26aufirst%3DJ.%2BA.%26aulast%3DDembski%26aufirst%3DM.%2BS.%26aulast%3DGao%26aufirst%3DY.%26aulast%3DGeorges%26aufirst%3DA.%2BT.%26aulast%3DGrenier%26aufirst%3DL.%26aulast%3DPak%26aufirst%3DR.%2BH.%26aulast%3DPatterson%26aufirst%3DJ.%26aulast%3DSydor%26aufirst%3DJ.%2BR.%26aulast%3DTibbitts%26aufirst%3DT.%2BT.%26aulast%3DTong%26aufirst%3DJ.%2BK.%26aulast%3DAdams%26aufirst%3DJ.%26aulast%3DPalombella%26aufirst%3DV.%2BJ.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520biological%2520evaluation%2520of%2520hydroquinone%2520derivatives%2520of%252017-amino-17-demethoxygeldanamycin%2520as%2520potent%252C%2520water-soluble%2520inhibitors%2520of%2520Hsp90%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D4606%26epage%3D4615" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Sydor, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Normant, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pien, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porter, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ge, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grenier, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pak, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ali, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dembski, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hudak, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patterson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Penders, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pink, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Read, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woodward, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grayzel, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrett, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palombella, V. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tong, J. K.</span><span> </span><span class="NLM_article-title">Development of 17-allylamino-17-demethoxygeldanamycin hydroquinone hydrochloride (IPI-504), an anticancer agent directed against Hsp90</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">103</span><span class="NLM_x">, </span> <span class="NLM_fpage">17408</span><span class="NLM_x">–</span> <span class="NLM_lpage">17413</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2006&pages=17408-17413&author=J.+R.+Sydorauthor=E.+Normantauthor=C.+S.+Pienauthor=J.+R.+Porterauthor=J.+Geauthor=L.+Grenierauthor=R.+H.+Pakauthor=J.+A.+Aliauthor=M.+S.+Dembskiauthor=J.+Hudakauthor=J.+Pattersonauthor=C.+Pendersauthor=M.+Pinkauthor=M.+A.+Readauthor=J.+Sangauthor=C.+Woodwardauthor=Y.+Zhangauthor=D.+S.+Grayzelauthor=J.+Wrightauthor=J.+A.+Barrettauthor=V.+J.+Palombellaauthor=J.+Adamsauthor=J.+K.+Tong&title=Development+of+17-allylamino-17-demethoxygeldanamycin+hydroquinone+hydrochloride+%28IPI-504%29%2C+an+anticancer+agent+directed+against+Hsp90"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSydor%26aufirst%3DJ.%2BR.%26aulast%3DNormant%26aufirst%3DE.%26aulast%3DPien%26aufirst%3DC.%2BS.%26aulast%3DPorter%26aufirst%3DJ.%2BR.%26aulast%3DGe%26aufirst%3DJ.%26aulast%3DGrenier%26aufirst%3DL.%26aulast%3DPak%26aufirst%3DR.%2BH.%26aulast%3DAli%26aufirst%3DJ.%2BA.%26aulast%3DDembski%26aufirst%3DM.%2BS.%26aulast%3DHudak%26aufirst%3DJ.%26aulast%3DPatterson%26aufirst%3DJ.%26aulast%3DPenders%26aufirst%3DC.%26aulast%3DPink%26aufirst%3DM.%26aulast%3DRead%26aufirst%3DM.%2BA.%26aulast%3DSang%26aufirst%3DJ.%26aulast%3DWoodward%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DGrayzel%26aufirst%3DD.%2BS.%26aulast%3DWright%26aufirst%3DJ.%26aulast%3DBarrett%26aufirst%3DJ.%2BA.%26aulast%3DPalombella%26aufirst%3DV.%2BJ.%26aulast%3DAdams%26aufirst%3DJ.%26aulast%3DTong%26aufirst%3DJ.%2BK.%26atitle%3DDevelopment%2520of%252017-allylamino-17-demethoxygeldanamycin%2520hydroquinone%2520hydrochloride%2520%2528IPI-504%2529%252C%2520an%2520anticancer%2520agent%2520directed%2520against%2520Hsp90%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2006%26volume%3D103%26spage%3D17408%26epage%3D17413" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Modi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stopeck, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gordon, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendelson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Solit, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bagatell, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wheler, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Norton, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cropp, G. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hannah, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hudis, C. A.</span><span> </span><span class="NLM_article-title">Combination of trastuzumab and tanespimycin (17-AAG, KOS-953) is safe and active in trastuzumab-refractory HER-2-overexpressing breast cancer: a phase I dose-escalation study</span> <span class="citation_source-journal">J. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">5410</span><span class="NLM_x">–</span> <span class="NLM_lpage">5417</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Fjm900357y&amp;key=10.1200%2FJCO.2007.11.7960" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Fjm900357y&amp;key=18048823" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Fjm900357y&amp;key=1%3ACAS%3A528%3ADC%252BD1cXnvVCisQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2007&pages=5410-5417&author=S.+Modiauthor=A.+T.+Stopeckauthor=M.+S.+Gordonauthor=D.+Mendelsonauthor=D.+B.+Solitauthor=R.+Bagatellauthor=W.+Maauthor=J.+Whelerauthor=N.+Rosenauthor=L.+Nortonauthor=G.+F.+Croppauthor=R.+G.+Johnsonauthor=A.+L.+Hannahauthor=C.+A.+Hudis&title=Combination+of+trastuzumab+and+tanespimycin+%2817-AAG%2C+KOS-953%29+is+safe+and+active+in+trastuzumab-refractory+HER-2-overexpressing+breast+cancer%3A+a+phase+I+dose-escalation+study"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Combination of trastuzumab and tanespimycin (17-AAG, KOS-953) is safe and active in trastuzumab-refractory HER-2-overexpressing breast cancer: a phase I dose-escalation study</span></div><div class="casAuthors">Modi, Shanu; Stopeck, Alison T.; Gordon, Michael S.; Mendelson, David; Solit, David B.; Bagatell, Rochelle; Ma, Weining; Wheler, Jennifer; Rosen, Neal; Norton, Larry; Cropp, Gillian F.; Johnson, Robert G.; Hannah, Alison L.; Hudis, Clifford A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Oncology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">34</span>),
    <span class="NLM_cas:pages">5410-5417</span>CODEN:
                <span class="NLM_cas:coden">JCONDN</span>;
        ISSN:<span class="NLM_cas:issn">0732-183X</span>.
    
            (<span class="NLM_cas:orgname">American Society of Clinical Oncology</span>)
        </div><div class="casAbstract">Purpose: This phase I study examd. whether a heat shock protein (Hsp) 90 inhibitor tanespimycin (17-AAG; KOS-953) could be administered safely in combination with trastuzumab at a dose that inhibits Hsp90 function in vivo in lymphocytes.  Patients and Methods: Patients with an advanced solid tumor progressing during std. therapy were eligible.  Patients were treated with weekly trastuzumab followed by i.v. tanespimycin, assessed in escalating dose levels.  Results: Twenty-five patients were enrolled onto four tanespimycin dose levels: 225 (n = 4), 300 (n = 3), 375 (n = 8), and 450 mg/m2 (n = 10).  Dose-limiting toxicity (DLT) was obsd. at the third and fourth cohort (1 patient each): more than 2-wk delay for grade 4 fatigue/grade 2 nausea and anorexia (375 mg/m2); more than 2-wk delay for thrombocytopenia (450 mg/m2).  Drug-related grade 3 toxicity included emesis, increased ALT, hypersensitivity reactions (two patients each), and drug-induced thrombocytopenia (n = 1).  Common mild to moderate toxicities included fatigue, nausea, diarrhea, emesis, headache, rash/pruritus, increased AST/ALT, and anorexia.  Pharmacokinetic anal. demonstrated no difference in tanespimycin kinetics with or without trastuzumab.  Pharmacodynamic testing showed reactive induction of Hsp70 (a marker of Hsp90 inhibition) in lymphocytes at all dose levels.  Antitumor activity was noted (partial response, n = 1; minor response, n = 4; stable disease ≥ 4 mo, n = 4).  Tumor regressions were seen only in patients with human epidermal growth factor receptor 2 (HER-2)-pos. metastatic breast cancer.  Conclusion: Tanespimycin plus trastuzumab is well tolerated and has antitumor activity in patients with HER-2+ breast cancer whose tumors have progressed during treatment with trastuzumab.  These data suggest that Hsp90 function can be inhibited in vivo to a degree sufficient to cause inhibition of tumor growth.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMOMgqgGMiFbVg90H21EOLACvtfcHk0lgkinU3k4PlbQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXnvVCisQ%253D%253D&md5=a99de102e2458d4428b39a239a06ada4</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1200%2FJCO.2007.11.7960&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2007.11.7960%26sid%3Dliteratum%253Aachs%26aulast%3DModi%26aufirst%3DS.%26aulast%3DStopeck%26aufirst%3DA.%2BT.%26aulast%3DGordon%26aufirst%3DM.%2BS.%26aulast%3DMendelson%26aufirst%3DD.%26aulast%3DSolit%26aufirst%3DD.%2BB.%26aulast%3DBagatell%26aufirst%3DR.%26aulast%3DMa%26aufirst%3DW.%26aulast%3DWheler%26aufirst%3DJ.%26aulast%3DRosen%26aufirst%3DN.%26aulast%3DNorton%26aufirst%3DL.%26aulast%3DCropp%26aufirst%3DG.%2BF.%26aulast%3DJohnson%26aufirst%3DR.%2BG.%26aulast%3DHannah%26aufirst%3DA.%2BL.%26aulast%3DHudis%26aufirst%3DC.%2BA.%26atitle%3DCombination%2520of%2520trastuzumab%2520and%2520tanespimycin%2520%252817-AAG%252C%2520KOS-953%2529%2520is%2520safe%2520and%2520active%2520in%2520trastuzumab-refractory%2520HER-2-overexpressing%2520breast%2520cancer%253A%2520a%2520phase%2520I%2520dose-escalation%2520study%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2007%26volume%3D25%26spage%3D5410%26epage%3D5417" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Drysdale, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brough, P. A.</span><span> </span><span class="NLM_article-title">Medicinal chemistry of Hsp90 inhibitors</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">859</span><span class="NLM_x">–</span> <span class="NLM_lpage">868</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Fjm900357y&amp;key=10.2174%2F156802608784911644" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Fjm900357y&amp;key=18673171" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Fjm900357y&amp;key=1%3ACAS%3A528%3ADC%252BD1cXnsVant7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2008&pages=859-868&author=M.+J.+Drysdaleauthor=P.+A.+Brough&title=Medicinal+chemistry+of+Hsp90+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Medicinal chemistry of Hsp90 inhibitors</span></div><div class="casAuthors">Drysdale, Martin J.; Brough, Paul A.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">859-868</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Heat shock protein (Hsp90) inhibitors are an increasingly interesting and important class of compds. where the first in class, natural product derived inhibitors such as 17-allylaminogeldanamycin (17-AAG), are entering late stage clin. development.  Recently the emergence of synthetic, small mol. inhibitors has been described and both NVP-AUY922 and BIIB021 have entered clin. development.  The medicinal chem. of these and other published small mol. Hsp90 inhibitors is described in this review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_sn_Ez1pvv7Vg90H21EOLACvtfcHk0ljeGNFkHphMFg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXnsVant7Y%253D&md5=3e85f368ba92e36692b957c6e73d44a8</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.2174%2F156802608784911644&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802608784911644%26sid%3Dliteratum%253Aachs%26aulast%3DDrysdale%26aufirst%3DM.%2BJ.%26aulast%3DBrough%26aufirst%3DP.%2BA.%26atitle%3DMedicinal%2520chemistry%2520of%2520Hsp90%2520inhibitors%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2008%26volume%3D8%26spage%3D859%26epage%3D868" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Chiosis, G.</span><span> </span><span class="NLM_article-title">Discovery and development of purine-scaffold Hsp90 inhibitors</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">1183</span><span class="NLM_x">–</span> <span class="NLM_lpage">1191</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Fjm900357y&amp;key=10.2174%2F156802606777812013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Fjm900357y&amp;key=16842155" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Fjm900357y&amp;key=1%3ACAS%3A528%3ADC%252BD28Xpt1ejtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2006&pages=1183-1191&author=G.+Chiosis&title=Discovery+and+development+of+purine-scaffold+Hsp90+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and development of purine-scaffold Hsp90 inhibitors</span></div><div class="casAuthors">Chiosis, Gabriela</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1183-1191</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Hsp90 allows cancer cells to tolerate the many components of dysregulated pathways in a transformation-specific manner by interacting with several client substrates, such as kinases, hormone receptors and transcription factors that are directly involved in driving multistep malignancy, and also with mutated oncogenic proteins required for the transformed phenotype.  This distinctive broad involvement in maintaining the transformed phenotype has suggested Hsp90 as an important target in cancer therapy.  Discovery of pharmacol. agents that selectively inhibit its function have aided in probing the biol. functions of Hsp90 at the mol. level and in validating it as a novel target for anticancer drug action.  Two natural product derivs., 17-allylamino-17-desmethoxy-geldanamycin (17AAG) and 17-dimethylaminoethylamino-17-desmethoxy-geldanamycin (17DMAG) have further entered clin. trials, proving that Hsp90 may be modulated pharmacol. without causing target related toxicities in humans.  In spite of their usefulness as proof-of-principle compds., the clin. use of these two agents has been encumbered with some limitations due to their structural characteristics and also to less than optimal pharmacol. profiles.  Thus, the identification of Hsp90 inhibitors with improved structural characteristics and better pharmacol. profiles is a major focus of interest in the field.  One such emerging class is the purine-scaffold series.  This review intends to inform the reader on efforts ranging from the discovery to their clin. translation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqtpMNMTF3zyLVg90H21EOLACvtfcHk0ljeGNFkHphMFg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xpt1ejtLw%253D&md5=f619bbb69cd7ac43a2112d56e5a904f2</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.2174%2F156802606777812013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802606777812013%26sid%3Dliteratum%253Aachs%26aulast%3DChiosis%26aufirst%3DG.%26atitle%3DDiscovery%2520and%2520development%2520of%2520purine-scaffold%2520Hsp90%2520inhibitors%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2006%26volume%3D6%26spage%3D1183%26epage%3D1191" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Chiosis, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodina, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moulick, K.</span><span> </span><span class="NLM_article-title">Emerging Hsp90 inhibitors: from discovery to clinic</span> <span class="citation_source-journal">Anticancer Agents Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">8</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Fjm900357y&amp;key=10.2174%2F187152006774755483" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Fjm900357y&amp;key=16475922" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Fjm900357y&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVChsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2006&pages=1-8&author=G.+Chiosisauthor=A.+Rodinaauthor=K.+Moulick&title=Emerging+Hsp90+inhibitors%3A+from+discovery+to+clinic"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Emerging Hsp90 inhibitors: from discovery to clinic</span></div><div class="casAuthors">Chiosis, G.; Rodina, A.; Moulick, K.</div><div class="citationInfo"><span class="NLM_cas:title">Anti-Cancer Agents in Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-8</span>CODEN:
                <span class="NLM_cas:coden">AAMCE4</span>;
        ISSN:<span class="NLM_cas:issn">1871-5206</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Hsp90 is a chaperone with important roles in maintaining transformation and in elevating the survival and growth potential of cancer cells.  Activation of signaling pathways mediated by Hsp90 protein clients is necessary for cell proliferation, regulation of cell cycle progression and apoptosis.  Addnl., gain-of-function mutations responsible for transformation often require Hsp90 for the maintenance of their folded, functionally active conformations.  These characteristics promise Hsp90 as an important target in cancer therapy and prompt for the identification, development and clin. translation of small mol. inhibitors of the chaperone.  This review intends to update the reader on the status of several existing and emerging classes of direct inhibitors of Hsp90 ATPase activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9M20C3VvXMLVg90H21EOLACvtfcHk0ljeGNFkHphMFg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVChsbw%253D&md5=647687cf4918d8b1f7c35e9197e41163</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.2174%2F187152006774755483&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F187152006774755483%26sid%3Dliteratum%253Aachs%26aulast%3DChiosis%26aufirst%3DG.%26aulast%3DRodina%26aufirst%3DA.%26aulast%3DMoulick%26aufirst%3DK.%26atitle%3DEmerging%2520Hsp90%2520inhibitors%253A%2520from%2520discovery%2520to%2520clinic%26jtitle%3DAnticancer%2520Agents%2520Med.%2520Chem.%26date%3D2006%26volume%3D6%26spage%3D1%26epage%3D8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Chiosis, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopes, E. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Solit, D.</span><span> </span><span class="NLM_article-title">Heat shock protein-90 inhibitors: a chronicle from geldanamycin to today's agents</span> <span class="citation_source-journal">Curr. Opin. Invest. Drugs (Thomson Scientific)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">534</span><span class="NLM_x">–</span> <span class="NLM_lpage">541</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Fjm900357y&amp;key=16784024" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Fjm900357y&amp;key=1%3ACAS%3A528%3ADC%252BD28XmsFyqtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2006&pages=534-541&author=G.+Chiosisauthor=E.+C.+Lopesauthor=D.+Solit&title=Heat+shock+protein-90+inhibitors%3A+a+chronicle+from+geldanamycin+to+today%27s+agents"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Heat shock protein-90 inhibitors: a chronicle from geldanamycin to today's agents</span></div><div class="casAuthors">Chiosis, Gabriela; Lopes, Eloisi Caldas; Solit, David</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Investigational Drugs (Thomson Scientific)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">534-541</span>CODEN:
                <span class="NLM_cas:coden">COIDAZ</span>;
        ISSN:<span class="NLM_cas:issn">1472-4472</span>.
    
            (<span class="NLM_cas:orgname">Thomson Scientific</span>)
        </div><div class="casAbstract">A review.  Heat shock protein (Hsp)90 is a chaperone with essential roles in maintaining transformation and in elevating the survival and growth potential of cancer cells.  The recognition of Hsp90 as an important target in cancer therapy has prompted the identification, development and clin. translation of a large array of Hsp90 inhibitors.  This review discusses the modalities that may interfere with this chaperone's function and describes the status of existing and emerging Hsp90 inhibitor classes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGraZ8Rv0_20LrVg90H21EOLACvtfcHk0lj1XWnEOKMzBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XmsFyqtbk%253D&md5=a863ba2ec3251f5a732b418c2d478918</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChiosis%26aufirst%3DG.%26aulast%3DLopes%26aufirst%3DE.%2BC.%26aulast%3DSolit%26aufirst%3DD.%26atitle%3DHeat%2520shock%2520protein-90%2520inhibitors%253A%2520a%2520chronicle%2520from%2520geldanamycin%2520to%2520today%2527s%2520agents%26jtitle%3DCurr.%2520Opin.%2520Invest.%2520Drugs%2520%2528Thomson%2520Scientific%2529%26date%3D2006%26volume%3D7%26spage%3D534%26epage%3D541" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Dymock, B. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drysdale, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonald, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Workman, P.</span><span> </span><span class="NLM_article-title">Inhibitors of HSP90 and other chaperones for the treatment of cancer</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">837</span><span class="NLM_x">–</span> <span class="NLM_lpage">847</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Fjm900357y&amp;key=10.1517%2F13543776.14.6.837" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Fjm900357y&amp;key=1%3ACAS%3A528%3ADC%252BD2cXktlyqsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=837-847&author=B.+W.+Dymockauthor=M.+J.+Drysdaleauthor=E.+McDonaldauthor=P.+Workman&title=Inhibitors+of+HSP90+and+other+chaperones+for+the+treatment+of+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitors of HSP90 and other chaperones for the treatment of cancer</span></div><div class="casAuthors">Dymock, Brian W.; Drysdale, Martin J.; McDonald, Edward; Workman, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">837-847</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Ashley Publications Ltd.</span>)
        </div><div class="casAbstract">A review with refs.  Mol. chaperones are proteins that ensure the appropriate folding, stability and function of other proteins in the cell.  There is increasing evidence that mol. chaperones are not only important in normal cell homeostasis and response to stresses, such as heat shock, but can also be involved in disease pathol.  In particular, HSP90 has emerged as an important potential drug target in oncol.  This is because it is essential for the stability of a long list of client proteins', including ErbB2/human epithelial growth factor receptor (HER)2, Raf-1, Akt/protein kinase B (PKB), Polo-1, Met, mutant p53 and human telomerase reverse transcriptase (hTERT), as well as the estrogen and androgen receptor.  Inhibition of HSP90 leads to depletion of these oncogenic clients by the ubiquitin proteasome pathway, thereby providing a simultaneous combinatorial attack on all of the hallmark phenotypic traits of cancer cells.  Because of the rapid progress made, this review focuses on the patents dealing with the discovery and application of small mol. inhibitors of HSP90, although limited coverage of other applications in the area of HSP90 and addnl. chaperones is also included.  Pioneering work with natural products, namely geldanamycin and related ansamycin antibiotics together with radicicol macrocycle derivs., established the therapeutic potential of inhibiting the essential N-terminal ATPase of HSP90 by competing at the nucleotide binding site.  A geldanamycin analog, 17-(desmethoxy), 17-allylamino geldanamycin (17AAG), is completing Phase I clin. trials with promising initial results.  The use of high-throughput screening and rational design based on X-ray crystal structures of HSP90 has led to the discovery of small mol. HSP90 inhibitors based on purine and pyrazole scaffolds.  The continued progression of these various compd. classes into clin. trials should help to establish proof of concept for inhibition of HSP90 as a viable therapeutic approach for the treatment of cancer and potentially other diseases.  This would in turn validate protein folding as a strategy for drug development and encourage addnl. chaperones to be explored as mol. targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZ19fmQE-bzbVg90H21EOLACvtfcHk0lj1XWnEOKMzBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXktlyqsL8%253D&md5=68f468698084591e41c9c0a337542ca1</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1517%2F13543776.14.6.837&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.14.6.837%26sid%3Dliteratum%253Aachs%26aulast%3DDymock%26aufirst%3DB.%2BW.%26aulast%3DDrysdale%26aufirst%3DM.%2BJ.%26aulast%3DMcDonald%26aufirst%3DE.%26aulast%3DWorkman%26aufirst%3DP.%26atitle%3DInhibitors%2520of%2520HSP90%2520and%2520other%2520chaperones%2520for%2520the%2520treatment%2520of%2520cancer%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2004%26volume%3D14%26spage%3D837%26epage%3D847" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Neckers, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neckers, K.</span><span> </span><span class="NLM_article-title">Heat-shock protein 90 inhibitors as novel cancer chemotherapeutics—an update</span> <span class="citation_source-journal">Expert Opin. Emerging Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">137</span><span class="NLM_x">–</span> <span class="NLM_lpage">149</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Fjm900357y&amp;key=10.1517%2F14728214.10.1.137" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Fjm900357y&amp;key=15757409" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Fjm900357y&amp;key=1%3ACAS%3A528%3ADC%252BD2MXislCrt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2005&pages=137-149&author=L.+Neckersauthor=K.+Neckers&title=Heat-shock+protein+90+inhibitors+as+novel+cancer+chemotherapeutics%E2%80%94an+update"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Heat-shock protein 90 inhibitors as novel cancer chemotherapeutics - an update</span></div><div class="casAuthors">Neckers, Len; Neckers, Katharine</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Emerging Drugs</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">137-149</span>CODEN:
                <span class="NLM_cas:coden">EOEDA3</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    
            (<span class="NLM_cas:orgname">Ashley Publications Ltd.</span>)
        </div><div class="casAbstract">A review.  Heat-shock protein 90 (Hsp90) is a mol. chaperone whose assocn. is required for stability and function of a growing no. of signalling proteins that have been implicated in cancer cell survival, including several mutated proteins that are only found in specific cancers.  Furthermore, a growing body of evidence suggests that cancer cells are particularly dependent on Hsp90 for their growth and survival, and, therefore, are more sensitive to the effects of its inhibition than are non-transformed cells and tissues.  Several chem. distinct Hsp90 inhibitors have shown encouraging antitumor activity in multiple preclin. model systems, and one Hsp90 inhibitor, the benzoquinone ansamycin 17-allylamino, 17-demethoxygeldanamycin, has completed five Phase I clin. trials, with a no. of Phase II trials soon to be underway or in progress.  Other Hsp90 inhibitors are either in Phase I clin. trial or under development.  This update will focus on how the latest developments in Hsp90 biol. may better inform the clin. development of Hsp90 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozi0ii7Nj7IbVg90H21EOLACvtfcHk0lj1XWnEOKMzBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXislCrt7o%253D&md5=91e907d6208cb717cbc3648f3d025dd3</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1517%2F14728214.10.1.137&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14728214.10.1.137%26sid%3Dliteratum%253Aachs%26aulast%3DNeckers%26aufirst%3DL.%26aulast%3DNeckers%26aufirst%3DK.%26atitle%3DHeat-shock%2520protein%252090%2520inhibitors%2520as%2520novel%2520cancer%2520chemotherapeutics%25E2%2580%2594an%2520update%26jtitle%3DExpert%2520Opin.%2520Emerging%2520Drugs%26date%3D2005%26volume%3D10%26spage%3D137%26epage%3D149" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Janin, Y. L.</span><span> </span><span class="NLM_article-title">Heat shock protein 90 inhibitors. A text book example of medicinal chemistry?</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">7503</span><span class="NLM_x">–</span> <span class="NLM_lpage">7512</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm050759r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=7503-7512&author=Y.+L.+Janin&title=Heat+shock+protein+90+inhibitors.+A+text+book+example+of+medicinal+chemistry%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1021%2Fjm050759r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050759r%26sid%3Dliteratum%253Aachs%26aulast%3DJanin%26aufirst%3DY.%2BL.%26atitle%3DHeat%2520shock%2520protein%252090%2520inhibitors.%2520A%2520text%2520book%2520example%2520of%2520medicinal%2520chemistry%253F%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D7503%26epage%3D7512" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Drysdale, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brough, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Massey, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jensen, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoepfer, J.</span><span> </span><span class="NLM_article-title">Targeting Hsp90 for the treatment of cancer</span> <span class="citation_source-journal">Curr. Opin. Drug Discovery Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">483</span><span class="NLM_x">–</span> <span class="NLM_lpage">495</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Fjm900357y&amp;key=16889231" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Fjm900357y&amp;key=1%3ACAS%3A528%3ADC%252BD28XntVChs7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2006&pages=483-495&author=M.+J.+Drysdaleauthor=P.+A.+Broughauthor=A.+Masseyauthor=M.+R.+Jensenauthor=J.+Schoepfer&title=Targeting+Hsp90+for+the+treatment+of+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting Hsp90 for the treatment of cancer</span></div><div class="casAuthors">Drysdale, Martin J.; Brough, Paul A.; Massey, Andrew; Jensen, Michael Rugaard; Schoepfer, Joseph</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Drug Discovery & Development</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">483-495</span>CODEN:
                <span class="NLM_cas:coden">CODDFF</span>;
        ISSN:<span class="NLM_cas:issn">1367-6733</span>.
    
            (<span class="NLM_cas:orgname">Thomson Scientific</span>)
        </div><div class="casAbstract">A review.  Heat shock protein (Hsp)90 is a mol. chaperone that is responsible for the correct folding of a large no. of proteins, which allows these proteins to achieve their functional conformation.  Client proteins of Hsp90 include many overexpressed or mutated oncogenes that are known to be crit. for the transformed phenotype obsd. in tumors.  The compds. 17-AAG (Kosan Biosciences Inc/National Cancer Institute) and 17-DMAG (Kosan Biosciences Inc/National Cancer Institute) are Hsp90 inhibitors that are derived from the prototypical ansamycin natural product Hsp90 inhibitor geldanamycin.  These compds. have demonstrated preclin. efficacy in mouse xenograft models, and are now undergoing phase II and I clin. trials, resp.  Preclin. efficacy studies of these compds. are collated and discussed in this review.  More recent disclosures of small-mol. Hsp90 inhibitors include purine and resorcinol analogs, and the first small-mol. Hsp90 compds. showing oral efficacy have been described.  Inhibition of Hsp90 not only results in the degrdn. of client proteins, but also results in the induction of another chaperone, Hsp70.  Hsp70 is known to be anti-apoptotic, and therefore the induction of Hsp70 may ultimately limit the efficacy of Hsp90 inhibitors under certain circumstances.  Histone deacetylase inhibitors have recently been demonstrated to exert some of their effect through modulation of Hsp90 chaperoning activity, and some mechanistic aspects of this control are also discussed herein.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-VkK7aR3PuLVg90H21EOLACvtfcHk0lgUV59k0g3cyg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XntVChs7k%253D&md5=117860d15c90611ea5da8fc356fe814f</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDrysdale%26aufirst%3DM.%2BJ.%26aulast%3DBrough%26aufirst%3DP.%2BA.%26aulast%3DMassey%26aufirst%3DA.%26aulast%3DJensen%26aufirst%3DM.%2BR.%26aulast%3DSchoepfer%26aufirst%3DJ.%26atitle%3DTargeting%2520Hsp90%2520for%2520the%2520treatment%2520of%2520cancer%26jtitle%3DCurr.%2520Opin.%2520Drug%2520Discovery%2520Dev.%26date%3D2006%26volume%3D9%26spage%3D483%26epage%3D495" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">McDonald, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Workman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, K.</span><span> </span><span class="NLM_article-title">Inhibitors of the HSP90 molecular chaperone: attacking the master regulator in cancer</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">1091</span><span class="NLM_x">–</span> <span class="NLM_lpage">1107</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Fjm900357y&amp;key=10.2174%2F156802606777812004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Fjm900357y&amp;key=16842148" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Fjm900357y&amp;key=1%3ACAS%3A528%3ADC%252BD28Xpt1ejt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2006&pages=1091-1107&author=E.+McDonaldauthor=P.+Workmanauthor=K.+Jones&title=Inhibitors+of+the+HSP90+molecular+chaperone%3A+attacking+the+master+regulator+in+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitors of the HSP90 molecular chaperone: attacking the master regulator in cancer</span></div><div class="casAuthors">McDonald, Edward; Workman, Paul; Jones, Keith</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1091-1107</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The heat shock protein 90 (HSP90) chaperones represent some 1-2% of all cellular protein and are key players in protein quality control in cells.  They are over expressed in many human cancers and the fact that many oncogenic proteins are clients has prompted much recent research on HSP90 inhibitors as new cancer therapeutics.  A brief introduction is followed by a detailed review of the various classes of inhibitors, both natural product-based and synthetic, that have emerged over the last decade.  The natural products geldanamycin, radicicol and novobiocin have provided the start points for new drugs in this area and their medicinal chem. is reviewed, including the exciting recent results emerging from clin. trials using geldanamycin analogs.  The detailed understanding of the binding mode of these compds. to HSP90 has been significantly enhanced by x-ray crystallog. of HSP90 constructs co-crystd. with various ligands.  Efforts to replace the natural product inhibitors with more drug-like synthetic compds. have mushroomed over the last 4 years.  The purines and the 3,4-diarylpyrazoles have proven to be the most successful and their medicinal chem. is reviewed with particular emphasis on structure-based design.  Protein/ligand co-crystal structures have shown that conserved water mols. in the active site are a vital part of the hydrogen-bonding network established on binding both natural product and synthetic inhibitors.  Medicinal chemists have used this information to develop high affinity lead compds.  Recent research provides the platform for exciting developments in the area of HSP90 inhibition over the next few years.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZvK2PleGilLVg90H21EOLACvtfcHk0lgUV59k0g3cyg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xpt1ejt7s%253D&md5=76ebc6e48e0b91a5a9dceba18f7c38f4</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.2174%2F156802606777812004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802606777812004%26sid%3Dliteratum%253Aachs%26aulast%3DMcDonald%26aufirst%3DE.%26aulast%3DWorkman%26aufirst%3DP.%26aulast%3DJones%26aufirst%3DK.%26atitle%3DInhibitors%2520of%2520the%2520HSP90%2520molecular%2520chaperone%253A%2520attacking%2520the%2520master%2520regulator%2520in%2520cancer%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2006%26volume%3D6%26spage%3D1091%26epage%3D1107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Messaoudi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peyrat, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brion, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alami, M.</span><span> </span><span class="NLM_article-title">Recent advances in Hsp90 inhibitors as antitumor agents</span> <span class="citation_source-journal">Anti-Cancer Agents Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">761</span><span class="NLM_x">–</span> <span class="NLM_lpage">782</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2008&pages=761-782&author=S.+Messaoudiauthor=J.+F.+Peyratauthor=J.+D.+Brionauthor=M.+Alami&title=Recent+advances+in+Hsp90+inhibitors+as+antitumor+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMessaoudi%26aufirst%3DS.%26aulast%3DPeyrat%26aufirst%3DJ.%2BF.%26aulast%3DBrion%26aufirst%3DJ.%2BD.%26aulast%3DAlami%26aufirst%3DM.%26atitle%3DRecent%2520advances%2520in%2520Hsp90%2520inhibitors%2520as%2520antitumor%2520agents%26jtitle%3DAnti-Cancer%2520Agents%2520Med.%2520Chem.%26date%3D2008%26volume%3D8%26spage%3D761%26epage%3D782" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Taldone, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gozman, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maharaj, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiosis, G.</span><span> </span><span class="NLM_article-title">Targeting Hsp90: small-molecule inhibitors and their clinical development</span> <span class="citation_source-journal">Curr. Opin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">370</span><span class="NLM_x">–</span> <span class="NLM_lpage">374</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Fjm900357y&amp;key=10.1016%2Fj.coph.2008.06.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Fjm900357y&amp;key=18644253" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Fjm900357y&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtFCktL7J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2008&pages=370-374&author=T.+Taldoneauthor=A.+Gozmanauthor=R.+Maharajauthor=G.+Chiosis&title=Targeting+Hsp90%3A+small-molecule+inhibitors+and+their+clinical+development"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting Hsp90: small-molecule inhibitors and their clinical development</span></div><div class="casAuthors">Taldone, Tony; Gozman, Alexander; Maharaj, Ronnie; Chiosis, Gabriela</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Pharmacology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">370-374</span>CODEN:
                <span class="NLM_cas:coden">COPUBK</span>;
        ISSN:<span class="NLM_cas:issn">1471-4892</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The Hsp90 multichaperone complex has important roles in the development and progression of malignant transformation.  Several small-mol. inhibitors of Hsp90 of diverse chemotypes have shown potent antitumor activity in a wide-range of malignancies, and are currently in clin. or late-stage preclin. investigation.  This review intends to update the reader on advances made over the past two years in the clin. development of Hsp90 inhibitors in advanced cancers.  It will refer to the two 17-AAG formulations, tanespimycin and IPI-504, and to synthetic small mols., among which are the purine-scaffold Hsp90 inhibitor CNF2024/BIIB021, the isoxazole deriv. VER-52296/NVP-AUY922, and the carbazol-4-one benzamide deriv. SNX-5422, and will present our current knowledge on their clin. performance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpaxbcGVj_eb7Vg90H21EOLACvtfcHk0lgUV59k0g3cyg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtFCktL7J&md5=2f471b76eec1e93de88ecaa46865db6d</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1016%2Fj.coph.2008.06.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.coph.2008.06.015%26sid%3Dliteratum%253Aachs%26aulast%3DTaldone%26aufirst%3DT.%26aulast%3DGozman%26aufirst%3DA.%26aulast%3DMaharaj%26aufirst%3DR.%26aulast%3DChiosis%26aufirst%3DG.%26atitle%3DTargeting%2520Hsp90%253A%2520small-molecule%2520inhibitors%2520and%2520their%2520clinical%2520development%26jtitle%3DCurr.%2520Opin.%2520Pharmacol.%26date%3D2008%26volume%3D8%26spage%3D370%26epage%3D374" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Taldone, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiosis, G.</span><span> </span><span class="NLM_article-title">Discovery and development of heat shock protein 90 inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">2225</span><span class="NLM_x">–</span> <span class="NLM_lpage">2235</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Fjm900357y&amp;key=10.1016%2Fj.bmc.2008.10.087" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Fjm900357y&amp;key=19017562" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Fjm900357y&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjsFWqtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2009&pages=2225-2235&author=T.+Taldoneauthor=W.+Sunauthor=G.+Chiosis&title=Discovery+and+development+of+heat+shock+protein+90+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and development of heat shock protein 90 inhibitors</span></div><div class="casAuthors">Taldone, Tony; Sun, Weilin; Chiosis, Gabriela</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2225-2235</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Heat shock protein 90 (Hsp90) is an important target in cancer because of its role in maintaining transformation and has recently become the focus of several drug discovery and development efforts.  While compds. with different modes of action are known, the focus of this review is on those classes of compds. which inhibit Hsp90 by binding to the N-terminal ATP pocket.  These include natural product inhibitors such as geldanamycin and radicicol and synthetic inhibitors comprised of purines, pyrazoles, isoxazoles and other scaffolds.  The synthetic inhibitors have been discovered either by structure-based design, high throughput screening and more recently using fragment-based design and virtual screening techniques.  This review will discuss the discovery of these different classes, as well as their development as potential clin. agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJ1tTxPzeWb7Vg90H21EOLACvtfcHk0liDQKEprPVVoA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjsFWqtLk%253D&md5=13800f6147289bd5c9260941b2a9dbdd</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2008.10.087&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2008.10.087%26sid%3Dliteratum%253Aachs%26aulast%3DTaldone%26aufirst%3DT.%26aulast%3DSun%26aufirst%3DW.%26aulast%3DChiosis%26aufirst%3DG.%26atitle%3DDiscovery%2520and%2520development%2520of%2520heat%2520shock%2520protein%252090%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2009%26volume%3D17%26spage%3D2225%26epage%3D2235" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Kasibhatla, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biamonte, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Busch, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karjian, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sensintaffar, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamal, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lough, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brekken, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lundgren, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grecko, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Timony, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ran, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mansfield, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fritz, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ulm, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burrows, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boehm, M. F.</span><span> </span><span class="NLM_article-title">Rationally designed high-affinity 2-amino-6-halopurine heat shock protein 90 inhibitors that exhibit potent antitumor activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">2767</span><span class="NLM_x">–</span> <span class="NLM_lpage">2778</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm050752%2B" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=2767-2778&author=S.+R.+Kasibhatlaauthor=K.+Hongauthor=M.+A.+Biamonteauthor=D.+J.+Buschauthor=P.+L.+Karjianauthor=J.+L.+Sensintaffarauthor=A.+Kamalauthor=R.+E.+Loughauthor=J.+Brekkenauthor=K.+Lundgrenauthor=R.+Greckoauthor=G.+A.+Timonyauthor=Y.+Ranauthor=R.+Mansfieldauthor=L.+C.+Fritzauthor=E.+Ulmauthor=F.+J.+Burrowsauthor=M.+F.+Boehm&title=Rationally+designed+high-affinity+2-amino-6-halopurine+heat+shock+protein+90+inhibitors+that+exhibit+potent+antitumor+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1021%2Fjm050752%2B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050752%252B%26sid%3Dliteratum%253Aachs%26aulast%3DKasibhatla%26aufirst%3DS.%2BR.%26aulast%3DHong%26aufirst%3DK.%26aulast%3DBiamonte%26aufirst%3DM.%2BA.%26aulast%3DBusch%26aufirst%3DD.%2BJ.%26aulast%3DKarjian%26aufirst%3DP.%2BL.%26aulast%3DSensintaffar%26aufirst%3DJ.%2BL.%26aulast%3DKamal%26aufirst%3DA.%26aulast%3DLough%26aufirst%3DR.%2BE.%26aulast%3DBrekken%26aufirst%3DJ.%26aulast%3DLundgren%26aufirst%3DK.%26aulast%3DGrecko%26aufirst%3DR.%26aulast%3DTimony%26aufirst%3DG.%2BA.%26aulast%3DRan%26aufirst%3DY.%26aulast%3DMansfield%26aufirst%3DR.%26aulast%3DFritz%26aufirst%3DL.%2BC.%26aulast%3DUlm%26aufirst%3DE.%26aulast%3DBurrows%26aufirst%3DF.%2BJ.%26aulast%3DBoehm%26aufirst%3DM.%2BF.%26atitle%3DRationally%2520designed%2520high-affinity%25202-amino-6-halopurine%2520heat%2520shock%2520protein%252090%2520inhibitors%2520that%2520exhibit%2520potent%2520antitumor%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D2767%26epage%3D2778" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group">Lundgren, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brekken, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huser, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powell, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Timple, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Busch, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neely, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sensintaffar, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Y. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKenzie, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scannevin, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamal, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kasibhatla, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boehm, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burrows, F. J.</span><span> </span><span class="NLM_article-title">BIIB021, an orally available, fully synthetic small-molecule inhibitor of the heat shock protein Hsp90</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">921</span><span class="NLM_x">–</span> <span class="NLM_lpage">929</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Fjm900357y&amp;key=10.1158%2F1535-7163.MCT-08-0758" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Fjm900357y&amp;key=19372565" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Fjm900357y&amp;key=1%3ACAS%3A528%3ADC%252BD1MXks1amt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=921-929&author=K.+Lundgrenauthor=H.+Zhangauthor=J.+Brekkenauthor=N.+Huserauthor=R.+E.+Powellauthor=N.+Timpleauthor=D.+J.+Buschauthor=L.+Neelyauthor=J.+L.+Sensintaffarauthor=Y.+C.+Yangauthor=A.+McKenzieauthor=J.+Friedmanauthor=R.+Scannevinauthor=A.+Kamalauthor=K.+Hongauthor=S.+R.+Kasibhatlaauthor=M.+F.+Boehmauthor=F.+J.+Burrows&title=BIIB021%2C+an+orally+available%2C+fully+synthetic+small-molecule+inhibitor+of+the+heat+shock+protein+Hsp90"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">BIIB021, an orally available, fully synthetic small-molecule inhibitor of the heat shock protein Hsp90</span></div><div class="casAuthors">Lundgren, Karen; Zhang, Hong; Brekken, John; Huser, Nanni; Powell, Rachel E.; Timple, Noel; Busch, David J.; Neely, Laura; Sensintaffar, John L.; Yang, Yong-ching; McKenzie, Andres; Friedman, Jessica; Scannevin, Robert; Kamal, Adeela; Hong, Kevin; Kasibhatla, Srinivas R.; Boehm, Marcus F.; Burrows, Francis J.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">921-929</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Inhibition of heat shock protein 90 (Hsp90) results in the degrdn. of oncoproteins that drive malignant progression, inducing cell death, making Hsp90 a target of substantial interest for cancer therapy.  BIIB021 is a novel, fully synthetic inhibitor of Hsp90 that binds competitively with geldanamycin in the ATP-binding pocket of Hsp90.  In tumor cells, BIIB021 induced the degrdn. of Hsp90 client proteins including HER-2, AKT, and Raf-1 and up-regulated expression of the heat shock proteins Hsp70 and Hsp27.  BIIB021 treatment resulted in growth inhibition and cell death in cell lines from a variety of tumor types at nanomolar concns.  Oral administration of BIIB021 led to the degrdn. of Hsp90 client proteins measured in tumor tissue and resulted in the inhibition of tumor growth in several human tumor xenograft models.  Studies to investigate the antitumor effects of BIIB021 showed activity on both daily and intermittent dosing schedules, providing dose schedule flexibility for clin. studies.  Assays measuring the HER-2 protein in tumor tissue and the HER-2 extracellular domain in plasma were used to show interdiction of the Hsp90 pathway and utility as potential biomarkers in clin. trials for BIIB021.  Together, these data show that BIIB021 is a promising new oral inhibitor of Hsp90 with antitumor activity in preclin. models.[Mol Cancer Ther 2009;8(4):921-9].</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSbI2RYG4aF7Vg90H21EOLACvtfcHk0liDQKEprPVVoA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXks1amt74%253D&md5=271e2311ab807bc74b2ac66b81e514e1</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-08-0758&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-08-0758%26sid%3Dliteratum%253Aachs%26aulast%3DLundgren%26aufirst%3DK.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DBrekken%26aufirst%3DJ.%26aulast%3DHuser%26aufirst%3DN.%26aulast%3DPowell%26aufirst%3DR.%2BE.%26aulast%3DTimple%26aufirst%3DN.%26aulast%3DBusch%26aufirst%3DD.%2BJ.%26aulast%3DNeely%26aufirst%3DL.%26aulast%3DSensintaffar%26aufirst%3DJ.%2BL.%26aulast%3DYang%26aufirst%3DY.%2BC.%26aulast%3DMcKenzie%26aufirst%3DA.%26aulast%3DFriedman%26aufirst%3DJ.%26aulast%3DScannevin%26aufirst%3DR.%26aulast%3DKamal%26aufirst%3DA.%26aulast%3DHong%26aufirst%3DK.%26aulast%3DKasibhatla%26aufirst%3DS.%2BR.%26aulast%3DBoehm%26aufirst%3DM.%2BF.%26aulast%3DBurrows%26aufirst%3DF.%2BJ.%26atitle%3DBIIB021%252C%2520an%2520orally%2520available%252C%2520fully%2520synthetic%2520small-molecule%2520inhibitor%2520of%2520the%2520heat%2520shock%2520protein%2520Hsp90%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2009%26volume%3D8%26spage%3D921%26epage%3D929" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Chandarlapaty, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawai, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silinski, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fadden, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Partdrige, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hall, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steed, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Norton, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Solit, D. B.</span><span> </span><span class="NLM_article-title">SNX2112, a Synthetic Heat Shock Protein 90 Inhibitor, Has Potent Antitumor Activity against HER Kinase-Dependent Cancers</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">240</span><span class="NLM_x">–</span> <span class="NLM_lpage">248</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50a&amp;dbid=16&amp;doi=10.1021%2Fjm900357y&amp;key=10.1158%2F1078-0432.CCR-07-1667" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50a&amp;dbid=8&amp;doi=10.1021%2Fjm900357y&amp;key=18172276" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50a&amp;dbid=32&amp;doi=10.1021%2Fjm900357y&amp;key=1%3ACAS%3A528%3ADC%252BD1cXoslGq" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2008&pages=240-248&author=S.+Chandarlapatyauthor=A.+Sawaiauthor=Q.+Yeauthor=A.+Scottauthor=M.+Silinskiauthor=K.+Huangauthor=P.+Faddenauthor=J.+Partdrigeauthor=S.+Hallauthor=P.+Steedauthor=L.+Nortonauthor=N.+Rosenauthor=D.+B.+Solit&title=SNX2112%2C+a+Synthetic+Heat+Shock+Protein+90+Inhibitor%2C+Has+Potent+Antitumor+Activity+against+HER+Kinase-Dependent+Cancers"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50aR"><div class="casContent"><span class="casTitleNuber">50a</span><div class="casTitle"><span class="NLM_cas:atitle">SNX2112, a Synthetic Heat Shock Protein 90 Inhibitor, Has Potent Antitumor Activity against HER Kinase-Dependent Cancers</span></div><div class="casAuthors">Chandarlapaty, Sarat; Sawai, Ayana; Ye, Qing; Scott, Anisa; Silinski, Melanie; Huang, Ken; Fadden, Pat; Partdrige, Jeff; Hall, Steven; Steed, Paul; Norton, Larry; Rosen, Neal; Solit, David B.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">240-248</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">PURPOSE: The heat shock protein 90 (Hsp90) chaperone plays an important role in transformation by regulating the conformational maturation and stability of oncogenic kinases and transcription factors.  Ansamycins, such as 17-(allylamino)-17-demethoxygeldanmycin (17-AAG), inhibit Hsp90 function; induce the degrdn. of Hsp90 client proteins such as HER2, and have shown activity in early clin. trials.  However, the utility of these drugs has been limited by their hepatotoxicity, poor soly., and poorly tolerated formulations.  Exptl. Design: We detd. the pharmacodynamic and antitumor properties of a novel, synthetic Hsp90 inhibitor, SNX-2112, in cell culture and xenograft models of HER kinase-dependent cancers.  RESULTS: We show in a panel of tumor cell lines that SNX-2112 and its prodrug SNX-5542 are Hsp90 inhibitors with properties and potency similar to that of 17-AAG, including: degrdn. of HER2, mutant epidermal growth factor receptor, and other client proteins, inhibition of extracellular signal-regulated kinase and Akt activation, and induction of a Rb-dependent G1 arrest with subsequent apoptosis.  SNX-5542 can be administered to mice orally on a daily schedule.  Following oral administration, SNX-5542 is rapidly converted to SNX-2112, which accumulates in tumors relative to normal tissues.  A single dose of SNX-5542 causes HER2 degrdn. and inhibits its downstream signaling for up to 24 h, and daily dosing results in regression of HER2-dependent xenografts.  SNX-5542 also shows greater activity than 17-AAG in a non-small cell lung cancer xenograft model expressing mutant EGFR.  CONCLUSIONS: These results suggest that Hsp90 inhibition with SNX-2112 (delivered as a prodrug) may represent a promising therapeutic strategy for tumors whose growth and survival is dependent on Hsp90 clients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqER6BYKwq_PLVg90H21EOLACvtfcHk0lglnSe3dirfcA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXoslGq&md5=d0aff2ef77885c47803acd1d6cb446c5</span></div><a href="/servlet/linkout?suffix=cit50a&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-07-1667&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-07-1667%26sid%3Dliteratum%253Aachs%26aulast%3DChandarlapaty%26aufirst%3DS.%26aulast%3DSawai%26aufirst%3DA.%26aulast%3DYe%26aufirst%3DQ.%26aulast%3DScott%26aufirst%3DA.%26aulast%3DSilinski%26aufirst%3DM.%26aulast%3DHuang%26aufirst%3DK.%26aulast%3DFadden%26aufirst%3DP.%26aulast%3DPartdrige%26aufirst%3DJ.%26aulast%3DHall%26aufirst%3DS.%26aulast%3DSteed%26aufirst%3DP.%26aulast%3DNorton%26aufirst%3DL.%26aulast%3DRosen%26aufirst%3DN.%26aulast%3DSolit%26aufirst%3DD.%2BB.%26atitle%3DSNX2112%252C%2520a%2520Synthetic%2520Heat%2520Shock%2520Protein%252090%2520Inhibitor%252C%2520Has%2520Potent%2520Antitumor%2520Activity%2520against%2520HER%2520Kinase-Dependent%2520Cancers%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2008%26volume%3D14%26spage%3D240%26epage%3D248" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit50b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Huang, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Veal, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fadden, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rice, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eaves, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strachan, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barabasz, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group"> Foley, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barta, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group"> Ma, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silinski, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group"> Hu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Partridge, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dubois, L. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freed, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steed, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ommen,  A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, E. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hughes, P. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woodward, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanson, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCall, W. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Markworth, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hinkley, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jenks, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geng, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Otto, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pronk, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verleysen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hall, S. E.</span><span> </span><span class="NLM_article-title">Discovery of Novel 2-Aminobenzamide Inhibitors of Heat Shock Protein 90 as Potent, Selective and Orally Active Antitumor Agents</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">4288</span><span class="NLM_x">–</span> <span class="NLM_lpage">4305</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm900230j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref50/cit50b&amp;dbid=32&amp;doi=10.1021%2Fjm900357y&amp;key=1%3ACAS%3A528%3ADC%252BD1MXns1Onsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=4288-4305&author=K.+H.+Huangauthor=J.+M.+Vealauthor=R.+P.+Faddenauthor=J.+W.+Riceauthor=J.+Eavesauthor=J.+P.+Strachanauthor=A.+F.+Barabaszauthor=B.+E.++Foleyauthor=T.+E.+Bartaauthor=W.++Maauthor=M.+A.+Silinskiauthor=M.++Huauthor=J.+M.+Partridgeauthor=A.+Scottauthor=L.+G.+Duboisauthor=T.+Freedauthor=P.+M.+Steedauthor=+A.+J.+Ommenauthor=E.+D.+Smithauthor=P.+F.+Hughesauthor=A.+R.+Woodwardauthor=G.+J.+Hansonauthor=W.+S.+McCallauthor=C.+J.+Markworthauthor=L.+Hinkleyauthor=M.+Jenksauthor=L.+Gengauthor=M.+Lewisauthor=J.+Ottoauthor=B.+Pronkauthor=K.+Verleysenauthor=S.+E.+Hall&title=Discovery+of+Novel+2-Aminobenzamide+Inhibitors+of+Heat+Shock+Protein+90+as+Potent%2C+Selective+and+Orally+Active+Antitumor+Agents"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50bR"><div class="casContent"><span class="casTitleNuber">50b</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Novel 2-Aminobenzamide Inhibitors of Heat Shock Protein 90 as Potent, Selective and Orally Active Antitumor Agents</span></div><div class="casAuthors">Huang, Kenneth H.; Veal, James M.; Fadden, R. Patrick; Rice, John W.; Eaves, Jeron; Strachan, Jon-Paul; Barabasz, Amy F.; Foley, Briana E.; Barta, Thomas E.; Ma, Wei; Silinski, Melanie A.; Hu, Mei; Partridge, Jeffrey M.; Scott, Anisa; DuBois, Laura G.; Freed, Tiffany; Steed, Paul M.; Ommen, Andy J.; Smith, Emilie D.; Hughes, Philip F.; Woodward, Angela R.; Hanson, Gunnar J.; McCall, W. Stephen; Markworth, Christopher J.; Hinkley, Lindsay; Jenks, Matthew; Geng, Lifeng; Lewis, Meredith; Otto, James; Pronk, Bert; Verleysen, Katleen; Hall, Steven E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">4288-4305</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A novel class of heat shock protein 90 (Hsp90) inhibitors was developed from an unbiased screen to identify protein targets for a diverse compd. library.  These indol-4-one and indazol-4-one derived 2-aminobenzamides showed strong binding affinity to Hsp90, and optimized analogs exhibited nanomolar antiproliferative activity across multiple cancer cell lines.  Heat shock protein 70 (Hsp70) induction and specific client protein degrdn. in cells on treatment with the inhibitors supported Hsp90 inhibition as the mechanism of action.  Computational chem. and X-ray crystallog. anal. of selected member compds. clearly defined the protein-inhibitor interaction and assisted the design of analogs. 4-[6,6-Dimethyl-4-oxo-3-(trifluoromethyl)-4,5,6,7-tetrahydro-1H-indazol-1-yl]-2-[(trans-4-hydroxycyclohexyl)amino]benzamide (SNX-2112) (I) was identified as highly selective and potent (IC50 Her2 = 11 nM, HT-29 = 3 nM); its prodrug amino-acetic acid 4-[2-carbamoyl-5-(6,6-dimethyl-4-oxo-3-trifluoromethyl-4,5,6,7-tetrahydro-indazol-1-yl)-phenylamino]-cyclohexyl ester methanesulfonate (SNX-5422) (II)was orally bioavailable and efficacious in a broad range of xenograft tumor models (e.g. 67% growth delay in a HT-29 model) and is now in multiple phase I clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFjrhELWrFkbVg90H21EOLACvtfcHk0lglnSe3dirfcA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXns1Onsrk%253D&md5=99e5039e1761e9099d634acd79a15a6a</span></div><a href="/servlet/linkout?suffix=cit50b&amp;dbid=16384&amp;doi=10.1021%2Fjm900230j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900230j%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DK.%2BH.%26aulast%3DVeal%26aufirst%3DJ.%2BM.%26aulast%3DFadden%26aufirst%3DR.%2BP.%26aulast%3DRice%26aufirst%3DJ.%2BW.%26aulast%3DEaves%26aufirst%3DJ.%26aulast%3DStrachan%26aufirst%3DJ.%2BP.%26aulast%3DBarabasz%26aufirst%3DA.%2BF.%26aulast%3DFoley%26aufirst%3DB.%2BE.%26aulast%3DBarta%26aufirst%3DT.%2BE.%26aulast%3DMa%26aufirst%3DW.%26aulast%3DSilinski%26aufirst%3DM.%2BA.%26aulast%3DHu%26aufirst%3DM.%26aulast%3DPartridge%26aufirst%3DJ.%2BM.%26aulast%3DScott%26aufirst%3DA.%26aulast%3DDubois%26aufirst%3DL.%2BG.%26aulast%3DFreed%26aufirst%3DT.%26aulast%3DSteed%26aufirst%3DP.%2BM.%26aulast%3DOmmen%26aufirst%3DA.%2BJ.%26aulast%3DSmith%26aufirst%3DE.%2BD.%26aulast%3DHughes%26aufirst%3DP.%2BF.%26aulast%3DWoodward%26aufirst%3DA.%2BR.%26aulast%3DHanson%26aufirst%3DG.%2BJ.%26aulast%3DMcCall%26aufirst%3DW.%2BS.%26aulast%3DMarkworth%26aufirst%3DC.%2BJ.%26aulast%3DHinkley%26aufirst%3DL.%26aulast%3DJenks%26aufirst%3DM.%26aulast%3DGeng%26aufirst%3DL.%26aulast%3DLewis%26aufirst%3DM.%26aulast%3DOtto%26aufirst%3DJ.%26aulast%3DPronk%26aufirst%3DB.%26aulast%3DVerleysen%26aufirst%3DK.%26aulast%3DHall%26aufirst%3DS.%2BE.%26atitle%3DDiscovery%2520of%2520Novel%25202-Aminobenzamide%2520Inhibitors%2520of%2520Heat%2520Shock%2520Protein%252090%2520as%2520Potent%252C%2520Selective%2520and%2520Orally%2520Active%2520Antitumor%2520Agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D4288%26epage%3D4305" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group">Brough, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aherne, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barril, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borgognoni, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boxall, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cansfield, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheung, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, N. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drysdale, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dymock, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eccles, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finch, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fink, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayes, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howes, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hubbard, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">James, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jordan, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lockie, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martins, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Massey, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matthews, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonald, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Northfield, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pearl, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prodromou, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ray, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raynaud, F. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roughley, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharp, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Surgenor, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walmsley, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webb, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Workman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, L.</span><span> </span><span class="NLM_article-title">4,5-Diarylisoxazole Hsp90 chaperone inhibitors: potential therapeutic agents for the treatment of cancer</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">196</span><span class="NLM_x">–</span> <span class="NLM_lpage">218</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm701018h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=196-218&author=P.+A.+Broughauthor=W.+Aherneauthor=X.+Barrilauthor=J.+Borgognoniauthor=K.+Boxallauthor=J.+E.+Cansfieldauthor=K.+M.+Cheungauthor=I.+Collinsauthor=N.+G.+Daviesauthor=M.+J.+Drysdaleauthor=B.+Dymockauthor=S.+A.+Ecclesauthor=H.+Finchauthor=A.+Finkauthor=A.+Hayesauthor=R.+Howesauthor=R.+E.+Hubbardauthor=K.+Jamesauthor=A.+M.+Jordanauthor=A.+Lockieauthor=V.+Martinsauthor=A.+Masseyauthor=T.+P.+Matthewsauthor=E.+McDonaldauthor=C.+J.+Northfieldauthor=L.+H.+Pearlauthor=C.+Prodromouauthor=S.+Rayauthor=F.+I.+Raynaudauthor=S.+D.+Roughleyauthor=S.+Y.+Sharpauthor=A.+Surgenorauthor=D.+L.+Walmsleyauthor=P.+Webbauthor=M.+Woodauthor=P.+Workmanauthor=L.+Wright&title=4%2C5-Diarylisoxazole+Hsp90+chaperone+inhibitors%3A+potential+therapeutic+agents+for+the+treatment+of+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1021%2Fjm701018h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm701018h%26sid%3Dliteratum%253Aachs%26aulast%3DBrough%26aufirst%3DP.%2BA.%26aulast%3DAherne%26aufirst%3DW.%26aulast%3DBarril%26aufirst%3DX.%26aulast%3DBorgognoni%26aufirst%3DJ.%26aulast%3DBoxall%26aufirst%3DK.%26aulast%3DCansfield%26aufirst%3DJ.%2BE.%26aulast%3DCheung%26aufirst%3DK.%2BM.%26aulast%3DCollins%26aufirst%3DI.%26aulast%3DDavies%26aufirst%3DN.%2BG.%26aulast%3DDrysdale%26aufirst%3DM.%2BJ.%26aulast%3DDymock%26aufirst%3DB.%26aulast%3DEccles%26aufirst%3DS.%2BA.%26aulast%3DFinch%26aufirst%3DH.%26aulast%3DFink%26aufirst%3DA.%26aulast%3DHayes%26aufirst%3DA.%26aulast%3DHowes%26aufirst%3DR.%26aulast%3DHubbard%26aufirst%3DR.%2BE.%26aulast%3DJames%26aufirst%3DK.%26aulast%3DJordan%26aufirst%3DA.%2BM.%26aulast%3DLockie%26aufirst%3DA.%26aulast%3DMartins%26aufirst%3DV.%26aulast%3DMassey%26aufirst%3DA.%26aulast%3DMatthews%26aufirst%3DT.%2BP.%26aulast%3DMcDonald%26aufirst%3DE.%26aulast%3DNorthfield%26aufirst%3DC.%2BJ.%26aulast%3DPearl%26aufirst%3DL.%2BH.%26aulast%3DProdromou%26aufirst%3DC.%26aulast%3DRay%26aufirst%3DS.%26aulast%3DRaynaud%26aufirst%3DF.%2BI.%26aulast%3DRoughley%26aufirst%3DS.%2BD.%26aulast%3DSharp%26aufirst%3DS.%2BY.%26aulast%3DSurgenor%26aufirst%3DA.%26aulast%3DWalmsley%26aufirst%3DD.%2BL.%26aulast%3DWebb%26aufirst%3DP.%26aulast%3DWood%26aufirst%3DM.%26aulast%3DWorkman%26aufirst%3DP.%26aulast%3DWright%26aufirst%3DL.%26atitle%3D4%252C5-Diarylisoxazole%2520Hsp90%2520chaperone%2520inhibitors%253A%2520potential%2520therapeutic%2520agents%2520for%2520the%2520treatment%2520of%2520cancer%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D196%26epage%3D218" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group">Eccles, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Massey, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raynaud, F. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharp, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Box, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valenti, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patterson, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haven Brandon, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gowan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boxall, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aherne, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowlands, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayes, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martins, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Urban, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boxall, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prodromou, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pearl, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">James, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matthews, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheung, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalusa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonald, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barril, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brough, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cansfield, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dymock, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drysdale, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finch, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howes, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hubbard, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Surgenor, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webb, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Workman, P.</span><span> </span><span class="NLM_article-title">NVP-AUY922: A Novel Heat Shock Protein 90 Inhibitor Active against Xenograft Tumor Growth, Angiogenesis, and Metastasis</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">2850</span><span class="NLM_x">–</span> <span class="NLM_lpage">2860</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2008&pages=2850-2860&author=S.+A.+Ecclesauthor=A.+Masseyauthor=F.+I.+Raynaudauthor=S.+Y.+Sharpauthor=G.+Boxauthor=M.+Valentiauthor=L.+Pattersonauthor=A.+Haven+Brandonauthor=S.+Gowanauthor=F.+Boxallauthor=W.+Aherneauthor=M.+Rowlandsauthor=A.+Hayesauthor=V.+Martinsauthor=F.+Urbanauthor=K.+Boxallauthor=C.+Prodromouauthor=L.+Pearlauthor=K.+Jamesauthor=T.+P.+Matthewsauthor=K.+M.+Cheungauthor=A.+Kalusaauthor=K.+Jonesauthor=E.+McDonaldauthor=X.+Barrilauthor=P.+A.+Broughauthor=J.+E.+Cansfieldauthor=B.+Dymockauthor=M.+J.+Drysdaleauthor=H.+Finchauthor=R.+Howesauthor=R.+E.+Hubbardauthor=A.+Surgenorauthor=P.+Webbauthor=M.+Woodauthor=L.+Wrightauthor=P.+Workman&title=NVP-AUY922%3A+A+Novel+Heat+Shock+Protein+90+Inhibitor+Active+against+Xenograft+Tumor+Growth%2C+Angiogenesis%2C+and+Metastasis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEccles%26aufirst%3DS.%2BA.%26aulast%3DMassey%26aufirst%3DA.%26aulast%3DRaynaud%26aufirst%3DF.%2BI.%26aulast%3DSharp%26aufirst%3DS.%2BY.%26aulast%3DBox%26aufirst%3DG.%26aulast%3DValenti%26aufirst%3DM.%26aulast%3DPatterson%26aufirst%3DL.%26aulast%3DHaven%2BBrandon%26aufirst%3DA.%26aulast%3DGowan%26aufirst%3DS.%26aulast%3DBoxall%26aufirst%3DF.%26aulast%3DAherne%26aufirst%3DW.%26aulast%3DRowlands%26aufirst%3DM.%26aulast%3DHayes%26aufirst%3DA.%26aulast%3DMartins%26aufirst%3DV.%26aulast%3DUrban%26aufirst%3DF.%26aulast%3DBoxall%26aufirst%3DK.%26aulast%3DProdromou%26aufirst%3DC.%26aulast%3DPearl%26aufirst%3DL.%26aulast%3DJames%26aufirst%3DK.%26aulast%3DMatthews%26aufirst%3DT.%2BP.%26aulast%3DCheung%26aufirst%3DK.%2BM.%26aulast%3DKalusa%26aufirst%3DA.%26aulast%3DJones%26aufirst%3DK.%26aulast%3DMcDonald%26aufirst%3DE.%26aulast%3DBarril%26aufirst%3DX.%26aulast%3DBrough%26aufirst%3DP.%2BA.%26aulast%3DCansfield%26aufirst%3DJ.%2BE.%26aulast%3DDymock%26aufirst%3DB.%26aulast%3DDrysdale%26aufirst%3DM.%2BJ.%26aulast%3DFinch%26aufirst%3DH.%26aulast%3DHowes%26aufirst%3DR.%26aulast%3DHubbard%26aufirst%3DR.%2BE.%26aulast%3DSurgenor%26aufirst%3DA.%26aulast%3DWebb%26aufirst%3DP.%26aulast%3DWood%26aufirst%3DM.%26aulast%3DWright%26aufirst%3DL.%26aulast%3DWorkman%26aufirst%3DP.%26atitle%3DNVP-AUY922%253A%2520A%2520Novel%2520Heat%2520Shock%2520Protein%252090%2520Inhibitor%2520Active%2520against%2520Xenograft%2520Tumor%2520Growth%252C%2520Angiogenesis%252C%2520and%2520Metastasis%26jtitle%3DCancer%2520Res.%26date%3D2008%26volume%3D68%26spage%3D2850%26epage%3D2860" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span>See <a href="http://www.clinicaltrials.gov" class="extLink">www.clinicaltrials.gov</a> for details of clinical trials relating Hsp90 inhibitors. Accessed on July 13, 2009.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=See+www.clinicaltrials.gov+for+details+of+clinical+trials+relating+Hsp90+inhibitors.+Accessed+on+July+13%2C+2009."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group">Congreve, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chessari, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tisi, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woodhead, A. J.</span><span> </span><span class="NLM_article-title">Recent developments in fragment-based drug discovery</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">3661</span><span class="NLM_x">–</span> <span class="NLM_lpage">3680</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm8000373" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=3661-3680&author=M.+Congreveauthor=G.+Chessariauthor=D.+Tisiauthor=A.+J.+Woodhead&title=Recent+developments+in+fragment-based+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1021%2Fjm8000373&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm8000373%26sid%3Dliteratum%253Aachs%26aulast%3DCongreve%26aufirst%3DM.%26aulast%3DChessari%26aufirst%3DG.%26aulast%3DTisi%26aufirst%3DD.%26aulast%3DWoodhead%26aufirst%3DA.%2BJ.%26atitle%3DRecent%2520developments%2520in%2520fragment-based%2520drug%2520discovery%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D3661%26epage%3D3680" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group">Erlanson, D. A.</span><span> </span><span class="NLM_article-title">Fragment-based lead discovery: a chemical update</span> <span class="citation_source-journal">Curr. Opin. Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">643</span><span class="NLM_x">–</span> <span class="NLM_lpage">652</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Fjm900357y&amp;key=10.1016%2Fj.copbio.2006.10.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Fjm900357y&amp;key=17084612" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Fjm900357y&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1eqs7zF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2006&pages=643-652&author=D.+A.+Erlanson&title=Fragment-based+lead+discovery%3A+a+chemical+update"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Fragment-based lead discovery: A chemical update</span></div><div class="casAuthors">Erlanson, Daniel A.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Biotechnology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">643-652</span>CODEN:
                <span class="NLM_cas:coden">CUOBE3</span>;
        ISSN:<span class="NLM_cas:issn">0958-1669</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Fragment-based lead discovery constructs drug leads from small mol. fragments.  In theory, this is a highly efficient method for drug discovery, and the technique has become enormously popular in the past few years.  In this review, I describe how a variety of approaches in fragment-based lead discovery - including NMR, x-ray crystallog., mass spectrometry, functional screening, and in silico screening - have produced drug leads.  Although the examples show that the technique can reliably generate potent mols., there is still much work to be done to maintain the efficiency of mols.' binding affinities as fragments are linked, expanded, and otherwise improved.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoa2pK6tEB4ZrVg90H21EOLACvtfcHk0lgsTTu19ASGFQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1eqs7zF&md5=9b13f54a7fd849df9e74b9a5f58be93d</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1016%2Fj.copbio.2006.10.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.copbio.2006.10.007%26sid%3Dliteratum%253Aachs%26aulast%3DErlanson%26aufirst%3DD.%2BA.%26atitle%3DFragment-based%2520lead%2520discovery%253A%2520a%2520chemical%2520update%26jtitle%3DCurr.%2520Opin.%2520Biotechnol.%26date%3D2006%26volume%3D17%26spage%3D643%26epage%3D652" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group">Hajduk, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greer, J.</span><span> </span><span class="NLM_article-title">A decade of fragment-based drug design: strategic advances and lessons learned</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">211</span><span class="NLM_x">–</span> <span class="NLM_lpage">219</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Fjm900357y&amp;key=10.1038%2Fnrd2220" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Fjm900357y&amp;key=17290284" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Fjm900357y&amp;key=1%3ACAS%3A528%3ADC%252BD2sXit12rtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=211-219&author=P.+J.+Hajdukauthor=J.+Greer&title=A+decade+of+fragment-based+drug+design%3A+strategic+advances+and+lessons+learned"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">A decade of fragment-based drug design: strategic advances and lessons learned</span></div><div class="casAuthors">Hajduk, Philip J.; Greer, Jonathan</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">211-219</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Since the early 1990s, several technol. and scientific advances - such as combinatorial chem., high-throughput screening and the sequencing of the human genome - have been heralded as remedies to the problems facing the pharmaceutical industry.  The use of these technologies in some form is now well established at most pharmaceutical companies; however, the return on investment in terms of marketed products has not met expectations.  Fragment-based drug design is another tool for drug discovery that has emerged in the past decade.  Here, we describe the development and evolution of fragment-based drug design, analyze the role that this approach can have in combination with other discovery technologies and highlight the impact that fragment-based methods have made in progressing new medicines into the clinic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpOB8K3AESqTbVg90H21EOLACvtfcHk0lgsTTu19ASGFQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXit12rtr4%253D&md5=bae574da3671475d8488615c3bfa9849</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1038%2Fnrd2220&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2220%26sid%3Dliteratum%253Aachs%26aulast%3DHajduk%26aufirst%3DP.%2BJ.%26aulast%3DGreer%26aufirst%3DJ.%26atitle%3DA%2520decade%2520of%2520fragment-based%2520drug%2520design%253A%2520strategic%2520advances%2520and%2520lessons%2520learned%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2007%26volume%3D6%26spage%3D211%26epage%3D219" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group">Hubbard, R. E.</span><span> </span><span class="NLM_article-title">Fragment approaches in structure-based drug discovery</span> <span class="citation_source-journal">J. Synchrotron Radiat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">227</span><span class="NLM_x">–</span> <span class="NLM_lpage">230</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Fjm900357y&amp;key=10.1107%2FS090904950705666X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Fjm900357y&amp;key=18421145" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Fjm900357y&amp;key=1%3ACAS%3A528%3ADC%252BD1cXksl2qtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2008&pages=227-230&author=R.+E.+Hubbard&title=Fragment+approaches+in+structure-based+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Fragment approaches in structure-based drug discovery</span></div><div class="casAuthors">Hubbard, Roderick E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Synchrotron Radiation</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">227-230</span>CODEN:
                <span class="NLM_cas:coden">JSYRES</span>;
        ISSN:<span class="NLM_cas:issn">0909-0495</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">A review.  There has been considerable interest recently in what is known as 'fragment-based lead discovery'.  The novel feature of the approach is to begin with small low-affinity compds.  The main advantage is that a larger potential chem. diversity can be sampled with fewer compds., which is particularly important for new target classes.  The approach relies on careful design of the fragment library, a method that can detect binding of the fragment to the protein target, detn. of the structure of the fragment bound to the target, and the conventional use of structural information to guide compd. optimization.  In this article the methods are reviewed, and experiences in fragment-based discovery of lead series of compds. against kinases such as PDK1 and ATPases such as Hsp90 are discussed.  The examples illustrate some of the key benefits and issues of the approach and also provide anecdotal examples of the patterns seen in selectivity and the binding mode of fragments across different protein targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMyf3C0s8UCLVg90H21EOLACvtfcHk0lgsTTu19ASGFQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXksl2qtrs%253D&md5=44ec2d62df13dea4dca716f634d6cdd3</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1107%2FS090904950705666X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS090904950705666X%26sid%3Dliteratum%253Aachs%26aulast%3DHubbard%26aufirst%3DR.%2BE.%26atitle%3DFragment%2520approaches%2520in%2520structure-based%2520drug%2520discovery%26jtitle%3DJ.%2520Synchrotron%2520Radiat.%26date%3D2008%26volume%3D15%26spage%3D227%26epage%3D230" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group">Jahnke, W.; Erlanson, D. A.</span> <span class="citation_source-book">Fragment-Based Approaches in Drug Discovery</span>; <span class="NLM_publisher-name">Wiley</span>: <span class="NLM_publisher-loc">Weinheim, Germany</span>,<span class="NLM_x"> </span><span class="NLM_year">2007</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&author=W.+Jahnke&author=D.+A.+Erlanson&title=Fragment-Based+Approaches+in+Drug+Discovery"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DJahnke%26aufirst%3DW.%26btitle%3DFragment-Based%2520Approaches%2520in%2520Drug%2520Discovery%26pub%3DWiley%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group">Jhoti, H.; Leach, A. R.</span> <span class="citation_source-book">Structure-Based Drug Discovery</span>; <span class="NLM_publisher-name">Springer</span>: <span class="NLM_publisher-loc">Dordrecht, The Netherlands</span>,<span class="NLM_x"> </span><span class="NLM_year">2007</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&author=H.+Jhoti&author=A.+R.+Leach&title=Structure-Based+Drug+Discovery"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DJhoti%26aufirst%3DH.%26btitle%3DStructure-Based%2520Drug%2520Discovery%26pub%3DSpringer%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group">Hubbard, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drysdale, M. J.</span><span> </span><span class="NLM_article-title">The SeeDs approach: integrating fragments into drug discovery</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">1568</span><span class="NLM_x">–</span> <span class="NLM_lpage">1581</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Fjm900357y&amp;key=10.2174%2F156802607782341109" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Fjm900357y&amp;key=17979768" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Fjm900357y&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVOrur7J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2007&pages=1568-1581&author=R.+E.+Hubbardauthor=B.+Davisauthor=I.+Chenauthor=M.+J.+Drysdale&title=The+SeeDs+approach%3A+integrating+fragments+into+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">The SeeDs approach: integrating fragments into drug discovery</span></div><div class="casAuthors">Hubbard, Roderick E.; Davis, Ben; Chen, Ijen; Drysdale, Martin J.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">1568-1581</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Finding novel compds. as starting points for optimization is a major challenge in drug discovery research.  Fragment-based methods have emerged in the past ten years as an effective way to sample chem. diversity with a limited no. of low mol. wt. compds.  The structures of the fragments(s) binding to the protein can then be used to design new compds. with increased affinity, specificity and novelty.  This article describes the Vernalis approach to fragment based drug discovery, called SeeDs (Structural exploitation of exptl. Drug startpoints).  The approach includes the design of a fragment library, identification of fragments that bind competitively to a target by ligand-based NMR techniques and protein crystal structures to characterize binding.  Fragments that bind are then evolved to hits, either by growing the fragment or by combining structural features from a no. of compds.  The process is illustrated with examples from recent medicinal chem. programs to discover compds. against the oncol. targets Hsp90 and PDK1.  In addn., we summarize our experience with using mol. docking calcns. to predict fragment binding and anecdotes on the selectivity and binding modes for fragments seen against a range of targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGox6z6oFlEi67Vg90H21EOLACvtfcHk0lhfzxSp7gF1oQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVOrur7J&md5=6bfa0109e33c2c23cc4c5a5bcd1ed12f</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.2174%2F156802607782341109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802607782341109%26sid%3Dliteratum%253Aachs%26aulast%3DHubbard%26aufirst%3DR.%2BE.%26aulast%3DDavis%26aufirst%3DB.%26aulast%3DChen%26aufirst%3DI.%26aulast%3DDrysdale%26aufirst%3DM.%2BJ.%26atitle%3DThe%2520SeeDs%2520approach%253A%2520integrating%2520fragments%2520into%2520drug%2520discovery%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2007%26volume%3D7%26spage%3D1568%26epage%3D1581" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group">Chiosis, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Timaul, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucas, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munster, P. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, F. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sepp-Lorenzino, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, N.</span><span> </span><span class="NLM_article-title">A small molecule designed to bind to the adenine nucleotide pocket of Hsp90 causes Her2 degradation and the growth arrest and differentiation of breast cancer cells</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">289</span><span class="NLM_x">–</span> <span class="NLM_lpage">299</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Fjm900357y&amp;key=10.1016%2FS1074-5521%2801%2900015-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Fjm900357y&amp;key=11306353" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Fjm900357y&amp;key=1%3ACAS%3A528%3ADC%252BD3MXjsVCitbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2001&pages=289-299&author=G.+Chiosisauthor=M.+N.+Timaulauthor=B.+Lucasauthor=P.+N.+Munsterauthor=F.+F.+Zhengauthor=L.+Sepp-Lorenzinoauthor=N.+Rosen&title=A+small+molecule+designed+to+bind+to+the+adenine+nucleotide+pocket+of+Hsp90+causes+Her2+degradation+and+the+growth+arrest+and+differentiation+of+breast+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">A small molecule designed to bind to the adenine nucleotide pocket of Hsp90 causes Her2 degradation and the growth arrest and differentiation of breast cancer cells</span></div><div class="casAuthors">Chiosis, Gabriela; Timaul, Merna N.; Lucas, Brian; Munster, Pamela N.; Zheng, Fuzhong F.; Sepp-Lorenzino, Laura; Rosen, Neal</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">289-299</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">Background: The Hsp90s contain a conserved pocket that binds ATP/ADP and plays an important role in the regulation of chaperone function.  Occupancy of this pocket by several natural products (geldanamycin (GM) and radicicol) alters Hsp90 function and results in the degrdn. of a subset of proteins (i.e. steroid receptors, Her2, Raf).  We have used the structural features of this pocket to design a small mol. inhibitor of Hsp90.  Results: The designed small mol. PU3 competes with GM for Hsp90 binding with a relative affinity of 15-20 μM.  PU3 induces degrdn. of proteins, including Her2, in a manner similar to GM.  Furthermore, PU3 inhibits the growth of breast cancer cells causing retinoblastoma protein hypophosphorylation, G1 arrest and differentiation.  Conclusions: PU3 is representative of a novel class of synthetic compds. that binds to Hsp90 and inhibits the proliferation of cancer cells.  These reagents could provide a new strategy for the treatment of cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqwVErTsVLPMrVg90H21EOLACvtfcHk0lhfzxSp7gF1oQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXjsVCitbs%253D&md5=6a51b7e8c95c320fa27f62d9f9f645f5</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1016%2FS1074-5521%2801%2900015-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1074-5521%252801%252900015-1%26sid%3Dliteratum%253Aachs%26aulast%3DChiosis%26aufirst%3DG.%26aulast%3DTimaul%26aufirst%3DM.%2BN.%26aulast%3DLucas%26aufirst%3DB.%26aulast%3DMunster%26aufirst%3DP.%2BN.%26aulast%3DZheng%26aufirst%3DF.%2BF.%26aulast%3DSepp-Lorenzino%26aufirst%3DL.%26aulast%3DRosen%26aufirst%3DN.%26atitle%3DA%2520small%2520molecule%2520designed%2520to%2520bind%2520to%2520the%2520adenine%2520nucleotide%2520pocket%2520of%2520Hsp90%2520causes%2520Her2%2520degradation%2520and%2520the%2520growth%2520arrest%2520and%2520differentiation%2520of%2520breast%2520cancer%2520cells%26jtitle%3DChem.%2520Biol.%26date%3D2001%26volume%3D8%26spage%3D289%26epage%3D299" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group">Lepre, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, J. W.</span><span> </span><span class="NLM_article-title">Theory and applications of NMR-based screening in pharmaceutical research</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">104</span><span class="NLM_x">, </span> <span class="NLM_fpage">3641</span><span class="NLM_x">–</span> <span class="NLM_lpage">3676</span></span><div class="citationLinks">[<a href="/doi/10.1021/cr030409h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Fjm900357y&amp;key=1%3ACAS%3A528%3ADC%252BD2cXlvFGiurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2004&pages=3641-3676&author=C.+A.+Lepreauthor=J.+M.+Mooreauthor=J.+W.+Peng&title=Theory+and+applications+of+NMR-based+screening+in+pharmaceutical+research"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Theory and Applications of NMR-Based Screening in Pharmaceutical Research</span></div><div class="casAuthors">Lepre, Christopher A.; Moore, Jonathan M.; Peng, Jeffrey W.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">104</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3641-3675</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrrS0z7FwNhp7Vg90H21EOLACvtfcHk0lhfzxSp7gF1oQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXlvFGiurY%253D&md5=2e43f7f4e6fc94e0022531c44804f0a3</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1021%2Fcr030409h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr030409h%26sid%3Dliteratum%253Aachs%26aulast%3DLepre%26aufirst%3DC.%2BA.%26aulast%3DMoore%26aufirst%3DJ.%2BM.%26aulast%3DPeng%26aufirst%3DJ.%2BW.%26atitle%3DTheory%2520and%2520applications%2520of%2520NMR-based%2520screening%2520in%2520pharmaceutical%2520research%26jtitle%3DChem.%2520Rev.%26date%3D2004%26volume%3D104%26spage%3D3641%26epage%3D3676" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group">Mayer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyer, B.</span><span> </span><span class="NLM_article-title">Characterisation of ligand binding by saturation transfer difference NMR spectroscopy</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">1784</span><span class="NLM_x">–</span> <span class="NLM_lpage">1788</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1999&pages=1784-1788&author=M.+Mayerauthor=B.+Meyer&title=Characterisation+of+ligand+binding+by+saturation+transfer+difference+NMR+spectroscopy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMayer%26aufirst%3DM.%26aulast%3DMeyer%26aufirst%3DB.%26atitle%3DCharacterisation%2520of%2520ligand%2520binding%2520by%2520saturation%2520transfer%2520difference%2520NMR%2520spectroscopy%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D1999%26volume%3D38%26spage%3D1784%26epage%3D1788" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group">Dalvit, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pevarello, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tato, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Veronesi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vulpetti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sundstrom, M.</span><span> </span><span class="NLM_article-title">Identification of compounds with binding affinity to proteins via magnetization transfer from bulk water</span> <span class="citation_source-journal">J. Biomol. NMR</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">65</span><span class="NLM_x">–</span> <span class="NLM_lpage">68</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Fjm900357y&amp;key=10.1023%2FA%3A1008354229396" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Fjm900357y&amp;key=11061229" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Fjm900357y&amp;key=1%3ACAS%3A528%3ADC%252BD3cXnvVGit7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2000&pages=65-68&author=C.+Dalvitauthor=P.+Pevarelloauthor=M.+Tatoauthor=M.+Veronesiauthor=A.+Vulpettiauthor=M.+Sundstrom&title=Identification+of+compounds+with+binding+affinity+to+proteins+via+magnetization+transfer+from+bulk+water"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of compounds with binding affinity to proteins via magnetization transfer from bulk water</span></div><div class="casAuthors">Dalvit, Claudio; Pevarello, Paolo; Tato, Marco; Veronesi, Marina; Vulpetti, Anna; Sundstrom, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biomolecular NMR</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">65-68</span>CODEN:
                <span class="NLM_cas:coden">JBNME9</span>;
        ISSN:<span class="NLM_cas:issn">0925-2738</span>.
    
            (<span class="NLM_cas:orgname">Kluwer Academic Publishers</span>)
        </div><div class="casAbstract">A powerful screening by NMR methodol. (WaterLOGSY), based on transfer of magnetization from bulk water, for the identification of compds. that interact with target biomols. (proteins, RNA and DNA fragments) is described.  The method exploits efficiently the large reservoir of H2O magnetization.  The high sensitivity of the technique reduces the amt. of biomol. and ligands needed for the screening, which constitutes an important requirement for high throughput screening by NMR of large libraries of compds.  Application of the method to a compd. mixt. against the cyclin-dependent kinase 2 (cdk2) protein is presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoR8Jo0PHYdALVg90H21EOLACvtfcHk0lhr10qU5nST2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXnvVGit7o%253D&md5=e0fd0e5815f9bd20ed09d8033882feb6</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1023%2FA%3A1008354229396&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FA%253A1008354229396%26sid%3Dliteratum%253Aachs%26aulast%3DDalvit%26aufirst%3DC.%26aulast%3DPevarello%26aufirst%3DP.%26aulast%3DTato%26aufirst%3DM.%26aulast%3DVeronesi%26aufirst%3DM.%26aulast%3DVulpetti%26aufirst%3DA.%26aulast%3DSundstrom%26aufirst%3DM.%26atitle%3DIdentification%2520of%2520compounds%2520with%2520binding%2520affinity%2520to%2520proteins%2520via%2520magnetization%2520transfer%2520from%2520bulk%2520water%26jtitle%3DJ.%2520Biomol.%2520NMR%26date%3D2000%26volume%3D18%26spage%3D65%26epage%3D68" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group">Hajduk, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olejniczak, E. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fesik, S. W.</span><span> </span><span class="NLM_article-title">One-Dimensional Relaxation and Diffusion-Edited NMR Methods for Screening Compounds that Bind to Macromolecules</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">119</span><span class="NLM_x">, </span> <span class="NLM_fpage">12257</span><span class="NLM_x">–</span> <span class="NLM_lpage">12261</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja9715962" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=119&publication_year=1997&pages=12257-12261&author=P.+J.+Hajdukauthor=E.+T.+Olejniczakauthor=S.+W.+Fesik&title=One-Dimensional+Relaxation+and+Diffusion-Edited+NMR+Methods+for+Screening+Compounds+that+Bind+to+Macromolecules"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1021%2Fja9715962&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja9715962%26sid%3Dliteratum%253Aachs%26aulast%3DHajduk%26aufirst%3DP.%2BJ.%26aulast%3DOlejniczak%26aufirst%3DE.%2BT.%26aulast%3DFesik%26aufirst%3DS.%2BW.%26atitle%3DOne-Dimensional%2520Relaxation%2520and%2520Diffusion-Edited%2520NMR%2520Methods%2520for%2520Screening%2520Compounds%2520that%2520Bind%2520to%2520Macromolecules%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1997%26volume%3D119%26spage%3D12257%26epage%3D12261" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group">Baurin, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aboul-Ela, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barril, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drysdale, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dymock, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finch, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fromont, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richardson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simmonite, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hubbard, R. E.</span><span> </span><span class="NLM_article-title">Design and characterization of libraries of molecular fragments for use in NMR screening against protein targets</span> <span class="citation_source-journal">J. Chem. Inf. Comput. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">2157</span><span class="NLM_x">–</span> <span class="NLM_lpage">2166</span></span><div class="citationLinks">[<a href="/doi/10.1021/ci049806z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Fjm900357y&amp;key=1%3ACAS%3A528%3ADC%252BD2cXotlaru78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2004&pages=2157-2166&author=N.+Baurinauthor=F.+Aboul-Elaauthor=X.+Barrilauthor=B.+Davisauthor=M.+Drysdaleauthor=B.+Dymockauthor=H.+Finchauthor=C.+Fromontauthor=C.+Richardsonauthor=H.+Simmoniteauthor=R.+E.+Hubbard&title=Design+and+characterization+of+libraries+of+molecular+fragments+for+use+in+NMR+screening+against+protein+targets"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Characterization of Libraries of Molecular Fragments for Use in NMR Screening against Protein Targets</span></div><div class="casAuthors">Baurin, Nicolas; Aboul-Ela, Fareed; Barril, Xavier; Davis, Ben; Drysdale, Martin; Dymock, Brian; Finch, Harry; Fromont, Christophe; Richardson, Christine; Simmonite, Heather; Hubbard, Roderick E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Computer Sciences</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2157-2166</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">0095-2338</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We have designed four generations of a low mol. wt. fragment library for use in NMR-based screening against protein targets.  The library initially contained 723 fragments which were selected manually from the Available Chems. Directory.  A series of in silico filters and property calcns. were developed to automate the selection process, allowing a larger database of 1.79M available compds. to be searched for a further 357 compds. that were added to the library.  A kinase binding pharmacophore was then derived to select 174 kinase-focused fragments.  Finally, an addnl. 61 fragments were selected to increase the no. of different pharmacophores represented within the library.  All of the fragments added to the library passed quality checks to ensure they were suitable for the screening protocol, with appropriate soly., purity, chem. stability, and unambiguous NMR spectrum.  The successive generations of libraries have been characterized through anal. of structural properties (mol. wt., lipophilicity, polar surface area, no. of rotatable bonds, and hydrogen-bonding potential) and by analyzing their pharmacophoric complexity.  These calcns. have been used to compare the fragment libraries with a drug-like ref. set of compds. and a set of mols. that bind to protein active sites.  In addn., an anal. of the overall results of screening the library against the ATP binding site of two protein targets (HSP90 and CDK2) reveals different patterns of fragment binding, demonstrating that the approach can find selective compds. that discriminate between related binding sites.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo652Eyyn5Lc7Vg90H21EOLACvtfcHk0lh5iDy_dWGQVQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXotlaru78%253D&md5=7376be270294dae6997609448513c5d7</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1021%2Fci049806z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci049806z%26sid%3Dliteratum%253Aachs%26aulast%3DBaurin%26aufirst%3DN.%26aulast%3DAboul-Ela%26aufirst%3DF.%26aulast%3DBarril%26aufirst%3DX.%26aulast%3DDavis%26aufirst%3DB.%26aulast%3DDrysdale%26aufirst%3DM.%26aulast%3DDymock%26aufirst%3DB.%26aulast%3DFinch%26aufirst%3DH.%26aulast%3DFromont%26aufirst%3DC.%26aulast%3DRichardson%26aufirst%3DC.%26aulast%3DSimmonite%26aufirst%3DH.%26aulast%3DHubbard%26aufirst%3DR.%2BE.%26atitle%3DDesign%2520and%2520characterization%2520of%2520libraries%2520of%2520molecular%2520fragments%2520for%2520use%2520in%2520NMR%2520screening%2520against%2520protein%2520targets%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Comput.%2520Sci.%26date%3D2004%26volume%3D44%26spage%3D2157%26epage%3D2166" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group">Huth, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petros, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kunzer, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wendt, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mack, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swift, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Judge, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richardson, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tahir, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matayoshi, E. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dorwin, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ladror, U. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Severin, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walter, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartley, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fesik, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elmore, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hajduk, P. J.</span><span> </span><span class="NLM_article-title">Discovery and design of novel HSP90 inhibitors using multiple fragment-based design strategies</span> <span class="citation_source-journal">Chem. Biol. Drug Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">12</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Fjm900357y&amp;key=10.1111%2Fj.1747-0285.2007.00535.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Fjm900357y&amp;key=17630989" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Fjm900357y&amp;key=1%3ACAS%3A528%3ADC%252BD2sXovFCktrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2007&pages=1-12&author=J.+R.+Huthauthor=C.+Parkauthor=A.+M.+Petrosauthor=A.+R.+Kunzerauthor=M.+D.+Wendtauthor=X.+Wangauthor=C.+L.+Lynchauthor=J.+C.+Mackauthor=K.+M.+Swiftauthor=R.+A.+Judgeauthor=J.+Chenauthor=P.+L.+Richardsonauthor=S.+Jinauthor=S.+K.+Tahirauthor=E.+D.+Matayoshiauthor=S.+A.+Dorwinauthor=U.+S.+Ladrorauthor=J.+M.+Severinauthor=K.+A.+Walterauthor=D.+M.+Bartleyauthor=S.+W.+Fesikauthor=S.+W.+Elmoreauthor=P.+J.+Hajduk&title=Discovery+and+design+of+novel+HSP90+inhibitors+using+multiple+fragment-based+design+strategies"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and design of novel HSP90 inhibitors using multiple fragment-based design strategies</span></div><div class="casAuthors">Huth, Jeffrey R.; Park, Chang; Petros, Andrew M.; Kunzer, Aaron R.; Wendt, Michael D.; Wang, Xilu; Lynch, Christopher L.; Mack, Jamey C.; Swift, Kerry M.; Judge, Russell A.; Chen, Jun; Richardson, Paul L.; Jin, Sha; Tahir, Stephen K.; Matayoshi, Edward D.; Dorwin, Sarah A.; Ladror, Uri S.; Severin, Jean M.; Walter, Karl A.; Bartley, Diane M.; Fesik, Stephen W.; Elmore, Steven W.; Hajduk, Philip J.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Biology & Drug Design</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-12</span>CODEN:
                <span class="NLM_cas:coden">CBDDAL</span>;
        ISSN:<span class="NLM_cas:issn">1747-0277</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">The mol. chaperone HSP90 has been shown to facilitate cancer cell survival by stabilizing key proteins responsible for a malignant phenotype.  The authors report here the results of parallel fragment-based drug design approaches in the design of novel HSP9O inhibitors.  Initial aminopyrimidine leads were elaborated using high-throughput org. synthesis to yield nanomolar inhibitors of the enzyme.  Second site leads were also identified which bound to HSP90 in two distinct conformations, an 'open' and 'closed' form.  Intriguingly, linked fragment approaches targeting both of these conformations were successful in producing novel, micromolar inhibitors.  Overall, this study shows that, with only a few fragment hits, multiple lead series can be generated for HSP90 due to the inherent flexibility of the active site.  Thus, ample opportunities exist to use these lead series in the development of clin. useful HSP90 inhibitors for the treatment of cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXkkVC5aQLFbVg90H21EOLACvtfcHk0lh5iDy_dWGQVQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXovFCktrY%253D&md5=ae1aa497320e997ae5c0971f7c9ab341</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1111%2Fj.1747-0285.2007.00535.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1747-0285.2007.00535.x%26sid%3Dliteratum%253Aachs%26aulast%3DHuth%26aufirst%3DJ.%2BR.%26aulast%3DPark%26aufirst%3DC.%26aulast%3DPetros%26aufirst%3DA.%2BM.%26aulast%3DKunzer%26aufirst%3DA.%2BR.%26aulast%3DWendt%26aufirst%3DM.%2BD.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DLynch%26aufirst%3DC.%2BL.%26aulast%3DMack%26aufirst%3DJ.%2BC.%26aulast%3DSwift%26aufirst%3DK.%2BM.%26aulast%3DJudge%26aufirst%3DR.%2BA.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DRichardson%26aufirst%3DP.%2BL.%26aulast%3DJin%26aufirst%3DS.%26aulast%3DTahir%26aufirst%3DS.%2BK.%26aulast%3DMatayoshi%26aufirst%3DE.%2BD.%26aulast%3DDorwin%26aufirst%3DS.%2BA.%26aulast%3DLadror%26aufirst%3DU.%2BS.%26aulast%3DSeverin%26aufirst%3DJ.%2BM.%26aulast%3DWalter%26aufirst%3DK.%2BA.%26aulast%3DBartley%26aufirst%3DD.%2BM.%26aulast%3DFesik%26aufirst%3DS.%2BW.%26aulast%3DElmore%26aufirst%3DS.%2BW.%26aulast%3DHajduk%26aufirst%3DP.%2BJ.%26atitle%3DDiscovery%2520and%2520design%2520of%2520novel%2520HSP90%2520inhibitors%2520using%2520multiple%2520fragment-based%2520design%2520strategies%26jtitle%3DChem.%2520Biol.%2520Drug%2520Des.%26date%3D2007%26volume%3D70%26spage%3D1%26epage%3D12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group">Barker, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barker, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boggio, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chauhan, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corden, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Courtney, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Falke, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fusar, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardiner, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamelin, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hesterkamp, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ichihara, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mather, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mercurio, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minucci, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montalbetti, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muller, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phillips, B. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varessi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whittaker, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winkler, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yarnold, C. J.</span><span> </span><span class="NLM_article-title">Fragment-Based Identification of Hsp90 Inhibitors</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">963</span><span class="NLM_x">–</span> <span class="NLM_lpage">966</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Fjm900357y&amp;key=10.1002%2Fcmdc.200900011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Fjm900357y&amp;key=19301319" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Fjm900357y&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmslChtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2009&pages=963-966&author=J.+J.+Barkerauthor=O.+Barkerauthor=R.+Boggioauthor=V.+Chauhanauthor=R.+K.+Chengauthor=V.+Cordenauthor=S.+M.+Courtneyauthor=N.+Edwardsauthor=V.+M.+Falkeauthor=F.+Fusarauthor=M.+Gardinerauthor=E.+M.+Hamelinauthor=T.+Hesterkampauthor=O.+Ichiharaauthor=R.+S.+Jonesauthor=O.+Matherauthor=C.+Mercurioauthor=S.+Minucciauthor=C.+A.+Montalbettiauthor=A.+Mullerauthor=D.+Patelauthor=B.+G.+Phillipsauthor=M.+Varessiauthor=M.+Whittakerauthor=D.+Winklerauthor=C.+J.+Yarnold&title=Fragment-Based+Identification+of+Hsp90+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Fragment-based Identification of Hsp90 Inhibitors</span></div><div class="casAuthors">Barker, John J.; Barker, Oliver; Boggio, Roberto; Chauhan, Viddhata; Cheng, Robert K. Y.; Corden, Vincent; Courtney, Stephen M.; Edwards, Neil; Falque, Virginie M.; Fusar, Fulvia; Gardiner, Mihaly; Hamelin, Estelle M. N.; Hesterkamp, Thomas; Ichihara, Osamu; Jones, Richard S.; Mather, Owen; Mercurio, Ciro; Minucci, Saverio; Montalbetti, Christian A. G. N.; Muller, Annett; Patel, Deepti; Phillips, Banu G.; Varasi, Mario; Whittaker, Mark; Winkler, Dirk; Yarnold, Christopher J.</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">963-966</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Heat shock protein 90 (Hsp90) plays a key role in stress response and protection of the cell against the effects of mutation.  Herein we report the identification of an Hsp90 inhibitor identified by fragment screening using a high-concn. biochem. assay, as well as its optimization by in silico searching coupled with a structure-based drug design (SBDD) approach.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsaGeZbmBYH7Vg90H21EOLACvtfcHk0lj2pwWxAmsv2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmslChtbk%253D&md5=c44357e5d1b341c6bc540798951a687f</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.200900011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.200900011%26sid%3Dliteratum%253Aachs%26aulast%3DBarker%26aufirst%3DJ.%2BJ.%26aulast%3DBarker%26aufirst%3DO.%26aulast%3DBoggio%26aufirst%3DR.%26aulast%3DChauhan%26aufirst%3DV.%26aulast%3DCheng%26aufirst%3DR.%2BK.%26aulast%3DCorden%26aufirst%3DV.%26aulast%3DCourtney%26aufirst%3DS.%2BM.%26aulast%3DEdwards%26aufirst%3DN.%26aulast%3DFalke%26aufirst%3DV.%2BM.%26aulast%3DFusar%26aufirst%3DF.%26aulast%3DGardiner%26aufirst%3DM.%26aulast%3DHamelin%26aufirst%3DE.%2BM.%26aulast%3DHesterkamp%26aufirst%3DT.%26aulast%3DIchihara%26aufirst%3DO.%26aulast%3DJones%26aufirst%3DR.%2BS.%26aulast%3DMather%26aufirst%3DO.%26aulast%3DMercurio%26aufirst%3DC.%26aulast%3DMinucci%26aufirst%3DS.%26aulast%3DMontalbetti%26aufirst%3DC.%2BA.%26aulast%3DMuller%26aufirst%3DA.%26aulast%3DPatel%26aufirst%3DD.%26aulast%3DPhillips%26aufirst%3DB.%2BG.%26aulast%3DVaressi%26aufirst%3DM.%26aulast%3DWhittaker%26aufirst%3DM.%26aulast%3DWinkler%26aufirst%3DD.%26aulast%3DYarnold%26aufirst%3DC.%2BJ.%26atitle%3DFragment-Based%2520Identification%2520of%2520Hsp90%2520Inhibitors%26jtitle%3DChemMedChem%26date%3D2009%26volume%3D4%26spage%3D963%26epage%3D966" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group">Barril, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brough, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drysdale, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hubbard, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Massey, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Surgenor, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, L.</span><span> </span><span class="NLM_article-title">Structure-based discovery of a new class of Hsp90 inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">5187</span><span class="NLM_x">–</span> <span class="NLM_lpage">5191</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=5187-5191&author=X.+Barrilauthor=P.+Broughauthor=M.+Drysdaleauthor=R.+E.+Hubbardauthor=A.+Masseyauthor=A.+Surgenorauthor=L.+Wright&title=Structure-based+discovery+of+a+new+class+of+Hsp90+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBarril%26aufirst%3DX.%26aulast%3DBrough%26aufirst%3DP.%26aulast%3DDrysdale%26aufirst%3DM.%26aulast%3DHubbard%26aufirst%3DR.%2BE.%26aulast%3DMassey%26aufirst%3DA.%26aulast%3DSurgenor%26aufirst%3DA.%26aulast%3DWright%26aufirst%3DL.%26atitle%3DStructure-based%2520discovery%2520of%2520a%2520new%2520class%2520of%2520Hsp90%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D5187%26epage%3D5191" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group">Knox, A. J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Price, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pawlak, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golfis, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flood, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fayne, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meegan, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lloyd, D. G.</span><span> </span><span class="NLM_article-title">Integration of Ligand and Structure-Based Virtual Screening for the Identification of the First Dual Targeting Agent for Heat Shock Protein 90 (Hsp90) and Tubulin</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">2177</span><span class="NLM_x">–</span> <span class="NLM_lpage">2180</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm801569z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Fjm900357y&amp;key=1%3ACAS%3A528%3ADC%252BD1MXktFGrt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=2177-2180&author=A.+J.+S.+Knoxauthor=T.+Priceauthor=M.+Pawlakauthor=G.+Golfisauthor=C.+T.+Floodauthor=D.+Fayneauthor=D.+C.+Williamsauthor=M.+J.+Meeganauthor=D.+G.+Lloyd&title=Integration+of+Ligand+and+Structure-Based+Virtual+Screening+for+the+Identification+of+the+First+Dual+Targeting+Agent+for+Heat+Shock+Protein+90+%28Hsp90%29+and+Tubulin"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Integration of Ligand and Structure-Based Virtual Screening for the Identification of the First Dual Targeting Agent for Heat Shock Protein 90 (Hsp90) and Tubulin</span></div><div class="casAuthors">Knox, Andrew J. S.; Price, Trevor; Pawlak, Michal; Golfis, Georgia; Flood, Christopher T.; Fayne, Darren; Williams, D. Clive; Meegan, Mary J.; Lloyd, David G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2177-2180</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We describe the discovery of a novel indazole-based scaffold that represents the "first-in-class" dual Hsp90/tubulin binding compd.  Individual known ligands for both targets shared similar 3',4',5'-trimethoxyphenyl cores, and from this it was hypothesized that application of an integrated ligand and structure-based virtual screening (VS) workflow could yield a single scaffold with dual binding affinity.  Following validation of the VS protocol, we successfully identified a novel dual inhibitor, sourced from a com. screening collection of 160 000 compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrRptEHjoTCsLVg90H21EOLACvtfcHk0lj2pwWxAmsv2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXktFGrt70%253D&md5=c8268f36a0da627404be37696c5afe4b</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1021%2Fjm801569z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm801569z%26sid%3Dliteratum%253Aachs%26aulast%3DKnox%26aufirst%3DA.%2BJ.%2BS.%26aulast%3DPrice%26aufirst%3DT.%26aulast%3DPawlak%26aufirst%3DM.%26aulast%3DGolfis%26aufirst%3DG.%26aulast%3DFlood%26aufirst%3DC.%2BT.%26aulast%3DFayne%26aufirst%3DD.%26aulast%3DWilliams%26aufirst%3DD.%2BC.%26aulast%3DMeegan%26aufirst%3DM.%2BJ.%26aulast%3DLloyd%26aufirst%3DD.%2BG.%26atitle%3DIntegration%2520of%2520Ligand%2520and%2520Structure-Based%2520Virtual%2520Screening%2520for%2520the%2520Identification%2520of%2520the%2520First%2520Dual%2520Targeting%2520Agent%2520for%2520Heat%2520Shock%2520Protein%252090%2520%2528Hsp90%2529%2520and%2520Tubulin%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D2177%26epage%3D2180" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">71</a></strong><div class="NLM_citation" id="rightTab-cit71"><span><span class="NLM_contrib-group">Barril, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hubbard, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morley, S. D.</span><span> </span><span class="NLM_article-title">Virtual screening in structure-based drug discovery</span> <span class="citation_source-journal">Mini. Rev. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">779</span><span class="NLM_x">–</span> <span class="NLM_lpage">791</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Fjm900357y&amp;key=15379645" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Fjm900357y&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmslajsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2004&pages=779-791&author=X.+Barrilauthor=R.+E.+Hubbardauthor=S.+D.+Morley&title=Virtual+screening+in+structure-based+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Virtual screening in structure-based drug discovery</span></div><div class="casAuthors">Barril, X.; Hubbard, R. E.; Morley, S. D.</div><div class="citationInfo"><span class="NLM_cas:title">Mini-Reviews in Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">779-791</span>CODEN:
                <span class="NLM_cas:coden">MMCIAE</span>;
        ISSN:<span class="NLM_cas:issn">1389-5575</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Recent advances in structure detn. and computational methods have encouraged the development of structure-based virtual screening.  Here we survey progress in the field and review the most recent methods, validation expts. and real applications, including an inhouse example of hit identification for the oncol. target Hsp90.  These results provide a basis for discussing the current state of structure-based virtual screening and to outline the developments that are expected to have a major impact in the near future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoy7o9-h9rF3bVg90H21EOLACvtfcHk0lgBUu0ambPHvQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmslajsbo%253D&md5=2625c1aec0337bcc67d6b62dd9b8a737</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBarril%26aufirst%3DX.%26aulast%3DHubbard%26aufirst%3DR.%2BE.%26aulast%3DMorley%26aufirst%3DS.%2BD.%26atitle%3DVirtual%2520screening%2520in%2520structure-based%2520drug%2520discovery%26jtitle%3DMini.%2520Rev.%2520Med.%2520Chem.%26date%3D2004%26volume%3D4%26spage%3D779%26epage%3D791" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref72"><div class="reference"><strong class="refLabel"><a href="#ref72" class="rightTabRefNumLink">72</a></strong><div class="NLM_citation" id="rightTab-cit72"><span><span class="NLM_contrib-group">Wright, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barril, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dymock, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheridan, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Surgenor, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beswick, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drysdale, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collier, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Massey, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fink, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fromont, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aherne, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boxall, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharp, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Workman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hubbard, R. E.</span><span> </span><span class="NLM_article-title">Structure−activity relationships in purine-based inhibitor binding to HSP90 isoforms</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">775</span><span class="NLM_x">–</span> <span class="NLM_lpage">785</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Fjm900357y&amp;key=10.1016%2Fj.chembiol.2004.03.033" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Fjm900357y&amp;key=15217611" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Fjm900357y&amp;key=1%3ACAS%3A528%3ADC%252BD2cXlt1Sjsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2004&pages=775-785&author=L.+Wrightauthor=X.+Barrilauthor=B.+Dymockauthor=L.+Sheridanauthor=A.+Surgenorauthor=M.+Beswickauthor=M.+Drysdaleauthor=A.+Collierauthor=A.+Masseyauthor=N.+Daviesauthor=A.+Finkauthor=C.+Fromontauthor=W.+Aherneauthor=K.+Boxallauthor=S.+Sharpauthor=P.+Workmanauthor=R.+E.+Hubbard&title=Structure%E2%88%92activity+relationships+in+purine-based+inhibitor+binding+to+HSP90+isoforms"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Activity Relationships in Purine-Based Inhibitor Binding to HSP90 Isoforms</span></div><div class="casAuthors">Wright, Lisa; Barril, Xavier; Dymock, Brian; Sheridan, Louisa; Surgenor, Allan; Beswick, Mandy; Drysdale, Martin; Collier, Adam; Massey, Andy; Davies, Nick; Fink, Alex; Fromont, Christophe; Aherne, Wynne; Boxall, Kathy; Sharp, Swee; Workman, Paul; Hubbard, Roderick E.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">775-785</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Inhibition of the ATPase activity of the chaperone protein HSP90 is a potential strategy for treatment of cancers.  We have detd. structures of the HSP90α N-terminal domain complexed with the purine-based inhibitor, PU3, and analogs with enhanced potency both in enzyme and cell-based assays.  The compds. induce upregulation of HSP70 and downregulation of the known HSP90 client proteins Raf-1, CDK4, and ErbB2, confirming that the mols. inhibit cell growth by a mechanism dependent on HSP90 inhibition.  We have also detd. the first structure of the N-terminal domain of HSP90β, complexed with PU3.  The structures allow a detailed rationale to be developed for the obsd. affinity of the PU3 class of compds. for HSP90 and also provide a structural framework for design of compds. with improved binding affinity and drug-like properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2Z11Wd4hiXrVg90H21EOLACvtfcHk0lgBUu0ambPHvQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXlt1Sjsrs%253D&md5=dd2146dba0f4b3198d5bc7023e645812</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2004.03.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2004.03.033%26sid%3Dliteratum%253Aachs%26aulast%3DWright%26aufirst%3DL.%26aulast%3DBarril%26aufirst%3DX.%26aulast%3DDymock%26aufirst%3DB.%26aulast%3DSheridan%26aufirst%3DL.%26aulast%3DSurgenor%26aufirst%3DA.%26aulast%3DBeswick%26aufirst%3DM.%26aulast%3DDrysdale%26aufirst%3DM.%26aulast%3DCollier%26aufirst%3DA.%26aulast%3DMassey%26aufirst%3DA.%26aulast%3DDavies%26aufirst%3DN.%26aulast%3DFink%26aufirst%3DA.%26aulast%3DFromont%26aufirst%3DC.%26aulast%3DAherne%26aufirst%3DW.%26aulast%3DBoxall%26aufirst%3DK.%26aulast%3DSharp%26aufirst%3DS.%26aulast%3DWorkman%26aufirst%3DP.%26aulast%3DHubbard%26aufirst%3DR.%2BE.%26atitle%3DStructure%25E2%2588%2592activity%2520relationships%2520in%2520purine-based%2520inhibitor%2520binding%2520to%2520HSP90%2520isoforms%26jtitle%3DChem.%2520Biol.%26date%3D2004%26volume%3D11%26spage%3D775%26epage%3D785" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref73"><div class="reference"><strong class="refLabel"><a href="#ref73" class="rightTabRefNumLink">73</a></strong><div class="NLM_citation" id="rightTab-cit73"><span><span class="NLM_contrib-group">Baurin, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richardson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foloppe, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jordan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roughley, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parratt, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greaney, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morley, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hubbard, R. E.</span><span> </span><span class="NLM_article-title">Drug-like annotation and duplicate analysis of a 23-supplier chemical database totalling 2.7 million compounds</span> <span class="citation_source-journal">J. Chem. Inf. Comput. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">643</span><span class="NLM_x">–</span> <span class="NLM_lpage">651</span></span><div class="citationLinks">[<a href="/doi/10.1021/ci034260m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Fjm900357y&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVGhs7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2004&pages=643-651&author=N.+Baurinauthor=R.+Bakerauthor=C.+Richardsonauthor=I.+Chenauthor=N.+Foloppeauthor=A.+Potterauthor=A.+Jordanauthor=S.+Roughleyauthor=M.+Parrattauthor=P.+Greaneyauthor=D.+Morleyauthor=R.+E.+Hubbard&title=Drug-like+annotation+and+duplicate+analysis+of+a+23-supplier+chemical+database+totalling+2.7+million+compounds"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">Drug-like Annotation and Duplicate Analysis of a 23-Supplier Chemical Database Totaling 2.7 Million Compounds</span></div><div class="casAuthors">Baurin, N.; Baker, R.; Richardson, C.; Chen, I.; Foloppe, N.; Potter, A.; Jordan, A.; Roughley, S.; Parratt, M.; Greaney, P.; Morley, D.; Hubbard, R. E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Computer Sciences</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">643-651</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">0095-2338</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We have implemented five drug-like filters, based on 1D and 2D mol. descriptors, and applied them to characterize the drug-like properties of com. available chem. compds.  In addn. to previously published filters (Lipinski and Veber), we implemented a filter for medicinal chem. tractability based on lists of chem. features drawn up by a panel of medicinal chemists.  A filter based on the modeling of aq. soly. (> 1 μM) was derived inhouse, as well as another based on the modeling of Caco-2 passive membrane permeability (> 10 nm/s).  A library of 2.7 million compds. was collated from the 23 compd. suppliers and analyzed with these filters, highlighting a tendency toward highly lipophilic compds.  The library contains 1.6M unique structures, of which 37% (607 223) passed all five drug-like filters.  None of the 23 suppliers provides all the members of the drug-like subset, emphasizing the benefit of considering compds. from various compd. suppliers as a source of diversity for drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVcetJEknX-bVg90H21EOLACvtfcHk0lgBUu0ambPHvQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVGhs7w%253D&md5=b038e9e8d97a6d62da3b6fe426570646</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1021%2Fci034260m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci034260m%26sid%3Dliteratum%253Aachs%26aulast%3DBaurin%26aufirst%3DN.%26aulast%3DBaker%26aufirst%3DR.%26aulast%3DRichardson%26aufirst%3DC.%26aulast%3DChen%26aufirst%3DI.%26aulast%3DFoloppe%26aufirst%3DN.%26aulast%3DPotter%26aufirst%3DA.%26aulast%3DJordan%26aufirst%3DA.%26aulast%3DRoughley%26aufirst%3DS.%26aulast%3DParratt%26aufirst%3DM.%26aulast%3DGreaney%26aufirst%3DP.%26aulast%3DMorley%26aufirst%3DD.%26aulast%3DHubbard%26aufirst%3DR.%2BE.%26atitle%3DDrug-like%2520annotation%2520and%2520duplicate%2520analysis%2520of%2520a%252023-supplier%2520chemical%2520database%2520totalling%25202.7%2520million%2520compounds%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Comput.%2520Sci.%26date%3D2004%26volume%3D44%26spage%3D643%26epage%3D651" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref74"><div class="reference"><strong class="refLabel"><a href="#ref74" class="rightTabRefNumLink">74</a></strong><div class="NLM_citation" id="rightTab-cit74"><span><span class="NLM_contrib-group">Howes, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barril, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dymock, B. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grant, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Northfield, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robertson, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Surgenor, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wayne, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">James, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matthews, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheung, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonald, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Workman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drysdale, M. J.</span><span> </span><span class="NLM_article-title">A fluorescence polarization assay for inhibitors of Hsp90</span> <span class="citation_source-journal">Anal. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">350</span><span class="NLM_x">, </span> <span class="NLM_fpage">202</span><span class="NLM_x">–</span> <span class="NLM_lpage">213</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=350&publication_year=2006&pages=202-213&author=R.+Howesauthor=X.+Barrilauthor=B.+W.+Dymockauthor=K.+Grantauthor=C.+J.+Northfieldauthor=A.+G.+Robertsonauthor=A.+Surgenorauthor=J.+Wayneauthor=L.+Wrightauthor=K.+Jamesauthor=T.+Matthewsauthor=K.+M.+Cheungauthor=E.+McDonaldauthor=P.+Workmanauthor=M.+J.+Drysdale&title=A+fluorescence+polarization+assay+for+inhibitors+of+Hsp90"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHowes%26aufirst%3DR.%26aulast%3DBarril%26aufirst%3DX.%26aulast%3DDymock%26aufirst%3DB.%2BW.%26aulast%3DGrant%26aufirst%3DK.%26aulast%3DNorthfield%26aufirst%3DC.%2BJ.%26aulast%3DRobertson%26aufirst%3DA.%2BG.%26aulast%3DSurgenor%26aufirst%3DA.%26aulast%3DWayne%26aufirst%3DJ.%26aulast%3DWright%26aufirst%3DL.%26aulast%3DJames%26aufirst%3DK.%26aulast%3DMatthews%26aufirst%3DT.%26aulast%3DCheung%26aufirst%3DK.%2BM.%26aulast%3DMcDonald%26aufirst%3DE.%26aulast%3DWorkman%26aufirst%3DP.%26aulast%3DDrysdale%26aufirst%3DM.%2BJ.%26atitle%3DA%2520fluorescence%2520polarization%2520assay%2520for%2520inhibitors%2520of%2520Hsp90%26jtitle%3DAnal.%2520Biochem.%26date%3D2006%26volume%3D350%26spage%3D202%26epage%3D213" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref75"><div class="reference"><strong class="refLabel"><a href="#ref75" class="rightTabRefNumLink">75</a></strong><div class="NLM_citation" id="rightTab-cit75"><span><span class="NLM_contrib-group">Wittenbrook, L. S.</span><span> </span><span class="NLM_article-title">Chemistry of <i>N</i>-cyanodithioimidocarbonic acid. III. Intermediate in heterocyclic synthesis</span> <span class="citation_source-journal">J. Heterocycl. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1975</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">37</span><span class="NLM_x">–</span> <span class="NLM_lpage">42</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=1975&pages=37-42&author=L.+S.+Wittenbrook&title=Chemistry+of+N-cyanodithioimidocarbonic+acid.+III.+Intermediate+in+heterocyclic+synthesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWittenbrook%26aufirst%3DL.%2BS.%26atitle%3DChemistry%2520of%2520N-cyanodithioimidocarbonic%2520acid.%2520III.%2520Intermediate%2520in%2520heterocyclic%2520synthesis%26jtitle%3DJ.%2520Heterocycl.%2520Chem.%26date%3D1975%26volume%3D12%26spage%3D37%26epage%3D42" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref76"><div class="reference"><strong class="refLabel"><a href="#ref76" class="rightTabRefNumLink">76</a></strong><div class="NLM_citation" id="rightTab-cit76"><span><span class="NLM_contrib-group">Clark, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shahhet, M. S.</span><span> </span><span class="NLM_article-title">Synthesis of thieno[2,3-<i>d</i>]pyrimidines from 4,6-dichloropyrimidine-5-carboxaldehydes</span> <span class="citation_source-journal">J. Heterocycl. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">1065</span><span class="NLM_x">–</span> <span class="NLM_lpage">1072</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=1993&pages=1065-1072&author=J.+Clarkauthor=M.+S.+Shahhet&title=Synthesis+of+thieno%5B2%2C3-d%5Dpyrimidines+from+4%2C6-dichloropyrimidine-5-carboxaldehydes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DClark%26aufirst%3DJ.%26aulast%3DShahhet%26aufirst%3DM.%2BS.%26atitle%3DSynthesis%2520of%2520thieno%255B2%252C3-d%255Dpyrimidines%2520from%25204%252C6-dichloropyrimidine-5-carboxaldehydes%26jtitle%3DJ.%2520Heterocycl.%2520Chem.%26date%3D1993%26volume%3D30%26spage%3D1065%26epage%3D1072" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref77"><div class="reference"><strong class="refLabel"><a href="#ref77" class="rightTabRefNumLink">77</a></strong><div class="NLM_citation" id="rightTab-cit77"><span><span class="NLM_contrib-group">Miyaura, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, H.</span><span> </span><span class="NLM_article-title">Palladium-Catalyzed Cross-Coupling Reactions of Organoboron Compounds</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">95</span><span class="NLM_x">, </span> <span class="NLM_fpage">2457</span><span class="NLM_x">–</span> <span class="NLM_lpage">2483</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=2005&pages=2457-2483&author=N.+Miyauraauthor=H.+Suzuki&title=Palladium-Catalyzed+Cross-Coupling+Reactions+of+Organoboron+Compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMiyaura%26aufirst%3DN.%26aulast%3DSuzuki%26aufirst%3DH.%26atitle%3DPalladium-Catalyzed%2520Cross-Coupling%2520Reactions%2520of%2520Organoboron%2520Compounds%26jtitle%3DChem.%2520Rev.%26date%3D2005%26volume%3D95%26spage%3D2457%26epage%3D2483" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref78"><div class="reference"><strong class="refLabel"><a href="#ref78" class="rightTabRefNumLink">78</a></strong><div class="NLM_citation" id="rightTab-cit78"><span><span class="NLM_contrib-group">Zhu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duquette, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, M.</span><span> </span><span class="NLM_article-title">An Improved Preparation of Arylboronates: Application in One-Pot Suzuki Biaryl Synthesis</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">3729</span><span class="NLM_x">–</span> <span class="NLM_lpage">3732</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo0269114" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2003&pages=3729-3732&author=L.+Zhuauthor=J.+Duquetteauthor=M.+Zhang&title=An+Improved+Preparation+of+Arylboronates%3A+Application+in+One-Pot+Suzuki+Biaryl+Synthesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1021%2Fjo0269114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo0269114%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DL.%26aulast%3DDuquette%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DM.%26atitle%3DAn%2520Improved%2520Preparation%2520of%2520Arylboronates%253A%2520Application%2520in%2520One-Pot%2520Suzuki%2520Biaryl%2520Synthesis%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2003%26volume%3D68%26spage%3D3729%26epage%3D3732" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref79"><div class="reference"><strong class="refLabel"><a href="#ref79" class="rightTabRefNumLink">79</a></strong><div class="NLM_citation" id="rightTab-cit79"><span><span class="NLM_contrib-group">Hughes, D. L.</span><span> </span><span class="NLM_article-title">The Mitsunobu Reaction</span> <span class="citation_source-journal">Org. React.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">335</span><span class="NLM_x">–</span> <span class="NLM_lpage">656</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Fjm900357y&amp;key=10.1002%2F0471264180.or042.02" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Fjm900357y&amp;key=1%3ACAS%3A528%3ADyaK2cXkvVajtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1992&pages=335-656&author=D.+L.+Hughes&title=The+Mitsunobu+Reaction"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">The Mitsunobu reaction</span></div><div class="casAuthors">Hughes, David L.</div><div class="citationInfo"><span class="NLM_cas:title">Organic Reactions (New York)</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">335-656</span>CODEN:
                <span class="NLM_cas:coden">ORREAW</span>;
        ISSN:<span class="NLM_cas:issn">0078-6179</span>.
    </div><div class="casAbstract">A review with 887 refs., mainly covering the di-Et azodicarboxylate/triphenylphosphine redox system with emphasis on the literature between 1981 and 1988.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKenjnWCm_GLVg90H21EOLACvtfcHk0lixwrGyASPj5Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXkvVajtb4%253D&md5=b863281e19bd0a84a975ba0824dbf42a</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1002%2F0471264180.or042.02&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F0471264180.or042.02%26sid%3Dliteratum%253Aachs%26aulast%3DHughes%26aufirst%3DD.%2BL.%26atitle%3DThe%2520Mitsunobu%2520Reaction%26jtitle%3DOrg.%2520React.%26date%3D1992%26volume%3D42%26spage%3D335%26epage%3D656" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref80"><div class="reference"><strong class="refLabel"><a href="#ref80" class="rightTabRefNumLink">80</a></strong><div class="note"><p class="first last">PDB codes: compound <b>10</b> (cocrystal) = <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2WI2">2WI2</a>, <b>10</b> (soak) = <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2WI3">2WI3</a>, <b>11</b> = <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2WI1">2WI1</a>, <b>12</b> = <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2WI4">2WI4</a>, <b>13</b> = <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2WI5">2WI5</a>, <b>21e</b> = <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2WI6">2WI6</a>, and <b>34d</b> = <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2WI7">2WI7</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref81"><div class="reference"><strong class="refLabel"><a href="#ref81" class="rightTabRefNumLink">81</a></strong><div class="NLM_citation" id="rightTab-cit81a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Dymock, B. W.; Drysdale, M. J.; Fromont, C.; Jordan, A.; Barril-Alonso, X.</span><span> </span><span class="NLM_article-title">Preparation of pyrimidothiophenes as HSP90 inhibitors</span>. PCT Int. Appl. WO200500521552,<span class="NLM_x"> </span><span class="NLM_year">2005</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&author=B.+W.+Dymock&author=M.+J.+Drysdale&author=C.+Fromont&author=A.+Jordan&author=X.+Barril-Alonso&title=Preparation+of+pyrimidothiophenes+as+HSP90+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit81a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DDymock%26aufirst%3DB.%2BW.%26atitle%3DPreparation%2520of%2520pyrimidothiophenes%2520as%2520HSP90%2520inhibitors%26date%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit81b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Brough, P. A.; Barril-Alonso, X.; Drysdale, M. J.</span><span> </span><span class="NLM_article-title">Preparation of pyrimidithiophene derivatives for use as HSP90 inhibitors</span>. PCT International Application WO2006090094,<span class="NLM_x"> </span><span class="NLM_year">2006</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&author=P.+A.+Brough&author=X.+Barril-Alonso&author=M.+J.+Drysdale&title=Preparation+of+pyrimidithiophene+derivatives+for+use+as+HSP90+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit81b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBrough%26aufirst%3DP.%2BA.%26atitle%3DPreparation%2520of%2520pyrimidithiophene%2520derivatives%2520for%2520use%2520as%2520HSP90%2520inhibitors%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref82"><div class="reference"><strong class="refLabel"><a href="#ref82" class="rightTabRefNumLink">82</a></strong><div class="NLM_citation" id="rightTab-cit82"><span><span class="NLM_contrib-group">Workman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Twentyman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balkwill, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balmain, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaplin, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Double, J.</span><span> </span><span class="NLM_article-title">United Kingdom Coordinating Committee on Cancer Research guidelines for the welfare of animals in experimental neoplasia, 2nd Ed</span> <span class="citation_source-journal">Br. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">77</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">10</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Fjm900357y&amp;key=10.1038%2Fbjc.1998.1" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=1998&pages=1-10&author=P.+Workmanauthor=P.+Twentymanauthor=F.+Balkwillauthor=A.+Balmainauthor=C.+Chaplinauthor=J.+Double&title=United+Kingdom+Coordinating+Committee+on+Cancer+Research+guidelines+for+the+welfare+of+animals+in+experimental+neoplasia%2C+2nd+Ed"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1038%2Fbjc.1998.1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fbjc.1998.1%26sid%3Dliteratum%253Aachs%26aulast%3DWorkman%26aufirst%3DP.%26aulast%3DTwentyman%26aufirst%3DP.%26aulast%3DBalkwill%26aufirst%3DF.%26aulast%3DBalmain%26aufirst%3DA.%26aulast%3DChaplin%26aufirst%3DC.%26aulast%3DDouble%26aufirst%3DJ.%26atitle%3DUnited%2520Kingdom%2520Coordinating%2520Committee%2520on%2520Cancer%2520Research%2520guidelines%2520for%2520the%2520welfare%2520of%2520animals%2520in%2520experimental%2520neoplasia%252C%25202nd%2520Ed%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D1998%26volume%3D77%26spage%3D1%26epage%3D10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1YET" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1YET','PDB','1YET'); return false;">PDB: 1YET</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1UY6" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1UY6','PDB','1UY6'); return false;">PDB: 1UY6</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2WI6" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2WI6','PDB','2WI6'); return false;">PDB: 2WI6</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2VCI" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2VCI','PDB','2VCI'); return false;">PDB: 2VCI</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2WI7" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2WI7','PDB','2WI7'); return false;">PDB: 2WI7</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2WI2" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2WI2','PDB','2WI2'); return false;">PDB: 2WI2</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2WI3" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2WI3','PDB','2WI3'); return false;">PDB: 2WI3</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2WI1" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2WI1','PDB','2WI1'); return false;">PDB: 2WI1</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2WI4" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2WI4','PDB','2WI4'); return false;">PDB: 2WI4</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2WI5" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2WI5','PDB','2WI5'); return false;">PDB: 2WI5</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i54"><a href="/doi/suppl/10.1021/jm900357y">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_72685"></div></div></div></div></div><hr /></hr><p class="last">Data relating to the PC3 human prostate cancer xenograft model for compound <b>34a</b>; experimental procedures for the FP assay and synthesis of the FP assay probe and methods and parameters relating to X-ray crystallography and protein production; full chemistry experimental procedures and characterization data; methods for analytical and preparative HPLC; commercial sources for fragment and in silico screening hits; protocols relating to the 1D NMR screening of fragments; description of the process applied for the in silico screening campaign. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm900357y/suppl_file/jm900357y_si_001.pdf">jm900357y_si_001.pdf (374.63 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm900357y&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Barticle%3Aarticle%3A10.1021%2Fjm900357y%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2009.52.issue-15%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm900357y" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                4MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679901c629093db2","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
